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Electrocardiograms have become one of the most important, and widely used medical 
tools for diagnosing diseases such as cardiac arrhythmias, conduction disorders, 
electrolyte imbalances, hypertension, coronary artery disease and myocardial infarction. 
This book reviews recent advancements in electrocardiography. The four sections of 
this volume, Cardiac Arrhythmias, Myocardial Infarction, Autonomic Dysregulation 
and Cardiotoxicology, provide comprehensive reviews of advancements in the clinical 
applications of electrocardiograms. This book is replete with diagrams, recordings, flow 
diagrams and algorithms which demonstrate the possible future direction for applying 
electrocardiography to evaluating the development and progression of cardiac diseases. 
The chapters in this book describe a number of unique features of electrocardiograms in 
adult and pediatric patient populations with predilections for cardiac arrhythmias and 
other electrical abnormalities associated with hypertension, coronary artery disease, 
myocardial infarction, sleep apnea syndromes, pericarditides, cardiomyopathies and 
cardiotoxicities, as well as innovative interpretations of electrocardiograms during 
exercise testing and electrical pacing.
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Preface 
A number of heart diseases in humans are rooted in the structure-function 
relationships of the lower animal hearts. These relations are observable during human 
embryonic organogenesis. The hearts of invertebrates and lower vertebrates are 
similar to the embryonic tubular hearts of higher vertebrates. These primitive ancestral
hearts possess cardiac myocytes that are electrically coupled by gap junctions such as 
those in mammalian and human hearts. The highest pacemaker activity occurs at the
receiving end of the primitive ancestral heart, thereby, resulting in waves of peristaltic 
contractions similar to those in gastrointestinal tracts. This tubular arrangement gives 
rise to atrial and ventricular chambers with well-developed and well-coupled cardiac
myocytes with low pacemaker activity, producing the rapid conduction and 
contraction of mammalian and human hearts. The forming chambers are made up of
rapidly proliferating myocytes with a surrounding area of slowly proliferating
trabecular myocardium. This slowly proliferating trabecular myocardium does not 
differentiate into normal myocardium of the heart chambers because it remains poorly
developed. The tightly coupled electrically by highly organized gap junctions and
intercalated discs give rise to the ventricular conduction system. Thus, the human 
ventricular conduction system arises from the embryonic myocardium, and permits
rapid conduction of cardiac excitation, and subsequent contraction of the pumping 
chambers of the heart. 
In contrast, to vertebrates, many invertebrates lack an autonomic nervous system for
organizing cardiac signaling and insuring responsiveness to a wide variety of complex
physiological stimuli. In lower vertebrates, the vagus nerve arises from the brain as a
cranial nerve and innervates the pacemaker cells of the heart. When stimulated, the
vagus slows the rate at which the cardiac phases of depolarization and repolarization 
are produced. In higher vertebrates with well- developed heart chambers, specialized
for receiving (atria) and pumping (ventricles), the atrial pacemaker cells are innervated 
by vagal parasympathetic, as well as by sympathetic nerve fibers. This arrangement
appears to subserve sophisticated tuning of the heart rate, and pumping activity
(contractility) to immediate changes in the physiological state of the animal, insuring
adequate flow of nutrients to the various tissue compartments, especially to the
complex brains and other vital organs of mammals. In mammals, vagal innervation of 
pacemaker cells in the sinoatrial node appears to arise from two main sources, the
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dorsal vagal nucleus in the dorsal brainstem and the nucleus ambiguous in the ventral 
brainstem. The vagal fibers from the dorsal vagal nucleus appear to be driven mainly 
by baroreceptor and other cardiovascular inputs. The signaling of these vagal fibers 
produces variability in the rate of sinoatrial node depolarization associated mainly 
with changes in blood pressure. The vagal fibers,which arise from the nucleus 
ambiguous, appear to be driven mainly by respiratory inputs and produces variability 
in the rate of the sinus node depolarization - known as heart rate variability or 
respiratory sinus arrhythmia. 
The measurement and analysis of heart rate variability has been introduced trough 
Advances in Electrocardiogram - Methods and Analysis. In the present book, Advances in 
Electrocardiograms - Clinical Applications, the reader will be presented with clinical 
applications of heart rate variability, as well as a wide range of pathophysiological 
conditions associated with abnormal electrocardiograms. From electrolyte disturbances 
to toxic exposures; from hypertension and myocardial infarction to cardiomyopathies; 
from sleep apneas to heart failures. Being mindful that the roots of many 
electrocardiographic abnormalities develop during embryonic organogenesis of the 
heart, will lead to improved recognition, diagnosis and treatment of cardiac diseases. 
 
Richard M. Millis, PhD 
Editor 
Dept. of Physiology & Biophysics 





dorsal vagal nucleus in the dorsal brainstem and the nucleus ambiguous in the ventral 
brainstem. The vagal fibers from the dorsal vagal nucleus appear to be driven mainly 
by baroreceptor and other cardiovascular inputs. The signaling of these vagal fibers 
produces variability in the rate of sinoatrial node depolarization associated mainly 
with changes in blood pressure. The vagal fibers,which arise from the nucleus 
ambiguous, appear to be driven mainly by respiratory inputs and produces variability 
in the rate of the sinus node depolarization - known as heart rate variability or 
respiratory sinus arrhythmia. 
The measurement and analysis of heart rate variability has been introduced trough 
Advances in Electrocardiogram - Methods and Analysis. In the present book, Advances in 
Electrocardiograms - Clinical Applications, the reader will be presented with clinical 
applications of heart rate variability, as well as a wide range of pathophysiological 
conditions associated with abnormal electrocardiograms. From electrolyte disturbances 
to toxic exposures; from hypertension and myocardial infarction to cardiomyopathies; 
from sleep apneas to heart failures. Being mindful that the roots of many 
electrocardiographic abnormalities develop during embryonic organogenesis of the 
heart, will lead to improved recognition, diagnosis and treatment of cardiac diseases. 
 
Richard M. Millis, PhD 
Editor 
Dept. of Physiology & Biophysics 












The Prognostic Role of ECG 
in Arterial Hypertension 
Stavros Dimopoulos1, Christos Manetos1, 
Eleni Koroboki2, John Terrovitis3 and Serafim Nanas1 
11st Critical Care Medicine Department, “Evangelismos” Hospital, 
2Hypertensive Center, Clinical Therapeutics, “Alexandra” Hospital, 
33rd Cardiology Department, “Laiko” Hospital, 
University of Athens, Athens, 
Greece 
1. Introduction 
Hypertension is very common and affects around 50 million Americans of which about 30% 
are not yet diagnosed. Hypertension is an under-diagnosed syndrome causing damage to 
the various target organs with no symptoms or only mild symptoms, also called a "silent 
killer" for this reason. Early diagnosis of arterial hypertension remains an important element 
in evaluating cardiovascular risk factors in general population. It is well established that 
isolated arterial hypertension increases the risk of left ventricular hypertrophy (LVH) and 
sudden death and prognostic indexes are necessary for risk stratification of these patients. 
The electrocardiogram (ECG) is a simple, non-invasive, low-cost method that can detect 
LVH, ventricular arrhythmias and ventricular repolarization abnormalities and confers 
useful prognostic information for patients with arterial hypertension 
2. Prognostic data 
It is well known that left ventricular hypertrophy (LVH) is associated with an increased 
incidence of ventricular arrhythmia and sudden cardiac death. Systemic arterial 
hypertension is one of the most important causes of pathological LVH and there is evidence 
indicating that hypertensive patients with LVH are at increased risk of sudden cardiac death 
(Haider 1998, Korren 1991). These patients are characterized by a high incidence of 
ventricular arrhythmias (Gallinier 1997, Messerli 1999, Dimopoulos 2009) and this 
observation has led to the logical hypothesis that these arrhythmias may be the cause of 
sudden cardiac death in these patients. However, the exact mechanism by which LVH, 
ventricular arrhythmias and sudden cardiac death are linked to each other has not been 
fully clarified yet. Premature ventricular beats, multiform beats, couplets and non-sustained 
ventricular tachycardia are commonly found in ECGs of hypertensive patients, are 
associated with LVH, and have a negative prognostic value (Gallinier 1997, Messerli 1999). 
Furthermore, ventricular repolarization abnormalities in the 12-lead surface ECG such as 
QT-interval prolongation, increased QT dispersion (Dimopoulos 2008,2009), T wave axis 
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(Salles 2008) and T wave alternans (Hennersdorf 2001)  have all been associated with 
ventricular arrhythmias and sudden cardiac death in arterial hypertension; however further 
research is required to establish their prognostic significance. 
2.1 LVH 
In arterial hypertension, LVH is a physiologic and expected response to pressure or volume 
overload and it is a well known marker of increased cardiovascular morbidity. Previous 
studies have extensively shown that antihypertensive agents can partially reverse LVH and 
their efficacy is well documented (Haider 1998, Kannel 1969,1970, Sokolow & Lyon 1949, 
Deverreux & Reichek 1982, Okin 2004,2009). Development of the typical strain pattern in 
response to LVH may reflect true subendocardial ischemia in the absence of coronary artery 
disease, since the increases in coronary artery blood flow (through coronary artery dilatation 
and capillary recruitment) are inadequate to compensate the demand posed by increased LV 
mass and wall thickness, in the setting of LVH. The increased mass of the left ventricle 
(representing both myocardial interstitial fibrosis and/or myocyte hypertrophy) can cause 
abnormalities of the QRS complex and QT-interval. Although the ECG has a low sensitivity 
(less than 50%) for detecting LVH, when LVH is identified by ECG, the specificity is higher 
than 90%. From these observations several criteria have been proposed so far, however none 
is considered to have optimal accuracy (Sokolow & Lyon 1949, Hancock 2009). A variety of 
ECG abnormalities have been described, as shown in Tables 1,2,3: 
 
R or S in any limb lead ≥20mm 
R waves in aVL > 11mm 
R in lead I + S in III > 25mm 
S waves in V1 or V2 ≥ 30mm 
R waves in V5 or V6 ≥ 30mm 
S waves in V1 + R waves in V5 or V6 > 35mm  
R waves in aVL+ S waves in V3 > 28mm (men) and 20 mm (women) 
Total QRS voltage from all 12 leads ≥175mm  
Onset of intrinsicoid deflection >0.05 seconds in V5 or V6 
Increased duration of the QRS complex ≥0.09 seconds 
Left axis deviation ≥-30o 
Table 1. Abnormalities in the QRS complex 
 
Terminal negativity of the P wave in V1 1mm X 1mm 
Table 2. Left atrial abnormality 
 
ST depression and T inversion in leads with tall R waves (left ventricular strain) 
Table 3. Abnormalities in the ST segment and T wave 
The following are the most frequently used criteria for the diagnosis of LVH, including the 
Sokolow-Lyon Index, Romhilt and Estes score, Cornell voltage criteria, Cornell product, 
total QRS voltage (Table 4,5,6,7,8): 
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S waves in V1 + R waves in V5 or V6 > 35mm 
R waves in aVL > 11mm 
Table 4. Sokolow-Lyon Index 
 
Score of  ≥ 5 points  predicts LVH, score  of  4 points = probable LVH 
3 points each 
1) P wave from left atrial abnormality 
2) any increase in voltage of the QRS complex (R or S in any limb lead ≥20mm or S waves 
in V1 or V2 ≥ 30mm or  R waves in V5 or V6 ≥ 30mm) 
3) ST-T abnormalities any shift in the ST segment but without digitalis 
2 points (left axis deviation ≥-30o) 
1 point each (duration of the QRS complex ≥0.09 seconds or intrinsicoid deflection ≥0.05 
seconds in V5 or V6 or ST-T abnormalities with digitalis) 
Table 5. Romhilt and Estes score 
 
R waves in aVL+ S waves in V3 > 28mm (men) and 20 mm (women) 
Table 6. Cornell voltage criteria 
 
Cornell voltage criteria x QRS duration in ms ≥ 2440 (in women  6 mm is added to Cornell 
voltage)   
Table 7. Cornell product 
 
Total QRS voltage from all 12 leads ≥175mm  
Table 8. Total QRS voltage 
Various epidemiological studies have previously demonstrated the importance of LVH for 
predicting cardiovascular events and sudden cardiac death. In the Framingham Heart Study 
the 3.4% of 5581 participants with ECG LVH and ST depression and T-wave flattening or 
inversion had a 3-fold increased risk for developing coronary heart disease after adjusting 
for age, gender, and blood pressure, (Kannel 1969, 1970). Similar results were found in the 
Copenhagen City Heart Study with enrollment of 11,634 participants with no evidence of 
ischemic heart disease at initial evaluation. In this study it was shown that ST depression 
and/or T-wave inversion (as defined by the Minnesota code) remained strongly predictive 
for cardiac events in multivariate analyses (Larsen 2002). The left ventricular (LV) strain-
pattern of ST segment depression and T-wave inversion on the left precordial leads of the 
standard resting ECG is now considered a valid marker of the presence of anatomic LV 
hypertrophy (LVH) (Salles 2006). The presence of typical ECG strain pattern is also 
independently associated with increased LV wall thickness and mass and independently 
associated with other adverse factors: increased 24-hour systolic blood pressure, prolonged 
maximum QTc-interval duration, higher serum creatinine and fasting glycemia, physical 
inactivity, as well as with the presence of two types of important target organ damage (CHD 
and peripheral arterial disease). In the Losartan Intervention For Endpoint reduction in 
hypertension (LIFE) study, it was demonstrated that therapy with losartan was more 
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Terminal negativity of the P wave in V1 1mm X 1mm 
Table 2. Left atrial abnormality 
 
ST depression and T inversion in leads with tall R waves (left ventricular strain) 
Table 3. Abnormalities in the ST segment and T wave 
The following are the most frequently used criteria for the diagnosis of LVH, including the 
Sokolow-Lyon Index, Romhilt and Estes score, Cornell voltage criteria, Cornell product, 
total QRS voltage (Table 4,5,6,7,8): 
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S waves in V1 + R waves in V5 or V6 > 35mm 
R waves in aVL > 11mm 
Table 4. Sokolow-Lyon Index 
 
Score of  ≥ 5 points  predicts LVH, score  of  4 points = probable LVH 
3 points each 
1) P wave from left atrial abnormality 
2) any increase in voltage of the QRS complex (R or S in any limb lead ≥20mm or S waves 
in V1 or V2 ≥ 30mm or  R waves in V5 or V6 ≥ 30mm) 
3) ST-T abnormalities any shift in the ST segment but without digitalis 
2 points (left axis deviation ≥-30o) 
1 point each (duration of the QRS complex ≥0.09 seconds or intrinsicoid deflection ≥0.05 
seconds in V5 or V6 or ST-T abnormalities with digitalis) 
Table 5. Romhilt and Estes score 
 
R waves in aVL+ S waves in V3 > 28mm (men) and 20 mm (women) 
Table 6. Cornell voltage criteria 
 
Cornell voltage criteria x QRS duration in ms ≥ 2440 (in women  6 mm is added to Cornell 
voltage)   
Table 7. Cornell product 
 
Total QRS voltage from all 12 leads ≥175mm  
Table 8. Total QRS voltage 
Various epidemiological studies have previously demonstrated the importance of LVH for 
predicting cardiovascular events and sudden cardiac death. In the Framingham Heart Study 
the 3.4% of 5581 participants with ECG LVH and ST depression and T-wave flattening or 
inversion had a 3-fold increased risk for developing coronary heart disease after adjusting 
for age, gender, and blood pressure, (Kannel 1969, 1970). Similar results were found in the 
Copenhagen City Heart Study with enrollment of 11,634 participants with no evidence of 
ischemic heart disease at initial evaluation. In this study it was shown that ST depression 
and/or T-wave inversion (as defined by the Minnesota code) remained strongly predictive 
for cardiac events in multivariate analyses (Larsen 2002). The left ventricular (LV) strain-
pattern of ST segment depression and T-wave inversion on the left precordial leads of the 
standard resting ECG is now considered a valid marker of the presence of anatomic LV 
hypertrophy (LVH) (Salles 2006). The presence of typical ECG strain pattern is also 
independently associated with increased LV wall thickness and mass and independently 
associated with other adverse factors: increased 24-hour systolic blood pressure, prolonged 
maximum QTc-interval duration, higher serum creatinine and fasting glycemia, physical 
inactivity, as well as with the presence of two types of important target organ damage (CHD 
and peripheral arterial disease). In the Losartan Intervention For Endpoint reduction in 
hypertension (LIFE) study, it was demonstrated that therapy with losartan was more 
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effective than atenolol in preventing CV morbidity and mortality with nearly identical 
reductions in systolic and diastolic pressure in both treatment arms. The presence of typical 
strain on the ECG in hypertensive patients with ECG LVH also identified patients at higher 
risk of CV morbidity and mortality in the setting of antihypertensive therapy associated 
with large decreases in systolic and diastolic pressure. The increased CV risk associated with 
ECG strain was independent of the improved prognosis with losartan therapy in the LIFE 
trial and persisted after adjusting for the greater baseline severity and prevalence of ECG 
LVH and the higher prevalence of other CV disorders in patients with strain pattern. The 
development of new ECG strain between baseline and year 1 during the LIFE study 
identified patients at increased risk of cardiovascular morbidity and mortality and all-cause 
mortality in the setting of antihypertensive therapy associated with substantial decreases in 
both systolic and diastolic pressure. The increased risk associated with new ECG strain was 
independent of the improved prognosis with losartan therapy and with regression of ECG 
LVH in LIFE (Okin 2004,2009). These findings suggest that more aggressive therapy may be 
warranted in hypertensive patients who develop new ECG strain to reduce the risk of 
cardiovascular morbidity, cardiovascular and all-cause mortality, and sudden death. The 
relationship of cardiovascular risk to ECG strain pattern on a single ECG has been 
demonstrated in population-based studies and in patients with hypertension. 
2.2 Ventricular arrhythmias, Lown score 
Previous studies have shown an increased incidence of number and severity of ventricular 
arrhythmias in patients with hypertensive LVH (Galinier 1997, Messerli 1999, Dimopoulos 
2008, Hennersdorf 2001). The average number of premature ventricular beats (PVB), and 
their severity according to a modified Lown’s score (a: absence of PVB; b: PVB < 30/h; c: 
PVB ≥ 30/h; d: multiform; e: couplets; f: nonsustained ventricular tachycardia; g: R on T = 
RR / QT ≤ 0.75) during a 24-hours ECG Holter are independent predictors of 
echocardiographically determined LVMI in normotensive and hypertensive elderly patients, 
as demonstrated in a previous study (Dimopoulos 2008). In that study, patients with arterial 
hypertension had a higher Lown’s score compared with normotensive subjects, and this 
increase was found to be higher in those hypertensives with LVH. The elderly population 
group had a greater number of PVB in contrast to younger subjects. Elderly patients were 
also characterized by a higher Lown’s score and a greater LVMI. Another study has 
previously shown that patients with LVH present frequent and complex ventricular 
premature beats and that the presence of non-sustained ventricular tachycardia has negative 
prognostic value in this population (Galinier 1997). However, the role of ventricular 
arrhythmias in arterial hypertension is still under investigation, with no clear evidence for 
high prognostic significance. 
2.3 Silent ischemia 
Transient changes of ST-segment (ST depression) is a phenomenon commonly observed in 
patients with arterial hypertension; although reported prevalence varied widely (from 15 to 
80%-Stramba 1998, Asmar 1996), it seems that the true value is around 20% (Uen 2006). 
These findings on ECG are interpreted as silent ischemia, due to the absence of angina 
pectoris or other angina equivalent symptoms and are attributed to transient mismatch of 
myocardial blood flow to the myocardial demands. It seems that more than 90% of these 
episodes, identified in the Holter electrocardiogram (ECG) of hypertensive patients, are 
silent. When transient ST depressions are detected, the risk of cardiovascular events 
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increases (Uen 2006, Sigurdson 1996, Szlachcic 1992). It is also well known that there is a 
circadian rhythm of transient ST depressions with a distinct peak in the early hours of the 
morning, similar to the peak period of myocardial infarction or sudden cardiac death 
(Asmar 1996). The ST depression is significantly more frequent in patients with known 
coronary heart disease, positive Sokolow index, as well as in patients who complain of 
dyspnea, have a smoking history or are on diuretics. The ST-segment depression is also 
observed more frequently in men than in women. The prevalence of ST-segment depression 
in patients with coronary heart disease is influenced by the severity of coronary heart 
disease (Uen 2006, Sigurdson 1996, Szlachcic 1992). This phenomenon is characterized by a 
significant rise of blood pressure, heart rate and double product before the appearance of ST 
depression. These parameters reach their peak during the ST depression. After ST 
depression resolution, they return to lower values. Apart from the systolic blood pressure, 
however, the other two parameters will remain significantly elevated compared with the 
mean 24-hour values. Other clinical predictors for the occurrence of cardiac ischemia during 
daily life are risk factors for silent ST-depression, indicating the presence of ischemic heart 
disease. A study showed that 24-hours ambulatory blood pressure monitoring (ABPM) has 
high predictive value, in contrast to office-based blood pressure measurements, for silent 
ST-segment depression. Interestingly, the office-based measurements, apart from the pulse 
pressure, are not predictive of the occurrence of ST-segment depression either in treated or 
in untreated hypertensive and normotensive hypertensive individuals. To what extent the 
24-hours mean values of the ST segment depression analysis reflect the severity of ischemic 
heart disease or have prognostic significance regarding the development of an ischemic 
event remains so far unknown, although a study has previously reported that silent 
ischemia may be predictive of adverse outcome in arterial hypertension (Schillaci 2004). 
2.4 QT-interval and QT-dispersion 
Increased left ventricular mass, as mentioned before has a high prevalence in patients with 
arterial hypertension, particularly in the elderly and has been associated with increased 
cardiovascular risk, including sudden death, (Haider 1998, Koren 1991, Dimopoulos 2009, 
Kannel 1969,1970, Bednar 2001, Okin 2000). The increased electrical instability due to non-
uniform left ventricular mass distribution has been suggested as a possible mechanism 
linking LVH and cardiovascular death. QT interval prolongation has been implicated in the 
origin of ventricular arrhythmias, possibly because of less uniform recovery of ventricular 
excitability in the setting of regional differences in cardiac sympathetic nervous system 
activity. In addition, the increased inhomogeneity of ventricular repolarization, induced by 
LVH, can be indirectly detected by QT dispersion, a relatively simple measurement of 12-
lead electrocardiogram (ECG) variability, and this index has been recently shown to be 
related to poor prognosis in large population studies (Okin 2000, Salles 2005, Elming 1998, 
Bruyne 1998, Sheehana 2004). Interestingly, heterogeneous ventricular repolarization was 
initially recognized in standard ECGs as early as 1934; however only recently QTc interval 
dispersion was identified as a marker of arrhythmia risk and sudden cardiac death in 
patients after myocardial infarction or with heart failure (Barr 1994, Glancy 1995, 
Anastasiou-Nana 2000). Furthermore, other studies subsequently demonstrated the 
presence of increased QT-dispersion in patients with systemic arterial hypertension, 
associated with ventricular arrhythmias and LVH (Dimopoulos 2008, Clarkson 1995, Mayet 
1996). QTc dispersion (QT-dispersion corrected for HR) was found to be an independent 
predictor of echocardiographically determined LVMI in normotensive and hypertensive 
elderly patients (Dimopoulos 2008). Patients with arterial hypertension had an increased 
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effective than atenolol in preventing CV morbidity and mortality with nearly identical 
reductions in systolic and diastolic pressure in both treatment arms. The presence of typical 
strain on the ECG in hypertensive patients with ECG LVH also identified patients at higher 
risk of CV morbidity and mortality in the setting of antihypertensive therapy associated 
with large decreases in systolic and diastolic pressure. The increased CV risk associated with 
ECG strain was independent of the improved prognosis with losartan therapy in the LIFE 
trial and persisted after adjusting for the greater baseline severity and prevalence of ECG 
LVH and the higher prevalence of other CV disorders in patients with strain pattern. The 
development of new ECG strain between baseline and year 1 during the LIFE study 
identified patients at increased risk of cardiovascular morbidity and mortality and all-cause 
mortality in the setting of antihypertensive therapy associated with substantial decreases in 
both systolic and diastolic pressure. The increased risk associated with new ECG strain was 
independent of the improved prognosis with losartan therapy and with regression of ECG 
LVH in LIFE (Okin 2004,2009). These findings suggest that more aggressive therapy may be 
warranted in hypertensive patients who develop new ECG strain to reduce the risk of 
cardiovascular morbidity, cardiovascular and all-cause mortality, and sudden death. The 
relationship of cardiovascular risk to ECG strain pattern on a single ECG has been 
demonstrated in population-based studies and in patients with hypertension. 
2.2 Ventricular arrhythmias, Lown score 
Previous studies have shown an increased incidence of number and severity of ventricular 
arrhythmias in patients with hypertensive LVH (Galinier 1997, Messerli 1999, Dimopoulos 
2008, Hennersdorf 2001). The average number of premature ventricular beats (PVB), and 
their severity according to a modified Lown’s score (a: absence of PVB; b: PVB < 30/h; c: 
PVB ≥ 30/h; d: multiform; e: couplets; f: nonsustained ventricular tachycardia; g: R on T = 
RR / QT ≤ 0.75) during a 24-hours ECG Holter are independent predictors of 
echocardiographically determined LVMI in normotensive and hypertensive elderly patients, 
as demonstrated in a previous study (Dimopoulos 2008). In that study, patients with arterial 
hypertension had a higher Lown’s score compared with normotensive subjects, and this 
increase was found to be higher in those hypertensives with LVH. The elderly population 
group had a greater number of PVB in contrast to younger subjects. Elderly patients were 
also characterized by a higher Lown’s score and a greater LVMI. Another study has 
previously shown that patients with LVH present frequent and complex ventricular 
premature beats and that the presence of non-sustained ventricular tachycardia has negative 
prognostic value in this population (Galinier 1997). However, the role of ventricular 
arrhythmias in arterial hypertension is still under investigation, with no clear evidence for 
high prognostic significance. 
2.3 Silent ischemia 
Transient changes of ST-segment (ST depression) is a phenomenon commonly observed in 
patients with arterial hypertension; although reported prevalence varied widely (from 15 to 
80%-Stramba 1998, Asmar 1996), it seems that the true value is around 20% (Uen 2006). 
These findings on ECG are interpreted as silent ischemia, due to the absence of angina 
pectoris or other angina equivalent symptoms and are attributed to transient mismatch of 
myocardial blood flow to the myocardial demands. It seems that more than 90% of these 
episodes, identified in the Holter electrocardiogram (ECG) of hypertensive patients, are 
silent. When transient ST depressions are detected, the risk of cardiovascular events 
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increases (Uen 2006, Sigurdson 1996, Szlachcic 1992). It is also well known that there is a 
circadian rhythm of transient ST depressions with a distinct peak in the early hours of the 
morning, similar to the peak period of myocardial infarction or sudden cardiac death 
(Asmar 1996). The ST depression is significantly more frequent in patients with known 
coronary heart disease, positive Sokolow index, as well as in patients who complain of 
dyspnea, have a smoking history or are on diuretics. The ST-segment depression is also 
observed more frequently in men than in women. The prevalence of ST-segment depression 
in patients with coronary heart disease is influenced by the severity of coronary heart 
disease (Uen 2006, Sigurdson 1996, Szlachcic 1992). This phenomenon is characterized by a 
significant rise of blood pressure, heart rate and double product before the appearance of ST 
depression. These parameters reach their peak during the ST depression. After ST 
depression resolution, they return to lower values. Apart from the systolic blood pressure, 
however, the other two parameters will remain significantly elevated compared with the 
mean 24-hour values. Other clinical predictors for the occurrence of cardiac ischemia during 
daily life are risk factors for silent ST-depression, indicating the presence of ischemic heart 
disease. A study showed that 24-hours ambulatory blood pressure monitoring (ABPM) has 
high predictive value, in contrast to office-based blood pressure measurements, for silent 
ST-segment depression. Interestingly, the office-based measurements, apart from the pulse 
pressure, are not predictive of the occurrence of ST-segment depression either in treated or 
in untreated hypertensive and normotensive hypertensive individuals. To what extent the 
24-hours mean values of the ST segment depression analysis reflect the severity of ischemic 
heart disease or have prognostic significance regarding the development of an ischemic 
event remains so far unknown, although a study has previously reported that silent 
ischemia may be predictive of adverse outcome in arterial hypertension (Schillaci 2004). 
2.4 QT-interval and QT-dispersion 
Increased left ventricular mass, as mentioned before has a high prevalence in patients with 
arterial hypertension, particularly in the elderly and has been associated with increased 
cardiovascular risk, including sudden death, (Haider 1998, Koren 1991, Dimopoulos 2009, 
Kannel 1969,1970, Bednar 2001, Okin 2000). The increased electrical instability due to non-
uniform left ventricular mass distribution has been suggested as a possible mechanism 
linking LVH and cardiovascular death. QT interval prolongation has been implicated in the 
origin of ventricular arrhythmias, possibly because of less uniform recovery of ventricular 
excitability in the setting of regional differences in cardiac sympathetic nervous system 
activity. In addition, the increased inhomogeneity of ventricular repolarization, induced by 
LVH, can be indirectly detected by QT dispersion, a relatively simple measurement of 12-
lead electrocardiogram (ECG) variability, and this index has been recently shown to be 
related to poor prognosis in large population studies (Okin 2000, Salles 2005, Elming 1998, 
Bruyne 1998, Sheehana 2004). Interestingly, heterogeneous ventricular repolarization was 
initially recognized in standard ECGs as early as 1934; however only recently QTc interval 
dispersion was identified as a marker of arrhythmia risk and sudden cardiac death in 
patients after myocardial infarction or with heart failure (Barr 1994, Glancy 1995, 
Anastasiou-Nana 2000). Furthermore, other studies subsequently demonstrated the 
presence of increased QT-dispersion in patients with systemic arterial hypertension, 
associated with ventricular arrhythmias and LVH (Dimopoulos 2008, Clarkson 1995, Mayet 
1996). QTc dispersion (QT-dispersion corrected for HR) was found to be an independent 
predictor of echocardiographically determined LVMI in normotensive and hypertensive 
elderly patients (Dimopoulos 2008). Patients with arterial hypertension had an increased 
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QTc dispersion compared with normotensive subjects, and this increase was found to be 
higher in those hypertensive patients with LVH. In a prospective study,  patients with QTcD 
≥45 ms had a higher rate of major cardiovascular events, higher LVMI, increased values of 
systolic and diastolic blood pressure, higher number of PVB and higher Lown’s score than 
patients with QTcD <45 ms (Dimopoulos 2009) . After adjustment for multiple known 
predictors of adverse outcome, QT interval corrected for heart rate remained associated with 
both all-cause and cardiovascular mortality. Increased QTc interval dispersion was also a 
significant predictor of cardiovascular mortality in LIFE trial (Saaden & Jones 2001). This 
additive risk prediction suggests that increased QTc and QTc interval dispersion on the 
surface ECG reflect different aspects of abnormal ventricular repolarization. However only 
few studies have investigated the prognostic role of QT-dispersion and QT-interval in 
arterial hypertension (Galinier 1997, Dimopoulos 2009, Oikarinen 2004, Saaden & Jones 
2001). Antihypertensive therapy with angiotensin-converting enzyme inhibitors, calcium 
antagonists and beta-blockers has been shown beneficial in terms of QT-dispersion 
normalization and/or LVH decrease (Tomiyama 1998, Karpanou 1998, Galetta 2005,Lim 
1999). Beta blockers are associated with a reduction in both QT and QTc interval dispersion, 
raising the possibility that a reduction in dispersion of ventricular repolarization may be an 
important antiarrhythmic mechanism of beta blockade.  
The direct linking mechanism between QT-dispersion, ventricular arrhythmias, LVH and 
adverse outcome has not been fully clarified yet. Increased QTc dispersion has been 
associated with increased regional heterogeneity of ventricular repolarization and it has 
been considered as a possible noninvasive surrogate marker of susceptibility to malignant 
ventricular arrhythmias and cardiovascular mortality in large population studies and, in 
cardiac patients (Okin 2000, Elming 1998, Bruyne 1998, Sheehana 2004, Barr 1994, Glancy 
1995, Anastasiou 2000). The degree of myocardial interstitial fibrosis induced by either 
systemic arterial hypertension and/or by ageing, as well as the inhomogeneous myocyte 
hypertrophy caused mainly by arterial hypertension, might play an important role in 
increasing action potential duration and amplitude in different myocardial regions 
(Dimopoulos 2008,2009). These myocardial electrical abnormalities may affect ventricular 
repolarization and might be the main cause of increased QTc dispersion in hypertensives. In 
order to maximize reproducibility of QT-dispersion measurements, it is important to follow 
certain methodological rules that are reported below.  
All 12-leads ECGs are obtained at a speed of 25 mm/sec. The ECG registration should be a 
simultaneous 12-lead ECG. QT intervals are measured manually on all possible leads. QT 
interval is defined as the interval from the onset of the QRS complex to the end of the T 
wave, which is defined as its return to the T-P baseline. If U wave is present, the QT interval 
is measured to the nadir of the curve between the T and U waves. QT intervals are then 
corrected with the Bazett’s formula to compensate for its known dependence on heart rate: 
QTc = QT / √RR. Measurements on QT and RR intervals should be carried out in 3 
consecutive cardiac cycles in all leads, and average values are then obtained. QTc dispersion 
is determined as the difference between the maximal and minimal QTc interval in different 
leads.  No subject should have fewer than 9 measurable ECG leads. Various studies have 
also demonstrated the predictive value of the QT interval and QTc interval dispersion 
measured automatically by computerized ECG for noninvasive risk stratification in a 
population-based sample. 
It should be mentioned that there are some methodological difficulties related to QT 
dispersion measurements, including the circadian variation of the QT interval. The QTc 
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interval dispersion has obvious predictive value, but inter- and intraobserver varialbility 
limits the wider clinical use. In perspective, it is important to decrease measurement errors 
by improving measurement technique, define precisely normal values and demonstrate 
predictive value in studies with large number of patients with arterial hypertension.  
2.5 T wave axis  
Two electrocardiographic markers of ventricular repolarization abnormalities have been 
recently proposed: spatial T-wave axis deviation and T (peak)-T (end)-interval duration. In a 
cross-sectional study (Salles 2008), 810 treatment-resistant hypertensive patients were 
evaluated. Maximum T(peak)-T(end)-interval duration (Tpe(max)) was considered 
prolonged if it was beyond the upper quartile value (120 ms), and the spatial T-wave axis on 
the frontal plane was considered abnormally deviated if >105 degrees or < 15 degrees. 
Tpe(max)-interval prolongation, as well as QTc-interval prolongation, was found to be 
associated with body mass index, 24-h systolic blood pressure (SBP), indexed LVM, serum 
potassium, and heart rate. Abnormal T-axis deviation was associated with male gender, 
presence of coronary heart disease, serum creatinine, 24-h SBP, LVM, and serum potassium. 
All three repolarization parameters (T-wave axis deviation, T (peak)-T (end)-interval and 
QTc-interval) were shown to be associated with increased LVM, after adjustment for 
possible confounders. However, when included together into the same model, only 
abnormal T-axis and QTc-interval prolongation remained independently associated with 
LVM. All three parameters were also increased in patients with concentric hypertrophy. It 
seems that only abnormal T-wave axis deviation appears to have distinct and additive 
prognostic value compared with the more classic marker, the QTc interval. More 
investigational studies are needed to evaluate the prognostic value of T-wave axis 
abnormalities in arterial hypertension, prior to clinical application of this index. 
2.6 T wave alternans (TWA) 
An association between the occurrence of TWA and inducibility of tachyarrhythmias has 
been reported in a previous electrophysiological study (Rosenbaum 1994). Another 
significant study (Hennersdorf 2001) has evaluated the significance of TWA in 51 patients 
with arterial hypertension. The patient population was divided into a group of 11 
consecutive patients who had survived arrhythmic events or cardiogenic syncope and a 
group of 40 consecutive patients without documented ventricular arrhythmias. Patients 
exercised with a gradual increase of workload to maintain a heart rate of at least 105/min. 
Workload was increased in a stepwise fashion to avoid a sudden increase of the heart rate, 
which could provoke a false positive test result. After recording 254 consecutive heartbeats, 
ECG signals were digitally processed by a spectral analysis method and analyzed. The beat 
domain power spectrum of the T wave (J point 160 ms through end of the T wave) was 
calculated every 16 beats from sequential overlapping 128-beat sequences. The magnitude of 
the TWA was measured at a frequency of 0.5 cycles per beat. The results of this study 
showed that the prevalence of TWA was higher in patients with LVH. There was also a 
significant correlation between patients with a positive TWA and a survived arrhythmic 
event. None of the patients without documented ventricular arrhythmias had a positive 
alternans tracing. The underlying mechanism of a positive TWA is not clear yet; it seems 
that there is an alteration in action potential morphology or dispersion of repolarization. The 
changes in morphology of the action potentials might lead to spatial inhomogeneity in 
refractoriness and may result in increased vulnerability to ventricular fibrillation. During 
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QTc = QT / √RR. Measurements on QT and RR intervals should be carried out in 3 
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is determined as the difference between the maximal and minimal QTc interval in different 
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measured automatically by computerized ECG for noninvasive risk stratification in a 
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interval dispersion has obvious predictive value, but inter- and intraobserver varialbility 
limits the wider clinical use. In perspective, it is important to decrease measurement errors 
by improving measurement technique, define precisely normal values and demonstrate 
predictive value in studies with large number of patients with arterial hypertension.  
2.5 T wave axis  
Two electrocardiographic markers of ventricular repolarization abnormalities have been 
recently proposed: spatial T-wave axis deviation and T (peak)-T (end)-interval duration. In a 
cross-sectional study (Salles 2008), 810 treatment-resistant hypertensive patients were 
evaluated. Maximum T(peak)-T(end)-interval duration (Tpe(max)) was considered 
prolonged if it was beyond the upper quartile value (120 ms), and the spatial T-wave axis on 
the frontal plane was considered abnormally deviated if >105 degrees or < 15 degrees. 
Tpe(max)-interval prolongation, as well as QTc-interval prolongation, was found to be 
associated with body mass index, 24-h systolic blood pressure (SBP), indexed LVM, serum 
potassium, and heart rate. Abnormal T-axis deviation was associated with male gender, 
presence of coronary heart disease, serum creatinine, 24-h SBP, LVM, and serum potassium. 
All three repolarization parameters (T-wave axis deviation, T (peak)-T (end)-interval and 
QTc-interval) were shown to be associated with increased LVM, after adjustment for 
possible confounders. However, when included together into the same model, only 
abnormal T-axis and QTc-interval prolongation remained independently associated with 
LVM. All three parameters were also increased in patients with concentric hypertrophy. It 
seems that only abnormal T-wave axis deviation appears to have distinct and additive 
prognostic value compared with the more classic marker, the QTc interval. More 
investigational studies are needed to evaluate the prognostic value of T-wave axis 
abnormalities in arterial hypertension, prior to clinical application of this index. 
2.6 T wave alternans (TWA) 
An association between the occurrence of TWA and inducibility of tachyarrhythmias has 
been reported in a previous electrophysiological study (Rosenbaum 1994). Another 
significant study (Hennersdorf 2001) has evaluated the significance of TWA in 51 patients 
with arterial hypertension. The patient population was divided into a group of 11 
consecutive patients who had survived arrhythmic events or cardiogenic syncope and a 
group of 40 consecutive patients without documented ventricular arrhythmias. Patients 
exercised with a gradual increase of workload to maintain a heart rate of at least 105/min. 
Workload was increased in a stepwise fashion to avoid a sudden increase of the heart rate, 
which could provoke a false positive test result. After recording 254 consecutive heartbeats, 
ECG signals were digitally processed by a spectral analysis method and analyzed. The beat 
domain power spectrum of the T wave (J point 160 ms through end of the T wave) was 
calculated every 16 beats from sequential overlapping 128-beat sequences. The magnitude of 
the TWA was measured at a frequency of 0.5 cycles per beat. The results of this study 
showed that the prevalence of TWA was higher in patients with LVH. There was also a 
significant correlation between patients with a positive TWA and a survived arrhythmic 
event. None of the patients without documented ventricular arrhythmias had a positive 
alternans tracing. The underlying mechanism of a positive TWA is not clear yet; it seems 
that there is an alteration in action potential morphology or dispersion of repolarization. The 
changes in morphology of the action potentials might lead to spatial inhomogeneity in 
refractoriness and may result in increased vulnerability to ventricular fibrillation. During 
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repeated episodes of ischemia, action potential alternans was detectable in 95% of the cases 
with ventricular fibrillation. The dispersion of repolarization is closely related to the 
temporo-spatial pattern of depolarization-repolarization, which can alternate on a beat-to-
beat basis. The temporo-spatial dispersion of cellular refractoriness seems to predispose the 
myocardium to wave front fractionation and subsequent reentry. It is noteworthy that the 
TWA can be influenced by various conditions such as ischemia, hypothermia, heart rate, 
and sympathetic tone. Drugs such as procainamide and amiodarone reduce magnitude of 
alternans and sotalol can lead to the conversion of TWA from negative to positive. In the 
case of cardiomyopathies, the development of small areas of scars and ischemia is 
considered to be of pathological relevance for the development of alterations in action 
potentials or dispersion of repolarization. Whether T wave alternans can be used as a 
clinical marker of susceptibility for sudden cardiac death and cardiovascular events is under 
research. 
3. Conclusions 
The electrocardiographic findings in patients with arterial hypertension are valuable tools 
for risk stratification of these patients, by predicting cardiovascular events and sudden 
cardiac death. The ECG strain pattern, an old parameter of well established value, should 
always be searched as it provides additional prognostic information beyond the one derived 
from echocardiographic LVH and LVM. Also among hypertensive patients with left 
ventricular hypertrophy, the presence of non-sustained ventricular tachycardia on ECG 
Holter monitoring identifies patients with a high risk of mortality, who need more 
aggressive care. Silent ischemia on ECG Holter should be taken into account as ST 
depression episodes have a high prevalence (about 20%) in hypertensive patients. ST 
depression and T-wave inversion may reflect true subendocardial ischemia in the absence of 
coronary artery disease. The prolonged QT interval and increased QT interval dispersion 
have been associated with LVH and ventricular arrhythmias and seem to contain significant 
predictive value, but inter- and intraobserver varialbility limit their wider clinical 
applicability. The analysis of T wave axis and T wave alternans might also be helpful for risk 
stratification in patients with arterial hypertension. However, the clinical usefulness of these 
indices in arterial hypertension and their possible role in monitoring medical treatment is 
under investigation and further research is needed prior to its clinical application. 
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1. Introduction  
Several studies have focused on the identification of patients at risk of sudden cardiac death, 
which is mostly due to depolarization and repolarization impairment. The measurement of 
QT interval indicates the total duration of ventricular myocardial depolarization and 
repolarization. Localized repolarization data can be obtained easily from the standard 12-
lead electrocardiogram (ECG), a non-invasive method extensively used as a tool for 
cardiovascular risk assessment. [1,2] Non-uniform myocardial repolarization time may 
result from inhomogeneity, variation of action potential duration between the individual 
leads of the 12-lead ECG, or localized delay in activation due to slow conduction or altered 
conduction pathways. To ensure the recording of the earliest depolarization at the latest 
repolarization of the ventricular myocardium, the maximum QT interval should be 
measured from the beginning of the earliest QRS complex to the end of the latest T wave 
from all leads of a simultaneous 12-lead ECG. Nevertheless, the QT interval may reflect 
increased inhomogeneity of myocardial repolarization, resulting from delayed 
repolarization in some areas of the myocardium, and it can be caused by a uniform increase 
in action potential duration. A measure that can help differentiate between these two 
conditions is the QT dispersion. Using both the QT prolongation and the QT dispersion the 
individual lead variation and the interlead variation provide a measure of repolarization 
heterogeneity. [3] 
The QT interval prolongation has been proposed as a marker of cardiovascular risk in the 
clinical setting and it has also been particularly associated with arrhythmias, sudden death 
and poor survival in apparently healthy subjects. [4,5] As for diabetic subjects, although 
some cross-sectional studies suggest that glycemic control, ischemic heart disease, and blood 
pressure, among other risk factors, are associated with the QT interval prolongation, its 
pathogenesis remains unclear. [6,8] Also, and increased mortality in newly diagnosed type 2 
diabetes patients has been associated with QT interval prolongation. [9,10] 
The aim of this study was to estimate the prevalence of QTc interval prolongation in diabetic 
and non-diabetic subjects, as well as to evaluate cross-sectionally and prospectively the 
associated risk factors of QTc interval prolongation and its clinical implications in subjects 
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1. Introduction  
Several studies have focused on the identification of patients at risk of sudden cardiac death, 
which is mostly due to depolarization and repolarization impairment. The measurement of 
QT interval indicates the total duration of ventricular myocardial depolarization and 
repolarization. Localized repolarization data can be obtained easily from the standard 12-
lead electrocardiogram (ECG), a non-invasive method extensively used as a tool for 
cardiovascular risk assessment. [1,2] Non-uniform myocardial repolarization time may 
result from inhomogeneity, variation of action potential duration between the individual 
leads of the 12-lead ECG, or localized delay in activation due to slow conduction or altered 
conduction pathways. To ensure the recording of the earliest depolarization at the latest 
repolarization of the ventricular myocardium, the maximum QT interval should be 
measured from the beginning of the earliest QRS complex to the end of the latest T wave 
from all leads of a simultaneous 12-lead ECG. Nevertheless, the QT interval may reflect 
increased inhomogeneity of myocardial repolarization, resulting from delayed 
repolarization in some areas of the myocardium, and it can be caused by a uniform increase 
in action potential duration. A measure that can help differentiate between these two 
conditions is the QT dispersion. Using both the QT prolongation and the QT dispersion the 
individual lead variation and the interlead variation provide a measure of repolarization 
heterogeneity. [3] 
The QT interval prolongation has been proposed as a marker of cardiovascular risk in the 
clinical setting and it has also been particularly associated with arrhythmias, sudden death 
and poor survival in apparently healthy subjects. [4,5] As for diabetic subjects, although 
some cross-sectional studies suggest that glycemic control, ischemic heart disease, and blood 
pressure, among other risk factors, are associated with the QT interval prolongation, its 
pathogenesis remains unclear. [6,8] Also, and increased mortality in newly diagnosed type 2 
diabetes patients has been associated with QT interval prolongation. [9,10] 
The aim of this study was to estimate the prevalence of QTc interval prolongation in diabetic 
and non-diabetic subjects, as well as to evaluate cross-sectionally and prospectively the 
associated risk factors of QTc interval prolongation and its clinical implications in subjects 
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with and without type 2 diabetes who had not suffered from previous myocardial infarction 
corroborated on the ECG.  
2. Methods 
The Mexico City Diabetes Study is a prospective, population-based investigation designed 
to describe the prevalence and incidence of diabetes and cardiovascular risk factors in low-
income urban population from Mexico City. The detailed methodology has been reported 
elsewhere. [11] Briefly, the sample size included 2282 men and non-pregnant women aged 
35 to 64 years who completed a baseline interview and physical examination in 1989-1990. 
Two follow-up visits were carried out in 1994-1996 (n=1773) and in 1998-2000 (n=1764). All 
evaluations included medical history, physical examination, ECG, and several laboratory 
tests. Current smoking was defined as at least one cigarette per day in the last year. Physical 
examination included an anthropometric evaluation with participants wearing lightweight 
clothing and no shoes. Height was measured using a stadiometer with subjects standing on 
the floor with the back against a wall; weight was measured using a clinical scale. Body 
mass index (BMI) was calculated as weight/height2 in kg/m2. Waist circumference (WC) 
was measured considering the umbilicus as the landmark. Systolic (SBP) and diastolic blood 
pressure (DBP) were measured 3 times in the right arm of seated subjects (after resting for at 
least 5 min) using a random zero sphygmomanometer (Hawksley, London). We used the 
average of the last 2 readings as the BP of the participants. Hypertension was defined as 
SBP140 mmHg, DBP90 mmHg, or treatment with antihypertensive drugs. In every visit, 
participants completed a 75-g oral glucose tolerance test. Diabetes was defined according to 
the World Health Organization criteria with a fasting glucose ≥7mmol/l (126 mg/dl), 2-
hour glucose ≥11.1 mmol/l (200 mg/dl), or treatment with oral antidiabetic drugs. [12] 
Fasting and 2-hour plasma glucose and insulin as well as fasting serum lipids and all other 
biomarkers were measured using previously reported methods [13] at the research 
laboratory of the Division of Clinical Epidemiology at the Medicine Department of the 
University of Texas Health Science Center at San Antonio, USA. Insulin resistance was 
estimated by the homeostasis model (HOMA-IR) as follows: [fasting insulin (units/ml) X 
fasting glucose (mmol/l)/22.5].  
A resting standard 12-lead ECG was taken with the subject in a supine position at each 
examination. A standard interpretation of ECGs at a reading center (Wake Forest 
University, EPICARE Center) was made using the Minnesota Code. [14] Heart rate (HR), 
QRS duration, R amplitude in AVL lead (R-AVL), S amplitude in V3 lead (SV3), left 
ventricular hypertrophy (LVH), QT interval, and myocardial infarction, among other 
variables, were coded. Left ventricular hypertrophy (LVH) was defined as (R-AVL) + (SV3) 
≥2600μv in men and ≥2200μv in women. Myocardial infaction was defined according to the 
following codes: Q-QS pattern with 1.1-1.2.7, Q-QS and T wave pattern 1.2.8-1.3, and wave T 
pattern with 5.1-5.3. QT interval was measured from the electrocardiogram tracing in lead II 
and defined as the first deflection of the QRS complex and the end as the point of maximal 
change in the slope as the T wave merges with the baseline. QT corrected (QTc) was 
calculated according to Bazzett’s formula as QT/square root of (R–R interval). The same 
measurement instruments were used throughout the study.  
The Institutional Review Boards of both The University of Texas Health Science Center and 
the Centro de Estudios en Diabetes approved the study protocol. Each participant gave 
informed consent. For this analysis, we included 1661 subjects, 218 with and 1443 without 
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type 2 diabetes, without myocardial infarction at baseline corroborrated by ECG, who were 
followed-up for a median of time of 4.26 and 3.32 years, respectively.  
2.1 Statistical analysis 
Comparisons of clinical and laboratory features were made according to diabetes status at 
baseline. Proportions and means (standard deviation [s.d.]) were compared by Pearson Chi2 
and by T student, respectively, while medians (interquartile range [IQR]) were compared by 
Wilcoxon test. QTc interval was analyzed as continuous and dichotomous variable. Because 
of the normal distribution of the QTc interval, all analyses were carried out using the 
original units. QTc interval prolongation, using the Bazzett´s formula, was defined as an 
interval ≥430 msec in men and 450 msec in women. Partial Pearson correlation between QTc 
interval and some risk factors were estimated in diabetic and non-diabetic subjects, 
separately. To estimate the association between some cardiovascular risk factors and QTc 
interval prolongation in diabetic and non-diabetic subjects, both together and separately, 
multiple linear regression for cross-sectional analysis and generalized estimating equations 
regression models (GEE), with family normal identity link, for longitudinal analysis were 
carried out. Models were performed with the forward method considering the biological 
and statistical relevance. Results are given as regression β coefficients and 95% confidence 
interval (95%CI). P value equal or less than 0.05 was considered significant. All analyses 
were done with Stata/SE 9.0 (Stata statistical software: Release 9. College Station. Texas: 
Stata Corporation, 2005). 
3. Results 
Characteristics of the sample 
A total of 1661 subjects (1443 non-diabetic and 218 diabetic subjects), aged 47.4±8.2 years at 
baseline were included. Table 1 shows comparisons of some QT interval risk factors 
between subjects with and without type 2 diabetes. Individuals with diabetes were older 
and had greater abdominal fat and upper-body fat accumulation, as well as higher BP levels, 
total cholesterol and fasting and 2-hour glucose levels compared with individuals without 
diabetes. The percentage of hypertension was higher for subjects with diabetes (27.1%) 
compared with non-diabetic subjects (13.0%); likewise, the proportion of individuals under 
antihypertensive medication was slightly greater in the diabetic group. Although the 
percentage of subjects who were under antihyperlipidemic medication was higher in 
subjects with diabetes compared with non-diabetic subjects, these differences were not 
significant. As for diabetic subjects, 136 (62.4%) were prevalent cases whereas 82 (37.6%) 
were incident cases, with a ratio 1:1.6. Mean of age at diagnosis of diabetes was 46.6 years 
(s.d. 8.0 years) and median of diabetes duration was 1.8 (IQR 25-75% 0-7.3).   
Some characteristic on the ECG were compared between diabetic and non-diabetic subjects 
at baseline and during follow-up and are shown in table 2. The mean of heart rate, QRS 
duration, and R amplitude in AVL lead were significant higher in diabetic compared with 
non-diabetic subjects. Mean of QTc by the Bazzet´s formula was significantly higher 
(p<0.001) in diabetic (414.0 msec) than in non-diabetic (404.3 msec) individuals. The 
prevalence of longer QTc interval (≥430 msec in men and ≥450 msec in women) was greater 
in diabetic (10.1%) compared with non-diabetic subjects (4.0%). Prevalence was remarkably 
higher in both diabetic and non-diabetic men (16.3% vs. 4.5%, p<0.001) compared with 
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with and without type 2 diabetes who had not suffered from previous myocardial infarction 
corroborated on the ECG.  
2. Methods 
The Mexico City Diabetes Study is a prospective, population-based investigation designed 
to describe the prevalence and incidence of diabetes and cardiovascular risk factors in low-
income urban population from Mexico City. The detailed methodology has been reported 
elsewhere. [11] Briefly, the sample size included 2282 men and non-pregnant women aged 
35 to 64 years who completed a baseline interview and physical examination in 1989-1990. 
Two follow-up visits were carried out in 1994-1996 (n=1773) and in 1998-2000 (n=1764). All 
evaluations included medical history, physical examination, ECG, and several laboratory 
tests. Current smoking was defined as at least one cigarette per day in the last year. Physical 
examination included an anthropometric evaluation with participants wearing lightweight 
clothing and no shoes. Height was measured using a stadiometer with subjects standing on 
the floor with the back against a wall; weight was measured using a clinical scale. Body 
mass index (BMI) was calculated as weight/height2 in kg/m2. Waist circumference (WC) 
was measured considering the umbilicus as the landmark. Systolic (SBP) and diastolic blood 
pressure (DBP) were measured 3 times in the right arm of seated subjects (after resting for at 
least 5 min) using a random zero sphygmomanometer (Hawksley, London). We used the 
average of the last 2 readings as the BP of the participants. Hypertension was defined as 
SBP140 mmHg, DBP90 mmHg, or treatment with antihypertensive drugs. In every visit, 
participants completed a 75-g oral glucose tolerance test. Diabetes was defined according to 
the World Health Organization criteria with a fasting glucose ≥7mmol/l (126 mg/dl), 2-
hour glucose ≥11.1 mmol/l (200 mg/dl), or treatment with oral antidiabetic drugs. [12] 
Fasting and 2-hour plasma glucose and insulin as well as fasting serum lipids and all other 
biomarkers were measured using previously reported methods [13] at the research 
laboratory of the Division of Clinical Epidemiology at the Medicine Department of the 
University of Texas Health Science Center at San Antonio, USA. Insulin resistance was 
estimated by the homeostasis model (HOMA-IR) as follows: [fasting insulin (units/ml) X 
fasting glucose (mmol/l)/22.5].  
A resting standard 12-lead ECG was taken with the subject in a supine position at each 
examination. A standard interpretation of ECGs at a reading center (Wake Forest 
University, EPICARE Center) was made using the Minnesota Code. [14] Heart rate (HR), 
QRS duration, R amplitude in AVL lead (R-AVL), S amplitude in V3 lead (SV3), left 
ventricular hypertrophy (LVH), QT interval, and myocardial infarction, among other 
variables, were coded. Left ventricular hypertrophy (LVH) was defined as (R-AVL) + (SV3) 
≥2600μv in men and ≥2200μv in women. Myocardial infaction was defined according to the 
following codes: Q-QS pattern with 1.1-1.2.7, Q-QS and T wave pattern 1.2.8-1.3, and wave T 
pattern with 5.1-5.3. QT interval was measured from the electrocardiogram tracing in lead II 
and defined as the first deflection of the QRS complex and the end as the point of maximal 
change in the slope as the T wave merges with the baseline. QT corrected (QTc) was 
calculated according to Bazzett’s formula as QT/square root of (R–R interval). The same 
measurement instruments were used throughout the study.  
The Institutional Review Boards of both The University of Texas Health Science Center and 
the Centro de Estudios en Diabetes approved the study protocol. Each participant gave 
informed consent. For this analysis, we included 1661 subjects, 218 with and 1443 without 
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type 2 diabetes, without myocardial infarction at baseline corroborrated by ECG, who were 
followed-up for a median of time of 4.26 and 3.32 years, respectively.  
2.1 Statistical analysis 
Comparisons of clinical and laboratory features were made according to diabetes status at 
baseline. Proportions and means (standard deviation [s.d.]) were compared by Pearson Chi2 
and by T student, respectively, while medians (interquartile range [IQR]) were compared by 
Wilcoxon test. QTc interval was analyzed as continuous and dichotomous variable. Because 
of the normal distribution of the QTc interval, all analyses were carried out using the 
original units. QTc interval prolongation, using the Bazzett´s formula, was defined as an 
interval ≥430 msec in men and 450 msec in women. Partial Pearson correlation between QTc 
interval and some risk factors were estimated in diabetic and non-diabetic subjects, 
separately. To estimate the association between some cardiovascular risk factors and QTc 
interval prolongation in diabetic and non-diabetic subjects, both together and separately, 
multiple linear regression for cross-sectional analysis and generalized estimating equations 
regression models (GEE), with family normal identity link, for longitudinal analysis were 
carried out. Models were performed with the forward method considering the biological 
and statistical relevance. Results are given as regression β coefficients and 95% confidence 
interval (95%CI). P value equal or less than 0.05 was considered significant. All analyses 
were done with Stata/SE 9.0 (Stata statistical software: Release 9. College Station. Texas: 
Stata Corporation, 2005). 
3. Results 
Characteristics of the sample 
A total of 1661 subjects (1443 non-diabetic and 218 diabetic subjects), aged 47.4±8.2 years at 
baseline were included. Table 1 shows comparisons of some QT interval risk factors 
between subjects with and without type 2 diabetes. Individuals with diabetes were older 
and had greater abdominal fat and upper-body fat accumulation, as well as higher BP levels, 
total cholesterol and fasting and 2-hour glucose levels compared with individuals without 
diabetes. The percentage of hypertension was higher for subjects with diabetes (27.1%) 
compared with non-diabetic subjects (13.0%); likewise, the proportion of individuals under 
antihypertensive medication was slightly greater in the diabetic group. Although the 
percentage of subjects who were under antihyperlipidemic medication was higher in 
subjects with diabetes compared with non-diabetic subjects, these differences were not 
significant. As for diabetic subjects, 136 (62.4%) were prevalent cases whereas 82 (37.6%) 
were incident cases, with a ratio 1:1.6. Mean of age at diagnosis of diabetes was 46.6 years 
(s.d. 8.0 years) and median of diabetes duration was 1.8 (IQR 25-75% 0-7.3).   
Some characteristic on the ECG were compared between diabetic and non-diabetic subjects 
at baseline and during follow-up and are shown in table 2. The mean of heart rate, QRS 
duration, and R amplitude in AVL lead were significant higher in diabetic compared with 
non-diabetic subjects. Mean of QTc by the Bazzet´s formula was significantly higher 
(p<0.001) in diabetic (414.0 msec) than in non-diabetic (404.3 msec) individuals. The 
prevalence of longer QTc interval (≥430 msec in men and ≥450 msec in women) was greater 
in diabetic (10.1%) compared with non-diabetic subjects (4.0%). Prevalence was remarkably 
higher in both diabetic and non-diabetic men (16.3% vs. 4.5%, p<0.001) compared with 
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 Non-diabetic subjects Diabetic subjects p value 
 n=1443 n=218  
Age (years) 46.6 (8.0) 52.5 (7.7) <0.001 
Age at diabetes diagnosis (years) - 47.8 (8.3) - 
Women (no., %) 848 (58.8) 138 (63.3) 0.204 
Current smoking (no., %) 487 (33.8) 65 (30.0) 0.269 
BMI (kg/m2) 28.0 (4.3) 29.1 (4.8) 0.001 
Waist circumference (cm)    
Men 93.6 (9.1) 98.8 (11.7) <0.001 
Women 97.8 (13.4) 101.6 (11.5) 0.002 
Hypertension (no., %) 188 (13.0) 61 (28.0) <0.001 
SBP (mmHg) 115.6 (16.1) 122.9 (18.6) <0.001 
DBP (mmHg) 72.5 (10.3) 75.4 (9.6) <0.001 
Total cholesterol (mmol/L)* 4.9 (4.2-5.6) 5.2 (4.5-5.9) <0.001 
HDL-C, (mmol/L)*    
Men 0.7 (0.6-0.9) 0.8 (0.7-0.9) 0.319 
Women 0.9 (0.7-1.0) 0.9 (0.7-1.0) 0.334 
Triglycerides (mmol/L)* 1.9 (1.4-2.8) 2.5 (1.8-3.6) <0.001 
Fasting glucose (mmol/L)* 4.7 (4.2-5.1) 8.9 (6.6-13.5) <0.001 
2-hour glucose (mmol/L)* 5.7 (4.6-6.8) 14.1 (11.6-18.8) <0.001 
Antihypertensive medication (no., %)† 67 (35.6) 27 (44.3) 0.227 
Antihyperlipidemic medication (no., %) 4 (0.3) 1 (0.5) 0.638 
Diabetes cases    
Prevalent - 136 (62.4) - 
Incident - 82 (37.6) - 
Hypoglycemic medication (no., %) - 143 (65.9) - 
Diabetes duration (years)* - 1.8 (0-7.3) - 
Duration of follow-up (years)* 3.32 (3.15-3.74) 4.26 (4.00-4.44) 0.0001 
*Median (IQR 25-75). 
†Only subjects with hypertension. 
Missing values in non-diabetic subjects: WC, 26; HDL-C, 2; 2-hour glucose, 1; antihyperlipidemic 
medication, 37.  
Missing values in diabetic subjects: current smoking, 1; WC, 3; triglycerides, 2; 2-hour glucose, 122; 
antihyperlipidemic medication, 9. 
Table 1. Characteristic of the study population by diabetes status 
women (6.5% vs. 3.7%, p>0.05). Similar differences were observed on the QTc interval as 
continuous and dichotomous variable during the follow-up. In addition, after stratifying by 
hypertension, prevalence of longer QTc interval was significantly higher in both diabetic 
(13.3%) and non-diabetic subjects (5.2%) with hypertension compared with diabetic (8.9%) 
and non-diabetic subjects (3.8%) without hypertension. When stratification was made by 
BMI<25 and BMI≥25, prevalence remained significantly higher in diabetic compared with 
non-diabetic subjects with normal weight (14% vs. 1.8%, respectively) and with 
overweigh/obesity (9.1% vs. 4.7%, respectively). 
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 Non-diabetic subjects Diabetic subjects p value 
 n=1443 mean (s.d.) 
n=218 
mean (s.d.)  
At baseline    
Heart rate (bpm) 65.2 (9.2) 70.9 (12.0) <0.001 
QRS duration (msec) 90.9 (10.4) 88.9 (10.7) 0.007 
R amplitude in AVL lead 294.4 (239.8) 346.8 (270.5) 0.003 
S amplitude in V3 lead 879.9 (523.3) 917.2 (545.1) 0.330 
LVH, no (%) 33 (2.3) 6 (2.8) 0.672 
QT interval (msec) 390.0 (25.4) 384.3 (28.5) 0.002 
QTc interval by the Bazzett´s formula 
(msec)  404.3 (22.5) 414.5 (23.8) <0.001 
QTc interval by the Bazzett´s formula ≥430 
in men and ≥450 in women (no., %)  58 (4.0) 22 (10.1) <0.001 
At the end of follow-up    
Heart rate (bpm) 62.8 (9.5) 66.6 (9.4) <0.0001 
QRS duration (msec) 89.9 (10.9) 88.0 (15.2) 0.027 
R amplitude in AVL lead 338.5 (224.5) 369.0 (233.4) 0.063 
S amplitude in V3 lead 815 (434.7) 880.3 (503.5) 0.045 
LVH, no (%) 20 (1.4) 6 (2.8) 0.130 
QTc interval by the Bazzett´s formula 
(msec)  406.7 (22.3) 416.1 (21.6) <0.001 
QTc interval by the Bazzett´s formula ≥430 
in men and ≥450 in women (no., %)      77 (5.3) 20 (9.2) 0.024 
Missing values in non-diabetic subjects: S amplitude in V3 lead 1. 
Bazzett´s formula: QT/square root of (R–R interval). 
Table 2. QTc interval segment and other electrocardiographic parameters in subjects with 
and without type 2 diabetes  
Figure 1 shows the relation between QTc interval and BMI in subjects with and without type 
2 diabetes according to age. The values of QTc interval were slightly greater in subjects with 
greater BMI in both diabetic and non-diabetic individuals, regardless of age group. A 
similar trend was observed when BMI was substituted for WC. (Data not shown) 
As for fasting glucose in diabetic subjects, a slight increment in the QTc interval was 
observed in subjects with higher levels of fasting glucose, particularly in subjects with levels 
between 12 mmol/l and 20 mmol/l. (Figure 2) For non-diabetic subjects, a modest 
increment in the QTc interval was observed when 2-hour glucose (≥6 mmol/l) and HOMA-
IR (≥10 units) increased (Figure 3).       
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medication, 37.  
Missing values in diabetic subjects: current smoking, 1; WC, 3; triglycerides, 2; 2-hour glucose, 122; 
antihyperlipidemic medication, 9. 
Table 1. Characteristic of the study population by diabetes status 
women (6.5% vs. 3.7%, p>0.05). Similar differences were observed on the QTc interval as 
continuous and dichotomous variable during the follow-up. In addition, after stratifying by 
hypertension, prevalence of longer QTc interval was significantly higher in both diabetic 
(13.3%) and non-diabetic subjects (5.2%) with hypertension compared with diabetic (8.9%) 
and non-diabetic subjects (3.8%) without hypertension. When stratification was made by 
BMI<25 and BMI≥25, prevalence remained significantly higher in diabetic compared with 
non-diabetic subjects with normal weight (14% vs. 1.8%, respectively) and with 
overweigh/obesity (9.1% vs. 4.7%, respectively). 
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Table 2. QTc interval segment and other electrocardiographic parameters in subjects with 
and without type 2 diabetes  
Figure 1 shows the relation between QTc interval and BMI in subjects with and without type 
2 diabetes according to age. The values of QTc interval were slightly greater in subjects with 
greater BMI in both diabetic and non-diabetic individuals, regardless of age group. A 
similar trend was observed when BMI was substituted for WC. (Data not shown) 
As for fasting glucose in diabetic subjects, a slight increment in the QTc interval was 
observed in subjects with higher levels of fasting glucose, particularly in subjects with levels 
between 12 mmol/l and 20 mmol/l. (Figure 2) For non-diabetic subjects, a modest 
increment in the QTc interval was observed when 2-hour glucose (≥6 mmol/l) and HOMA-
IR (≥10 units) increased (Figure 3).       
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Fig. 1. Comparison between QTc interval level and BMI at baseline in subjects with and without 
type 2 diabetes stratifying by age <50 (upper panel) years and ≥50 years (bottom panel). 
In diabetic subjects, partial Pearson correlations with QTc interval were statistically 
significant for age (rho=0.15, p=0.024), BMI (rho=0.19, p=0.006), and WC (rho=0.20, 
p=0.003). No significant correlation with diabetes duration was observed. In non-diabetic 
subjects, correlations with QTc interval were significant for age (rho=0.16, p<0.0001), SPB 
(rho=0.10, p=0.0002), DBP (rho=0.07, p=0.008), BMI (rho=0.23, p<0.0001), and WC (rho=0.21, 
p<0.0001). During follow-up, the correlation of QTc interval with BMI and WC remained 
significant (p<0.001) in both diabetic (BMI, rho=0.24 and WC, rho=0.25) and non-diabetic 
individuals (BMI, rho =0.23 and WC, rho=0.26). 
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Fig. 2. Comparison between QTc interval level and fasting glucose level at baseline in 
subjects with type 2 diabetes. 
Cross-sectional analysis 
In the whole sample, QTc interval prolongation was significantly associated with age, sex, 
BMI, and diabetes. For each unit of change on age (year), the QTc interval increased 0.36 
msec (95%CI 0.23; 0.49). For each unit of increment on BMI, the QTc interval increased 0.75 
msec (95%CI 0.51; 1.00). Women had a greater QTc interval mean than men (difference of 
13.36 msec (95%CI 11.36; 15.76). Regarding diabetes, the difference on the QTc interval 
between diabetic and non-diabetic subjects was 6.33 msec (95%CI 3.24; 9.43). Models 
stratified by diabetes status were also performed. In diabetic subjects, risk factors 
significantly associated with QTc interval were sex and BMI, whereas age had a borderline 
significance. For each unit of increment on BMI, the QTc interval increased 0.72 msec (95%CI 
0.07; 1.37). Women had a greater QTc interval than men (difference of 15.93 msec, 95%CI 
9.50; 22.35). In non-diabetic subjects, risk factors significantly associated with QTc interval 
were age (beta=0.35, 95%CI 0.21; 0.50), sex (beta=13.69, 95%CI 11.27; 16.10), BMI (beta=0.62, 
95%CI 0.33; 0.91), hypertension (beta=4.18, 95%CI 0.14; 8.22), and HOMA-IR (beta=0.43, 
95%CI 0.08; 0.78) (Table 3). 
Longitudinal analysis  
When the whole sample was considered, the progression of QTc interval prolongation was 
significantly associated with age, sex, BMI, hypertension, and diabetes. The QTc interval 
prolongation increased with age (beta= 0.33, 95%CI 0.24; 0.42) and BMI (beta= 0.73, 95%CI 
0.56; 0.90). Women had a greater QTc interval prolongation than men (difference of 11.84 
msec, 95%CI 10.09; 13.59), as did diabetic compared with non-diabetic subjects (difference of 
6.58 msec, 95%CI 4.02; 9.13). In a model restricted to diabetic subjects, the QTc interval was 
predicted by sex (beta= 11.18, 95%CI 6.27; 16.10), BMI (beta= 0.84, 95%CI 0.38; 1.30), and 
fasting glucose (beta= 0.42, 95%CI 0.11; 0.74). In non-diabetic subjects, predictors of QTc 
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Fig. 1. Comparison between QTc interval level and BMI at baseline in subjects with and without 
type 2 diabetes stratifying by age <50 (upper panel) years and ≥50 years (bottom panel). 
In diabetic subjects, partial Pearson correlations with QTc interval were statistically 
significant for age (rho=0.15, p=0.024), BMI (rho=0.19, p=0.006), and WC (rho=0.20, 
p=0.003). No significant correlation with diabetes duration was observed. In non-diabetic 
subjects, correlations with QTc interval were significant for age (rho=0.16, p<0.0001), SPB 
(rho=0.10, p=0.0002), DBP (rho=0.07, p=0.008), BMI (rho=0.23, p<0.0001), and WC (rho=0.21, 
p<0.0001). During follow-up, the correlation of QTc interval with BMI and WC remained 
significant (p<0.001) in both diabetic (BMI, rho=0.24 and WC, rho=0.25) and non-diabetic 
individuals (BMI, rho =0.23 and WC, rho=0.26). 
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Fig. 2. Comparison between QTc interval level and fasting glucose level at baseline in 
subjects with type 2 diabetes. 
Cross-sectional analysis 
In the whole sample, QTc interval prolongation was significantly associated with age, sex, 
BMI, and diabetes. For each unit of change on age (year), the QTc interval increased 0.36 
msec (95%CI 0.23; 0.49). For each unit of increment on BMI, the QTc interval increased 0.75 
msec (95%CI 0.51; 1.00). Women had a greater QTc interval mean than men (difference of 
13.36 msec (95%CI 11.36; 15.76). Regarding diabetes, the difference on the QTc interval 
between diabetic and non-diabetic subjects was 6.33 msec (95%CI 3.24; 9.43). Models 
stratified by diabetes status were also performed. In diabetic subjects, risk factors 
significantly associated with QTc interval were sex and BMI, whereas age had a borderline 
significance. For each unit of increment on BMI, the QTc interval increased 0.72 msec (95%CI 
0.07; 1.37). Women had a greater QTc interval than men (difference of 15.93 msec, 95%CI 
9.50; 22.35). In non-diabetic subjects, risk factors significantly associated with QTc interval 
were age (beta=0.35, 95%CI 0.21; 0.50), sex (beta=13.69, 95%CI 11.27; 16.10), BMI (beta=0.62, 
95%CI 0.33; 0.91), hypertension (beta=4.18, 95%CI 0.14; 8.22), and HOMA-IR (beta=0.43, 
95%CI 0.08; 0.78) (Table 3). 
Longitudinal analysis  
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6.58 msec, 95%CI 4.02; 9.13). In a model restricted to diabetic subjects, the QTc interval was 
predicted by sex (beta= 11.18, 95%CI 6.27; 16.10), BMI (beta= 0.84, 95%CI 0.38; 1.30), and 
fasting glucose (beta= 0.42, 95%CI 0.11; 0.74). In non-diabetic subjects, predictors of QTc 
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Table 3. Risk factors associated with the QT interval prolongation in subjects with and 
without type 2 diabetes. Cross-sectional analysis 
interval prolongation were age (beta=0.34, 95%CI 0.25; 0.44), sex (beta=12.23, 95%CI 10.29; 
14.18), BMI (beta=0.64, 95%CI 0.44; 0.83), hypertension (beta=3.72, 95%CI 1.57; 5.87), 
HOMA-IR (beta=0.45, 95%CI 0.16; 0.75) (Table 4). Antihypertensive therapy had a negative 
effect in QTc prolongation. In a multivariate model with diabetes duration equal or greater 
than 1 year, the increment of QT interval prolongation remained similar for fasting glucose 
(beta=0.38, 95%CI 0.06; 0.70, p=0.021), whereas a significant increment with diabetes 
duration was observed (beta=0.42, 95%CI 0.04; 0.80, p=0.032). (Data not shown)  
4. Discussion 
The methods used in the Mexico City Diabetes Study meet the accepted international 
criteria in terms of study protocol,  diagnostic algorithms, and particularly 
electrocardiographic interpretations. [11] The ECGs were interpreted without disclosure of 
clinical or laboratory data, in a reference center recognized as a gold standard for this 
procedure. A rigorous quality control procedure was followed along the study. In this 
population, there is a high prevalence of cardiovascular risk factors, namely overweight, 
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(0.56; 0.90) <0.0001 
Hypertension 3.72  (1.57; 5.87) 0.001 
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(0.74; 4.52) 0.006 
Fasting glucose  
(mmol/L) - - 
0.42 
(0.11; 0.74) 0.009 - - 
HOMA-IR 0.45  (0.16; 0.75) 0.002 - - - - 
Diabetes - - - - 6.58  (4.02; 9.13) <0.0001 
Diabetes duration 
(years) - - 
0.24  




(-6.50; -0.64) 0.017 - - 
-1.27  
(-3.78; 1.24)  
Hypoglycemic 
medication - - 
-3.00  
(-8.41; 2.41) 0.277 - - 
Models were run by using generalized estimating equations with family normal and identity link. 
Table 4. Risk factors associated with the QT interval prolongation in subjects with and 
without type 2 diabetes. Longitudinal analysis 
obesity, diabetes, hypertension, and dyslipidemia. [15-17] This circumstance offers a unique 
opportunity to study the effect of the above-mentioned factors on the QTc interval as a 
proxy for the repercussions of the electrophysiologic phenomena on the heart cycle. Our 
findings clearly show the deleterious effects of the identified cardiovascular risk factors on 
the QTc interval, particularly those related to insulin resistance.  
In the present study, prevalence of QTc interval prolongation was higher in diabetic that in 
non-diabetic subjects without previous myocardial infarction detected by ECG, 
independently of age and sex. As expected, subjects with diabetes had 6 times the risk of 
developing QTc interval prolongation compared with non-diabetic subjects. In multivariate 
models, QTc interval prolongation was consistently predicted by sex, BMI, and fasting 
glucose in diabetic subjects. In non-diabetic subjects, age, sex, BMI, hypertension, HOMA-
IR, and antihypertensive medication predicted QTc interval prolongation. In both groups, 
results were largely unchanged when WC was used in place of BMI, or when 2-hour glucose 
was included instead of fasting and HOMA-IR in diabetic and non-diabetic subjects, 
respectively. 
Several studies have demonstrated that the prevalence of prolonged QTc interval is higher 
in subjects with type 2 diabetes (26%) than in subjects without. [18-21] Also, the QTc interval 
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prolongation has been associated with a high risk of ischemic heart disease, ventricular 
fibrillation, and sudden death (range 2 to 5) in several studies, even in subjects with short 
duration of diabetes. [10] In our study, we observed a significantly higher proportion of 
prolonged QTc interval in diabetic compared with non-diabetic subjects (10.1% vs. 4.0%). 
After adjustment for other risk factors, the mean difference on the QTc interval between 
diabetic and non-diabetic subjects was 6.33 msec. It has been suggested that this difference 
relates to the sympathetic activity present in diabetes, which reduces both the ability to 
regulate heart rate and the heart rate variability. [19,20]  
As for diabetes duration, it has been reported as a risk factor for chronic complications, 
including QTc interval prolongation, the latter being related to neuropathy in subjects with 
diabetes. [19] In our study, neither at baseline nor at follow-up duration of diabetes was 
significantly associated with QTc interval, which could be explained, in part, by the high 
proportion of new cases at baseline (37.6%). When the analysis was restricted to subjects 
with diabetes duration equal or greater than 1 year, QTc interval prolongation was 
predicted by duration, independently of other risk factors, despite the short median 
duration of the disease in subjects with previous diagnosis of diabetes (median 5.4 years, 
IQR 2.1-10.6). 
We found a significant prospective association between fasting plasma glucose and 
prolonged QTc interval in diabetic subjects, even after adjustment for other risk factors. 
Some studies have reported an association between fasting glucose and QTc interval, 
particularly in individuals in the normal high level or with impaired fasting glucose, after 
adjustment for diabetes duration, among other risk factors. [21-22] However, other studies 
have not found any significant association. [23] As for non-diabetic subjects, we noted an 
independent association between HOMA-IR and QT-interval prolongation. These results 
showed an important degree of insulin resistance, maybe related to overweight and obesity 
in this population, and both predicted QTc interval prolongation. No association was 
observed with fasting plasma glucose in this group. By contrast, previous studies have 
reported an association between plasma glucose and QT interval in healthy subjects [24], 
even after hyperglycemic clamp insulin release, which suggests that the effect of glucose on 
the QTc interval is not mediated by insulin.  
The association of higher BMI with the prolongation of the QTc interval observed in the 
non-diabetic group is not clearly seen in the diabetic group, probably because of the effect of 
weight loss as a result of poor metabolic control. It is particularly interesting the finding that 
HOMA-IR index has a significant association with the prolongation of the QTc duration in 
both the cross-sectional and the prospective analyses. The pathophysiologic implications 
direct our attention to the cellular effects of insulin resistance in the electrophysiology that 
mediates the depolarization and repolarization of the myocardium. Somewhat surprisingly, 
we could not show a demonstrable effect of therapy for diabetes or hypertension in the QTc 
duration. 
Some of the limitations with the QT interval evaluation relate to the lack of accuracy and 
reproducibility of the measurements, since there is no standard method for analysis and 
lead selection. The definition for the end of the QT interval is unclear as well, and may 
represent a changing T wave morphology that could provide a measure of altered disparity 
of repolarization. [25,26] Nevertheless, its application as a non-invasive and cost-effective 
screening tool is invaluable for cardiovascular risk stratification of population. On the other 
hand, because of the lack of QT interval dispersion measurement in this study, we were not 
able to determine the type of variation on repolarization.  
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opportunity to study the effect of the above-mentioned factors on the QTc interval as a 
proxy for the repercussions of the electrophysiologic phenomena on the heart cycle. Our 
findings clearly show the deleterious effects of the identified cardiovascular risk factors on 
the QTc interval, particularly those related to insulin resistance.  
In the present study, prevalence of QTc interval prolongation was higher in diabetic that in 
non-diabetic subjects without previous myocardial infarction detected by ECG, 
independently of age and sex. As expected, subjects with diabetes had 6 times the risk of 
developing QTc interval prolongation compared with non-diabetic subjects. In multivariate 
models, QTc interval prolongation was consistently predicted by sex, BMI, and fasting 
glucose in diabetic subjects. In non-diabetic subjects, age, sex, BMI, hypertension, HOMA-
IR, and antihypertensive medication predicted QTc interval prolongation. In both groups, 
results were largely unchanged when WC was used in place of BMI, or when 2-hour glucose 
was included instead of fasting and HOMA-IR in diabetic and non-diabetic subjects, 
respectively. 
Several studies have demonstrated that the prevalence of prolonged QTc interval is higher 
in subjects with type 2 diabetes (26%) than in subjects without. [18-21] Also, the QTc interval 
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prolongation has been associated with a high risk of ischemic heart disease, ventricular 
fibrillation, and sudden death (range 2 to 5) in several studies, even in subjects with short 
duration of diabetes. [10] In our study, we observed a significantly higher proportion of 
prolonged QTc interval in diabetic compared with non-diabetic subjects (10.1% vs. 4.0%). 
After adjustment for other risk factors, the mean difference on the QTc interval between 
diabetic and non-diabetic subjects was 6.33 msec. It has been suggested that this difference 
relates to the sympathetic activity present in diabetes, which reduces both the ability to 
regulate heart rate and the heart rate variability. [19,20]  
As for diabetes duration, it has been reported as a risk factor for chronic complications, 
including QTc interval prolongation, the latter being related to neuropathy in subjects with 
diabetes. [19] In our study, neither at baseline nor at follow-up duration of diabetes was 
significantly associated with QTc interval, which could be explained, in part, by the high 
proportion of new cases at baseline (37.6%). When the analysis was restricted to subjects 
with diabetes duration equal or greater than 1 year, QTc interval prolongation was 
predicted by duration, independently of other risk factors, despite the short median 
duration of the disease in subjects with previous diagnosis of diabetes (median 5.4 years, 
IQR 2.1-10.6). 
We found a significant prospective association between fasting plasma glucose and 
prolonged QTc interval in diabetic subjects, even after adjustment for other risk factors. 
Some studies have reported an association between fasting glucose and QTc interval, 
particularly in individuals in the normal high level or with impaired fasting glucose, after 
adjustment for diabetes duration, among other risk factors. [21-22] However, other studies 
have not found any significant association. [23] As for non-diabetic subjects, we noted an 
independent association between HOMA-IR and QT-interval prolongation. These results 
showed an important degree of insulin resistance, maybe related to overweight and obesity 
in this population, and both predicted QTc interval prolongation. No association was 
observed with fasting plasma glucose in this group. By contrast, previous studies have 
reported an association between plasma glucose and QT interval in healthy subjects [24], 
even after hyperglycemic clamp insulin release, which suggests that the effect of glucose on 
the QTc interval is not mediated by insulin.  
The association of higher BMI with the prolongation of the QTc interval observed in the 
non-diabetic group is not clearly seen in the diabetic group, probably because of the effect of 
weight loss as a result of poor metabolic control. It is particularly interesting the finding that 
HOMA-IR index has a significant association with the prolongation of the QTc duration in 
both the cross-sectional and the prospective analyses. The pathophysiologic implications 
direct our attention to the cellular effects of insulin resistance in the electrophysiology that 
mediates the depolarization and repolarization of the myocardium. Somewhat surprisingly, 
we could not show a demonstrable effect of therapy for diabetes or hypertension in the QTc 
duration. 
Some of the limitations with the QT interval evaluation relate to the lack of accuracy and 
reproducibility of the measurements, since there is no standard method for analysis and 
lead selection. The definition for the end of the QT interval is unclear as well, and may 
represent a changing T wave morphology that could provide a measure of altered disparity 
of repolarization. [25,26] Nevertheless, its application as a non-invasive and cost-effective 
screening tool is invaluable for cardiovascular risk stratification of population. On the other 
hand, because of the lack of QT interval dispersion measurement in this study, we were not 
able to determine the type of variation on repolarization.  
 




In this study, in addition to specific cardiovascular risk factors associated with the QTc 
interval prolongation in diabetic and non-diabetic subjects, general excess of body weight 
measured by BMI was a significant risk factor for both groups. Our findings clearly show 
the deleterious effects of the identified cardiovascular risk factors on the QTc interval, 
particularly those related to insulin resistance. In diabetic subjects, the lack of metabolic 
control (measured by fasting glucose level) predicted strongly the QTc prolongation, 
whereas in non-diabetic subjects the presence of insulin resistance (HOMA-IR) predicted it. 
Given the cardiovascular clinical implications of QTc interval in subjects with and without 
diabetes, further interventional researches are needed to confirm whether the metabolic 
control in diabetic subjects and the decrease of insulin resistance in non-diabetic subjects 
together with weight reduction can prevent QTc interval prolongation.  
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The Prevalence and Prognostic Value of 
Rest Premature Ventricular Contractions 




This chapter discusses research conducted to evaluate the prognostic significance of 
premature ventricular contractions (PVCs) on a routine electrocardiogram (ECG), and to 
evaluate their relationship to heart rate, heart failure and sport participation. Identifying 
parameters to help risk stratify patients and provide prognostic implications can help 
identify individuals who may benefit from early diagnosis and intervention. Our discussion 
utilizes research from a large database of computerized 12-lead ECGs, including 45,402 
members of the US Veterans Administration, of which 352 were known to have heart 
failure. In addition, 750 athletes were analyzed. Echocardiograms and treadmill tests were 
performed on all those with heart failure and echocardiograms were part of the annual 
physical exam of the college athletes.  
Briefly, there were 1731 patients with PVCs (3.8%) in the total veteran population. Twenty-
nine of the 352 with heart failure exhibited a PVC (8%) and 5 of the 750 athletes exhibited a 
PVC (0.7%). Compared to patients without PVCs, those with PVCs had significantly higher 
all-cause (39% vs. 22%, p<0.001) and cardiovascular mortality (20% vs. 8%, p<0.001). PVCs 
remain a significant predictor even after adjustment for age and other ECG abnormalities. 
The presence of multiple PVCs or complex morphologies did not add significant additional 
prognostic information. Those patients with PVCs had a significantly higher heart rate than 
those without PVCs (meanSD: 78.615 vs. 73.516 bpm, p<0.001). When patients were 
divided into groups by heart rate (<60, 60-79, 80-99 and >100 bpm) and by the presence or 
absence of PVCs, mortality increased progressively with heart rate and doubled with the 
presence of PVCs. Using regression analysis, heart rate was demonstrated to be an 
independent and significant predictor of PVCs. 
We identified 352 patients (64 ± 11 years; 7 females) with a history of clinical HF undergoing 
treadmill testing for clinical reasons at the VAPAHCS (1987-2007). Patients with rest PVCs 
were defined as having ≥1 PVC on the ECG prior to testing (n=29; 8%).During a median 
follow-up period of 6.2 years, there were 178 deaths of which 76 (42.6%) were due to CV 
causes. At baseline, compared to patients without rest PVCs, those with rest PVCs had a 
lower ejection fraction (EF) (30% vs. 45%) and the prevalence of EF≤35% was higher (75% vs. 
41%). They were more likely to have smoked (76% vs. 55%).The all-cause and CV mortality 
rates were significantly higher in the rest PVCs group (72% vs. 49%, p=0.01 and 45% vs. 
20%, p=0.002; respectively). After adjusting for age, beta-blocker use, rest ECG findings, 
resting heart rate (HR), EF, maximal systolic blood pressure, peak HR and exercise capacity, 
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rest PVCs was associated with a 5.5 –fold increased risk of CV mortality (p=0.004). 
Considering the presence of PVCs during exercise and/or recovery did not affect our results. 
All five athletes with at least one PVC on a routine screening ECG as part of the annual 
physical exams had normal echocardiograms and no clinical manifestations of heart disease. 
Thus, we concluded that PVCs on a resting ECG are a significant and independent predictor 
of all-cause and cardiovascular mortality. Increased heart rate predicts mortality in patients 
with and without PVCs and the combination dramatically increases mortality. These 
findings together with the demonstrated independent association of heart rate with PVCs 
suggest that a hyper-adrenergic state is present in patients with PVCs and that it likely 
contributes to their adverse prognosis. In patients with heart failure the presence of PVCs on 
a resting ECG is associated with a significant increase in risk of CV death independent of 
age and exercise capacity. PVCs are rare in young athletes and do not appear to be 
associated with cardiac disease. 
2. Background 
Premature ventricular contractions (PVCs) are common electrocardiographic findings in 
patients with and without structural heart disease. Prior evidence suggests that the presence 
of PVCs has prognostic value but it is unclear what underlying process they represent. A 
surprising observation in some studies has been an apparent association between higher 
mean resting heart rates and the presence of PVCs. Activation of the sympathetic nervous 
system is an important factor in the genesis of ventricular arrhythmias (Anderson, 2003; 
Podrid, Fuchs & Candinas, 1990). Enhanced automaticity, triggered activity, and reentry are 
all mechanisms generating rhythm abnormalities; all three mechanisms are markedly 
potentiated by the action of catecholamines. We sought to make use of our large database of 
electrocardiogram (ECG) data to confirm the prognostic significance of PVCs and analyze 
the interaction between heart rate and PVCs. We hypothesized that both elevated heart rate 
and the presence of PVCs are markers of sympathetic nervous system (SNS) activity and 
would, therefore, be correlated with each other and predictive of mortality. This would 
support the other lines of evidence suggesting that the sympathetic nervous system is active 
in the genesis of PVCs.  
3. Research methods 
3.1 Study population 
All initial ECGs of consecutive veterans (outpatient and inpatient) who obtained ECGs for 
any reason at the Palo Alto VA Medical Center from April 1987 until December 1999 were 
considered in the study. From these 46,959 ECGs, those with atrial fibrillation and paced 
rhythms were excluded, leaving 45,402 for analysis.  
3.2 Electrocardiography 
Computerized 12-lead resting 10-second ECG recordings were digitally recorded on the 
Marquette MAC system. Only the initial ECG was considered for patients with multiple 
ECGs in the database. Most of the ECG analysis was performed using the GE/Marquette 
ECG analysis program (www.gemedicalsystems.com). PVCs were defined as at least one 
QRS complex that was premature, ectopic shaped and had a QRS duration of greater than 
120 ms. All ECGs classified as having PVCs were manually over-read by two cardiologists. 
 
The Prevalence and Prognostic Value of Rest Premature Ventricular Contractions 
 
29 
Of the ECGs originally classified as having PVCs present, 14% were found to be 
misclassified as having PVCs when none were present. The most common reason for these 
errors was misclassification of artifact or of aberrantly-conducted supraventricular beats. All 
the misclassified patients were reclassified into the ‘PVC absent’ group, leaving 1731 
patients for analysis in the ‘PVC present’ group.  
The ‘PVC present’ ECGs were then reviewed to categorize the patterns and morphologic 
characteristics of confirmed PVCs. These characteristics included presence of multiple PVCs 
on a single 10-sec ECG, presence of couplets or salvos (≥3 consecutive PVCs), presence of 
bigeminal or trigeminal rhythm, and presence of multiform PVC morphologies. For the 
purposes of this study, complex PVCs were defined as repetitive PVCs (≥2 consecutive) and 
multiform morphologies. Non-sustained ventricular tachycardia was rarely documented on 
these short recordings and the few short runs of 3 or more consecutive beats were not 
analyzed separately.  
Heart rate was determined by the program by counting all QRS complex templates in 10 
seconds and multiplying by six. When PVCs were present, the R-R interval between the 
normal, dominant sinus QRS complexes (NN) was manually measured except when the 
pattern of PVCs made it impossible (i.e., bigeminy). This NN interval was used to calculate 
the intrinsic sinus rate. 
An ‘abnormal’ ECG was defined as the presence of one or more of the following: pathologic 
Q waves, left or right bundle branch block, intraventricular conduction delay, Wolff-
Parkinson-White syndrome, right or left ventricular hypertrophy (Romhilt-Estes), left atrial 
enlargement, or abnormal ST segments. All remaining ECGs were classified as ‘normal’. 
3.3 Follow-up 
The Social Security Death Index and California Health Department Service were used to 
ascertain vital status as of 12/31/00. Cause of death was available from the latter and deaths 
determined by the Social Security Death Index were classified by review of the Veteran’s 
Affairs clinical data base. All-cause death and cardiovascular death were used as endpoints. 
Mean follow-up was 5.5 years. Data regarding cardiac interventions or events was not 
available.  
3.4 Statistical methods 
Number Crunching System SoftwareÔ (Kaysville, UT) was used for all statistical analyses 
after transferring the data from a Microsoft ACCESS (Redmond, WA) database. Unpaired 
two-tailed t tests were used for univariate comparison of variables. Cox proportional hazard 
analysis was performed to evaluate those with and without PVCs and those with multiple 
and complex PVCs. Multivariate Cox hazard function analysis was performed to 
demonstrate if the various PVC characteristics were independently and significantly 
associated with time until death after considering age and other ECG abnormalities. 
Analysis was repeated using data from only those patients with normal ECGs. Kaplan Meier 
survival analysis was again performed after patients were divided into groups by heart rate 
(<60, 60-79, 80-99 and >100 bpm) and by the presence or absence of PVCs. Multivariate 
regression analysis was performed with heart rate as the dependent variable and with the 
following independent variables: age, gender, abnormal/normal ECG classification, in- or 
outpatient status and PVCs present or not. Logistic regression was performed with PVCs as 
the dependent variable and with the following independent variables: age, gender, 
abnormal/normal ECG classification, PVCs present or absent and in- or outpatient status.  
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After exclusion of patients with atrial fibrillation and paced rhythms, there were 43,671 
patients without PVCs and 1731 patients with PVCs (3.8%). Demographic and ECG 
characteristics of the groups are shown in Table I. The group with PVCs was older than 
those without PVCs (mean age  SD: 65  12 vs. 56  15, P<0.001). As this was a VA study, 
the patients are 90% male but there was a slightly higher percentage of men among those 
with PVCs (90% vs. 94%, p=0.01). There were no significant differences between height, 
weight or BMI. Patients with PVCs had a significantly higher prevalence of Q waves, LVH, 
LAE, bundle branch blocks and ECGs classified as abnormal. Of the ECG characteristics 
evaluated, only RVH was similar between the groups. 
 






Age 56±15 56±15 65±12 <0.001 
Males 90.0% 90% 94% 0.01 
Height 69±4 69±4 69±4 0.3 
Weight 182 ± 40 182 ± 40 184 ± 41 0.1 
BMI 27±6 27±6 27±6 0.4 
Outpatients 73% 73% 70% 0.004 
ECG Findings 
Heart rate 73.7 ± 16 73.5 ± 16 78.6 ± 15 <0.001 
Q Wave 13% 11% 23% <0.001 
LVH 5% 5% 8 % <0.001 
RVH 0.3% 0.3% 0.3% 0.6 
RBBB 4% 3% 7% <0.001 
LBBB 1% 1% 3% <0.001 
LAE 4% 3.8% 10.7% <0.001 
Abnormal ECG 24% 23% 43% <0.001 
Age, height (inches), weight (pounds), BMI and heart rate are presented as the mean ± SEM. 
BMI = body mass index; ECG = electrocardiogram; LAE = left atrial enlargement; LBBB = left bundle 
branch block; LVH = left ventricular hypertrophy; PVC = premature ventricular contraction; RBBB = 
right bundle branch block; RVH = right ventricular hypertrophy 
Table I. Demographics and ECG findings in patients with and without PVCs. 
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Those patients with PVCs had a significantly higher heart rate than those without PVCs 
(mean  SD: 78.6  15 vs. 73.5  16 bpm, P<0.001). This heart rate difference persisted when 
patients were sub-grouped by gender, race, outpatient vs. inpatient status and those with 
otherwise normal ECGs (i.e., least likely to have structural heart disease). Those patients 
with PVCs always had a significantly higher mean heart rate. Further analysis of heart rate 
differences showed that women had a significantly lower mean HR than men (71.1 ± 13.7 vs 
74.0 ± 16.2, p<0.001), outpatients had a lower mean heart rate than inpatients (72.5 ± 15.0 vs 
76.9 ± 17.7, p<0.001), and those with an otherwise normal ECG had a lower heart rate than 



















Age 65±12 66±11 0.05 65±12 68±10 <0.001 
Height 69±3 69±3 0.26 69±3 70±3 0.30 
Weight 186±39 186±39 >0.9 186±39 184±37 0.52 
BMI 27±6 27±6 0.4 27±6 27±6 0.36 
Outpatients 68% 68% 0.89 68% 67% 0.68 
ECG Findings 
Heart rate 77±16 81±15 <0.001 79±16 84±14 <0.001 
Q Wave 25% 23% 0.32 23% 31% 0.007 
LVH 8 % 9% 0.59 8% 11% 0.18 
RVH 0.3% 0.5% 0.60 0.3% 1.5% 0.009 
RBBB 7% 7% 0.81 7% 7% 0.85 
LBBB 3% 3% 0.77 3% 3% 0.81 
LAE 10% 11% 0.81 10.5% 10.6% >0.9 
Abnormal ECG 48% 47% 0.72 47% 54% 0.04 
Age, height (inches), weight (pounds), BMI and heart rate are presented as the mean ± SEM. 
BMI = body mass index; ECG = electrocardiogram; LAE = left atrial enlargement; LBBB = left bundle 
branch block; LVH = left ventricular hypertrophy; PVC = premature ventricular contraction; RBBB = 
right bundle branch block; RVH = right ventricular hypertrophy. 
Table II. Demographics and ECG findings in patients with single versus multiple and non-
complex versus complex PVCs. 
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Table II. Demographics and ECG findings in patients with single versus multiple and non-
complex versus complex PVCs. 
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Multiple PVCs (≥2 PVC per ECG) were present in 47% patients with PVCs. Of these 10% 
were couplets or salvos, 21% had multiform morphologies, and 15% had ventricular 
bigeminal or trigeminal patterns. The demographics and prevalence of ECG abnormalities 
for these patients are shown in Table II. Patients with multiple PVCs were older than those 
with only single PVCs present on the ECG. Those with complex forms were older than those 
with non-complex morphologies. There were no statistically significant differences in the 
prevalence of Q waves, LVH, right or left bundle branch block between those patients with 
or without multiple PVCs. Patients with complex PVCs had statistically significantly more Q 
waves on their ECGs than those without complex PVCs (p=0.007).  
The average annual all-cause mortality in the total population was 3.9% with mortality in 
those with PVCs (6.7%) significantly higher than for those without PVCs (3.8%) (Table III). 
The average annual CV mortality in the total population was 1.5% (39% of the deaths) with 
CV mortality in those with PVCs (3.5%) significantly higher than for those without PVCs 
(1.4%). Those with complex PVCs had an annual CV mortality rate of 5.1%. The hazard 
ratios for patients with all types of PVCs were significantly increased when compared to 
patients having no PVCs on an ECG. The age-adjusted hazard ratios in patients with any 
PVCs versus those with no PVCs was 1.39 (95% CI 1.29 - 1.50) for all cause mortality and 
1.81 (95% CI 1.62 - 2.01) for cardiovascular mortality. There was no statistically significant 
difference in mortality between patients who had multiple (≥2) PVCs per ECG and those 
with only single PVCs. The age-adjusted hazard ratio for complex PVCs (versus no PVCs) 
for all-cause and cardiovascular mortality in all patients was 1.6 (95% CI 1.3-1.9) and 2.1 
(95% CI 1.6-2.8), respectively. Patients with complex PVCs appeared to have increased all-
cause and CV mortality as compared to those with non-complex PVCs but the difference in 
survival did not achieve statistical significance. Similar findings resulted when the analysis 
was limited to patients with normal resting ECGs. After considering age, BMI, and ECG 
findings in a Cox hazard model, the presence of any resting PVCs were found to be 







All-cause mortality 23% 22% 39% <0.001 
Annual all-cause 
mortality 3.9% 3.8% 6.7% <0.001 
CV mortality 8.3% 7.9% 19.6% <0.001 
Annual CV mortality 1.5% 1.4% 3.5% <0.001 
CV = cardiovascular; PVC = premature ventricular contraction. 
Table III. Mortality in patients with and without PVCs. 
When patients were divided into groups by heart rate (<60, 60-79, 80-99 and >100 bpm) and 
by the presence or absence of PVCs, mortality increased progressively with heart rate and 
doubled with the presence of PVCs (Table IV, Figure 1). Cardiovascular mortality ranged 
from a low of 6.3% in those with heart rates less than 60 bpm and no PVCs to a high of 
26.1% in those with a heart rate > 100 bpm and PVCs. Within each heart rate group, there 
was a significant increase in mortality when PVCs were present (p<0.001). The differences in 
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event free survival between groups is also clearly demonstrated with Kaplan-Meier 
cumulative survival curve (Figure 2). The PVC and heart rate stratifications performed 
similarly when patients were divided into those with normal and abnormal ECGs. Cox 
regression analysis (controlled for age, gender, outpatient vs. inpatient status and normal vs. 
abnormal ECG) demonstrates that PVCs (RR 1.61, 95% CI 1.44-1.80, p<0.001) and heart rate 
(RR 1.02 for each 1 bpm increase, 95% CI 1.01-1.02, p<0.001) are independent predictors of 
cardiovascular mortality. 
 







 Without PVCs 
# of patients 8,077 22,090 10,677 2,827 
CV mortality 6.3% 7.3% 9.4% 11.3% 
Annual CV mortality 1.1% 1.3% 1.7% 2.0% 
 With PVCs 
# of patients 150 832 596 153 
CV mortality 12.0% 17.1% 23.3% 26.1% 
Annual CV mortality 2.2% 3.1% 4.2% 4.7% 
CV = cardiovascular; PVC = premature ventricular contraction 





























Fig. 1. Differences in cardiovascular mortality between patients without PVCs (black) and 
those with PVCs (gray) are shown. Within each heart rate group, there is a significant 
increase in mortality when PVCs are present (p<0.001). Mortality also increases as heart rate 
increases in both patients with and without PVCs (p<0.001). PVC = premature ventricular 
contraction 
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Logisitic regression controlled for age, gender and normal vs. abnormal ECG was 
performed to confirm that heart rate was a significant and independent predictor of the 
presence of PVCs (OR 1.40 for each 20 bpm, 95% CI 1.33 to 1.48, p<0.001). 
Although patients with PVCs were older than those without PVCs (univariate analysis 
above), age alone cannot explain the different heart rates because regression analysis 
showed that resting heart rate did not change significantly with age (slope of less than 1 
bpm per decade). When multiple regression analysis was performed to evaluate predictors 
of heart rate, age did not demonstrate a statistically significant contribution. 
 
Fig. 2. Kaplan-Meier cumulative survival curves demonstrate decreasing survival with 
increasing heart rate among patients without PVCs and more significant declines in survival 
in those with PVCs. The curves followed a consistent order with increasing mortality with 
increasing rate and with the matching color coded line with PVCs exhibiting an increased 
mortality. PVC = premature ventricular contraction 
5. Discussion 
5.1 PVCs 
The “PVC hypothesis” that PVC suppression would prevent sudden death was popularized 
by Lown and others in the 1960’s and 1970’s and was accepted as dogma well into the late 
1980’s. It was based on seemingly sound logic that that sudden death in myocardial 
infarction survivors is due to ventricular fibrillation (Nikolic & Bishop 1982; Pratt, Francis & 
Luck, 1983) and that PVCs precede and therefore identify those patients who are susceptible 
to these episodes (Lown, 1971). It was assumed that the suppression of PVCs with 
antiarrhythmic drugs would be beneficial but the disappointing results of the CAST trials 
(CAST Investigators, 1989, 1992) negated the causal role theory of PVCs. In fact, the negating 




























 Heart Rate Group 
 
The Prevalence and Prognostic Value of Rest Premature Ventricular Contractions 
 
35 
mechanisms cannot replace the evidence based approach. Partly due to these results, PVCs 
are generally ignored on a routine ECG. But, PVCs may still have an important role in risk 
stratification even if treatment with antiarrhythmic medications is not appropriate.  
A higher prevalence of PVCs has been seen in patients with coronary artery disease 
(Bikkina, Larson, & Levy, 1992), hypertension (Vogt et al., 1990), accompanying ECG 
abnormalities (Fisher & Tyroler, 1973), and nearly every form of structural heart disease. 
PVCs also increase with age (Flegg, 1988; Kostis et al., 1982). In the acute phase of 
myocardial infarction, PVCs are seen in 80-90% of patients and have been related to residual 
ischemia (Mukharji et al., 1984), degree of coronary narrowing (Minisi et al., 1988), degree of 
left ventricular involvement (Bigger et al., 1984; Tracy et al., 1987), and age of infarction 
(Kostis et al., 1987).  
In patients without established cardiovascular disease, there have been conflicting findings 
with some authors concluding that PVCs are benign in this population (Fleg & Kennedy, 
1992; Rodstein, Wolloch, & Gubner, 1971) and others reporting increased mortality (Abdalla 
et al., 1987; Bikkina, Larson, & Levy, 1992; Rabkin, Mathewson & Tate, 1981) although the 
methods used to determine true absence of coronary artery disease varied greatly between 
studies. Our results are consistent with the Framingham Heart Study of 6,033 men and 
women who underwent one hour ambulatory electrocardiography (Bikkina, Larson, & 
Levy, 1992). After adjusting for age and traditional risk factors for coronary artery disease, 
there was a significant and independent association between asymptomatic ectopy in men 
without clinically apparent coronary heart disease and the risk for all-cause mortality (RR 
2.3) as well as death from coronary heart disease (RR 2.1). Such an association was not seen 
in women or in men with known coronary artery disease.  
The idea that looking at the frequency and morphology of PVCs might provide additional 
predictive power has been investigated. Ismaile et al. reported findings from a prospective 
study of 15,637 apparently healthy white men who underwent screening for the Multiple 
Risk Factor Intervention Trial (MRFIT) (Abdalla et al., 1987). They used 2 minute resting 
rhythm strips and concluded that the presence of frequent or complex PVCs is associated 
with a significant and independent risk for sudden cardiac death (RR 4.2; RR 3.0 for the 
presence of any PVCs). Our study confirms the risk predicted by any PVC but only shows a 
non-significant trend towards worse outcome with complex or multiple PVCs. This may be 
because we looked at all-cause and cardiovascular mortality but did not limit our outcome 
to sudden death. 
5.2 Heart rate 
Gillman et al. evaluated 4,530 untreated hypertensives using 36-year follow-up data from 
the Framingham Study (Gillman et al., 1993). Regression analysis, after adjustment for age 
and systolic blood pressure, showed that there was a two-fold increase in cardiovascular 
mortality for each heart rate increment of 40 beats/min. In a French study of 19,386 subjects 
undergoing routine health examinations, resting tachycardia was demonstrated to be a 
predictor of non-cardiovascular mortality in both genders, and of cardiovascular mortality 
in men, independent of age and blood pressure (Benetos et al., 1999). Heart rate on the initial 
ECG after acute myocardial infarction has also been shown to be an independent predictor 
of prognosis (Hathaway et al., 1998). Our results add to the evidence that heart rate is an 
important prognostic variable. 
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Several large studies confirm our finding of heart rate not being related to age (Gillum, 1988; 
Morcet et al., 1999; Simpson et al., 2002; Spodick et al., 1992). There are conflicting reports in 
the literature as to the association of gender and heart rate. Some studies suggest that heart 
rate is higher in women (Gillum, 1988; Morcet et al., 1999) while others confirm our finding 
of heart rate being lower in women (Simpson et al., 2002).  
5.3 PVCs and heart rate 
Few studies have evaluated the relationship of resting PVCs with increased heart rate on an 
ECG. The Atherosclerosis Risk In Communities (ARIC) study reported the prevalence of 
PVCs in 15,792 individuals aged 45-65 years on a longer than normal ECG recording of 2-
minutes (Simpson et al., 2002). PVCs were present in 6% of these middle-aged adults and 
faster sinus rates were directly related to PVC prevalence.  
The relationship of PVCs to heart rate has been described in a series of studies using Holter 
monitoring. The relationship between the frequency of PVCs and underlying heart rate was 
reported in patients with frequent PVCs; the most frequent relationship was an increase in 
PVCs with increasing heart rate (Acanfora et al., 1993; Winkle, 1982) It has also been shown 
that there are three reproducible trends characterizing the dynamic behavior of PVCs: a 
tachycardia-enhanced pattern (28%), a bradycardia-enhanced pattern (24%), and an 
indifferent pattern in the remainder of patients (48%) (Pitzalis et al. 1997). Another study 
suggested that beta-blockers were most effective in reducing PVC frequency in the 
tachycardia and indifferent groups (Pitzalis et al., 1996). Propafenone has also been shown 
to be most effective in tachycardia-enhanced patients (Saikawa et al., 2001). 
5.4 Sympathetic nervous system 
Several lines of evidence suggest that activation of the sympathetic nervous system (SNS) 
plays a primary role in the generation of PVCs, ventricular arrhythmias and sudden cardiac 
death (Grassi et al., 2003; Podrid, Fuchs & Candinas, 1990). Circulating catecholamines and 
increased heart rate are known to interact with all three major mechanisms involved in the 
generation of arrhythmias: enhanced automaticity, triggered automaticity, and reentry 
(Stein et al., 1998). Substantial experimental data from animal studies shows that activation 
of the SNS is a strong stimulus for the development of ventricular tachyarrhythmias. It is 
well established that medications with beta-blocking properties help to decrease the 
frequency of PVCs (Krittayaphong et al, 2002) and prevent sudden death (JAMA, 1982; 
Pederson, 1985). Decreased sympathetic tone and improvement of cardiac autonomic 
regulation appear to play a major role in the ability of beta-blockers to reduce PVCs 
(Acanfora et al., 2000). 
Studies of genetic disorders, animal models, and spontaneous human arrhythmias have 
helped to create a better understanding of this relationship.1 Infusion of nerve growth factor 
into animal models, designed to mimic long-term elevations of sympathetic activity and 
signaling, resulted in apoptosis, hypertrophy, and fibrosis. In human studies, changes in 
heart rate have been shown to occur prior to the onset of PVCs and ventricular arrhythmias 
(Anderson et al., 1999; Nemec, Hammill & Shen, 1999; Pitzalis et al, 1997; Sapoznikov, Luria 
& Gotsman, 1999). The propensity for PVCs and ventricular arrhythmias is highest when 
there are superimposed effects of short-, intermediate, and long-term changes. 
Parasympathetic inhibition of SNS activity may be part of a normal regulatory process that 
is lost in patients with severe heart failure and other disorders. 
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Some investigators have proposed the nerve sprouting hypothesis of ventricular arrhythmia 
to explain arrhythmic events seen in patients with a history of myocardial infarction (Chen 
et al, 2001). The theory is that myocardial damage results in nerve injury which is followed 
by sympathetic nerve sprouting and regionally increased sympathetic tone. The increased 
SNS activity in the local area of remodeled myocardium results in PVCs, ventricular 
tachycardia/fibrillation and sudden death. Support for this hypothesis was provided by an 
evaluation of cardiac nerves in explanted native hearts of human transplant recipients (Cao 
et al., 2000). Infusion of nerve growth factor into the left stellate ganglion of dogs was also 
shown to result in increased development of ventricular arrhythmias (Cao et al., 2000). The 
recurring theme of research in this area is that the response to injury results in 
heterogeneous sympathetic innervation which is highly arrhythmogenic (Verrier & 
Antzelevitch, 2004).  
5.5 Study limitations 
The population in our study included a relatively diverse group of all consecutive inpatients 
and outpatients who had a 12-lead ECG for any reason; the only exclusion criteria were the 
presence of atrial fibrillation or a paced rhythm. This differs from many previous studies of 
either more narrowly defined high-risk populations of patients referred to 
electrophysiologists or more broadly defined low-risk community epidemiological cohorts. 
These differences may be an advantage as our study is clinically based and includes all 
patients at our facility referred for an ECG. Base-line clinical data, laboratory studies and 
diagnostic tests such as echocardiograms or cardiac catheterizations were not available. 
Information on medications, especially beta-blockers, would have been very useful. The 
ECGs were obtained over the span of more than a decade during which time there were 
changes in practice patterns and beta-blocker usage. However, there is no reason to think 
that beta-blocker usage would be less in those with PVCs (such that this would explain their 
higher heart rate). We also lack other markers of sympathetic activity to confirm our 
hypothesis. An important limitation of the study is that PVCs are identified on a single 10 
second ECG recording. This ‘snapshot’ might not be expected to provide as much clinically 
meaningful information as longer term ambulatory ECG monitoring but, the extremely 
large number of patients available for analysis allows significant results to be obtained. The 
4% prevalence of PVCs found in our study compares favorably with a rate of 2-7% in 
previous epidemiologic studies including those using 2-min rhythm strips. (Crow et al., 
1975; Fisher & Tyroler, 1973; Kostis et al., 1987; Simpson et al., 200).  
Overall, this is a retrospective analysis and, as such, should be considered hypothesis 
generating rather than conclusive evidence of a cause and effect relationship. The predictive 
models generated here should be validated using other electrocardiographic databases and 
in prospective evaluations. 
6. Conclusions 
Our study suggests that the simple 12-lead ECG provides valuable information and can 
complement more advanced strategies for arrhythmic risk stratification. The presence of any 
PVC on a single ECG is a powerful predictor of all-cause and cardiovascular mortality. The 
presence of multiple or complex PVCs was not a significantly better predictor although 
there was a trend towards worse prognosis in patients with complex forms. These 
observations are true even in those patients with otherwise normal baseline ECGs. 
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Our study suggests that the simple 12-lead ECG provides valuable information and can 
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PVC on a single ECG is a powerful predictor of all-cause and cardiovascular mortality. The 
presence of multiple or complex PVCs was not a significantly better predictor although 
there was a trend towards worse prognosis in patients with complex forms. These 
observations are true even in those patients with otherwise normal baseline ECGs. 
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Regression analysis demonstrates that heart rate is a significant and independent predictor 
of the presence of PVCs. Our findings support the hypothesis that activation of the 
sympathetic nervous system is an important factor in the genesis of PVCs and ventricular 
arrhythmias. The presence of elevated heart rate is a significant prognostic factor and the 
combination of increased heart rate and PVCs dramatically increases mortality. 
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1. Introduction 
One of the challenges that physicians taking care of children face is the interpretation of an 
electrocardiogram (ECG). The findings on ECG should be seen in the light of a patient’s 
clinical presentation. In this evidence-based chapter, we will explore the most common 
pediatric arrhythmias, including sinus arrhythmia, premature beats, brady-arrhythmias, 
escape rhythms and tachy-arrhythmias including different types of atrial, junctional and 
ventricular tachycardias. The objective of this chapter is to familiarize the reader with ECG 
interpretation of common pediatric arrhythmias in children and young adults. 
2. Sinus arrhythmia  
2.1 Definition: Sinus arrhythmia is the normal variation in the rate of the sino-atrial (SA) 
node that is mainly associated with the respiratory phases.  
2.2 Incidence: It is common in children and the incidence decreases with age(Kaushal and 
Taylor 2002). 
2.3 Mechanism: It occurs due to change in sinus node function related to changes in the 
autonomic tone. Inspiration and expiration are associated with increased and decreased 
heart rate due to decreased and increased parasympathetic tone, respectively(Coker et al. 
1984). Sinus arrhythmia disappears with conditions associated with elevated sympathetic 
tone causing increased heart rate.  
2.4 Clinical presentation: Auscultation reveals irregular heart rhythm which varies with 
respiration.  
2.5 ECG: ECG reveals sinus rhythm with variation in P-P interval preceding the change in R-
R intervals without any significant change in P-R interval (Figure 1).  
2.6 Management: No work-up is needed because sinus arrhythmia is a normal variant with 
excellent prognosis. 
3. Ectopic complexes (premature beats) 
3.1 Premature atrial contractions 
3.1.1 Definition: Premature atrial contraction (PAC), or atrial premature beat, is a premature 
discharge arising from an atrial focus other than the sino-atrial (SA) node. 
3.1.2 Incidence: PACs were reported in 14% of full-term infants on 24-hour ECGs (Southall et 
al. 1980). Among 10-13 year old boys with healthy hearts, 13% had singlet PACs (Scott et al. 
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Fig. 1. Sinus arrhythmia 
1980). On 24-hour ECG monitoring, 64% of young women (Sobotka et al. 1981) and 56% of 
male adolescents had PACs (Brodsky et al. 1977). Frequent causes of PACs include intake of 
caffeine, nicotine, alcohol, and other stimulants. PACs can be associated with atrial 
enlargement, electrolyte abnormalities, mechanical trauma, chronic pulmonary disease, and 
heart failure.  
3.1.3 Mechanism: PACs can occur either due to a re-entry mechanism, (Wallace and Daggett 
1964) automaticity outside of the SA node, or triggered activity (Wit and Cranefield 1977).  
3.1.4 Natural history: PACs can give rise to atrial fibrillation and flutter, especially in older 
post-operative patients(Jideus et al. 2006). They may subside with removal or correction of 
the inciting stimuli. Control of congestive heart failure, ischemic heart disease, pulmonary 
disease, and electrolyte abnormalities may decrease the incidence of PACs.  
3.1.5 Clinical presentation: Patients with PACs may be asymptomatic or perceive them as 
palpitations. They may be incidentally detected as irregular heart rhythm on auscultation. 
3.1.6 ECG: A PAC presents as a P-wave that appears earlier than expected on an ECG. The 
P-wave morphology may appear different. The PR interval in a PAC is often different than 
the previous PR interval. PACs can have three possible outcomes: 1) block at the AV node 
due to AV nodal refractoriness (Figure 2a), 2) conduct normally through the AV node 
(Figure 2b), or 3) conduct with aberrancy due to His-bundle refractoriness (Figure 2c). There 
is no compensatory ventricular pause. 
3.1.7 Work-up: A 12-lead ECG is usually adequate for evaluation; however, Holter 
monitoring may be performed. 
3.1.8 Management and Prognosis: Control of exogenous factors will decrease the incidence of 
PACs. No physical restrictions need to be imposed on children without heart and/or lung 
disease, or electrolyte abnormalities. Beta blocker like bisoprolol decreased PACs by 50%, 
although 25% of these patients had adverse reactions associated with beta blockade 
(Sugimoto et al. 1986). Prognosis is excellent for patients with PACs with normal hearts and 
needs no treatment. 
 
 
Fig. 2.a Premature atrial complex that is blocked 
 




Fig. 2.b Premature atrial complex that is normally conducted 
 
Fig. 2.c Premature atrial complex that is conducted with aberrancy 
3.2 Premature ventricular contractions 
3.2.1 Definition: A premature ventricular contraction (PVC) or ventricular premature beat 
(VPB) is an early ventricular beat that originates below the bifurcation of the bundle of His. 
It is characterized by a premature wide QRS complex that is morphologically different 
compared to the baseline QRS complexes (Sherron et al. 1985; Olgin and Zipes 2005b). 
3.2.2 Incidence: PVCs follow a bi-modal distribution and are seen in 18% of neonates, 20% of 
toddlers, 16% of school children, 20-30% of adolescents and subsequent increases in late 
adulthood (Southall et al. 1980). On 24-hour ECG monitoring of subjects without heart 
disease, 54% of young women (Sobotka et al. 1981) and 50% of young males had PVCs 
(Brodsky et al. 1977). Surgically-corrected Tetralogy of Fallot patients have an incidence of 6-
48% (Vaksmann et al. 1990),(Chandar et al. 1990). 
3.2.3 Mechanism: Three mechanisms inducing PVCs include: automaticity, re-entry, and 
triggered activity. PVCs can result from mechanical, electrical, and chemical stimulation 
leading to ventricular depolarization. Abnormalities in metabolism, electrolytes, or 
iatrogenic causes can initiate PVCs in children. Both slow and fast heart rates are associated 
with PVCs (Sherron et al. 1985). 
3.2.4 Natural history: PVCs increase with age and are more common in males (Silka and 
Garson 1999). In the absence of heart disease, PVCs are inconsequential under the age of 30 
years but influence risk of sudden death in those over 30 years (Chiang et al. 1969). PVCs 
may be present in those with increased vagal tone such as athletes or in those with increased 
stimulation such as intake of caffeine, alcohol, and/or nicotine. In adults without structural 
heart disease, PVCs induced during exercise and recovery phases were associated with 
increased risk of mortality (Frolkis et al. 2003). PVCs also occur in those with surgically-
corrected congenital heart disease, myocarditis, right-ventricular dysfunction, congestive 
heart failure, cardiomyopathy, ventricular hypertrophy, myocardial infarction, ventricular 
non-compaction and iatrogenic causes (Chandar et al. 1990; Vaksmann et al. 1990; Espinola-
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Fig. 2.c Premature atrial complex that is conducted with aberrancy 
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3.2.5 Clinical presentation: PVCs are the most common cause of irregular heart beats in 
children. They are usually detected incidentally and occasionally produce symptoms. Single 
PVCs are generally well-tolerated by children. Symptoms secondary to PVCs include 
palpitations, lightheadedness, fatigue, chest pain, and shortness of breath.  
3.2.6 ECG: To be classified as PVC, four criteria should be met: 1) premature QRS without a 
premature P wave, 2) difference in QRS morphology between PVC and regular QRS 
complex, 3) prolonged QRS duration for age, and 4) different QRS and T wave vectors. 
Unifocal PVCs have a fixed morphology, as opposed to PACs with aberrant conduction. 
Multifocal PVCs have different morphologies due to the different locations of onset and 
electrical instability of the ventricle (Silka and Garson 1999). There is a compensatory pause 
after PVC, i.e., R-R interval produced by SA node initiated QRS complexes on either side of 
the PVC is equal to twice the normal R-R interval (figure 3). PVCs may present as isolated, 
couplets, bigeminy or trigeminy pattern. If the PVC originates in the right ventricle, the QRS 
morphology appears as a left bundle branch block pattern and if the PVC originates in the 
left ventricle, the QRS morphology appears as a right bundle branch block pattern. 
3.2.7 Differential diagnoses: 1) Premature atrial complex with aberrant conduction, 2) 
premature junctional complex with aberrant conduction, and 3) anterograde conduction 
over an accessory pathway with pre-excitation. 
 
 
Fig. 3. Premature ventricular complex with a compensatory pause  
3.2.8 Work-up: A detailed history of episodes is necessary. A history of congenital heart disease 
with subsequent surgical correction should be obtained. In addition to an ECG and 24-hour 
Holter monitoring, an exercise test is important in determining whether the frequency of PVCs 
or symptoms worsen with activity (Paridon 2006; Zipes 2006). Multifocal PVCs in structural 
heart disease require further workup. Echocardiography and electrophysiology studies may 
be warranted in surgically corrected patients or those with structural heart disease if there are 
PVCs and malignant ventricular arrhythmias (Case 1999). 
3.2.9 Management and Prognosis: Management of PVCs depends on two factors: 1) a history of 
structural heart disease or surgically corrected congenital heart disease, and 2) the 
symptoms experienced by the patient. In children, PVCs are considered to be benign if they 
disappear with exercise (Attina et al. 1987). The majority of children with normal hearts 
presenting with asymptomatic single PVC, bigeminy, or trigeminy do not require treatment. 
Given that surgically-corrected congenital heart disease is associated with increased 
predisposition to non-sustained ventricular tachycardia and sudden cardiac death, children 
may require treatment with anti-arrhythmics under the supervision of a pediatric 
cardiologist. Beta-blockers can assist in suppressing PVCs in symptomatic patients 
(Alexander 2001a). If symptoms are not medically controlled, catheter ablation is an option 
(Zhu et al. 1995). Prognosis depends on whether there is underlying structural and 
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metabolic heart disease. PVCs inducible during exercise can be ominous in patients with 
structural heart disease and are of higher significance (Silka and Garson 1999). Athletes with 
structural heart disease in high-risk groups with PVCs should be restricted to low-intensity 
sports (Zipes and Garson 1994). 
3.3 Premature junctional complexes 
3.3.1 Definition: A premature junctional complex (PJC) or beat (PJB) is a premature discharge 
that originates in the AV junction either at the level of the AV node or the bundle of His, in 
the absence of a preceding atrial discharge. 
3.3.2 Incidence: PJCs can occur in structurally normal or abnormal hearts and in all age 
groups. The incidence and prevalence are not well known. Among 16-19 year old males, 
0.21% had premature junctional complexes on 12-lead ECG and similar in other age groups 
(Hiss and Lamb 1962). 
3.3.3 Mechanism: PJCs arise due to increased automaticity or triggered activity due to after 
depolarizations within the AV junction (Hoffman and Cranefield 1964; Rosen et al. 1980). 
PJCs may predispose the patient to ventricular tachycardia. Potential causes include normal 
variants, use of stimulants or alcohol, hypokalemia, hypoxemia, ischemia, and digitalis 
toxicity (Sherron et al. 1985). 
3.3.4 Clinical presentation: It may be incidentally detected or may produce symptoms like 
palpitations, syncope, or dizziness.  
3.3.5 ECG: ECG shows QRS complex morphology similar to sinus node originated 
activation, without preceding P-wave. A PJC conducting to the ventricle with aberrancy has 
a QRS complex comparable to PVC. A retrograde P-wave may appear before, during, or 
after the QRS complex (Sherron et al. 1985) (Figure 4).  
3.3.6 Work-up: Depending on the frequency of the PJCs, an ECG can identify the premature 
complexes. If unsuccessful, a 24-hour Holter monitor may be used. An electrophysiology 
study maybe needed to identify the location of the origin of the PJCs; origin distal to the AV 
node can initiate ventricular tachycardia (Sherron et al. 1985). 
3.3.7 Management and Prognosis: Patients with PJCs are usually left untreated. The 
management of underlying causes is essential to decrease symptomatic PJCs. If symptoms 
are severe, medical management and pacing may be warranted to increase the heart rate.  
 
 
Fig. 4. Premature junctional complex 
4. Bradyarrhythmias 
4.1 Sinus node dysfunction (SND) 
4.1.1 Definition: The inability of the sino-atrial (SA) node to discharge/activate (sinus 
pause/arrest) or inappropriately activate (tachycardia-bradycardia syndrome) the atrial tissue. 
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4.1.2 Incidence: SND is relatively uncommon in children with normal cardiac anatomy and 
the exact incidence is unknown. However, it is a common problem in those who have had 
surgery for congenital heart disease (CHD), especially in patients with Mustard, Senning, 
and Fontan procedures (Fishberger 2001). Approximately 2/3 of all immediate post-
transplant patients have SND (Jacquet et al. 1990). 
4.1.3 Mechanism: In sinus node pause/arrest, there is a lack of discharge from the SA node; 
causing no activation of the atria. With sinus node exit block, the activation may be delayed 
significantly or blocked completely at the nodal region, without activation of the atria. In 
tachycardia-bradycardia syndrome, severe sinus bradycardia is followed by tachycardia in 
the form of atrial flutter in the pediatric population and atrial fibrillation/flutter in adults 
with repaired congenital heart disease (Duster et al. 1985; Gelatt et al. 1994).  
4.1.4 Natural history: Sinus node dysfunction may present as severe sinus bradycardia, sinus 
pause or arrest, periods of junctional rhythm, and/or alternating tachycardia-bradycardia 
periods. Sinus node dysfunction increases in frequency with age of the patient and time 
from surgery. 
4.1.5 Clinical presentation: It depends on the age, underlying cardiac conduction abnormality, 
and hemodynamic status. Although majority of children with structurally normal hearts 
remain asymptomatic; fatigue, exercise intolerance, palpitations, chest pain, dizziness, and 
syncope may occur (Fishberger 2001). These symptoms are more frequent in those with 
corrected congenital heart disease. Infants present with poor feeding, lethargy or heart 
failure. Sudden death is an uncommon presentation. 
4.1.6 ECG: ECG may show severe sinus bradycardia, sinus pause, junctional rhythm, and/or 
atrial fibrillation/flutter. Due to the short duration, significant episodes can be missed. 
4.1.7 Work-up: Non-invasive testing includes a 12-lead ECG, a Holter monitor, an event 
monitor and exercise stress test. Depending on the frequency of the symptoms and the age 
group, a 24-hour Holter monitor can be employed. In an older age group with less frequent 
symptoms, an event recorder can be used to record rhythm abnormalities. In patients who 
are able to exercise, a treadmill stress test will show lower heart rate response to maximal 
exercise and rapid decrease in heart rate during recovery time immediately after the test 
(Martin and Kugler 1999; Fishberger 2001). Intrinsic heart rate (IHR) is the heart rate with 
complete blockade of autonomic activity with atropine and propranolol (Jose AD and 
Collison D, 1970). Normal value of IHR is defined as 118.1 – (0.57 x age). The intrinsic heart 
rate decreases with age in complete autonomic blockade but decreases at a faster rate in 
patients with SND (Benditt et al. 1984). In invasive testing, an electrophysiology study is 
undertaken to evaluate sinus node automaticity, and conduction time. Sino-atrial 
conduction time (SACT) and sinus node recovery time (SNRT) are assessed with premature 
atrial stimulation and atrial overdrive pacing, respectively. The length of SNRT evaluates 
the sinus node automaticity; prolongation of SNRT indicates suppression of sinus node 
automatic function. 
4.1.8 Management and Prognosis: Medical treatment is dependent on the type of sinus node 
dysfunction and the presence of associated symptoms. Choice of medications should be 
selected cautiously and the patient should be monitored closely.  
1. Sinus bradycardia and pause/arrest < 3 sec: no further management; pause/arrest > 3 
sec requires evaluation. In severe sinus bradycardia with hemodynamic instability, 
sympathomimetic drugs such as atropine and isoproterenol or transcutaneous pacing 
are used.  
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2. Tachycardia-Bradycardia syndrome management is difficult. Drugs used to manage 
tachycardia may worsen sinus bradycardia and should be used judiciously and may 
necessitate cardiac pacing. 
With failed medical therapy and the need for long-term anti-arrhythmic medications, 
pacemaker implantation is indicated. According to the 2002 ACC guidelines for pacemaker 
implantation (Gregaratos 2002), documented symptomatic bradycardia (Class I), 
symptomatic chronotropic incompetence (Class I), syncope of unknown etiology with 
electrophysiologic studies suggestive of SND (Class IIa), and chronic awake heart rate < 40 
(Class IIb) are primary indicators for permanent pacing. Permanent pacing is indicated in 
bradycardia-tachycardia (Class IIa). In refractory or symptomatic SND patients who have 
failed medical therapy, permanent pacemaker implantation improves clinical status. 
Pacemaker implantation can provide anti-bradycardia pacing in severe bradycardia; in 
tachycardia-bradycardia syndrome, pacemaker can provide anti-tachycardia and anti-
bradycardia pacing.  
4.2 First-degree atrio-ventricular heart block 
4.2.1 Definition: Delay in atrio-ventricular conduction at the level of the atrial tissue, AV 
node, and/or the His-Purkinje system. 
4.2.2 Incidence: First degree AV block has been detected in 6% of neonates (Ferrer 1977). 
Among 10-13 year old males, 8.5% had first degree heart block (Scott et al. 1980).  
4.2.3 Mechanism: Common mechanism in pediatric patients is hypervagotonia. However, 
other causes include medications which prolong AV-node refractory period, electrolyte 
abnormalities, hypothermia, hypothyroidism, rheumatic fever, myocarditis, Lyme disease, 
congenital heart disease that stretches the atria at the AV node area, cardiac surgery, and 
myopathies (Weindling 2001). Four sites for first degree AV block with a normal QRS 
include: atrium (3-20%) (Sherron et al. 1985), AV node (35-90%) (Sherron et al. 1985), Bundle 
of His (15%) (Sherron et al. 1985) and infra-Hisian conduction system. It is more common in 
endocardial cushion defects and Ebstein’s anomaly of the tricuspid valve due to intraatrial 
conduction delay (Sherron et al. 1985). Increased vagal tone, calcium-channel blockers, 
digoxin, and beta-blockers are common causes of AV nodal delay. Quinidine, procainamide, 
and disopyramide impair phase 0 depolarization and cause delay in bundle of His 
conduction. Finally, prolongation of conduction in the infra-Hisian region can be caused by 
sodium-channel blockers as above. With first degree AV block with a wide QRS complex, 
conduction in the AV node or the bundle of His is delayed; bilateral bundle branch 
conduction is slowed in most cases; two levels of conduction delay can also be seen (Peuch 
et al. 1976). 
4.2.4 Natural history: First degree heart block has the potential, although rarely, to progress 
to higher-degree heart blocks in myocarditis, and adults with ischemic heart disease. In a 30-
year follow up of adult males with moderate P-R interval prolongation, first degree heart 
block was benign (Mymin et al. 1986).  
4.2.5 Clinical presentation: Patients with first degree AV block are asymptomatic unless 
associated with significant left ventricular (LV) dysfunction. Marked prolongation of the PR 
interval can cause symptoms mimicking pacemaker-like syndrome. 
4.2.6 ECG: There is prolongation of PR interval beyond the normal ranges for age. Normal P-
R interval naturally varies with age in the pediatric population and prolongation of the P-R 
interval should be viewed in this context (Figure 5). 
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4.2.7 Work-up: An ECG can detect first degree block with or without infranodal disease 
based on QRS pattern. Atropine and exercise stress testing decrease the vagal tone and 
enhance AV nodal conduction, thereby shortening the PR interval. If the delay is due to 
infranodal disease, the conduction delay is worsened. Electrophysiology study can be used 
to determine the site of conduction delay.  
4.2.8 Management and Prognosis: Family history of rhythm or connective tissue disease 
should be obtained. Repeat ECGs are indicated in those with suspected progression to 
higher grade blocks. Indications for a pacemaker include first degree block with symptoms 
suggestive of a pacemaker-like syndrome (Class IIa), and presence of first degree block in 
neuromuscular diseases and LV dysfunction (Class IIb) (Gregaratos 2002). 
 
 
Fig. 5. First degree AV block 
4.3 Second-degree atrio-ventricular heart block 
4.3.1 Definition: Second-degree heart block is atrio-ventricular block in which some atrial 
discharges are not conducted to the ventricles. It is classified as Mobitz type I (Wenckebach 
phenomena), Mobitz type II and high grade.  
4.3.2 Incidence: Wenckebach phenomena was detected in 2% of infants, 7% of toddlers and 
6% of children at rest (von Bernuth et al. 1989).  
4.3.3 Mechanism: Mobitz type I (Wenckebach) block occurs at the AV node and His-Purkinje 
system in a ratio of 3:1, respectively (Peuch et al. 1976). Wenckebach phenomenon results from 
hypervagotonia in athletes and young subjects (Stein et al. 2002). Previous cardiac surgery and 
ischemic heart disease in adulthood are associated with Wenckebach phenomena. Mobitz type 
II block occurs infra-nodally in most cases (Dhingra et al. 1974).  
4.3.4 Natural history: Mobitz type I block is usually benign. However, in pediatric population 
without heart disease, Mobitz type I block may serve as intermediary prior to development 
of idiopathic complete heart block (Young et al. 1977). In adults, second degree AV-nodal 
block proximal to the His bundle has a benign course in those without heart disease; but is 
associated with poor prognosis in those with underlying heart disease (Strasberg et al. 1981). 
Mobitz type II can progress to symptomatic complete heart block and is associated with 
Stokes-Adams attacks and sudden death (Dhingra et al. 1974).  
4.3.5 Clinical presentation: Mobitz type I block is usually well tolerated; but may present with 
significant bradycardia. Patients with Mobitz type II block may be asymptomatic; but can 
present with bradycardia, exercise intolerance, syncope, postural hypotension, and sudden 
death. 
4.3.6 ECG: Mobitz type I shows progressive prolongation of PR interval followed by a non-
conducted atrial discharge (Figure 6a). Mobitz type II is characterized by stable PR interval 
with intermittent failed conduction (Figure 6b). PR interval can be normal or prolonged. 
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4.3.7 Work-up: ECG is diagnostic. If ECG is inconclusive, a 24-hour monitor is suggested. If 
there is one conducted beat in a cycle as in a 2:1 block, it is difficult to differentiate between 
Mobitz types I and II blocks; atropine can be used to elicit a 3:2 conduction in Mobitz type I 
block. Response to atropine suggests the block to be at or proximal to the AV node. If 
exercise initiates or exacerbates Mobitz type I block, infranodal location of the block is 
suspected. An electrophysiology study is indicated if there is unexplained syncope, and AV 
block distal to the AV node, to identify the location of the block (Zipes et al. 1995). In 
complete or high grade second degree AV block, an echocardiogram is indicated (Cheitlin et 
al. 2003).  
4.3.8 Management: Medical management of Mobitz type I includes identification and 
treatment of underlying causes. Sympathomimetic agents such as scopolamine, 
theophylline, or glycopyrrolate can be used in symptomatic bradycardia secondary to 
increased vagal tone. In patients with Mobitz type II, syncope is a poor prognostic factor 
(Dhingra et al. 1974). Symptomatic chronic bradycardia in Mobitz type I and type II (Class I), 
Mobitz type II with bifascicular or trifascicular block (Class I), Mobitz type II with wide QRS 
(Class I), asymptomatic Mobitz type II (Class IIa), and neuromuscular disease with AV block 
(Class IIb) are all indications for permanent pacemaker implantation (Gregaratos 2002).  
 
 
Fig. 6.a Second degree Type I AV block (Wenckebach) 
 
 
Fig. 6.b Second degree Type II (Mobitz) AV block 
4.4 Third-degree (Complete) Atrio-Ventricular Heart Block 
4.4.1 Definition: Complete failure of conduction of atrial impulses to the ventricles. 
4.4.2 Incidence: Complete heart block may be acquired or congenital. The most common 
cause of acquired complete heart block in pediatric patients is surgery for left ventricular 
outflow tract obstruction, repair of corrected transposition of the great arteries (L-TGA), 
ventricular septal defects and TOF. Acquired complete AV block is also seen in Lyme 
carditis, myocarditis, myopathies, and metabolic diseases. Congenital complete heart block 
occurs 1 per 15,000 to 1 per 22,000 live births and is often associated with maternal 
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4.3.7 Work-up: ECG is diagnostic. If ECG is inconclusive, a 24-hour monitor is suggested. If 
there is one conducted beat in a cycle as in a 2:1 block, it is difficult to differentiate between 
Mobitz types I and II blocks; atropine can be used to elicit a 3:2 conduction in Mobitz type I 
block. Response to atropine suggests the block to be at or proximal to the AV node. If 
exercise initiates or exacerbates Mobitz type I block, infranodal location of the block is 
suspected. An electrophysiology study is indicated if there is unexplained syncope, and AV 
block distal to the AV node, to identify the location of the block (Zipes et al. 1995). In 
complete or high grade second degree AV block, an echocardiogram is indicated (Cheitlin et 
al. 2003).  
4.3.8 Management: Medical management of Mobitz type I includes identification and 
treatment of underlying causes. Sympathomimetic agents such as scopolamine, 
theophylline, or glycopyrrolate can be used in symptomatic bradycardia secondary to 
increased vagal tone. In patients with Mobitz type II, syncope is a poor prognostic factor 
(Dhingra et al. 1974). Symptomatic chronic bradycardia in Mobitz type I and type II (Class I), 
Mobitz type II with bifascicular or trifascicular block (Class I), Mobitz type II with wide QRS 
(Class I), asymptomatic Mobitz type II (Class IIa), and neuromuscular disease with AV block 
(Class IIb) are all indications for permanent pacemaker implantation (Gregaratos 2002).  
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4.4.1 Definition: Complete failure of conduction of atrial impulses to the ventricles. 
4.4.2 Incidence: Complete heart block may be acquired or congenital. The most common 
cause of acquired complete heart block in pediatric patients is surgery for left ventricular 
outflow tract obstruction, repair of corrected transposition of the great arteries (L-TGA), 
ventricular septal defects and TOF. Acquired complete AV block is also seen in Lyme 
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connective tissue disease, in particular systemic lupus erythematosis (Michaelsson and 
Engle 1972). Spontaneous complete heart block is seen in left atrial isomerism, endocardial 
cushion defects and in 20% of patients with L-TGA (Huhta et al. 1983; Lundstrom et al. 
1990).  
4.4.3 Mechanism: Possible mechanisms include abnormal development of the conduction 
system and the AV node, or acquired most commonly after cardiac surgery. The escape 
rhythms below the AV node take over when the atrial discharge is not conducted to the 
ventricles. The rate of the escape rhythm correlates with the level of the block, with the 
proximal sites having a higher rate. 
4.4.4 Natural history: Complete heart block is associated with L-TGA and septal defects, as 
well as sequelae of maternal connective tissue. Mortality is highest during the neonatal 
period (Roberts and Gillette 1977). Congenital complete heart block in structurally normal 
heart, when uncorrected, leads to cardiac enlargement with impaired ventricular systolic 
function (Beaufort-Krol et al. 2007). There is a significant correlation between persistent 
heart rate of 50 or less and incidence of syncope, pre-syncope, and/or sudden death 
(Karpawich et al. 1981; Dewey et al. 1987).  
4.4.5 Clinical presentation: Many patients are asymptomatic in early life. Symptoms range 
from none to palpitations, chest pain, weakness, syncope, exercise intolerance, dizziness, 
and congestive heart failure in congenital complete heart block. Symptoms are usually 
dependent on ventricular rate, frequency of premature ventricular beats, and atrio-
ventricular synchrony.  
4.4.6 ECG: Complete heart block is depicted by atrio-ventricular conduction blockade. In 
patients with normal hearts, the QRS complex is narrow if the block is at the AV node or His 
bundle; the QRS complex is wide if the block occurs after the bifurcation of the bundle of 
His (Weindling 2001). An ECG should be used to differentiate complete heart block from 
accelerated junctional rhythm or severe sinus bradycardia with appropriate junctional 
escape rate (Weindling 2001). Complete heart block is associated with a prior lesser-degree 
block (25%) and accompanied or preceded by bundle branch block (Levine et al. 1956). 
Associated prolongation of QT interval is seen in about 18% of congenital complete heart 
block (Figure 7). 
4.4.7 Work-up: A 12-lead ECG establishes the diagnosis. In symptomatic patients treated with 
a pacemaker and with a suspicion of another arrhythmia (Class I), and patients with 
premature, concealed junctional depolarizations as in pseudo-AV block (Class II), an 
electrophysiology study is indicated (Zipes et al. 1995). In patients with complete AV block 
or advanced second-degree AV block, an echocardiogram is used to visualize cardiac 
function, size, structure, and valvular regurgitation (Cheitlin et al. 2003; Beaufort-Krol et al. 
2007). Exercise stress testing in asymptomatic patients with congenital complete heart block 
is used to determine degree of exercise tolerance and arrhythmias associated with exercise 
(Gibbons et al. 2002). 
4.4.8 Management and Prognosis: Primary mode of management of patients with complete 
heart block is pacemaker implantation. The time of pacemaker implantation is controversial. 
Third degree AV block with symptomatic bradycardia, post-operative complete heart block 
that does not resolve in 7-10 days, and congenital complete heart block with wide QRS 
escape rhythm and ventricular dysfunction, and congenital complete heart block with rate 
<50 bpm are Class I indications for pacemaker implantation (Gregaratos 2002). Prognosis for 
neonates and infants post pacemaker implantation is very good (Aellig et al. 2007).  
 




Fig. 7. Third degree (complete) AV block 
4.5 Atrial escape rhythm 
4.5.1 Definition: Atrial escape rhythm arises from ectopic atrial foci during periods of severe 
sinus bradycardia or significant sinus node dysfunction. These atrial ectopic foci have 
slower spontaneous rates and are unstable. The exact incidence of atrial escape rhythm is 
not known 
4.5.2 Mechanism: The automaticity of an ectopic atrial focus generates a faster rate than the 
dysfunctional sinus node by escaping overdrive suppression of the SA node. Atrial escape 
rhythm rate is between 60-80 beats per minute (Dubin 2000). 
4.5.3 Natural history: Atrial escape rhythm occurs in sinus node dysfunction and severe sinus 
bradycardia. Resolution or treatment of a slow underlying sinus rhythm resolves the atrial 
escape rhythm. Automaticity in ectopic foci are more responsive to autonomic control 
compared to the SA node (Randall et al. 1981). 
4.5.4 Clinical presentation: Most symptoms are secondary to underlying rhythm abnormalities 
such as sinus node dysfunction with severe sinus bradycardia, sinus pause and/or sinus 
arrest. These include dizziness, exercise intolerance, and possible syncope. 
4.5.5 ECG: The P-wave morphology differs from the sinus P-wave. The P-wave is smaller 
and shorter in duration with the P-wave axis dependent on the location of the ectopic focus. 
The PR interval may be shorter than the normal PR interval due to the proximity of the 
ectopic atrial focus to the AV node. The atrial escape rhythm is slower than the normal sinus 
rate.  
4.5.6 Work-up: Work-up is focused on identifying the underlying abnormality leading to 
increased automaticity or suppression of the sinus node. 
4.5.7 Management and Prognosis: In symptomatic patients, slow sinus rhythm is managed 
with sympathomimetic agents. If unresponsive to medical treatment, pacemaker 
implantation may be necessary for management of sinus node dysfunction or severe sinus 
bradycardia. 
4.6 Atrio-ventricular junctional escape rhythm 
4.6.1 Definition: AV junctional escape rhythm is defined as an ectopic rhythm starting in the 
AV junction due to failure of the atrial impulse to conduct. The ectopic rhythm may 
originate between the AV node and the bundle of His.  
4.6.2 Incidence: Episodes of junctional escape rhythm were reported in 19% of full-term 
neonates (Southall et al; Southall et al. 1980). 
4.6.3 Mechanism: AV junctional escape rhythm occurs due to enhanced automaticity or a 
reentry mechanism. The ectopic focus can occur below the AV node and at or above the 
bundle of His, in the absence or suppression of an SA node or atrial impulse (Gamble et al. 
2007). Due to the lack of overdrive suppression from the higher pacemakers, the AV 
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junction has its intrinsic automaticity. The junctional escape rate ranges between 40-60 beats 
per minute (Dubin 2000). 
4.6.4 Natural history: The junctional pacemaker can exist in the region of the distal AV node 
or the proximal portion of the His-bundle near the AV-node (Alison et al. 1995). Nodal 
escape rhythm is associated with apnea (Valimaki and Tarlo 1971). The rate of AV junctional 
escape rhythm varies with underlying conditions, such as sick sinus syndrome, complete 
heart block, ablation of AV node, congenital heart surgery, hypertrophic cardiomyopathy, 
and ischemia (Kleinfeld and Boal 1978; Alison et al. 1995; Shepard et al. 1998). Inflammation, 
hypoxia, metabolic, drugs, or electrolyte disturbances are implicated in the etiology of 
junctional rhythms (Fisch and Knoebel 1970). 
4.6.5 Clinical presentation: Symptoms pertaining to AV junctional escape rhythm are related 
to suppression of the sino-atrial tissues and or failure to conduct to the junction. Symptoms 
include dizziness, exercise intolerance, near syncope or syncope. 
4.6.6 ECG: In AV junctional escape rhythm, there are no P-waves before the QRS complexes; 
they may occur simultaneously or follow the QRS complexes. The QRS complex is narrow if 
the focus is closer to the AV node or wide if proximal to the His bundle bifurcation. In the 
case of complete AV block, P-waves of sinus origin are dissociated from the QRS complexes. 
4.6.7 Work-up: ECG may identify the rhythm; if unsuccessful, a Holter monitor can help 
identify the rhythm abnormality. Workup should also include identifying the causes listed 
above. 
4.6.8 Management and Prognosis: Pacemaker implantation may be needed in symptomatic 
bradycardia due to junctional escape rhythm. 
4.7 Idioventricular escape rhythm 
4.7.1 Definition: Ventricular escape (idioventricular) rhythm arises below the bifurcation of 
the His bundle. The ventricular escape results when the higher pacemaker systems are 
unable to generate and/or conduct an impulse to the ventricles. It is rare and incidence is 
not known. 
4.7.2 Mechanism: The automaticity of the ventricular myocardium is pronounced in the 
absence of supraventricular impulses. The overdrive suppression from higher pacemaker 
centers is absent, leading to the automaticity of the ventricular focus to conduct to the 
ventricles. Idioventricular rate ranges from 20-40 beats per minute (Dubin 2000). 
4.7.3 Natural history: Idioventricular rhythm is seen with hypothermia, drugs, and ischemia 
(Talbot and Greaves 1976).  
4.7.4 Clinical presentation: Stokes-Adams syncopal attacks are more prevalent in ventricular 
escape rhythm than atrial or junctional escape rhythms. This is also accompanied by 
dizziness and exercise intolerance. 
4.7.5 ECG: The ECG shows wide QRS complexes with a rate of 20-40 beats per minute. If P-
waves exist, they occur independently and are dissociated from the ventricular beats. 
4.7.6 Work-up: ECG is the first step in diagnosing ventricular escape rhythm. Holter and 
event recorders are alternatives when ECG is not diagnostic. Electrophysiology study is 
indicated (class IIA) in patients with suspected bradyarrhythmias with syncope (Zipes 
2006). An EP study can establish the level of the AV block. 
4.7.7 Management and Prognosis: Symptomatic relief is important in patients with ventricular 
escape rhythm. Pacemaker implantation with ventricular pacing is essential to avoid Stokes-
Adams attacks. 
 




5.1 Atrial tachy-arrhythmias 
5.1.1 Physiologic (appropriate) sinus tachycardia 
5.1.1.1 Definition: Sinus tachycardia is an automatic rhythm characterized by rapid discharge 
from the sinus node due to physiologic influences (Walsh 2001b; Blomstrom-Lundqvist et al. 
2003; Blomstrom-Lundqvist 2003). The rate of sinus tachycardia is dependent on age. 
5.1.1.2 Incidence: Dependent on the body’s increased sympathetic response to physiologic 
phenomena, such as fever, dehydration, anxiety, pain, medications, anemia, hyperthyroidism 
and heart failure.  
5.1.1.3 Mechanism: Occurs due to increased automaticity with rate variability associated with 
increased sympathetic response or vagal withdrawal. 
5.1.1.4 Natural history: Decreasing the underlying enhanced sympathetic tone or increasing 
the vagal tone will decrease the sinus tachycardia. 
5.1.1.5 Clinical presentation: The inciting factor for sympathetic response or vagal withdrawal 
is the usual presenting symptom. Very high rate of sinus tachycardia can compromise 
cardiac output by decreasing the ventricular filling time.  
5.1.1.6 ECG: There is a normal P-wave axis and a P-wave precedes each QRS complex (Van 
Hare 1999). P-waves may have larger amplitude and become peaked (Blomstrom-Lundqvist 
2003). 
5.1.1.7 Work-up: Identify the extrinsic factors causing the tachycardia and treat them. It is 
also necessary to rule out inappropriate sinus tachycardia (see below).  
5.1.1.8 Management and Prognosis: Prognosis depends on the nature of the underlying cause. 
No specific treatment is required for physiologic sinus tachycardia except treatment of the 
underlying causes. Beta-adrenergic receptor blockers may occasionally be used for 
treatment of physiologic symptomatic sinus tachycardia (Blomstrom-Lundqvist 2003). 
5.1.2 Inappropriate Sinus Tachycardia (IST) 
5.1.2.1 Definition: Elevated resting heart rate for the physiological state and/or an exaggerated 
heart rate response to exercise or stress (Krahn et al. 1995; Blomstrom-Lundqvist 2003).  
5.1.2.2 Incidence: IST often follows a viral illness or physical trauma, usually in women (90%) 
who are generally healthy physically and emotionally (Fogoros 2006). 
5.1.2.3 Mechanism: Etiology is not known. The mechanism may involve a primary sino-atrial 
(SA) node disorder with increased automaticity, a dysautonomia with increased 
sympathetic tone, decreased parasympathetic tone, and/or increased SA node beta-
adrenergic sensitivity, or impaired baroreflex control (Krahn et al. 1995; Fogoros 2006; 
Morillo and Guzman 2007). Another mechanism is stimulation of the beta-adrenergic 
receptors by anti-beta adrenergic autoantibodies (Chiale et al. 2006).  
5.1.2.4 Natural history: IST is more common in women in the 20s and 30s, who are otherwise 
healthy. It is likely to improve over time (Fogoros 2006). 
5.1.2.5 Clinical presentation: Palpitations, lightheadedness, exercise intolerance, and fatigue 
are common symptoms. Patients may also have orthostatic intolerance, chest pain, anxiety, 
depression, headache and myalgia, gastro-intestinal disturbances, and diaphoresis (Shen 
2005; Fogoros 2006). Only consistent finding on physical exam is tachycardia (Shen 2005; 
Fogoros 2006). 
5.1.2.6 ECG: P-wave morphology and axis is similar to that of normal sinus rhythm (Shen 
2005). There is tachycardia at rest on ECG. 
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escape rhythm varies with underlying conditions, such as sick sinus syndrome, complete 
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and ischemia (Kleinfeld and Boal 1978; Alison et al. 1995; Shepard et al. 1998). Inflammation, 
hypoxia, metabolic, drugs, or electrolyte disturbances are implicated in the etiology of 
junctional rhythms (Fisch and Knoebel 1970). 
4.6.5 Clinical presentation: Symptoms pertaining to AV junctional escape rhythm are related 
to suppression of the sino-atrial tissues and or failure to conduct to the junction. Symptoms 
include dizziness, exercise intolerance, near syncope or syncope. 
4.6.6 ECG: In AV junctional escape rhythm, there are no P-waves before the QRS complexes; 
they may occur simultaneously or follow the QRS complexes. The QRS complex is narrow if 
the focus is closer to the AV node or wide if proximal to the His bundle bifurcation. In the 
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4.7.3 Natural history: Idioventricular rhythm is seen with hypothermia, drugs, and ischemia 
(Talbot and Greaves 1976).  
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5.1 Atrial tachy-arrhythmias 
5.1.1 Physiologic (appropriate) sinus tachycardia 
5.1.1.1 Definition: Sinus tachycardia is an automatic rhythm characterized by rapid discharge 
from the sinus node due to physiologic influences (Walsh 2001b; Blomstrom-Lundqvist et al. 
2003; Blomstrom-Lundqvist 2003). The rate of sinus tachycardia is dependent on age. 
5.1.1.2 Incidence: Dependent on the body’s increased sympathetic response to physiologic 
phenomena, such as fever, dehydration, anxiety, pain, medications, anemia, hyperthyroidism 
and heart failure.  
5.1.1.3 Mechanism: Occurs due to increased automaticity with rate variability associated with 
increased sympathetic response or vagal withdrawal. 
5.1.1.4 Natural history: Decreasing the underlying enhanced sympathetic tone or increasing 
the vagal tone will decrease the sinus tachycardia. 
5.1.1.5 Clinical presentation: The inciting factor for sympathetic response or vagal withdrawal 
is the usual presenting symptom. Very high rate of sinus tachycardia can compromise 
cardiac output by decreasing the ventricular filling time.  
5.1.1.6 ECG: There is a normal P-wave axis and a P-wave precedes each QRS complex (Van 
Hare 1999). P-waves may have larger amplitude and become peaked (Blomstrom-Lundqvist 
2003). 
5.1.1.7 Work-up: Identify the extrinsic factors causing the tachycardia and treat them. It is 
also necessary to rule out inappropriate sinus tachycardia (see below).  
5.1.1.8 Management and Prognosis: Prognosis depends on the nature of the underlying cause. 
No specific treatment is required for physiologic sinus tachycardia except treatment of the 
underlying causes. Beta-adrenergic receptor blockers may occasionally be used for 
treatment of physiologic symptomatic sinus tachycardia (Blomstrom-Lundqvist 2003). 
5.1.2 Inappropriate Sinus Tachycardia (IST) 
5.1.2.1 Definition: Elevated resting heart rate for the physiological state and/or an exaggerated 
heart rate response to exercise or stress (Krahn et al. 1995; Blomstrom-Lundqvist 2003).  
5.1.2.2 Incidence: IST often follows a viral illness or physical trauma, usually in women (90%) 
who are generally healthy physically and emotionally (Fogoros 2006). 
5.1.2.3 Mechanism: Etiology is not known. The mechanism may involve a primary sino-atrial 
(SA) node disorder with increased automaticity, a dysautonomia with increased 
sympathetic tone, decreased parasympathetic tone, and/or increased SA node beta-
adrenergic sensitivity, or impaired baroreflex control (Krahn et al. 1995; Fogoros 2006; 
Morillo and Guzman 2007). Another mechanism is stimulation of the beta-adrenergic 
receptors by anti-beta adrenergic autoantibodies (Chiale et al. 2006).  
5.1.2.4 Natural history: IST is more common in women in the 20s and 30s, who are otherwise 
healthy. It is likely to improve over time (Fogoros 2006). 
5.1.2.5 Clinical presentation: Palpitations, lightheadedness, exercise intolerance, and fatigue 
are common symptoms. Patients may also have orthostatic intolerance, chest pain, anxiety, 
depression, headache and myalgia, gastro-intestinal disturbances, and diaphoresis (Shen 
2005; Fogoros 2006). Only consistent finding on physical exam is tachycardia (Shen 2005; 
Fogoros 2006). 
5.1.2.6 ECG: P-wave morphology and axis is similar to that of normal sinus rhythm (Shen 
2005). There is tachycardia at rest on ECG. 
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5.1.2.7 Diagnosis: Criteria for diagnosis include: a) persistent sinus tachycardia during the 
day with increased rate in response to activity and normalization during sleep per 24-hour 
Holter recording, b) non-paroxysmal tachycardia and symptoms, c) P-wave morphology 
and activation similar to sinus rhythm, and d) exclusion of secondary causes of sinus 
tachycardia (Blomstrom-Lundqvist 2003). 
5.1.2.8 Work-up: In addition to the ECG, a 24-holter monitor will document elevated mean 
heart rates above normal for age, elevated daytime heart rates, and/or exaggerated 
elevation in sinus rate from supine to upright position (Shen 2005). A diagnostic 
electrophysiology (EP) study should be considered if the etiology of the tachycardia is 
unclear (to rule out sinus node re-entry tachycardia). EP study consistent with IST would 
include slow warm up and cool down phases suggesting sinus node involvement, surface P-
wave similar to that of normal sinus rhythm, and earliest activation arising near the sinus 
node area along the crista terminalis during mapping. IST is not initiated with programmed 
stimulation of the atria (Lin and Callans 2004). In addition to electrophysiology testing, there 
is also a need for autonomic dysregulation testing. Neurologic, cardiovascular 
rehabilitation, and psychiatric consultations are often necessary because IST is a diagnosis of 
exclusion (Shen 2005). 
5.1.2.9 Management and Prognosis: Treatment involves a multidisciplinary approach. 
Medications including beta blockers, calcium channel blockers and class IC anti-arrhythmic 
agents decrease SA node automaticity (Chiale et al. 2006). However in patients with IST 
secondary to autonomic dysregulation, control of heart rate does not always lead to 
resolution of symptoms. In patients with no evidence of autonomic dysregulation if 
biofeedback, meditation, and medical therapy fail, superolateral crista terminalis ablation 
could be considered (Shen 2005; Fogoros 2006). Risks of RF ablation include SVC syndrome, 
diaphragmatic paralysis and persistent junctional rhythm. The prognosis of IST is benign 
over a mean follow-up of 6 years (Still et al. 2005). 
5.1.3 Sinus Node Re-entry Tachycardia 
5.1.3.1 Definition: Sino-atrial node re-entry tachycardia (SNRT) is a paroxysmal arrhythmia 
characterized by a re-entry mechanism that is located entirely within the SA node or the 
perisinus atrial tissue (Lin and Callans 2004).  
5.1.3.2 Incidence: Incidence of SNRT is underestimated due to lack of symptoms very often. 
In patients undergoing electrophysiology study for supraventricular tachycardia, incidence 
ranges from 1.8%-16.9% (Blomstrom-Lundqvist 2003). Incidence of SNRT is higher (10%) in 
those with underlying organic heart disease (Garson Jr. and Gillette 1981).  
5.1.3.3 Mechanism: A re-entry mechanism is present but it is not known whether the entire 
circuit is within the SA node or involves perisinus atrial tissue. 
5.1.3.4 Clinical presentation: Patients are often asymptomatic. Symptoms include palpitations, 
lightheadedness, presyncope, and rarely syncope (Gomes et al. 1985). 
5.1.3.5 ECG: SNRT heart rate ranges from 80-200 beats/min. P-wave axis and morphology 
are similar to that of normal sinus rhythm. P-R interval is shorter than R-P interval. An 
atrio-ventricular (AV) nodal Wenckebach block may be present (Olgin and Zipes 2005a). 
5.1.3.6 Diagnosis: Criteria for diagnosis include: a) paroxysmal tachycardia, b) P-wave 
morphology and endocardial atrial activation similar to that of normal sinus rhythm, c) 
inducibility with programmed premature atrial stimuli irrespective of the location of 
stimulation or the AV junction, d) the ability to terminate the arrhythmia with atrial 
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premature beat or atrial pacing, and e) termination with vagal maneuvers or adenosine 
(Narula 1974; Blomstrom-Lundqvist 2003).  
5.1.3.7 Work-up: Electrophysiology study is indicated in patients with frequent and poorly-
tolerated episodes of tachycardia, unclear mechanism of tachycardia, and refractoriness to 
medications.  
5.1.3.8 Management and Prognosis: Vagal maneuvers or adenosine may interrupt the 
tachycardia. Acutely, atrial pacing is effective. Beta blockers, calcium channel blockers, 
amiodarone, and digitalis can benefit patients with increased frequency of symptoms. 
However, prophylactic treatment of SNRT is not recommended. In patients undergoing an 
electrophysiology study, catheter ablation can be successful (Goya et al. 1999).  
5.1.4 Ectopic (focal) Atrial Tachycardia 
5.1.4.1 Definition: Ectopic or focal atrial tachycardia (EAT) is a tachycardia mediated by 
inappropriate atrial impulse generation from a single atrial focus outside of the SA node 
(Walsh 2001a). 
5.1.4.2 Incidence: EAT is commonly found in children and teenagers and makes up 
approximately 15% of all newly diagnosed supraventricular tachycardias across all ages 
(Walsh 2001a). Both genders are equally affected. Prevalence of EAT is 0.34% in 
asymptomatic male patients and 0.46% in symptomatic male patients (Poutiainen et al. 
1999). 
5.1.4.3 Mechanism: EAT can be due to three mechanisms: a) enhanced automaticity, b) 
triggered activity, and c) microreentry (Roberts-Thomson et al. 2006). The tachycardia 
cannot be initiated or terminated with programmed stimuli (Walsh 2001a). However, the 
exact mechanism is difficult to ascertain. 
5.1.4.4 Natural history: In the majority of patients, the course is benign. Persistent incessant 
EAT can lead to ventricular dysfunction, congestive heart failure and low cardiac output 
states, termed tachycardia-mediated cardiomyopathy. However, termination of the rhythm 
can lead to improvement in ventricular function (Packer et al. 1986; Naheed et al. 1995). 
There is slowing of heart rate with time, with reversion to sinus rhythm or change in P-wave 
morphology (Poutiainen et al. 1999). 
5.1.4.5 Clinical presentation: Young patients are often asymptomatic until onset of left 
ventricular dysfunction. Patients may also have palpitations, lightheadedness, and exercise 
intolerance even with normal LV function (Walsh 2001a).  
5.1.4.6 ECG: ECG shows a supraventricular tachycardia with rates within normal range to 
300 beats per minute. ECG criteria for diagnosis include: a) the P-wave morphology and axis 
different than that of normal sinus rhythm, b) acceleration after initiation and deceleration 
before termination, c) unaffected by presence of an atrio-ventricular block, and d) an initial 
P-wave of the tachycardia similar to the subsequent P-waves (Olgin and Zipes 2005a). The 
QRS complex is similar to that of sinus rhythm.  
5.1.4.7 Work-up: The location of the ectopic focus can be determined by noting P-wave 
frontal plane axis. “Warm-up” and “cool-down” patterns can be appreciated and suggestive 
of an automatic mechanism. AV-block (Mobitz 1) can be appreciated episodically during 
sleep. Adenosine administration will demonstrate AV-block with continuous marching of P-
waves (Figure 8). When the ectopic focus is close to the sinus node and/or there is poor 
ventricular function, electrophysiology testing is necessary to differentiate between sinus 
tachycardia, atrial flutter, and ectopic atrial tachycardia. Difficulty to terminate tachycardia 
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5.1.2.7 Diagnosis: Criteria for diagnosis include: a) persistent sinus tachycardia during the 
day with increased rate in response to activity and normalization during sleep per 24-hour 
Holter recording, b) non-paroxysmal tachycardia and symptoms, c) P-wave morphology 
and activation similar to sinus rhythm, and d) exclusion of secondary causes of sinus 
tachycardia (Blomstrom-Lundqvist 2003). 
5.1.2.8 Work-up: In addition to the ECG, a 24-holter monitor will document elevated mean 
heart rates above normal for age, elevated daytime heart rates, and/or exaggerated 
elevation in sinus rate from supine to upright position (Shen 2005). A diagnostic 
electrophysiology (EP) study should be considered if the etiology of the tachycardia is 
unclear (to rule out sinus node re-entry tachycardia). EP study consistent with IST would 
include slow warm up and cool down phases suggesting sinus node involvement, surface P-
wave similar to that of normal sinus rhythm, and earliest activation arising near the sinus 
node area along the crista terminalis during mapping. IST is not initiated with programmed 
stimulation of the atria (Lin and Callans 2004). In addition to electrophysiology testing, there 
is also a need for autonomic dysregulation testing. Neurologic, cardiovascular 
rehabilitation, and psychiatric consultations are often necessary because IST is a diagnosis of 
exclusion (Shen 2005). 
5.1.2.9 Management and Prognosis: Treatment involves a multidisciplinary approach. 
Medications including beta blockers, calcium channel blockers and class IC anti-arrhythmic 
agents decrease SA node automaticity (Chiale et al. 2006). However in patients with IST 
secondary to autonomic dysregulation, control of heart rate does not always lead to 
resolution of symptoms. In patients with no evidence of autonomic dysregulation if 
biofeedback, meditation, and medical therapy fail, superolateral crista terminalis ablation 
could be considered (Shen 2005; Fogoros 2006). Risks of RF ablation include SVC syndrome, 
diaphragmatic paralysis and persistent junctional rhythm. The prognosis of IST is benign 
over a mean follow-up of 6 years (Still et al. 2005). 
5.1.3 Sinus Node Re-entry Tachycardia 
5.1.3.1 Definition: Sino-atrial node re-entry tachycardia (SNRT) is a paroxysmal arrhythmia 
characterized by a re-entry mechanism that is located entirely within the SA node or the 
perisinus atrial tissue (Lin and Callans 2004).  
5.1.3.2 Incidence: Incidence of SNRT is underestimated due to lack of symptoms very often. 
In patients undergoing electrophysiology study for supraventricular tachycardia, incidence 
ranges from 1.8%-16.9% (Blomstrom-Lundqvist 2003). Incidence of SNRT is higher (10%) in 
those with underlying organic heart disease (Garson Jr. and Gillette 1981).  
5.1.3.3 Mechanism: A re-entry mechanism is present but it is not known whether the entire 
circuit is within the SA node or involves perisinus atrial tissue. 
5.1.3.4 Clinical presentation: Patients are often asymptomatic. Symptoms include palpitations, 
lightheadedness, presyncope, and rarely syncope (Gomes et al. 1985). 
5.1.3.5 ECG: SNRT heart rate ranges from 80-200 beats/min. P-wave axis and morphology 
are similar to that of normal sinus rhythm. P-R interval is shorter than R-P interval. An 
atrio-ventricular (AV) nodal Wenckebach block may be present (Olgin and Zipes 2005a). 
5.1.3.6 Diagnosis: Criteria for diagnosis include: a) paroxysmal tachycardia, b) P-wave 
morphology and endocardial atrial activation similar to that of normal sinus rhythm, c) 
inducibility with programmed premature atrial stimuli irrespective of the location of 
stimulation or the AV junction, d) the ability to terminate the arrhythmia with atrial 
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premature beat or atrial pacing, and e) termination with vagal maneuvers or adenosine 
(Narula 1974; Blomstrom-Lundqvist 2003).  
5.1.3.7 Work-up: Electrophysiology study is indicated in patients with frequent and poorly-
tolerated episodes of tachycardia, unclear mechanism of tachycardia, and refractoriness to 
medications.  
5.1.3.8 Management and Prognosis: Vagal maneuvers or adenosine may interrupt the 
tachycardia. Acutely, atrial pacing is effective. Beta blockers, calcium channel blockers, 
amiodarone, and digitalis can benefit patients with increased frequency of symptoms. 
However, prophylactic treatment of SNRT is not recommended. In patients undergoing an 
electrophysiology study, catheter ablation can be successful (Goya et al. 1999).  
5.1.4 Ectopic (focal) Atrial Tachycardia 
5.1.4.1 Definition: Ectopic or focal atrial tachycardia (EAT) is a tachycardia mediated by 
inappropriate atrial impulse generation from a single atrial focus outside of the SA node 
(Walsh 2001a). 
5.1.4.2 Incidence: EAT is commonly found in children and teenagers and makes up 
approximately 15% of all newly diagnosed supraventricular tachycardias across all ages 
(Walsh 2001a). Both genders are equally affected. Prevalence of EAT is 0.34% in 
asymptomatic male patients and 0.46% in symptomatic male patients (Poutiainen et al. 
1999). 
5.1.4.3 Mechanism: EAT can be due to three mechanisms: a) enhanced automaticity, b) 
triggered activity, and c) microreentry (Roberts-Thomson et al. 2006). The tachycardia 
cannot be initiated or terminated with programmed stimuli (Walsh 2001a). However, the 
exact mechanism is difficult to ascertain. 
5.1.4.4 Natural history: In the majority of patients, the course is benign. Persistent incessant 
EAT can lead to ventricular dysfunction, congestive heart failure and low cardiac output 
states, termed tachycardia-mediated cardiomyopathy. However, termination of the rhythm 
can lead to improvement in ventricular function (Packer et al. 1986; Naheed et al. 1995). 
There is slowing of heart rate with time, with reversion to sinus rhythm or change in P-wave 
morphology (Poutiainen et al. 1999). 
5.1.4.5 Clinical presentation: Young patients are often asymptomatic until onset of left 
ventricular dysfunction. Patients may also have palpitations, lightheadedness, and exercise 
intolerance even with normal LV function (Walsh 2001a).  
5.1.4.6 ECG: ECG shows a supraventricular tachycardia with rates within normal range to 
300 beats per minute. ECG criteria for diagnosis include: a) the P-wave morphology and axis 
different than that of normal sinus rhythm, b) acceleration after initiation and deceleration 
before termination, c) unaffected by presence of an atrio-ventricular block, and d) an initial 
P-wave of the tachycardia similar to the subsequent P-waves (Olgin and Zipes 2005a). The 
QRS complex is similar to that of sinus rhythm.  
5.1.4.7 Work-up: The location of the ectopic focus can be determined by noting P-wave 
frontal plane axis. “Warm-up” and “cool-down” patterns can be appreciated and suggestive 
of an automatic mechanism. AV-block (Mobitz 1) can be appreciated episodically during 
sleep. Adenosine administration will demonstrate AV-block with continuous marching of P-
waves (Figure 8). When the ectopic focus is close to the sinus node and/or there is poor 
ventricular function, electrophysiology testing is necessary to differentiate between sinus 
tachycardia, atrial flutter, and ectopic atrial tachycardia. Difficulty to terminate tachycardia 
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with pacing maneuvers and external cardioversion are suggestive of EAT (Walsh 2001a). 
Echocardiography at the time of diagnosis is important to document the ventricular function 
(Naheed et al. 1995).  
5.1.4.8 Management and Prognosis: Paroxysmal and incessant atrial tachycardia are difficult to 
treat medically (Blomstrom-Lundqvist 2003). Acute therapy includes IV verapamil and IV beta 
blockers. There is no termination of tachycardia with atrial pacing, except for mild slowing of 
the heart rate. DC cardioversion is usually not effective but may be effective in those with 
micro-re-entry mechanism. Class IA (e.g. quinidine) and IC (e.g. flecainide, propafenone) anti-
arrhythmics are indicated for those without cardiac failure and Class III (amiodarone) is 
recommended in those with poor ventricular function (Blomstrom-Lundqvist 2003). Chronic 
therapy includes calcium channel blockers, Classes IA, IC, and III anti-arrhythmics; Class IC is 
not indicated in those with coronary artery disease. Intravenous amiodarone or oral sotalol can 
reduce rates and restore sinus rhythm (Skinner and Sharland 2008). Catheter ablation is 
successful in 86-90% with recurrence rate of 8% (Walsh 2001a; Hsieh and Chen 2002). In 
children, 75% had restoration of normal sinus rhythm after medical therapy (Naheed et al. 
1995). In patients with drug refractory EAT or incessant AT with tachycardia-induced 
cardiomyopathy, best option is ablation of the focus (Blomstrom-Lundqvist 2003). Because 
digitalis toxicity can elicit atrial tachycardia, check digitalis levels and avoid hypokalemia. 
 
 
Fig. 8. Ectopic atrial tachycardia with effect of adenosine 
5.1.5 Multifocal (chaotic) Atrial Tachycardia 
5.1.5.1 Definition: Tachycardia characterized by electrocardiographic finding of multiple (at 
least three) distinct P-wave morphologies with irregular P-P intervals, isoelectric baseline 
between P-waves and ventricular rate >100 beats/min (Blomstrom-Lundqvist 2003). 
5.1.5.2 Incidence: MAT is a rare entity. In the pediatric age group, it is reported exclusively in 
neonates and infants, mostly associated with a normal heart (Kastor 1990). It is also 
associated with post-operative congenital heart disease, hypertrophic and dilated 
cardiomyopathies, and unrepaired atrial septal defects (Walsh 2001a). Incidence is 0.2% 
among infants presenting with new onset arrhythmias (Salim et al. 1995). It is associated 
with significant respiratory disease in adults. It is also associated with hypoxemia, glucose 
intolerance, hypokalemia, digitalis, and chronic renal failure (Kones et al. 1974). 
5.1.5.3 Mechanism: Exact mechanism of MAT is unclear; however, automaticity versus 
triggered activity is postulated (Walsh 2001a). 
5.1.5.4 Natural history: Spontaneous resolution may occur in 50-80% of patients with MAT by 
12-18 months of age (Sokoloski 1999). There is no recurrence of MAT in infants with normal 
cardiac structure (Walsh 2001a). 
5.1.5.6 Clinical presentation: Most patients are asymptomatic at the time of detection. If 
tachycardia is persistent, cardiomyopathy develops and symptoms consistent with 
cardiomyopathy arise. 
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5.1.5.7 ECG: Diagnostic criteria include: 1) irregular atrial rates, 2) at least three different P-
wave configurations, 3) isoelectric baseline between discrete P waves, 4) irregular P-P, P-R, 
and R-R intervals, and 5) absence of a dominant atrial pacemaker (Sokoloski 1999). Atrial 
rate may range from 150-500 beats/minute.  
5.1.5.8 Work-up: Meeting ECG criteria is sufficient for diagnosis of MAT (figure 9). 
5.1.5.9 Management and Prognosis: It is usually not responsive to DC cardioversion, vagal 
maneuvers, or IV antiarrhythmics. However, digoxin, beta blockers, amiodarone, and 
flecainide are options to consider. Calcium channel blockers are not indicated in neonates 
and infants less than one year of age. When drug therapy is successful, it should be 
continued for 6-12 months. In rare cases with medication refractory MAT, multiple foci 
ablation is required. In refractory cases, AV node ablation with ventricular pacemaker 
implantation may be necessary (Walsh 2001a). 
 
 
Fig. 9. Multifocal atrial tachycardia 
5.1.6 Atrial flutter 
5.1.6.1 Definition: Atrial flutter is a regular atrial tachycardia due to a macro-reentrant 
rhythm confined to the atrium. There are two types of atrial flutter: 1) typical or Type I and 
2) atypical or Type II. Typical atrial flutter is the most common, cavo-tricuspid isthmus-
dependent, terminated by rapid atrial pacing and is further divided into counter-clockwise 
and clockwise circuits. Atypical atrial flutter has a faster rate (>350 beats/minute), and is not 
cavo-tricuspid isthmus-dependent (Saoudi et al. 2001; Waldo 2004). Left atrial flutter is also 
considered to be atypical (Garan 2008).  
5.1.6.2 Incidence: In a study of 380 patients with first flutter episode between 1 and 25 years 
of life, 81% had congenital heart disease, and 8% had normal hearts (Garson Jr. et al. 1985). 
Among adults, the incidence of atrial flutter overall was 88 per 100,000 person-years with 
male predominance (4:1) and is noted in patients with heart failure, pulmonary disease, 
thyrotoxicosis, post repair of congenital heart defects, and mitral valve disease (Granada et 
al. 2000; Waldo 2004). The incidence of atypical atrial flutter is rare in patients without prior 
cardiac surgery. Atypical right atrial flutter occurs in 8% of patients with atrial flutter (Yang 
et al. 2001). Persistent or recurrent atrial flutter is common in patients post-cardiac surgery 
(Waldo 2004). 
5.1.6.3 Mechanism: The mechanism of atrial flutter is re-entry with an excitable gap, within 
the atrium, right more than left (Waldo 2004). The flutter circuit requires an initially 
activated region to repolarize as the action potential travels through the slow conduction 
tissue and reactivates the initial part, thereby creating a re-entry circuit. The atrial activation 
along the circuit proceeds from the coronary sinus superiorly to the high right atrium area 
and craniocaudally along the free wall and medially to the isthmus between the tricuspid 
valve and the inferior vena cava in a counter-clockwise manner. There is an area of slow 
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with pacing maneuvers and external cardioversion are suggestive of EAT (Walsh 2001a). 
Echocardiography at the time of diagnosis is important to document the ventricular function 
(Naheed et al. 1995).  
5.1.4.8 Management and Prognosis: Paroxysmal and incessant atrial tachycardia are difficult to 
treat medically (Blomstrom-Lundqvist 2003). Acute therapy includes IV verapamil and IV beta 
blockers. There is no termination of tachycardia with atrial pacing, except for mild slowing of 
the heart rate. DC cardioversion is usually not effective but may be effective in those with 
micro-re-entry mechanism. Class IA (e.g. quinidine) and IC (e.g. flecainide, propafenone) anti-
arrhythmics are indicated for those without cardiac failure and Class III (amiodarone) is 
recommended in those with poor ventricular function (Blomstrom-Lundqvist 2003). Chronic 
therapy includes calcium channel blockers, Classes IA, IC, and III anti-arrhythmics; Class IC is 
not indicated in those with coronary artery disease. Intravenous amiodarone or oral sotalol can 
reduce rates and restore sinus rhythm (Skinner and Sharland 2008). Catheter ablation is 
successful in 86-90% with recurrence rate of 8% (Walsh 2001a; Hsieh and Chen 2002). In 
children, 75% had restoration of normal sinus rhythm after medical therapy (Naheed et al. 
1995). In patients with drug refractory EAT or incessant AT with tachycardia-induced 
cardiomyopathy, best option is ablation of the focus (Blomstrom-Lundqvist 2003). Because 
digitalis toxicity can elicit atrial tachycardia, check digitalis levels and avoid hypokalemia. 
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neonates and infants, mostly associated with a normal heart (Kastor 1990). It is also 
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cardiomyopathies, and unrepaired atrial septal defects (Walsh 2001a). Incidence is 0.2% 
among infants presenting with new onset arrhythmias (Salim et al. 1995). It is associated 
with significant respiratory disease in adults. It is also associated with hypoxemia, glucose 
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5.1.5.3 Mechanism: Exact mechanism of MAT is unclear; however, automaticity versus 
triggered activity is postulated (Walsh 2001a). 
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5.1.5.7 ECG: Diagnostic criteria include: 1) irregular atrial rates, 2) at least three different P-
wave configurations, 3) isoelectric baseline between discrete P waves, 4) irregular P-P, P-R, 
and R-R intervals, and 5) absence of a dominant atrial pacemaker (Sokoloski 1999). Atrial 
rate may range from 150-500 beats/minute.  
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5.1.5.9 Management and Prognosis: It is usually not responsive to DC cardioversion, vagal 
maneuvers, or IV antiarrhythmics. However, digoxin, beta blockers, amiodarone, and 
flecainide are options to consider. Calcium channel blockers are not indicated in neonates 
and infants less than one year of age. When drug therapy is successful, it should be 
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Fig. 9. Multifocal atrial tachycardia 
5.1.6 Atrial flutter 
5.1.6.1 Definition: Atrial flutter is a regular atrial tachycardia due to a macro-reentrant 
rhythm confined to the atrium. There are two types of atrial flutter: 1) typical or Type I and 
2) atypical or Type II. Typical atrial flutter is the most common, cavo-tricuspid isthmus-
dependent, terminated by rapid atrial pacing and is further divided into counter-clockwise 
and clockwise circuits. Atypical atrial flutter has a faster rate (>350 beats/minute), and is not 
cavo-tricuspid isthmus-dependent (Saoudi et al. 2001; Waldo 2004). Left atrial flutter is also 
considered to be atypical (Garan 2008).  
5.1.6.2 Incidence: In a study of 380 patients with first flutter episode between 1 and 25 years 
of life, 81% had congenital heart disease, and 8% had normal hearts (Garson Jr. et al. 1985). 
Among adults, the incidence of atrial flutter overall was 88 per 100,000 person-years with 
male predominance (4:1) and is noted in patients with heart failure, pulmonary disease, 
thyrotoxicosis, post repair of congenital heart defects, and mitral valve disease (Granada et 
al. 2000; Waldo 2004). The incidence of atypical atrial flutter is rare in patients without prior 
cardiac surgery. Atypical right atrial flutter occurs in 8% of patients with atrial flutter (Yang 
et al. 2001). Persistent or recurrent atrial flutter is common in patients post-cardiac surgery 
(Waldo 2004). 
5.1.6.3 Mechanism: The mechanism of atrial flutter is re-entry with an excitable gap, within 
the atrium, right more than left (Waldo 2004). The flutter circuit requires an initially 
activated region to repolarize as the action potential travels through the slow conduction 
tissue and reactivates the initial part, thereby creating a re-entry circuit. The atrial activation 
along the circuit proceeds from the coronary sinus superiorly to the high right atrium area 
and craniocaudally along the free wall and medially to the isthmus between the tricuspid 
valve and the inferior vena cava in a counter-clockwise manner. There is an area of slow 
 
Advances in Electrocardiograms – Clinical Applications 
 
58
conduction in the posteroinferior aspect of the circuit. The clockwise or reverse typical 
circuit proceeds in the opposite direction (Sokoloski 1999).  
5.1.6.4 Natural history: In patients less than one year of age and with no previous cardiac 
surgery, atrial flutter spontaneously converts in 26%. Congestive heart failure was more 
prevalent in those with atrial flutter of long duration. Of the infants with decreased 
ventricular function, all recovered normal function after conversion to sinus rhythm. If 
patients had additional arrhythmia, recurrence of atrial flutter was more likely (Texter et al. 
2006). Atrial flutter persisting over a long period of time can evolve into atrial fibrillation 
(Waldo 2004). 
5.1.6.5 Clinical presentation: In neonates, 80% are asymptomatic and 20% may present with 
congestive heart failure (Texter et al. 2006). Older patients can experience palpitations, 
dizziness, chest tightness, chest pain, shortness of breath, and fatigue. Hypotension, poor 
exercise tolerance, congestive heart failure and impaired cardiac output can also result from 
atrial flutter (Blomstrom-Lundqvist 2003; Andrew and Montenero 2007).  
5.1.6.6 ECG: Counterclockwise (typical) atrial flutter has negative flutter (F) waves in the 
inferior leads II, III, and aVF and positive F waves in Lead V1 (figure 10). Clockwise (reverse 
typical) atrial flutter shows positive F waves in the inferior leads II, III, and aVF and 
negative F waves in lead V1 (Blomstrom-Lundqvist 2003). In typical atrial flutter, P waves 
are absent. The flutter rate can range from 240-340 beats/minute with no isoelectric interval 
between consecutive waves. Flutter rates in infants can be as high as 580 beats/minute with 
rapid ventricular response rates of 200 beats/minute with 2:1 AV conduction in 75% and 
variable block in the remainder (Texter et al. 2006). Flutter waves typically have 90-degree 
axis. The QRS complexes appear normal unless there is rate-dependent aberrancy or block.  
5.1.6.7 Work-up: Echocardiogram is indicated in those with congestive heart failure to 
evaluate ventricular function and structure. 
5.1.6.8 Management and Prognosis: Management of atrial flutter is accomplished through 
electrical cardioversion, rapid atrial pacing, pharmacological therapy, and catheter ablation. 
The goal of flutter management is to decrease the ventricular rate and to restore normal 
sinus rhythm. Chronic anti-arrhythmic therapy may not be needed in those with 
uncomplicated, asymptomatic atrial flutter after conversion to sinus rhythm (Texter et al. 
2006; Skinner and Sharland 2008). Drugs are successful in controlling atrial flutter in about 
58% of young patients. Amiodarone, digoxin, and propranolol are found to be effective 
(Garson Jr. et al. 1985). Atrial flutter causing hemodynamic instability should be terminated 
acutely with electrical cardioversion (2J/Kg) (Class 1 level of evidence) (Blomstrom-
Lundqvist 2003; Texter et al. 2006). Although cardioversion is successful acutely, atrial 
flutter recurs frequently. Recurrences of atrial flutter can be prevented by administering 
Class IA, IC, and III anti-arrhythmic agents. Ventricular rate can be controlled with AV-
nodal blockers such as digitalis and class II (beta blockers), III (amiodarone, sotalol), and IV 
(calcium channel blockers) anti-arrhythmic agents. Flecainide (Class IC anti-arrhythmic) 
should be administered with an AV-node blocking agent. As flecainide slows the atrial rate, 
it may facilitate 1:1 AV conduction, leading to clinical compromise (Skinner and Sharland 
2008). Calcium channel antagonists are contraindicated in children less than one year of age. 
When atrial flutter is refractory to medical management, transesophageal atrial overdrive 
pacing (TEAP) and catheter ablation are excellent options. In a study by Ajisaka (1997), 
paroxysmal atrial flutter was terminated in greater than 50 percent of the adult subjects with 
low-output, short-duration TEAP (Ajisaka et al. 1997). In young adults with repaired 
congenital heart disease, 50-88% had successful ablation of recurrent atrial flutter 
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(Blomstrom-Lundqvist 2003). Catheter ablation is used to create a bidirectional conduction 
block across the cavo-tricuspid isthmus. In addition to palliating with catheter ablation, 
underlying causes of atrial flutter such as stimulants and sympathomimetic agents should 
also be eliminated. 
 
 
Fig. 10. Atrial flutter 
5.1.7 Intra-atrial Reentry Tachycardia 
5.1.7.1 Definition: Intra-atrial reentry tachycardia (IART) is a group of reentry tachycardia 
associated with repaired or unrepaired congenital heart disease (CHD). It is also known as 
slow atrial flutter, incisional atrial tachycardia, and macro-reentrant atrial tachycardia. It is 
very often a long-term complication of cardiac surgery involving the atrium (Triedman 
2001). It is frequently associated with Fontan, Mustard, Senning, repaired tetralogy of Fallot, 
and TAPVR repairs. Risk factors for IART are older age of surgery and long-term follow-up.  
5.1.7.2 Incidence: Incidence of IART often depends on the congenital heart disease and the 
surgery preceding the onset. Structural heart disease is evident in about 89% of patients 
with IART (Haines and DiMarco 1990).  
5.1.7.3 Mechanism: IART has a re-entrant mechanism defined within the atrium and does not 
necessarily follow the atrial flutter circuit. Majority of the reentrant circuits are mainly 
confined to the right atrium (Triedman 2001). 
5.1.7.4 Natural history: IART is intimately associated with atrial fibrillation and thromboembolic 
phenomena. Natural history is associated with increased frequency of recurrences, regardless 
of treatment with anti-arrhythmic medications or ablation (Triedman 2004). Intermediate 
follow-up post ablation of IART shows frequent recurrence with new IART configurations 
(Triedman et al. 1997). 
5.1.7.5 Clinical presentation: Symptoms in patients with IART can range from being 
asymptomatic to congestive heart failure to significant cardiovascular compromise, 
including sudden cardiac death (Triedman 2004). Sinus node dysfunction with symptomatic 
bradycardia is a common association with IART. 
5.1.7.6 ECG: Flutter morphology or uniform P waves are frequently noted with constant 
cycle length longer than typical atrial flutter (figure 11). Multiple ECG morphologies can be 
obtained from a single patient due to various activation mechanisms. There is often 1:1 AV 
conduction based on the cycle length. There is sudden onset and termination with pacing 
and is entrainable (Triedman 2001; Triedman 2004).  
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(Blomstrom-Lundqvist 2003). Catheter ablation is used to create a bidirectional conduction 
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5.1.7.7 Work-up: In refractory atrial reentry arrhythmias, an electrophysiology study must be 
conducted to further elucidate the nature of the substrate responsible for IART.  
5.1.7.8 Management and Prognosis: Acute management in cardiovascular compromise consists of 
direct current (DC) cardioversion. Other options in clinically stable patients include anti-
arrhythmic medications, atrial overdrive pacing, and anti-tachycardia pacing with pacemakers 
and transesophageal pacing. For chronic therapy, sotalol and amiodarone have been reported 
to be effective in approximately 60% (Triedman 2001). Implanted anti-tachycardia pacemakers 
provide relief from symptomatic tachycardia and bradycardia associated with sinus node 
dysfunction. In cases refractory to medical management, catheter ablation can be attempted. 
Intra-operative surgical Maze procedure is reserved for patients that have failed catheter 
ablation or are scheduled to undergo surgery for another indication. 
 
 
Fig. 11. Intra-atrial re-entrant tachycardia 
6.1 Atrio-Ventricular Reciprocating Tachycardia 
6.1.1 Definition: Atrio-ventricular reciprocating tachycardia (AVRT) is a re-entrant 
tachycardia with an accessory electrical connection between the atrial and ventricular 
myocardium in addition to the AV node (Blaufox and Saul 2001). The accessory pathway 
(AP) can be “concealed” with only retrograde conduction, “manifest” with antegrade or 
bidirectional conduction. The manifestation of antegrade conduction is presence of pre-
excitation with short PR on the electrocardiogram during sinus rhythm suggestive of Wolff-
Parkinson-White (WPW) syndrome. Orthodromic AVRT employs prograde conduction 
through the AV node and bundle of His with retrograde conduction through the AP. 
Antidromic AVRT employs AP for atrio-ventricular conduction with retrograde conduction 
through the bundle of His and AV node. 
6.1.2 Incidence: AVRT is the most common cause of supraventricular tachycardia in children 
without prior cardiac surgery or neuromuscular disease, comprising 73 to 85 percent (Ko et 
al. 1992; Etheridge and Judd 1999). It is more common in infancy compared to AVNRT, the 
incidence of which increases in older children (Ko et al. 1992). Accessory pathways are 
associated with congenital heart defects in 6-26% of the children. The common heart defects 
associated with accessory pathways are Ebstein’s anomaly of the tricuspid valve, ventricular 
inversion (L-TGA), hypertrophic cardiomyopathy, and mitral valve prolapse (Van Hare 
1999). 
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6.1.3 Mechanism: As the name suggests, AVRT has a reentrant mechanism. The reentrant 
mechanism is characterized by an accessory pathway in the left or right atrio-ventricular 
grooves, i.e. extranodal pathway. Atriofascicular and nodofascicular (Mahaim), and 
atrionodal (James) AP are other variants. The left free wall is the most common site of the 
AP, followed by posteroseptal and right free wall AP (Calkins et al. 1999). Even in patients 
with manifest AP, orthodromic narrow complex reciprocating tachycardia is still the most 
common manifestation. 
6.1.4 Natural history: In patients with WPW syndrome with onset less than 2 months of age, 
SVT disappeared in 93% and reappeared in 31% at an average age of 8 years (Perry and 
Garson Jr. 1990). In patients with onset after 5 years of age, seventy eight percent had 
persistence at 7 years of follow-up. Multiple and right-sided AP were more frequent in 
patients with congenital heart disease (Perry and Garson Jr. 1990). Congenital heart defects 
are present in 20 - 37% of patients with WPW (Deal et al. 1985; Perry and Garson Jr. 1990). 
Patients with WPW syndrome are also prone to develop atrial fibrillation with increased 
risk of sudden death (Hare 1999).  
6.1.5 Clinical presentation: Symptoms are usually paroxysmal but may be incessant. 
Symptoms may occur with or without triggers, including activity and exertion. Location, 
rate, duration of tachycardia, and the type of AP very often determine the nature of 
symptoms. Infants tolerate higher rates of tachycardia compared to adolescents and adults. 
Patients perceive sensed tachycardia with or without associated symptoms including 
dizziness, lightheadedness, and mild chest discomfort. Heart failure symptoms with 
orthopnea, paroxysmal nocturnal dyspnea, fatigue, tachypnea, diaphoresis are often present 
in those with persistent tachycardia (Van Hare 1999). Sudden death is attributed to the 
presence of atrial fibrillation with rapid ventricular response across the accessory pathway 
(Van Hare 1999). In orthodromic AVRT, shortness of breath, fatigue, and dizziness are 
common; syncope is less common (Blaufox and Saul 2001). In antidromic AVRT, dizziness, 
syncope, and tendency towards unstable ventricular rhythm are more common than 
orthodromic AVRT (Blaufox and Saul 2001).  
6.1.6 ECG: ECG findings are determined by presence of tachycardia, normal sinus rhythm, 
and type of accessory pathway. In normal sinus rhythm, WPW syndrome is evident by the 
presence of pre-excitation (delta wave) with short PR interval. The pre-excited complex is a 
fusion complex resulting from initial pre-excitation of ventricular myocardium adjacent to 
the AP giving rise to the delta wave, followed by fusion of depolarization of the remainder 
of the ventricular myocardium by normal conduction. In orthodromic AVRT, the QRS 
complexes are narrow due to normal prograde conduction through the AV node and bundle 
of His and retrograde conduction via the AP (figure 12). Orthodromic AVRT have RP 
interval shorter than the PR interval with a P-wave on the upstroke of the T-wave during 
tachycardia, which differentiates it from AVNRT (Van Hare 1999). In antidromic AVRT, the 
QRS complexes are wide due to antegrade conduction down the AP and retrograde 
conduction across the AV node or another AP. AV block terminates the tachycardia due to 
the role of AV node in the tachycardia. WPW is characterized by wide QRS complexes with 
short PR interval. Mahaim AP has pre-excitation with widened QRS complexes but normal 
PR interval and usually manifest as a wide complex tachycardia with left bundle branch 
block pattern. Though the terminology is obsolete, Lown-Ganong-Levine (LGL) syndrome 
has normal QRS complexes with short PR interval.  
6.1.7 Work-up: Baseline ECG during sinus rhythm may show pre-excitation. Depending on 
the frequency of sensed tachycardia or other symptoms, a Holter monitor or a loop recorder 
can be used. Echocardiogram may be obtained to rule out structural heart defects. In 
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5.1.7.7 Work-up: In refractory atrial reentry arrhythmias, an electrophysiology study must be 
conducted to further elucidate the nature of the substrate responsible for IART.  
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direct current (DC) cardioversion. Other options in clinically stable patients include anti-
arrhythmic medications, atrial overdrive pacing, and anti-tachycardia pacing with pacemakers 
and transesophageal pacing. For chronic therapy, sotalol and amiodarone have been reported 
to be effective in approximately 60% (Triedman 2001). Implanted anti-tachycardia pacemakers 
provide relief from symptomatic tachycardia and bradycardia associated with sinus node 
dysfunction. In cases refractory to medical management, catheter ablation can be attempted. 
Intra-operative surgical Maze procedure is reserved for patients that have failed catheter 
ablation or are scheduled to undergo surgery for another indication. 
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6.1.3 Mechanism: As the name suggests, AVRT has a reentrant mechanism. The reentrant 
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with manifest AP, orthodromic narrow complex reciprocating tachycardia is still the most 
common manifestation. 
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are present in 20 - 37% of patients with WPW (Deal et al. 1985; Perry and Garson Jr. 1990). 
Patients with WPW syndrome are also prone to develop atrial fibrillation with increased 
risk of sudden death (Hare 1999).  
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Symptoms may occur with or without triggers, including activity and exertion. Location, 
rate, duration of tachycardia, and the type of AP very often determine the nature of 
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Patients perceive sensed tachycardia with or without associated symptoms including 
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in those with persistent tachycardia (Van Hare 1999). Sudden death is attributed to the 
presence of atrial fibrillation with rapid ventricular response across the accessory pathway 
(Van Hare 1999). In orthodromic AVRT, shortness of breath, fatigue, and dizziness are 
common; syncope is less common (Blaufox and Saul 2001). In antidromic AVRT, dizziness, 
syncope, and tendency towards unstable ventricular rhythm are more common than 
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fusion complex resulting from initial pre-excitation of ventricular myocardium adjacent to 
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of the ventricular myocardium by normal conduction. In orthodromic AVRT, the QRS 
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block pattern. Though the terminology is obsolete, Lown-Ganong-Levine (LGL) syndrome 
has normal QRS complexes with short PR interval.  
6.1.7 Work-up: Baseline ECG during sinus rhythm may show pre-excitation. Depending on 
the frequency of sensed tachycardia or other symptoms, a Holter monitor or a loop recorder 
can be used. Echocardiogram may be obtained to rule out structural heart defects. In 
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patients with pre-excitation, exercise stress test to stratify the risk of sudden catastrophic 
event can be performed. Persistent pre-excitation at peak exercise may suggest a short 
refractory period of the accessory fiber with a higher risk for sudden catastrophic event 
(Blaufox and Saul 2001). To differentiate between narrow complex tachycardias, including 
concealed pathways, AVNRT, and atrial tachycardias, an EP study is required. An EP study 
will also assist in differentiating antidromic AVRT from other wide-complex tachycardias.  
6.1.8 Management and Prognosis: Acute management in patients with significant hemodynamic 
compromise requires synchronized DC cardioversion. Adenosine administration is effective 
and esmolol may be used. Flecainide and procainamide are recommended in pre-excited SVT 
(Blomstrom-Lundqvist 2003). Digoxin and calcium channel blockers are contra-indicated in 
patients with WPW syndrome.  In stable patients, vagal maneuvers may be effective in 
terminating the arrhythmia. Calcium channel blockers are contraindicated in infants. Catheter 
ablation is a class I indication for managing AVRT (Blomstrom-Lundqvist 2003). Left free wall 
AP was predictive of ablation success while right free wall, posteroseptal, septal, and multiple 
APs were predictive of recurrence (Calkins et al. 1999). Medical therapy includes beta blockers 
to block AV node conduction and decrease premature ectopic beats, and class IA, IC, and III 
antiarrhythmics (Triedman 2001).  
 
 
Fig. 12. Orthodromic AV reciprocating tachycardia 
6.2 Atrio-Ventricular Node Reentry Tachycardia 
6.2.1 Definition: Atrio-ventricular node reentry tachycardia (AVNRT) is a re-entry tachycardia 
that is dependent on existence of dual discrete pathways within or in proximity of the AV 
node, one with slow conduction and short effective refractory period and the other with fast 
conduction and long refractory period (Zimmerman 2001; Lockwood et al. 2004). The typical 
ventricular rate in children ranges from 120 to 280 beats/minute (Zimmerman 2001). AVNRT 
is often associated with an accessory pathway. 
6.2.2 Incidence: AVNRT is the most common SVT in adults but consists of 13% of SVT in 
children without underlying heart disease and rarely in children under two years of age (Ko 
et al. 1992). In infants, 15% of SVT was due to AVNRT (Etheridge and Judd 1999). 
6.2.3 Mechanism: Dual AV node physiology is present in 33-35% of the children without 
clinical or inducible AVNRT in congenital or acquired heart disease (Casta et al. 1980). The 
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“slow-fast” or typical form of the AVNRT is the most common form. A premature atrial or 
junctional beat blocks the fast pathway with subsequent antegrade conduction through the 
slow pathway. If the fast pathway recovers as the impulse conducts through the slow 
pathway, the substrate for reentry is present. In the less common “fast-slow” or atypical 
form of AVNRT, the premature atrial impulse is blocked in the slow pathway and is 
conducted antegrade along the fast pathway. If the slow pathway recovers, a reentry 
substrate is present; antegrade conduction down the fast pathway and retrograde 
conduction up the slow pathway is present (Zimmerman 2001). The least common form is 
the “slow-slow” dual node physiology. There is retrograde atrial activation with early atrial 
activation in the low right atrium, followed by left and remaining right atrial activation 
(Olgin and Zipes 2005a). 
6.2.4 Natural history: AVNRT is not life-threatening and patients with minimal symptoms do 
well without therapy. Female patients are more symptomatic and tend to present with 
syncope (Drago et al. 2006).  
6.2.5 Clinical presentation: Symptoms include palpitations, chest pain, heart failure, and 
shock, and rarely syncope, dependent on the duration of the AVNRT. Tachycardia is 
paroxysmal. 
6.2.6 ECG: AVNRT is a regular narrow QRS complex tachycardia with abrupt onset and 
termination. The QRS complex may appear wider in case of baseline bundle branch block or 
rate dependent aberrant conduction. There is no pre-excitation appreciated during normal 
sinus rhythm in sole AVNRT. In slow-fast AVNRT, retrograde P-waves are not appreciated 
and are located within the terminal part of the QRS complexes. In fast-slow AVNRT, the P 
waves have a superior axis with RP interval longer than PR interval. 
6.2.7 Work-up: An electrophysiology study is indicated to definitively establish the diagnosis 
of AVNRT and dual AV node physiology. 
6.2.8 Management and Prognosis: Management of AVNRT is based on the frequency and the 
symptoms during the episodes. In those with infrequent, asymptomatic episodes, no 
treatment is necessary. Paroxysmal episodes may be terminated with Valsalva maneuver or 
carotid sinus massage. In acute decompensation, DC synchronized cardioversion, 
adenosine, IV beta blockers or digoxin can be employed (Zimmerman 2001). In patients with 
infrequent episodes desiring complete control, ablation is recommended. Patients with 
recurrent AVNRT refractory to beta blockers and calcium channel blockers, flecanide and 
sotalol are class IIA recommendations. In recurrent, symptomatic patients with significant 
side effects of medications and those with poorly tolerated AVNRT, catheter ablation of the 
slow AV nodal pathway is suggested (Blomstrom-Lundqvist 2003).  
7. Junctional Tachy-arrhythmias 
7.1 Junctional Ectopic Tachycardia 
7.1.1 Definition: Junctional ectopic tachycardia (JET), also called junctional automatic 
tachycardia, is an incessant tachycardia characterized by rapid heart rate with the focus of 
abnormal automaticity in the junction. Ventricular rates in patients with JET ranges from 
140-370 beats/minute (Villain et al. 1990). 
7.1.2 Incidence: Incidence of JET occurs in two cohorts: neonatal and post-operative patients. 
Congenital JET occurs in the first six months of life and a family history is usually present 
(Sarubbi et al. 2002). Overall, JET occurs in 1% of congenital heart repairs (Walsh 2001a). JET 
occurred in 22% of Tetralogy of Fallot (TOF) repairs, 10% of atrio-ventricular septal defect 
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patients with pre-excitation, exercise stress test to stratify the risk of sudden catastrophic 
event can be performed. Persistent pre-excitation at peak exercise may suggest a short 
refractory period of the accessory fiber with a higher risk for sudden catastrophic event 
(Blaufox and Saul 2001). To differentiate between narrow complex tachycardias, including 
concealed pathways, AVNRT, and atrial tachycardias, an EP study is required. An EP study 
will also assist in differentiating antidromic AVRT from other wide-complex tachycardias.  
6.1.8 Management and Prognosis: Acute management in patients with significant hemodynamic 
compromise requires synchronized DC cardioversion. Adenosine administration is effective 
and esmolol may be used. Flecainide and procainamide are recommended in pre-excited SVT 
(Blomstrom-Lundqvist 2003). Digoxin and calcium channel blockers are contra-indicated in 
patients with WPW syndrome.  In stable patients, vagal maneuvers may be effective in 
terminating the arrhythmia. Calcium channel blockers are contraindicated in infants. Catheter 
ablation is a class I indication for managing AVRT (Blomstrom-Lundqvist 2003). Left free wall 
AP was predictive of ablation success while right free wall, posteroseptal, septal, and multiple 
APs were predictive of recurrence (Calkins et al. 1999). Medical therapy includes beta blockers 
to block AV node conduction and decrease premature ectopic beats, and class IA, IC, and III 
antiarrhythmics (Triedman 2001).  
 
 
Fig. 12. Orthodromic AV reciprocating tachycardia 
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(Olgin and Zipes 2005a). 
6.2.4 Natural history: AVNRT is not life-threatening and patients with minimal symptoms do 
well without therapy. Female patients are more symptomatic and tend to present with 
syncope (Drago et al. 2006).  
6.2.5 Clinical presentation: Symptoms include palpitations, chest pain, heart failure, and 
shock, and rarely syncope, dependent on the duration of the AVNRT. Tachycardia is 
paroxysmal. 
6.2.6 ECG: AVNRT is a regular narrow QRS complex tachycardia with abrupt onset and 
termination. The QRS complex may appear wider in case of baseline bundle branch block or 
rate dependent aberrant conduction. There is no pre-excitation appreciated during normal 
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infrequent episodes desiring complete control, ablation is recommended. Patients with 
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sotalol are class IIA recommendations. In recurrent, symptomatic patients with significant 
side effects of medications and those with poorly tolerated AVNRT, catheter ablation of the 
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tachycardia, is an incessant tachycardia characterized by rapid heart rate with the focus of 
abnormal automaticity in the junction. Ventricular rates in patients with JET ranges from 
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7.1.2 Incidence: Incidence of JET occurs in two cohorts: neonatal and post-operative patients. 
Congenital JET occurs in the first six months of life and a family history is usually present 
(Sarubbi et al. 2002). Overall, JET occurs in 1% of congenital heart repairs (Walsh 2001a). JET 
occurred in 22% of Tetralogy of Fallot (TOF) repairs, 10% of atrio-ventricular septal defect 
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repairs, and 3.7% of VSD repairs (Dodge-Khatami et al. 2002). Predictors of post-operative 
JET were younger age (Hoffman et al. 2002), lower body weight (Rekawek et al. 2007), 
resection of muscle bundles, higher bypass temperatures, and relief of right ventricular 
outflow tract obstruction through the right atrium (Dodge-Khatami et al. 2002).  
7.1.3 Mechanism: Although the mechanism of JET is unclear, abnormal (enhanced) 
automaticity of the junction has been put forth. In post-operative congenital heart disease 
patients, it is hypothesized that direct trauma or infiltrative hemorrhage of the conduction 
system leads to enhanced automaticity of the His bundle (Dodge-Khatami et al. 2002).  
7.1.4 Natural history: Congenital JET is associated with high mortality, most of which is 
attributed to sudden cardiac death (Villain et al. 1990). Concurrent arrhythmias may co-exist 
with JET, such as complete heart block, ventricular tachycardia, and persistent junctional 
reciprocating tachycardia. Post-operative JET is a transient state lasting on average 36 hours 
(Walsh 2001a) and is associated with higher mortality and longer intensive care unit (ICU) 
stay (Andreasen et al. 2008).  
7.1.5 Clinical presentation: Congenital JET presents with cardiomegaly with concomitant heart 
failure in more than 50 percent, death in 35 percent (Villain et al. 1990), hydrops fetalis, and 
echocardiographic evidence of left ventricular dysfunction. In post-operative JET, the 
decreased ventricular filling time leads to cardiovascular compromise. 
7.1.6 ECG: ECG criteria include 1) QRS morphology similar to that of sinus rhythm, 2) rapid 
ventricular rate, and 3) dissociated sinus rhythm with atrial rate often less than ventricular 
rate or retrograde 1:1 conduction (Walsh 2001a). If variability exists in R-R interval, 
appropriately timed P-waves may conduct to the ventricular tissue (Figure 13). 
 
 
Fig. 13. Junctional ectopic tachycardia 
7.1.7 Work-up: An electrophysiology study is generally not necessary in patients with JET, 
unless ablation is being considered for medication-refractory symptoms (Walsh 2001a). In 
cases of 1:1 retrograde conduction across the AV node, adenosine can clarify the underlying 
rhythm by blocking the AV node. 
7.1.8 Management and Prognosis: Management of post-operative JET includes achievement of 
AV synchrony and rate control. Atrial pacing above the rate of JET may establish rate control 
(Walsh 2001a). Post-operative JET is generally responsive to intravenous amiodarone, a class 
III antiarrhythmic (Shah and Rhodes 1998). Mean length of time for termination of post-
operative JET after loading and infusion of amiodarone was 4.5 hours with majority achieving 
control within 12 hours (Plumpton et al. 2005). Decreasing the body core temperature to 32-34 
°C, decreasing the sympathomimetic catecholamine levels, optimizing volume, electrolytes 
and hemoglobin contribute to decreased ventricular rate by decreasing the automaticity 
(Cabrera et al. 2002). Magnesium supplementation has been shown to be beneficial in 
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prevention of post-operative JET (Dorman et al. 2000). JET is unresponsive to DC 
cardioversion, overdrive pacing, and programmed atrial or ventricular stimulation (Sarubbi et 
al. 2003). Pharmacologic treatment of congenital JET with monotherapy is less successful than 
combined therapy with amiodarone, digoxin or class IA medication (Sarubbi et al. 2002). 
Patients with drug-refractory congenital JET should undergo catheter ablation with 
maintenance of the normal atrio-ventricular conduction (Walsh 2001a). A pacemaker is 
recommended in those children with evidence of impaired conduction with atrial stimulation, 
sinus dysfunction, or spontaneous AV block on ECG or Holter monitor (Walsh 2001a).  
7.2 Persistent Junctional Reciprocating Tachycardia 
7.2.1 Definition: Persistent or permanent junctional reciprocating tachycardia (PJRT) is an 
incessant tachycardia characterized by prograde conduction through the AV node and 
retrograde conduction through a slow accessory pathway located in the posteroseptal (74%) 
region with decremental conduction properties (Critelli, G. et al. 1984; Lindinger, A. et al. 
1998; Vaksmann, G. et al. 2006). PJRT is a narrow complex tachycardia with rates ranging 
from 120-250 beats/min and infants having higher tachycardia rates than children 
(Dorostkar et al. 1999). 
7.2.2 Incidence: PJRT consists of 1% to 6% of all supraventricular tachycardia (Dorostkar et al. 
1999; Blaufox and Saul 2001). It can present in infancy and into early childhood. 
7.2.3 Mechanism: PJRT has a reentrant mechanism with accessory pathways which are 
mostly isolated and in patients without congenital heart disease (Vaksmann, G et al. 2006).  
7.2.4 Natural history: In a recent study by Vaksmann et al (2006), PJRT resolved 
spontaneously in 22 percent (Vaksmann, G et al. 2006). Long term persistence of PJRT can 
lead to tachycardia-mediated cardiomyopathy, which resolves with appropriate rate control 
(Lindinger, A et al. 1998; Noe et al. 2002). Uncontrolled PJRT may lead to death. 
7.2.5 Clinical presentation: Patients often are asymptomatic in childhood. Symptomatic 
patients present with intermittent palpitations, exercise intolerance, and syncope (Dorostkar 
et al. 1999).  
7.2.6 ECG: ECG shows retrograde P-wave in leads II, III, aVF, and left lateral leads, and R-P 
interval longer than P-R interval (Dorostkar et al. 1999). The long R-P interval is attributed 
to the slow retrograde conduction. In sinus rhythm, there is no delta wave and P-R interval 
is normal (Critelli, G et al. 1984). QRS complexes are narrow. 
7.2.7 Work-up: PJRT is likely under-diagnosed in childhood and patients present with heart 
failure with associated ventricular dysfunction. An ECG and Holter monitor should be 
considered. An echocardiogram should be performed to assess the cardiac function and 
structure and serial echocardiograms are necessary in those with depressed LV function. An 
electrophysiology study and catheter ablation may be performed in refractory PJRT 
associated with decreased ventricular function (Dorostkar et al. 1999). 
7.2.8 Management and Prognosis: Many patients with stable infrequent episodes and slow 
tachycardia may not require medical therapy (Lindinger, A et al. 1998). In pediatric patients, 
amiodarone and verapamil alone had success rates of 84-94% (Vaksmann, G et al. 2006). 
Digoxin alone had a success rate of 50%. Hence, medical therapy with anti-arrhythmic drugs 
should be advocated prior to consideration of catheter ablation (Drago et al. 2001). Pediatric 
and adult patients with medication-refractory incessant PJRT should undergo direct current 
catheter ablation, with good safety and efficacy (Aguinaga et al. 1998).  
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8.1 Ventricular Tachycardia 
8.1.1 Definition: Ventricular tachycardia (VT) is a tachycardia with rates greater than 120 
beats per minute and originating within the ventricles or the lower conduction system with 
ventriculo-atrial dissociation. Non-sustained VT is defined as a three or more consecutive 
beats of ventricular origin that terminate spontaneously with no hemodynamic compromise 
and lasting less than 30 seconds. Sustained VT persists longer than 30 seconds or requires 
medical or electrical intervention to terminate the tachycardia (AHA 2007).  
8.1.2 Incidence: In healthy teenage boys, short episodes of ventricular tachycardia were 
present in 3% (Dickinson and Scott 1984). Incidence of VT is higher in patients with 
congenital heart disease. Approximately 30% of post-operative tetralogy of Fallot patients 
had sustained monomorphic VT and 4.4% had polymorphic VT, which contributes to 2% 
annual risk of sudden cardiac death (Khairy et al. 2004; Walsh, E. and Cecchin, F. 2007). VT 
originates in the RVOT in 60%-80% of structurally normal hearts (Lerman et al. 2004). 
Idiopathic VT is also associated with aortic valve disease, corrected transposition of the 
great arteries, Ebstein’s anomaly of the tricuspid valve, Eisenmenger’s syndrome, long QT 
syndrome, unrepaired tetralogy of Fallot, arrhythmogenic right ventricular dysplasia, and 
myocardial infarction (Callans, D. and Josephson, M. 2004; Fontaine et al. 2004; Walsh, E. P. 
and Cecchin, F. 2007).  
8.1.3 Mechanism: Ventricular tachycardia characterized by a re-entry mechanism can be 
initiated and terminated with programmed stimuli (Callans, D and Josephson, ME 2004). VT 
may also be secondary to automaticity or triggered activity. 
8.1.4 Natural history: Post-operative congenital heart disease patients are at high risk of VT 
and sudden cardiac death. In patients with normal hearts, younger children (90%) and older 
populations (50%-70%) have resolution of VT within 2 to 10 years (Alexander 2001b). 
However, symptomatic younger patients had worse prognosis (Davis et al. 1996). In patients 
with normal intracardiac anatomy, only 50% have an actual diagnosis such as hypertrophic 
cardiomyopathy, dilated cardiomyopathy, myocarditis, myocardial hamartoma, and 
metabolic disease (Davis et al. 1996). Ventricular tachycardia is present in 50%-60% of 
patients with dilated cardiomyopathy and responsible for 8%-50% of deaths (Galvin and 
Ruskin 2004). 
8.1.5 Clinical presentation: Clinical presentation is variable (Davis et al. 1996). Symptoms may 
range from palpitations, light headedness, syncope, shortness of breath, neck fullness, and 
chest pain to death (Silka and Garson Jr. 1999). 
8.1.6 ECG: Monomorphic VT is a wide complex tachycardia with same QRS morphology, 
which suggests a single re-entrant focus (figure 14). Polymorphic VT is a wide complex 
tachycardia with variable QRS morphology. Torsades de pointe is a form of polymorphic 
VT and associated with long QT syndrome and variable electrical activation. (Figure 15) 
8.1.7 Work-up: Obtain a thorough personal and family history including history of sudden 
cardiac death. An ECG of the arrhythmia is useful but very difficult to capture very often; 
however, a resting ECG is a class 1 recommendation (Zipes and Camm 2006). Check 
electrolytes, in particular hypokalemia, hyperkalemia, and hypomagnesemia. In patients 
with recurrent syncope, a holter monitor or event recorder is indicated. An echocardiogram 
is necessary to identify structural heart disease and evaluate cardiac function in those at risk 
for sudden cardiac death such as dilated, hypertrophic, and arrhythmogenic RV dysplasia, 
myocarditis, and inherited disorders (Zipes and Camm 2006). An exercise stress test is 
indicated in all individuals, regardless of age, known or suspected to have exercise-induced 
ventricular tachycardia. An electrophysiology study is warranted in patients with 
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congenital/structural heart disease, those with unknown etiology of VT, and those with 
syncope of unknown etiology with LV dysfunction (Zipes and Camm 2006).  
8.1.8 Management and Prognosis: All wide complex tachycardias need to be treated like 
ventricular tachycardia unless proven otherwise. A-V dissociation, superior QRS axis and 
positive or negative concordance of QRS complexes in the precordial leads suggest 
ventricular origin. In patients with normal hearts, episodes of non-sustained VT has good 
prognosis. Avoid medications that prolong QT interval and correct electrolyte 
abnormalities. In patients with sustained VT with hemodynamic compromise, direct current 
(DC) cardioversion is indicated (Zipes and Camm 2006). In stable monomorphic VT, IV 
procainamide or amiodarone, and/or transvenous catheter pace termination maybe 
employed. In patients with polymorphic VT, DC cardioversion, IV amiodarone and beta 
blockers maybe employed. Internal cardiac defibrillator is indicated in patients with 
congenital heart disease who have survived cardiac arrest, patients with severely impaired 
ventricular function, and those on chronic optimal medical therapy with a life expectancy of 









Fig. 15. Torsades de pointe 
 
Advances in Electrocardiograms – Clinical Applications 
 
66
8.1 Ventricular Tachycardia 
8.1.1 Definition: Ventricular tachycardia (VT) is a tachycardia with rates greater than 120 
beats per minute and originating within the ventricles or the lower conduction system with 
ventriculo-atrial dissociation. Non-sustained VT is defined as a three or more consecutive 
beats of ventricular origin that terminate spontaneously with no hemodynamic compromise 
and lasting less than 30 seconds. Sustained VT persists longer than 30 seconds or requires 
medical or electrical intervention to terminate the tachycardia (AHA 2007).  
8.1.2 Incidence: In healthy teenage boys, short episodes of ventricular tachycardia were 
present in 3% (Dickinson and Scott 1984). Incidence of VT is higher in patients with 
congenital heart disease. Approximately 30% of post-operative tetralogy of Fallot patients 
had sustained monomorphic VT and 4.4% had polymorphic VT, which contributes to 2% 
annual risk of sudden cardiac death (Khairy et al. 2004; Walsh, E. and Cecchin, F. 2007). VT 
originates in the RVOT in 60%-80% of structurally normal hearts (Lerman et al. 2004). 
Idiopathic VT is also associated with aortic valve disease, corrected transposition of the 
great arteries, Ebstein’s anomaly of the tricuspid valve, Eisenmenger’s syndrome, long QT 
syndrome, unrepaired tetralogy of Fallot, arrhythmogenic right ventricular dysplasia, and 
myocardial infarction (Callans, D. and Josephson, M. 2004; Fontaine et al. 2004; Walsh, E. P. 
and Cecchin, F. 2007).  
8.1.3 Mechanism: Ventricular tachycardia characterized by a re-entry mechanism can be 
initiated and terminated with programmed stimuli (Callans, D and Josephson, ME 2004). VT 
may also be secondary to automaticity or triggered activity. 
8.1.4 Natural history: Post-operative congenital heart disease patients are at high risk of VT 
and sudden cardiac death. In patients with normal hearts, younger children (90%) and older 
populations (50%-70%) have resolution of VT within 2 to 10 years (Alexander 2001b). 
However, symptomatic younger patients had worse prognosis (Davis et al. 1996). In patients 
with normal intracardiac anatomy, only 50% have an actual diagnosis such as hypertrophic 
cardiomyopathy, dilated cardiomyopathy, myocarditis, myocardial hamartoma, and 
metabolic disease (Davis et al. 1996). Ventricular tachycardia is present in 50%-60% of 
patients with dilated cardiomyopathy and responsible for 8%-50% of deaths (Galvin and 
Ruskin 2004). 
8.1.5 Clinical presentation: Clinical presentation is variable (Davis et al. 1996). Symptoms may 
range from palpitations, light headedness, syncope, shortness of breath, neck fullness, and 
chest pain to death (Silka and Garson Jr. 1999). 
8.1.6 ECG: Monomorphic VT is a wide complex tachycardia with same QRS morphology, 
which suggests a single re-entrant focus (figure 14). Polymorphic VT is a wide complex 
tachycardia with variable QRS morphology. Torsades de pointe is a form of polymorphic 
VT and associated with long QT syndrome and variable electrical activation. (Figure 15) 
8.1.7 Work-up: Obtain a thorough personal and family history including history of sudden 
cardiac death. An ECG of the arrhythmia is useful but very difficult to capture very often; 
however, a resting ECG is a class 1 recommendation (Zipes and Camm 2006). Check 
electrolytes, in particular hypokalemia, hyperkalemia, and hypomagnesemia. In patients 
with recurrent syncope, a holter monitor or event recorder is indicated. An echocardiogram 
is necessary to identify structural heart disease and evaluate cardiac function in those at risk 
for sudden cardiac death such as dilated, hypertrophic, and arrhythmogenic RV dysplasia, 
myocarditis, and inherited disorders (Zipes and Camm 2006). An exercise stress test is 
indicated in all individuals, regardless of age, known or suspected to have exercise-induced 
ventricular tachycardia. An electrophysiology study is warranted in patients with 
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congenital/structural heart disease, those with unknown etiology of VT, and those with 
syncope of unknown etiology with LV dysfunction (Zipes and Camm 2006).  
8.1.8 Management and Prognosis: All wide complex tachycardias need to be treated like 
ventricular tachycardia unless proven otherwise. A-V dissociation, superior QRS axis and 
positive or negative concordance of QRS complexes in the precordial leads suggest 
ventricular origin. In patients with normal hearts, episodes of non-sustained VT has good 
prognosis. Avoid medications that prolong QT interval and correct electrolyte 
abnormalities. In patients with sustained VT with hemodynamic compromise, direct current 
(DC) cardioversion is indicated (Zipes and Camm 2006). In stable monomorphic VT, IV 
procainamide or amiodarone, and/or transvenous catheter pace termination maybe 
employed. In patients with polymorphic VT, DC cardioversion, IV amiodarone and beta 
blockers maybe employed. Internal cardiac defibrillator is indicated in patients with 
congenital heart disease who have survived cardiac arrest, patients with severely impaired 
ventricular function, and those on chronic optimal medical therapy with a life expectancy of 









Fig. 15. Torsades de pointe 
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Ventricular paced rhythms can mask ECG changes of several conditions. This is because the 
paced ventricular rhythm does not follow the normal pattern of depolarization through the 
bundle of His and the bundle branches. Instead, depolarization initially occurs at the tip of the 
pacemaker lead which is usually at the apex or the septum. The depolarization then proceeds 
through the myocardium from one cardiomyocyte to another rather than through the 
conduction system of the heart. This results in abnormal depolarization and repolarization 
patterns.  Thus the QRS complex is usually widened and the T wave is usually of opposite 
polarity to the QRS complex. Reaching a diagnosis from a single ECG already rendered 
abnormal by the paced rhythm is not easy. It is thus useful to have a baseline ECG available 
for comparison. Changes in the axis, QRS width and QRS complex morphology can give 
important clues to the diagnosis. ECG changes of acute myocardial infarction in patients with 
a ventricular paced rhythm are well described. There is very limited data on the usefulness of 
paced ECG in the diagnosis of other conditions. 
2. Acute myocardial infarction 
Like most other conditions, ECG finings of acute myocardial infarction can be masked by 
paced rhythms. Pacing leads are traditionally placed in the right ventricular apex. Most 
studies of ECG findings of myocardial infarction are in patients with pacing leads placed at 
this location. The ECG pattern of right ventricular apical pacing resembles a left bundle 
branch block (LBBB) and the diagnostic criteria are also similar. The increasing use of other 
pacing sites like the interventricular septum and outflow tract as well as biventricular 
pacing will result in different ECG findings but some general rules will still apply. There is 
lack of data on the ECG diagnosis of myocardial infarction when the pacing lead tip is 
placed at locations other than the apex. As these alternate pacing sites gain popularity, the 
criteria for myocardial infarction recognition that is discussed below may not apply. 
Traditionally ECG changes in myocardial infarction in the setting of LBBB include ST 
segment abnormalities, abnormal Q waves and Cabrera’s sign.1 There are however some 
differences in the setting of LBBB and ventricular pacing. The most important difference is 
in value of Q waves in the diagnosis. Abnormal Q waves in leads V5 and V6 along with 
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increased r in lead V1 is very specific for anterior wall myocardial infarction in the setting of 
LBBB. In right ventricular pacing, these Q waves however could simply reflect differences in 
the lead tip position rather than myocardial infarction.1,2 Thus Q in leads V5 and V6 could 
be normal finding in right ventricular pacing. A well positioned lead at the RV apex rarely 
generates a qR complex in lead I, and probably never produces a qR complex in V5 and V6 
in the absence of an MI. Thus presence of Q waves in these leads, though useful should be 
used with the caveat that if the lead tip is not at the right ventricular apex, then Q waves 
may also be normally seen in these leads. Another important point is to differentiate a qR/ 
QR from a QS complex. This differentiation is important because a QS complex carries no 
diagnostic value during RV pacing in any of the leads (QS complexes can be normal in leads 
I, II, III, aVF, V5, and V6) whereas qR/ QR complex can have diagnostic value.2 One cannot 
determine the age of the MI from the QRS complex changes. 
ST segment changes are the most useful findings in diagnosing myocardial infarction in 
patients with paced rhythms. The GUSTO-1 trial has provided useful information in this 
regard. In this trial, 32 patients had ventricular paced rhythm. The only ECG criterion with a 
high specificity and statistical significance for the diagnosis of an acute myocardial infarction 
was ST segment elevation 5 mm in leads with a negative QRS complex.3 Shape of the ST 
segment which exhibit upward convexity are useful in this context. Two other criteria with 
acceptable specificity were ST elevation 1 mm in leads with concordant QRS polarity and ST 
depression 1 mm in leads V1, V2, or V3.3,4 It is important to remember that though these 
criteria are fairly specific, their sensitivity is low. The ECG criterion with the highest sensitivity 
for the diagnosis of an acute myocardial infarction was ST segment elevation 5 mm in leads 
with a negative QRS complex and even this criterion has a sensitivity of only around 50%. 
The GUSTO-1 trial also included 131 patients with LBBB.5 These ST segment diagnostic 
criteria were the similar for patients with LBBB and ventricular paced rhythms. The 
difference in the setting of paced rhythm as compared to LBBB was that of the 3 criteria, the 
one with the greatest value for the diagnosis of an acute MI in paced rhythm was ST 
segment elevation 5 mm in leads with a negative QRS complex, whereas in the setting of 
LBBB the criteria with the greatest value was ST elevation 1 mm in leads with concordant 
QRS polarity. 
Another classical sign described is the Cabrera’s sign.1,2 Like other signs, this has also been 
adapted from the criteria diagnosing myocardial infarction in the setting of LBBB. Cabrera’s 
sign is described as notching of the ascending limb of the S wave usually in leads V3 and V4, 
and sometimes in leads V2 and V5. The notch should be ≥ 0.03 seconds and present in 2 
leads.2 It has low sensitivity but is a very specific sign. 
The diagnostic criteria described above are for anterior wall myocardial infarctions. 
Infarctions at other sites are usually masked by the paced rhythm. Cabrera’s sign in both 
leads III and aVF may be of some value in diagnosing inferior wall myocardial infarction. 
Similarly ST elevation in lead V4R may occur in acute right ventricular infarction. This sign 
should however be taken with extreme caution unless accompanied by signs of inferior 
myocardial infarction. 
There are a few important factors that could confound the diagnosis. Retrograde P waves in 
the terminal part of the QRS complex may mimic Cabrera’s sign. Because of cardiac memory 
repolarization abnormalities, mostly T wave inversions may occur if the patient reverts to 
spontaneous rhythm. These T wave inversions are secondary to pacing per se and not 
related to ischemia. These can occur even after very short duration of pacing. 
 


























Fig. 1. ECG at presentation showing that all ventricular beats are paced. The pacing spike is 
followed by a wide QRS complex (QRS duration 300 milliseconds). The QRS complex is 
merging with T waves. No definite P waves are seen. (With permission, Bahl A et al, Indian 
Heart J 2009;61:93-4). 
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Fig. 2. ECG after correction of hyperkalemia. All ventricular beats are still paced but the 
QRS duration has narrowed to 190 milliseconds. The QRS complexes are greater in 
amplitude and the peaks are sharper in morphology. Definite P waves are seen in leads V1 
and V2. (With permission, Bahl A et al, Indian Heart J 2009;61:93-4). 
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3. Widening of the QRS complex 
Widening of the QRS complex is an important though non-specific sign in patients with 
paced rhythm.  A baseline paced ECG is ideally required if this sign is to be used in clinical 
situations. QRS prolongation should trigger an alarm bell. Any observer during failed 
cardiopulmonary resuscitations in patients on temporary or permanent pacemakers would 
have noted gradual prolongation of the QRS complex with the passage of time. The QRS 
complex gradually becomes very wide and resembles a T wave. This is a poor prognostic 
sign and indicates progressive myocardial ischemia and dysfunction.  
Studies using balloon inflation at time of percutaneous coronary intervention have shown 
that QRS prolongation could also be a marker of myocardial ischemia on the paced 
electrocardiogram.6 In addition, electrolyte imbalance as in hyperkalemia could also result 
in QRS prolongation. Thus any change in QRS duration from baseline should be noted as it 
could be an important indicator of several pathologies. 
4. Hyperkalemia 
ECG is a useful guide in diagnosing hyperkalemia in patients in sinus rhythm. Initial change 
is usually a peaked T wave. This is followed by widening of QRS complexes, 
intraventricular conduction defects, prolongation of PR interval, absence of P wave, heart 
blocks, and the classical sine wave. This is because severe hyperkalemia decreases the phase 
0 of the action potential resulting in widening of the QRS complex. The QRS complex 
continues to widen and ultimately blends with the T wave resulting in a sine wave 
morphology. Typical ECG changes of hyperkalemia can also be seen even during paced 
rhythm. These changes include QRS widening and reduction in amplitude of the QRS 
complex.7,8 The QRS widening can be quite marked in some cases. These changes are 
especially well appreciated if an old ECG is available for comparison. Typical sine waves 
may also be seen on a paced ECG rhythm. These changes revert back to the baseline with 
correction of hyperkalemia. These ECG findings of hyperkalemia that reverted back to 
baseline after correction of hyperkalemia are illustrated in figures 1 and 2. 
To summarize, a number of medical conditions are best diagnosed during paced rhythms 
when a baseline ECG is available. All patients with pacemakers should have a recorded 
baseline 12 lead ECG available. In case the patient with pacemaker has his own rhythm a 12 
lead ECG with magnet should be kept as a taken. This would be available as a record of the 
paced rhythm in case the patient later becomes pacemaker dependant and has a 
continuously paced rhythm.   
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1. Introduction 
The pericardium surrounds the heart and consists of a visceral layer, which is contiguous 
with the epicardium of the heart, and a parietal layer, which forms a sac around the heart 
(Wann & Passen, 2008). Located between the parietal and visceral layers is a potential space 
called the pericardial cavity. The pericardial cavity normally contains as much as 50 mL of 
an ultrafiltrate of plasma. Anatomically, the pericardium isolates the heart from the rest of 
the mediastinum and thorax. Physiologically and under normal circumstances, the 
pericardium may have little if any significant role. The pericardial structure and function 
may be impacted by numerous pathologic conditions. Many of these conditions are listed in 
Table 1. A common and nonspecific condition affecting the pericardium is acute pericarditis. 
Acute pericarditis is a clinical syndrome that may present with chest pain, a pericardial 
friction rub, and gradual repolarization changes in the electrocardiogram (ECG). The 
diagnosis of acute pericarditis requires at least 2 of these 3 elements (Imazio et al, 2003) 
2. Etiology of acute pericarditis  
Infectious Viral  Cocksacie A & B, Echovirus, 
Adenovirus, Mumps, Hepatitis, HIV 
 Pyogenic Pneumococcus, Streptococcus, 
Staphylococcus, Neisseria and 
Legionella 
 Fungal Histoplasmosis, Coccidiomycosis 
 Other Tuberculous, Syphilitic, Protozoal and 
Parasitic 
Metabolic Uremia/ Dialysis   
 Hypothyroidism  
Neoplasm Primary or Metastatic 
Tumors 
Primary tumors or tumors metastatic to 
the pericardium (lung, breast, 
lymphoma, and leukemia)  
Trauma Iatrogenic Penetrating/Non-penetrating chest wall 
Post-irradiation, Post thoracic surgery, 
catheter or pacemaker perforation  
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(Wann & Passen, 2008). Located between the parietal and visceral layers is a potential space 
called the pericardial cavity. The pericardial cavity normally contains as much as 50 mL of 
an ultrafiltrate of plasma. Anatomically, the pericardium isolates the heart from the rest of 
the mediastinum and thorax. Physiologically and under normal circumstances, the 
pericardium may have little if any significant role. The pericardial structure and function 
may be impacted by numerous pathologic conditions. Many of these conditions are listed in 
Table 1. A common and nonspecific condition affecting the pericardium is acute pericarditis. 
Acute pericarditis is a clinical syndrome that may present with chest pain, a pericardial 
friction rub, and gradual repolarization changes in the electrocardiogram (ECG). The 
diagnosis of acute pericarditis requires at least 2 of these 3 elements (Imazio et al, 2003) 
2. Etiology of acute pericarditis  
Infectious Viral  Cocksacie A & B, Echovirus, 
Adenovirus, Mumps, Hepatitis, HIV 
 Pyogenic Pneumococcus, Streptococcus, 
Staphylococcus, Neisseria and 
Legionella 
 Fungal Histoplasmosis, Coccidiomycosis 
 Other Tuberculous, Syphilitic, Protozoal and 
Parasitic 
Metabolic Uremia/ Dialysis   
 Hypothyroidism  
Neoplasm Primary or Metastatic 
Tumors 
Primary tumors or tumors metastatic to 
the pericardium (lung, breast, 
lymphoma, and leukemia)  
Trauma Iatrogenic Penetrating/Non-penetrating chest wall 
Post-irradiation, Post thoracic surgery, 
catheter or pacemaker perforation  
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Autoimmune Sarcoidosis  
 Collagen Vascular 
Disorders 
SLE, Rheumatoid Arthritis, Ankylosing 
Spondylitis, Scleroderma, Wegeners , 
Rheumatic Fever 
Hypersensitivity Drug Induced  Procainamide, Hydralazine, Phenytoin, 
INH, Minoxidil, Methysergide, 
Anticoagulation  
Others Acute Myocardial 
Infarction 
Dresslers Pericarditis 
 Aortic dissection  With leakage into the pericardial sac 
 IBD  
 Syndromes Loefflers Syndrome /Whipples Disease 
 Familial Familial Mediterranean Fever/Familial 
Pericarditis 
Table 1. Causes of acute pericarditis (Zayas et al, 1995 ) 
3. Clinical features  
The chest pain associated with acute pericarditis is often described as severe, retrosternal, 
left sided precordial pain that is referred to the neck, arms, or the left shoulder. The pain 
is usually pleuritic, consequent to accompanying pleural inflammation and is 
characteristically, relieved by sitting up, leaning forward and may be intensified by lying 
supine (Troughten et al, 2004). The most specific sign of acute pericarditis is a pericardial 
friction rub, although it is intermittently present and often varies in intensity. It is 
characterized as a high-pitched scratchy sound and is heard best in end expiration and 
along the left sternal border with the patient leaning forward. A triple cadence is 
classically described, which coincides with atrial systole, ventricular systole, and rapid 
ventricular filling during early diastole. However, the triphasic rub occurs in only about 
half of patients.   The origin of the sound has been attributed to the visceral and parietal 
layers of the pericardial sac rubbing together during different phases of the cardiac cycle 
(Spodick, 1975).   
4. Diagnosis 
4.1 Serum boimarkers 
Laboratory testing for acute pericarditis is nonspecific and provides limited guidance in 
determining a cause. White blood cell count, erythrocyte sedimentation rate, and serum C-
reactive protein level are modestly elevated in acute pericarditis regardless of the etiology. 
Surprisingly, a significant number of patients with pericarditis, with or without myocarditis 
or myocardial infarction have elevated creatinine kinase MB fraction and or troponin I 
values. This observation suggests that there is a significant incidence of silent myocarditis in 
patients who present with acute pericarditis (Imazio et al, 2003). If a particular etiology for 
pericarditis is suspected, the clinical presentation and associated co-morbid conditions 
should direct decisions for additional laboratory studies, such as rheumatoid factor, cardiac 
enzymes, antinuclear antibodies, or sputum samples to assess for mycobacteria.  
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4.2 Electrocardiography  
The ECG is a rapid, inexpensive and noninvasive test that can be very useful in establishing 
the diagnosis of acute pericarditis. In one study, 90% of patients with the diagnosis of acute 
pericarditis are found to have ECG changes (Marinella, 1998).  The electrocardiogaphic 
patterns  of acute pericarditis were first reported in 1929 by Scott, Feil and Katz. They 
described transitory elevation of the ST segments in all three limb leads of the 
electrocardiogram in a case of hemopericardium and in one of purulent pericarditis (Veer 
and Norris 1937). Since then, the diagnosis of pericarditis is often times made with ECG 
changes.  
In acute pericarditis, the observed electrocardiographic changes are a direct result of the 
inflammatory process taking place between the pericardial layers. The electrocardiogram is 
altered because of the extension of the inflammatory process to the sub epicardial 
myocardium (Bonow et al, 2008). The two classical ECG findings of acute pericarditis are ST 
elevation and PR depression. Elevation of the ST segment is the most sensitive and most 
consistent ECG finding.  Typically the ST elevation is usually 1.0 - 2.0 mm and may be 
present in the majority of the standard ECG leads.  The exception to this observation may be 
seen in leads AVR and V1 where the ST segment is always depressed (Koos et al, 2009).  The 
morphology of the ST segment elevation in acute pericarditis is characteristically concave 
 
 
Fig. 1. An electrocardiogram in acute pericarditis showing diffuse up sloping ST segment 
elevations seen best here in leads II, AVL, AVF and V2 to V6. There is also subtle PR 
segment deviation (positive in aVR, negative in most other leads) (Hewitt el al, 2010) 
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and facing upwards. Some causes of pericarditis do not result in significant inflammation of 
the epicardium and may not be associated with the typical ECG changes. An illustration of 
this is uremic pericarditis, in which there is prominent fibrin deposition but little or no 
epicardial inflammation. As a result, the ECG usually does not exhibit the previously 
described ECG changes (Rutsky & Rostand, 1989).  The ST segment elevations observed 
with acute pericarditis are often transient and are sometimes followed (after a variable time) 
by diffuses T wave inversions. The T wave inversions are also transient and may resolve 
completely with time (Maisch et al, 2004). Accordingly, there are some patients with clinical 
signs and symptoms of pericarditis, yet have a normal or non specific pattern on ECG.  In 
the majority of patients, however, some electrocardiographic abnormality persists for an 
extended period of time. This is usually in the form of persistent T wave inversion 
(especially chronic pericarditis syndromes) (Maisch et al, 2004). The PR segment depression 
is another electrocardiographic sign of acute pericarditis. It is a very specific sign and is 
attributed to subepicardial atrial injury and is visible in all leads except aVR and V1. 
Conversely, these leads may exhibit PR-segment elevation as a manifestation of atrial wall 
inflammation (Hurst 2006). Thus, in acute pericarditis, the PR and ST segments typically 
change in opposite directions. 
In acute pericarditis, the observed ECG changes typically evolve in four stages. Although all 
cases of pericarditis may not include each of these stages, as many as 50% do ( Spodick, 
2003) . The typical evolution of ECG changes in pericarditis is described below in Tables 2-5. 
 
Stage Time of 
Onset 
Classical ECG Findings Illustration 
Stage 1 Hours to 
days  
 Diffuse concave ST elevation 
with reciprocal ST depression 
in AVR and V1 
 PR segment elevation in lead 
AVR 
 Depression of the PR segment 
in all other limb leads 
 
Table 2. Stage 1 of pericarditis  
 
Stage Time of 
Onset 
Classical ECG findings Illustration 
Stage 2  Within 1st 
week  
 Normalization of ST 
segments, with J point 
returning to normal  
 T wave amplitude begin to 
decrease 
 
Table 3. Stage 2 of pericarditis  
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Stage Time of 
Onset 
Classic ECG Finding Illustration 
Stage 3 2-3 Weeks   Diffuse T wave 
inversions, generally 
after the ST segments 
have become isoelectric 
 
Table 4. Stage 3 of pericarditis  
 
Stage Time of 
Onset 
Classic ECG Finding Illustration 
Stage 4 Up to 3 
months  
 Normalization of the 
ECG or 
 Indefinite persistence of 
T wave inversions 
("chronic" pericarditis)  
 
Table 5. Stage 4 of pericarditis  
The ECG findings of acute pericarditis can often times be both subtle and confusing. In 
evaluating patients with chest discomfort and an abnormal ECG, there are other conditions 
that may mimic acute pericarditis and must be considered as well. These include an acute 
myocardial infarction and the early pattern of repolarization.  Table 6 lists useful clues in 
differentiating acute pericarditis from these conditions.  
While both acute pericarditis and acute myocardial infarction can present with chest pain 
and elevations in cardiac biomarkers, the electrocardiographic changes in acute pericarditis 
differ from those in ST elevation myocardial infarctions ( STEMI)  in several ways.  
 Morphology — The ST segment elevation in acute pericarditis begins at the J point, 
which represents the junction between the end of the QRS complex and the beginning 
of the ST segment. The ST segment elevation rarely exceeds 5 mm, and usually retains 
its normal concavity. In contrast the typical finding in a STEMI presentation is convex 
(dome-shaped) ST elevation that may be more than 5 mm in height (Surawicz & 
Knilans, 2008). 
 Distribution — ST segment elevations in infarction are characteristically limited to 
anatomical groupings of leads that correspond to the localized vascular area of the 
infarct (anteroseptal and anterior leads V1 to V4; lateral leads I, aVL, V5, V6; inferior 
leads II, III, aVF). The pericardium envelops the heart therefore the ST changes are more 
generalized and typically are present in most leads in pericarditis.  
 Reciprocal changes — STEMI is often associated with reciprocal ST segment changes, 
which are not seen with pericarditis except in leads aVR and V1. 
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ECG Findings Acute Pericarditis Myocardial Infarction  Early Repolarization 
ST Segment 
Change  
Concave upward Convex upward Concave upward 
Q waves Absent Present Absent 
Reciprocal ST 
changes 
Absent Present Absent 
Location of ST 
elevation 
Limb and precordial 
leads 
Area of involved artery Precordial Leads 
ST/T ratio in 
lead V6 
>0.25 N/A <0.25 
Loss of R wave 
voltage 
Absent Present Absent 
PR segment 
depression 




Table 6. A comparison of ECG’s in acute pericarditis, acute myocardial infarction and early 
repolarization.  
 Concurrent ST and T wave changes — ST segment elevation and T wave inversions do 
not generally occur simultaneously in pericarditis, while they commonly coexist in a 
STEMI. Peaked T waves (>10mm high in precordial leads, >5 mm high in limb leads), 
can be seen in STEMI but are not typical of pericarditis (Surawicz & Knilans, 2008). 
 Q waves — Pathologic Q waves, which may occur with extensive injury in STEMI, are 
generally not seen in pericarditis. The abnormal Q waves in MI reflect the loss of 
positive depolarization voltages because of transmural myocardial necrosis. 
Pericarditis, on the other hand, generally causes only superficial inflammation. 
Abnormal Q waves are not seen unless there is concomitant myocarditis or preexisting 
cardiomyopathy or myocardial infarction (Imazio, 2011). 
 PR segment — PR elevation in aVR with PR depression in other leads due to a 
concomitant atrial current of injury is frequently seen in acute pericarditis but rarely 
seen in acute STEMI. 
 QT prolongation — Prolongation of the QT interval with regional T wave inversion (in 
the absence of drug effects or relevant metabolic disorders) favors the diagnosis of 
myocardial ischemia (or myopericarditis) over pericarditis alone (Marinella, 2008). 
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The early repolarization variant seen on an ECG may be present in as many as 30% of young 
adults and is often confused with acute pericarditis (Klatskey et al, 2003). The following 
electrocardiographic features can be helpful in distinguishing acute pericarditis from early 
repolarization: 
 ST elevations occur in both the limb and precordial leads in most cases of acute 
pericarditis (47 of 48 in one study), whereas about one-half of subjects with early 
repolarization have no ST deviations in the limb leads . In early repolarization, ST 
elevation is most often present in the anterior and lateral chest leads (V3-V6), although 
other leads can be involved ( Spodick, 1976). 
 PR deviation and evolution of the ST and T changes strongly favor pericarditis, as 
neither is seen in early repolarization( Ginzton & Laks, 1972)  
While uncommon, one of the most feared seqealae of acute pericarditis is the progression to 
cardiac tamponade. Cardiac tamponade is the result of the accumulation of fluid in the 
pericardial space to the point that it causes obstruction to the inflow of blood to the heart. 
This condition, if not recognized and treated promptly, is often fatal. The most common 
ECG sign of a large pericardial effusion is low voltage of the QRS complexes. This finding is 
most likely due to the attenuation of cardiac potentials caused by the fluid surrounding the 
heart as well as inflammatory mechanisms affecting the pericardium and myocardium 
(Brusch et al, 2001). Low voltage on the ECG (Figure 2) is said to be present when the 
cumulative amplitude of the QRS complexes in each of the six limb leads is 5 mm (0.5 mV) 
or less (Luenn et al, 2006). Another ECG pattern that may be observed in patients with a 
large pericardial effusion is total electrical alternans (Figure 3). The pattern of electrical 
alternans is characterized by a cyclic beat-to-beat variation in the QRS axis in the limb and 
precordial leads. This is a direct result of the beat to beat movement of the heart, both to and 
fro, that can occur in the presence of a large pericardial effusion (Billakanty and  Bashir , 
2006). The observations of electrical alternans with low QRS voltage and sinus tachycardia is 
a highly specific sign of pericardial effusion. Unfortunately, this triad of observations is only 
modestly sensitive in that there may be situation where larger pericardial effusion is present 
and some or all of these findings are absent. 
 
 
Fig. 2. An ECG in a patient with a large pericardial effusion. Note the presence of low 
voltage QRS in all leads.  
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Fig. 2. An ECG in a patient with a large pericardial effusion. Note the presence of low 
voltage QRS in all leads.  
 




Fig. 3. An ECG in a patient with a large pericardial effusion. Note the alternating QRS axis in 
all precordial leads.  
4.3 Chest radiograph  
The chest radiograph is usually normal in uncomplicated acute idiopathic pericarditis. It is 
frequently useful to exclude pathology in the mediastinum or lung fields that may be the 
cause of pericarditis, such as thoracic malignancy or infection. A pericardial effusion should 
be suspected when cardiomegaly is observed and the cardiac silhouette takes on a 
symmetric “flask like” appearance, shown in Figure 4. (Spodick, 2003).   
 
 
Fig. 4. Chest X ray suggestive of a large pericardial effusion. 
4.4 Echocardiography  
The transthoracic echocardiography (TTE) is frequently normal in patients with acute 
idiopathic pericarditis. The main reason for its performance is for assessing the size and 
nature of any associated pericardial effusion. The observation of fibrin strand within the 
pericardial effusion is indicative of a pericardial inflammatory response (Verhaert et al, 
2010). Transthoracic echocardiography is also essential in evaluating for presence or absence 
cardiac tamponade. This physiologic condition may be recognized by collapse of the right 
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atrium or right ventricle during diastole or marked variation in the transmitral and 
transpulmonary valve velocity profiled with respiration (Fowler 1993). In one series of 300 
consecutive patients with acute pericarditis, pericardial effusion was present in 180 patients 
(60%). In most cases the effusion was small or moderate in size without hemodynamic 
consequences. Cardiac tamponade was present in only 5% of patients (Imazio et al, 2004). 
TTE is not needed in every patient with pericarditis, it is recommended in patients with 
clinical features that would suggest the presence of a systemic disorder. These might include 
prolonged fever, an immunocompromised state, recent trauma, elevation of cardiac 
enzymes greater than 2 weeks, and abnormal chest x-ray or clinical signs of cardiac 
tamponade. (Imazio et al, 2004, 2007) 
4.5 CT/MRI 
The presence of pericardial fluid or thickening may be confirmed by a CT or MRI scan. 
These techniques may be superior to echocardiography in detecting loculated pericardial 
effusions, pericardial thickening presence of pericardial masses or any associated 
intrathoracic pathology (Verhaert et al, 2010). Neither CT nor MRI scanning however is 
needed to establish the diagnosis of pericarditis. Rather, these studies are generally reserved 
the evaluation of other pathologic conditions which may be the cause of pericarditis.  
5. Treatment  
The foundation of treatment for pericarditis is to reduce and ultimately eliminate the 
inflammatory process that exists between the pericardial layers. For patients with idiopathic 
pericarditis, nonsteroidal anti-inflammatory drugs (NSAIDs) should be used with the goal 
of relieving chest pain, inflammation, and fever. Aspirin, ibuprofen, and indomethacin are 
the most commonly prescribed NSAIDs. Ibuprofen may be preferred given its reportedly 
lower incidence of side effects compared to the other medications. (Zayas et al, 1995) 
Indomethacin is an acceptable alternative, but it should be avoided in patients with 
coronary artery disease because of its adverse effects on coronary blood flow and blood 
pressure (Maisch et al, 2004). Aspirin is favored in patients with a recent history of 
myocardial infarction since other NSAIDs tend to impede scar formation (Hammerman et 
al, 1984). The use of NSAIDs in the setting of acute myocardial infarction has been 
associated with an increased incidence of ventricular aneurysm formation and cardiac 
rupture (Imazio et al, 2004).  Patients who respond slowly or inadequately to NSAIDS may 
require supplementary narcotic analgesics and or a brief course of colchicine or steroids. In 
cases where the etiology of pericarditis has been identified, treatment should be focused on 
the underlying cause. For patients who have chronic kidney failure, increasing the 
frequency of dialysis usually results in improvement in the signs and symptoms of uremic 
pericarditis. Patients who have cancer may show some response to chemotherapy or 
radiation therapy. For purulent pericarditis related to a bacterial or fungal process, 
treatment consists of antimicrobials and surgical drainage of purulent material from the 
pericardium space. For patients with pericardial effusion causing a tamponade, drainage of 
the effusion is indicated. Needle pericardiocentesis, via a sub xiphoid approach, is effective 
in most medical patients with cardiac tamponade when the effusion is circumferential and 
moderately large (Imazio et al, 2007).  
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Fig. 4. Chest X ray suggestive of a large pericardial effusion. 
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the effusion is indicated. Needle pericardiocentesis, via a sub xiphoid approach, is effective 
in most medical patients with cardiac tamponade when the effusion is circumferential and 
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Most cases of acute pericarditis subside within 2 weeks. In approximately 15%of  cases, 
symptoms may recur (Marinella, 1998). This is particularly true if the pericarditis is related 
to an ongoing and underlying illness such as an autoimmune disease or uremia. Typically, 
physicians should schedule a follow-up visit with these patients two weeks after the onset of 
their illness unless additional symptoms or medication related problems intervene. An ECG 
should also be considered at four weeks, bearing in mind that residual T-wave inversion 
may be present for several weeks during stage III of acute pericarditis.  
7. Conclusion 
In conclusion, acute pericarditis can be caused by many underlying conditions. Acute 
pericarditis can be diagnosed clinically with when associated with chest pain, pericardial 
friction rub and typical ECG changes. The ECG changes associated with acute pericarditis 
have been described as evolving through four stages including PR segment depression, ST 
segment elevation, T wave inversion and eventual normalization. Certain features of the 
ECG can help in differentiate the diagnosis of pericarditis from acute myocardial infarction 
or early repolarization, though this differentiation may be difficult.  Treatment should be 
focused on the relief of symptoms and specific to any underlying cause. For patients with 
idiopathic pericarditis, NSAIDs are typically most effective. The prognosis associated with 
acute pericarditis is very good. Prompt recognition and treatment of this condition may 
prevent its progression to more serious complications.  
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1. Introduction 
Atrial fibrillation is the most common sustained arrhythmia and the major cardiac cause of 
stroke (Sellers & Newby, 2011). Recent studies in patients and animals with paroxysmal atrial 
fibrillation had shown that the arrhythmia was triggered by focal sources from muscular 
sleeves originated in the left atria extending into pulmonary veins (Date et al.,2007; Chen et 
al.,2001; Patterson et al., 2007; Honjo et al., 2003). What is more, the autonomic nervous system 
has a crucial role in the genesis, maintenance and abruption of atrial fibrillation (Duffy& Wit, 
2008; Sandres et al.,2004), and there is a fat pad localized in superior vena cava and the root of 
aorta as the origin of cardiac nerve, being called SVC-Ao fat pad (Kapa et al.,2010; Volders 
,2010; Ji et al.,2010). The mechanism of atrial fibrillation involves multiple effects (Chiou et 
al.,1997; Tsuboi et al.,2000; Hoffmann et al., 2006; Haissaguerre et al.1998; Wit & Boyden,2007), 
the expression of connexins is changed and is associated with increased propensity for 
arrhythmias (Kanagaratnam et al., 2002, Herve et al., 2007, Stergiopoulos et al., 1999, Verheule 
S et al., 2002, Kanagaratnam et al., 2007; Valiunas et al.,2001; Valiunas et al.,2000; Cottrell et 
al.,2002; Elenes et al.,1999). Pulmonary veins and left atria are the primary structure of genesis, 
persistence of atrial fibrillation. Vagus nerve plays a key role in the initiation and maintenance 
of atrial fibrillation, it can mediate the electrical remodeling of atria and pulmonary vein, 
enhance the maintenance and stability of atrial fibrillation,. However, these effects can be 
inhibited by avianizing vagus nerve. 
2. Overview of gap junction structure 
The name “gap junction” was cioned from their appearance in electron micrographs in the 60s 
(Revel & Karnovsky, 1967). They are specialized at cell-cell contact regions that contain tens to 
thousands of intercellular channels that link two apposed cells. These channels facilitate a form 
of intercellular communication by permitting the regulated passage of ions and small 
molecules from one cell to another (Bennett & Goodenough, 1978). The gap junction 
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membrane channel is composed of macular aggregations of intercellular channels permitting 
the direct intercellular transfer of ions and small molecules. Each intercellular channel is 
formed by the apposition of two hexameric transmembrane channels (connexons), one from 
each cell (Yeager & Gilula, 1992). Each intercellular channel is composed of two oligomers 
with each of two adjacent tissue cells contributing one oligomer. Each connexon is built from 
six copies of one or more members of a protein family called the connexins (Unger et al., 1999; 
Perkins et al., 1998). The functional cell-cell channel is formed by the end-to-end docking of the 
extracellular domains of the two connexons. Therefore, the gap junction membrane channel 
can be thought of as a dimmer of two hexamers joined together in the gap region. In this 
manner, the membrane channel extends across both cell membranes. 
Vertebrate gap junction channels are assembled to form multimers of one or more different 
proteins from a multigene family of homologous protein, which are composed of an entirely 
different gene family but the sequences predict a similar folding pattern. Up to now, more 
than 20 different connexin genes have been identified in the mouse genome and at least 6 
others have been identified in other vertebrates. Connexins are highly homologous proteins 
with 50%-80% identity between amino acid sequences and display considerable amino acid 
sequences conservation between species. The distribution and developmental regulation of 
connexins are tissue specific. The predicted molecular mass of the connexin protein family 
ranges from ~26 to ~60KDa, and the proteins are named “connexin” followed by their 
predicted molecular mass. The connexin family can be subdivided into two classifications 
called α and β based on similarities in certain regions of the primary sequence. The x-ray 
diffraction analysis by Tibbitts etal. (1990) indicated that there was more α-helical content that 
could be accounted for by four transmembrane helices. The El and E2 loops are thought to be 
as rigid as the transmembrane domain (Hoh et al., 1993; Sosinsky, 1992). Hence, the 
extracellular region is visible with the crystallographic averaging used. Each extracellular 
protrusion may therefore include an extension of the intramembrane α-helical structure 
(Tibbitts et al., 1990). Mutagenesis studies have suggested that the extracellular loops contain 
disulfide-bonded β-sheet conformation (Foote & Nicholson, 1997), which would be expected to 
act as a rigid domain, for instance, connexin43 (isolated from heart tissue, Yeager & Gilula, 
1992), connexin32 and connexin 26 (isolated from liver tissue, Fallon & Goodenough, 1981; 
Hertzberg, 1984) would be seen for the same structure . In the human heart, 4 main isoforms 
are expressed. Connexin43 is expressed in all chambers of the heart, but predominantly in the 
ventricles. Connexin45 is found in the conduction system of the heart and at low levels in the 
atrial and ventricular working myocardium and connexin37 is located in the endothelial gap 
junctions in many vessels. Finally, connexin40 is expressed mainly in the atrial working 
myocardium, the conduction system, and the vasculature. Connexin40 was first described in 
a range of animal species and subsequently mapped to human chromosome. It became 
apparent that connexin40 was expressed in the atrioventricular conduction system and 
abundantly expressed in the atrial but not in the ventricular gap junctions. Recently, a new 
connexin was described in the mouse heart, i.e. connexin30.2 (the human equivalent is 
connexin31.9), which in mice seems responsible for slowing of impulse conduction in the 
atrioventricular node. However, the role of connexin31.9 in the human heart is unclear, for it 
is not detectable in the human cardiac conduction system. Connexons formed the functional 
intercellular channel, which is defined as homotypic when the connexin composition of the 
contributing connexons is identical or heterotypic when different. The ability of connexins to 
form homomeric/ heterotypic channels has been examined in the Xenopus oocyte and HeLa 
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cell expression systems as well as in other settings. Connexin43 and connexin40 are co-
expressed in several tissues, including cardiac atrial and ventricular myocytes and 
vascular smooth muscle. It has been shown that these connexins form functional 
homomeric/homotypic channels with distinct permeability and gating properties. 
3. Connexon and the heart development 
In the certebrate embryo, a single outflow vessel initially develops from the common 
ventricules undergo septation to form the four-chamber heart (Kirby & Waldo, 1995). The 
four-chambered heart develops from a single straight tube composed of three layers: an 
inner endocardium and outer myocardium separated by a thick extracellular matrix called 
cardiac jelly. The growing tube loops, with the convexity of the loop demarcating a 
functional inflow from an outflow portion of the looped tube. This original convexity forms 
the two ventricles by expansion and septation, and as the ventricular septum forms, the 
inflow and outflow must be redefined. Initially, all of the inflow is through the 
atrioventricular canal connecting a common atrium to the presumptive left ventricle; the 
entire outflow is from the presumptive right ventricle into the aortic sac via the conotruncus. 
Several septa are formed simultaneously, making a rearrangement of inflow and outflow 
critical. The atrioventricular canal is divided into left and right channels, the nascent right 
and left ventricles are separated by the ventricular septum, the conotruncus is converted 
into aortic vestibule and semilunar valve continuous with the left ventricle, and the 
pulmonary infundibulum and semilunar valve originating from the right ventricle (see 
Fig1.). Concomitantly, the outflow tract septates and rotates to generate the pulmonary and 
 
 
Fig. 1. Major events in development of the heart from a single straight tube. Early looping is 
probably a function of the myocardium. Convergence of the outflow and inflow tracts 
occurs during late looping and is critical for normal wedging. Wedging produces alignment 
of the three components that complete outflow septation. A, aorta; V, ventricle; P, 
pulmonary trunk; RA, right atrium; LA, left atrium; RV, right ventricle; LV, left ventricle. 
 
Advances in Electrocardiograms – Clinical Applications 
 
96
membrane channel is composed of macular aggregations of intercellular channels permitting 
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cell expression systems as well as in other settings. Connexin43 and connexin40 are co-
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Several septa are formed simultaneously, making a rearrangement of inflow and outflow 
critical. The atrioventricular canal is divided into left and right channels, the nascent right 
and left ventricles are separated by the ventricular septum, the conotruncus is converted 
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aortic outflow tracts, becoming connected to the right and left ventricular chambers, 
respectively. This morphogenetic sequence is significantly affected by the activity of neural 
crest cells. With the development of heart, the co-expression of multiple connexins in 
diverse tissues support the idea that communication between cells does not depend on just 
one type of connexin, which results in forming heterotypic channels with properties 
different from those homotypic parental connexons. 
Pluripotent mammalian embryonic stem cells, which are derived from the inner cell mass of 
preimplantation blastocysts, have the capacity to differentiate into cells of all three germ 
layers. Under suitable conditions, embryonic stem cells remain pluripotent through 
repeated rounds of cell division in culture. The recent isolation of human embryonic stem 
cells has spurred great interest in their potential use for therapeutic tissue repair because 
appropriate manipulation of the culture environment can induce both mouse and human 
embryonic stem cells to differentiate in vitro into specific somatic cell types, and the result 
shows human embryonic stem cells express RNA encoding most of the known human 
connexin genes. The mRNA of Cx25, Cx26, Cx30.3, Cx31, Cx31.1, Cx31.9, Cx37, Cx40, Cx43, 
Cx45, and Cx46 for all of the undifferentiated human embryonic stem cultures that were 
detected. The remaining connexins (Cx30, Cx30.2, Cx32, Cx36, Cx47, Cx59, and Cx62) were 
also reliably detected (Rackauskas et al., 2010). 
4. Cardiac electrical properties of connexins and the methods for detection 
For effective cardiac output, it is essential that electrical excitation spread rapidly throughout 
the atria and ventricles. This is effected by electrical coupling through gap junction channels at 
contact sites between myocytes (Danik te al., 2008; Harris, 2001; Söhl & Willecke, 2004; 
Moreno, 2004). These channels form a low-resistance pathway between adjacent myocytes and 
consist of connexin proteins. The connexin family is a large multigene family, and the channels 
formed by different members of this family have distinct electrical and regulatory properties 
(Reisner et al., 2009; Gros & Jongsma, 1996; Verheijck et al., 2001; Valiunas et al., 2002). Voltage 
sensitivity is particularly important in regulating the intercellular coupling between excitable 
cells. Cx43 channels are relatively insensitive to changes in transjunctional voltage compared 
with channels composed of Cx45 (Rackauskas et al., 2007; Bruzzone et al., 1993; Haubrich et al., 
1996). Each gap junction composing hemichannel contains two Vj sensitive gates. The fast gate 
is located at the cytoplasmic entrance of hemichannels and operates from open to residual 
state. The slow, or “loop” gate is located toward extracellular ends of hemichannels and 
exhibits slow gating transition to the fully closed state. Cx26, Cx30, Cx50 close at positive 
voltages, and Cx31, Cx32, Cx37, Cx40, Cx43, Cx45, Cx57 at negative. Interestingly, Cx46 
hemichannels close at both, positive and negative voltages. Besides, each type of connexon has 
a certain sensitivity to H+, it is showed the order of decreasing sensitivity to PH: 
Cx50>Cx46>Cx45>Cx26>Cx37>Cx43>Cx40>Cx32, anyway, it is not completely clear whether 
H+ acts directly on GJ channels. Cytoplasmic C-tail of connexins contains multiple serine, 
threonine, and tyrosine residues that may be phosphorylated by various protein kinases 
(Valiunas et al., 2000; Haubrich et al., 1996). Phosphorylation modifies electrical and metabolic 
communication between contiguous cells by changing channel molecular structure that affects 
channel unitary conductance, mean open time, or open probability. Moreover, 
phosphorylation alters the net charge of C-terminus that in turn may modulate voltage or pH 
sensitivity of the connexins(Kirchhoff et al.,2000,1998; Bukauskas et al., 2004). 
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From the gene level to protein expression, noval methods of detection of gap junctions can 
lead us to realize the therapeutic potential, including morphological diversities, 
ultrastructure and spatial heterogeneity. The authors induced rapid persistent atrial pacing 
dogs and did a comparison between removal and retention of cardiac vagus nerve in dogs 
(superior vena cava and aorta root fat pad, SVC-Ao fat pad ), then recorded the effective 
refractory period and the dispersion of effective refractory period, analyzed the expression 
of atrial and pulmonary vein connexin40, connexin43 and the heterogeneity of its spatial 
distribution and the changs of atrial collagen volume fraction, tried to illuminate the 
correlation of atrial fibrillation with connexin40, connexin43 remodeling and the function of 
vagus nerve. There was obvious shortness of effective refractory period in atrial fibrillation 
animal models, while the removal of vagus nerve could attenuate this effect, meanwhile, the 
quantity and distribution of connexin40 and connexin43 changed at different locations and 
the deposit of collagen fibers, which might explain the mechanism of electrical heterogeneity 
and the structural remodeling originated from the pulmanory vein and left atria for the 
atrial fibrillation.  
5. The distribution of connexins in heart and the relationship with arrhythmia 
Gap junction remodeling is a common response to many forms of heart disease (Strom et 
al.,2010; Burstein et al.,2009; Kieken et al.,2009; Qu et al., 2009; Yamada et al.,2008). Previous 
studies have demonstrated that loss of cell-cell coupling is highly arrhythmic (Chaldoupi et 
al., 2009), however, a detailed understanding of arrhythmia dynamics has been lacking. 
With respect to mechanistically link a primary perturbation of gap junction function with 
arrhythmia, conduction properties, arrhythmia dynamics, and cellular electrophysiological 
characteristics have been detected (Zhou et al., 2008; Severs et al., 2008; Gutstein et al., 2001). 
Accumulative evidences showed that ventricular gap junctions contain at least 20 times 
more connexin43 than connexin40, while atrial gap junctions contain much more connexin40 
than connexin43 (Kontogeorgis et al., 2008; Lin et al., 2010). In the ventricle, the 
heterogeneous loss of connexin43 gap junctions in a murine conditional cardiac connexin43 
knockout model best exemplified how the focal loss of cardiac gap junctions lead to 
significant dispersion of conduction, increased incidence of spontaneous arrhythmias, and 
loss of ventricular systolic function with only minor reductions in overall connexin43 
expression. The gating of connexin43-containing ventricular gap junctions during the action 
potential is also proposed to promote cardiac arrhythmias via inactivation and recovery that 
depends on transjunctional voltage (Vj) and contributes to conduction slowing or block and 
the formation of reentrant arrhythmias. In the atria, targeted gene deletion of connexin40 in 
mice produced multiple aberrations: P wave and PQ interval prolongation, prolonged sinus-
node-recovery time, prolonged Wenckebach period, burst-pacing induced atrial 
tachyarrhythmias, reduced atrial, A-V node, and left bundle branch conduction velocity, 
right bundle branch block, and reduced interatrial conduction heterogeneity(Leaf et al., 
2008; Gutstein et al., 2005). There are close correlation between electrical properties and the 
anatomy of pulmonary veins and left atria. In animal studies, data showed that segmental 
muscle disconnection and differential muscle narrowing at pulmonary vein and left atria 
junctions and complex fiber orientations within the pulmonary vein provide robust 
anatomical bases for conduction disturbance at the pulmonary vein and left atria junction 
and complex intra pulmonary vein conduction patterns (Date et al., 2007).  
 
Advances in Electrocardiograms – Clinical Applications 
 
98
aortic outflow tracts, becoming connected to the right and left ventricular chambers, 
respectively. This morphogenetic sequence is significantly affected by the activity of neural 
crest cells. With the development of heart, the co-expression of multiple connexins in 
diverse tissues support the idea that communication between cells does not depend on just 
one type of connexin, which results in forming heterotypic channels with properties 
different from those homotypic parental connexons. 
Pluripotent mammalian embryonic stem cells, which are derived from the inner cell mass of 
preimplantation blastocysts, have the capacity to differentiate into cells of all three germ 
layers. Under suitable conditions, embryonic stem cells remain pluripotent through 
repeated rounds of cell division in culture. The recent isolation of human embryonic stem 
cells has spurred great interest in their potential use for therapeutic tissue repair because 
appropriate manipulation of the culture environment can induce both mouse and human 
embryonic stem cells to differentiate in vitro into specific somatic cell types, and the result 
shows human embryonic stem cells express RNA encoding most of the known human 
connexin genes. The mRNA of Cx25, Cx26, Cx30.3, Cx31, Cx31.1, Cx31.9, Cx37, Cx40, Cx43, 
Cx45, and Cx46 for all of the undifferentiated human embryonic stem cultures that were 
detected. The remaining connexins (Cx30, Cx30.2, Cx32, Cx36, Cx47, Cx59, and Cx62) were 
also reliably detected (Rackauskas et al., 2010). 
4. Cardiac electrical properties of connexins and the methods for detection 
For effective cardiac output, it is essential that electrical excitation spread rapidly throughout 
the atria and ventricles. This is effected by electrical coupling through gap junction channels at 
contact sites between myocytes (Danik te al., 2008; Harris, 2001; Söhl & Willecke, 2004; 
Moreno, 2004). These channels form a low-resistance pathway between adjacent myocytes and 
consist of connexin proteins. The connexin family is a large multigene family, and the channels 
formed by different members of this family have distinct electrical and regulatory properties 
(Reisner et al., 2009; Gros & Jongsma, 1996; Verheijck et al., 2001; Valiunas et al., 2002). Voltage 
sensitivity is particularly important in regulating the intercellular coupling between excitable 
cells. Cx43 channels are relatively insensitive to changes in transjunctional voltage compared 
with channels composed of Cx45 (Rackauskas et al., 2007; Bruzzone et al., 1993; Haubrich et al., 
1996). Each gap junction composing hemichannel contains two Vj sensitive gates. The fast gate 
is located at the cytoplasmic entrance of hemichannels and operates from open to residual 
state. The slow, or “loop” gate is located toward extracellular ends of hemichannels and 
exhibits slow gating transition to the fully closed state. Cx26, Cx30, Cx50 close at positive 
voltages, and Cx31, Cx32, Cx37, Cx40, Cx43, Cx45, Cx57 at negative. Interestingly, Cx46 
hemichannels close at both, positive and negative voltages. Besides, each type of connexon has 
a certain sensitivity to H+, it is showed the order of decreasing sensitivity to PH: 
Cx50>Cx46>Cx45>Cx26>Cx37>Cx43>Cx40>Cx32, anyway, it is not completely clear whether 
H+ acts directly on GJ channels. Cytoplasmic C-tail of connexins contains multiple serine, 
threonine, and tyrosine residues that may be phosphorylated by various protein kinases 
(Valiunas et al., 2000; Haubrich et al., 1996). Phosphorylation modifies electrical and metabolic 
communication between contiguous cells by changing channel molecular structure that affects 
channel unitary conductance, mean open time, or open probability. Moreover, 
phosphorylation alters the net charge of C-terminus that in turn may modulate voltage or pH 
sensitivity of the connexins(Kirchhoff et al.,2000,1998; Bukauskas et al., 2004). 
The Remodeling of Connexins Localized at 
Pulmonary Vein – Left Atria in Triggering and Maintenance of Atrial Fibrillation 
 
99 
From the gene level to protein expression, noval methods of detection of gap junctions can 
lead us to realize the therapeutic potential, including morphological diversities, 
ultrastructure and spatial heterogeneity. The authors induced rapid persistent atrial pacing 
dogs and did a comparison between removal and retention of cardiac vagus nerve in dogs 
(superior vena cava and aorta root fat pad, SVC-Ao fat pad ), then recorded the effective 
refractory period and the dispersion of effective refractory period, analyzed the expression 
of atrial and pulmonary vein connexin40, connexin43 and the heterogeneity of its spatial 
distribution and the changs of atrial collagen volume fraction, tried to illuminate the 
correlation of atrial fibrillation with connexin40, connexin43 remodeling and the function of 
vagus nerve. There was obvious shortness of effective refractory period in atrial fibrillation 
animal models, while the removal of vagus nerve could attenuate this effect, meanwhile, the 
quantity and distribution of connexin40 and connexin43 changed at different locations and 
the deposit of collagen fibers, which might explain the mechanism of electrical heterogeneity 
and the structural remodeling originated from the pulmanory vein and left atria for the 
atrial fibrillation.  
5. The distribution of connexins in heart and the relationship with arrhythmia 
Gap junction remodeling is a common response to many forms of heart disease (Strom et 
al.,2010; Burstein et al.,2009; Kieken et al.,2009; Qu et al., 2009; Yamada et al.,2008). Previous 
studies have demonstrated that loss of cell-cell coupling is highly arrhythmic (Chaldoupi et 
al., 2009), however, a detailed understanding of arrhythmia dynamics has been lacking. 
With respect to mechanistically link a primary perturbation of gap junction function with 
arrhythmia, conduction properties, arrhythmia dynamics, and cellular electrophysiological 
characteristics have been detected (Zhou et al., 2008; Severs et al., 2008; Gutstein et al., 2001). 
Accumulative evidences showed that ventricular gap junctions contain at least 20 times 
more connexin43 than connexin40, while atrial gap junctions contain much more connexin40 
than connexin43 (Kontogeorgis et al., 2008; Lin et al., 2010). In the ventricle, the 
heterogeneous loss of connexin43 gap junctions in a murine conditional cardiac connexin43 
knockout model best exemplified how the focal loss of cardiac gap junctions lead to 
significant dispersion of conduction, increased incidence of spontaneous arrhythmias, and 
loss of ventricular systolic function with only minor reductions in overall connexin43 
expression. The gating of connexin43-containing ventricular gap junctions during the action 
potential is also proposed to promote cardiac arrhythmias via inactivation and recovery that 
depends on transjunctional voltage (Vj) and contributes to conduction slowing or block and 
the formation of reentrant arrhythmias. In the atria, targeted gene deletion of connexin40 in 
mice produced multiple aberrations: P wave and PQ interval prolongation, prolonged sinus-
node-recovery time, prolonged Wenckebach period, burst-pacing induced atrial 
tachyarrhythmias, reduced atrial, A-V node, and left bundle branch conduction velocity, 
right bundle branch block, and reduced interatrial conduction heterogeneity(Leaf et al., 
2008; Gutstein et al., 2005). There are close correlation between electrical properties and the 
anatomy of pulmonary veins and left atria. In animal studies, data showed that segmental 
muscle disconnection and differential muscle narrowing at pulmonary vein and left atria 
junctions and complex fiber orientations within the pulmonary vein provide robust 
anatomical bases for conduction disturbance at the pulmonary vein and left atria junction 
and complex intra pulmonary vein conduction patterns (Date et al., 2007).  
 
Advances in Electrocardiograms – Clinical Applications 
 
100 
6. The anatomy and electrical activation in pulmonary vein and left atria 
Catheter radiofrequency ablation of triggers originated from the pulmonary veins may 
successfully terminate paroxysmal atrial fibrillation (Jais et al., 1994). Because ablation 
within the pulmonary veins may result in stenosis of the pulmonary veins, the junctions 
between the pulmonary veins and the left atria have become new ablation targets for 
achieving electrical pulmonary vein isolation (Haissaguerre et al., 1998, 2000). Segmental 
ablation can successfully isolate the pulmonary vein by placing radiofrequency lesions in 
only 21% to 59% of the circumference of the pulmonary veins ostia (Pappone et al., 2000; 
Oral et al., 2002). Previous studies showed that ectopic beats originated from the pulmonary 
vein propagated to the left atria with characteristically long conduction time, often with 
conduction delay or block within the pulmonary vein or at the pulmonary vein and left atria 
junction (Nathan & Eliakim, 1966). The complex arrangement of myocardial fibers in the 
pulmonary vein and/or in the pulmonary vein and left atria junction is a possible reason for 
conduction delay or block in the pulmonary vein and left atria junction and within the 
pulmonary vein (Saito et al., 2000). Ho et al reported that a differential thickness of muscle 
sleeves could also account for a variable safety factor of propagation across the pulmonary 
vein and left atria junction (Ho et al., 2001). Hocini reported that zones of activation delay 
were observed in canine pulmonary veins and correlated with abrupt changes in fascicle 
orientation (Hocini et al., 2002). Hamabe identified that segmental muscle disconnection and 
differential muscle narrowing at pulmonary vein and left atria junctions and complex fiber 
orientations within the pulmonary vein provide robust anatomical bases for conduction 
disturbance at the pulmonary vein and left atria junction and complex intra pulmonary vein 
conduction patterns (Hamabe et al., 2003, see Fig2. and Fig3).  
 
 
Fig. 2. Ectopic excitement exsiting in pulmanory veins and left atria conjunction, 
propagating into atria and forming reentry, which is so called”Atrial firbrillation begets 
Atrial fibrillation”. SVC, superior vena cava; IVC, inferior vena cava; LIPV, left inferior 
pulmanory vein; RIPV, right inferior pulmanory vein; LSPV: left superior pulmanory vein; 
RSPV: right superior pulmanory vein. LA: left atria; RA: right atria. 
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Fig. 3. Electrical remodeling of atria, Acetylcholine injecting at RAA activates ganglion to 
output impulse and effects on the excited foci in pulmanory veins, therefore, the arrhythmia 
perpetuates. Ach, acetylcholine; RAA: right atrial appendage; RSPV: right superior 
pulmanory vein; LSPV: left superior pulmanory vein. (Lu et al. 2008) 
The autopsied heart showed that myocardial cells were localized to pulmonary vein 
between 9 and 38 mm from the pulmonary vein and left atria junction (Roux et al., 2004). 
The sleeve was composed of circularly and longitudinally oriented bundles of 
cardiomyocytes. The peripheral end of the myocardial sleeve was irregular. The longest 
myocardial sleeves were found in the superior veins and were longitudinally oriented. At 
the pulmonary vein and left atria junction, the circular bundles were not often 
circumferential. Pulmonary vein myocardial architecture confirmed the possibility of 
initiating atrial fibrillation. Tan (Tan et al., 2006) examined 192 sections in 32 veins obtained 
from 8 healthy human heart, each segment included between 7 and 20 mm of the adjoining 
left atria, and found 1) pulmonary vein and left atria muscular discontinuities and abrupt 
90° changes in myober orientation were present in the pulmonary vein and left atria 
junction in over half of all segments examined; 2) These anisotropic features were found 
more frequently in the anterosuperior than posteroinferior junctions; 3) Adrenergic and 
cholinergic nerve densities were highest in the left atria within 5 mm from the pulmonary 
vein and left atria junction, higher in the superior aspect of left superior pulmanory vein, 
anterosuperior aspect of right superior pulmanory vein, and inferior aspects of the both 
inferior pulmanory veins than diametrically opposite, and higher in the epicardial than 
endocardial half of the tissue; 4) adrenergic and cholinergic nerves were highly co-located at 
tissue and cellular levels of spatial organization. Tan suggest that: 1) the pulmonary vein 
and left atria junction contains anatomical substrates (muscular discontinuities and abrupt 
ber orientation changes) to support reentry; 2) there are no good empiric targets for 
segmental pulmonary vein isolation because of the widespread distributions of pulmonary 
vein and left atria muscular discontinuities; 3) the left atria region close to the pulmonary 
vein and left atria junction rather than farther away in the left atria or pulmonary vein 
would be the most appropriate target for autonomic modulation procedures; 4) it is not 
possible to selectively ablate either adrenergic or cholinergic nerves in this location because 
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both nerve types are highly co-located in this region. Steiner found that pulmanory vein 
myocardial sleeves frequently harbour pathological lesions, particularly senile atrial 
amyloid, and scarring in atrial fibrillation (Steiner et al., 2005). The degree of scarring of the 
sleeves did not correlate with the degree of coronary atherosclerosis, and inferred the 
genesis of the scarring is not post necrotic but degenerative, due to diffuse hypoxia of the 
sleeve myocardium. Amyloidosis and particularly scarring of pulmanory vein myocardial 
sleeves appear generally in the elderly population as an arrhythmogenic substrate for atrial 
fibrillation.  
In animal studies, pacing had different effects on connexin40 and connexin43 gap junctions, 
collagen content increased as well (Yeh et al., 2006). They found there was a 98% increase in 
connexin43 in pacing 2 weeks, and a 74% increase in pacing 6-8weeks animals. In contrast, 
connexin40 decreased 47% in pacing 2 weeks but increased 44% in pacing 6-8weeks animals. 
Our studies also found the moderate to severe deposit of collagen fibers in canine atria after 
persistent rapid atrial pacing (XIONG et al., 2010, see Fig4. and Fig5.), connexin40 mRNA 
expression decreased in left atria and right atria, but increased in left atria appendage, right 
atria appendage and atrial septum; connexin43 mRNA expression was reduced in left atria, 
right atria, left atrial appendage and right atrial appendage while increased in atiral septum 
(see Fig6., Fig7. and Fig8.). The pacing induced collagen remodeling and modulation on 
connexin40 mRNA and connexin43 mRNA expressions could be partially attenuated by 
removing SVC-Ao fat pad suggesting vagal nervation plays a key role in the initiation and 
preservation of atrial fibrillation． 
 
 
Fig. 4. Different degree of collagen fibers deposits at intercellular substance.1A to 1E: normal 
distribution of collagen fibers in the whole atria; 2A to 2E: severe degree of collagen fibers 
deposits at different locations of atria after persistent atrial pacing; 3A to 3E: moderate 
degree of collagen fibers deposits at different locations of atria after persistent atrial pacing 
without SVC-Ao fat pad.A: left atria; B: right atria; C: left atrial appendage; D: right atrial 
appendage; E: atrial septum; SVC-Ao fat pad: superior vena cava and aorto root fat pad. 
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Fig. 5. Collagen fibers wrap the cardiac muscle cells and interrupt the normal intercellular 






Fig. 6. Collagen Volume Fraction compared among three different groups. There was no 
significant spatial difference on collagen distribution in sham operated group and SVC-Ao 
fat pad removal group, while significant spatial difference on collagen distribution in SVC-
Ao fat pad reserved group. CVF: collagen volume fraction; SVC-Ao fat pad: superior vena 
cava and aorto root fat pad; LA: left atria; RA: right atria; LAA: left atrial appendage; RAA: 
right atrial appendage; AS: atrial septum. 
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Fig. 6. Collagen Volume Fraction compared among three different groups. There was no 
significant spatial difference on collagen distribution in sham operated group and SVC-Ao 
fat pad removal group, while significant spatial difference on collagen distribution in SVC-
Ao fat pad reserved group. CVF: collagen volume fraction; SVC-Ao fat pad: superior vena 
cava and aorto root fat pad; LA: left atria; RA: right atria; LAA: left atrial appendage; RAA: 
right atrial appendage; AS: atrial septum. 
 







Fig. 7. Expression of Cx40 mRNA compared among three different groups. There was 
significant difference of increased Cx40 mRNA expression after persistent atrial pacing, the 
expression at atria in SVC-Ao fat pad removal group but that at atrial appendage in SVC-Ao 
fat pad reserved group are the significant difference. SVC-Ao fat pad: superior vena cava 
and aorto root fat pad; LA: left atria; RA: right atria; LAA: left atrial appendage; RAA: right 






Fig. 8. Expression of Cx43 mRNA compared among three different groups. There was 
significant difference of increased Cx43 mRNA expression in SVC-Ao fat pad removal 
group but decreased Cx43 mRNA expression in SVC-Ao fat pad reserved group. The most 
interesting locations are left and right atria. SVC-Ao fat pad: superior vena cava and aorto 
root fat pad; LA: left atria; RA: right atria; LAA: left atrial appendage; RAA: right atrial 
appendage; AS: atrial septum; Cx43: connexin 43. 
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ECG in Acute Myocardial Infarction 
in the Reperfusion Era 
Massimo Napodano and Catia Paganelli 
University of Padova, 
Italy 
1. Introduction  
Acute myocardial infarction can be defined from a number of different perspectives 
related to clinical, electrocardiographic, biochemical and pathological characteristic. The 
electrocardiogram (ECG) is the most important diagnostic tool in the diagnosis of ST-segment 
elevation myocardial infarction (STEMI), and therefore it should be accomplished immediately 
at hospital admission. In fact, it represents an important step not only for STEMI diagnosis, but 
also and more importantly for the therapeutic plan. The present article pertains to 
electrocadiographic findings in patients affected by persistent STEMI. Moreover, it takes into 
account the clinical utility of ECG in the diagnosis and therapeutic decisions of evolving 
STEMI, as well as the prognostic implications of the ECG evolutions in the reperfusion era.  
2. Evolving ECG changes occurring in the early phase of ST-elevation 
myocardial infarction  
Typically, the ECG in the evolving STEMI shows five abnormalities, which develop in turn: 
hyperacute T waves, ST-segment elevation, abnormal Q waves, T-waves inversion, 
normalization of the ST-segment (Figure 1). 
2.1 Hyperacute T waves 
The T-waves represent the period of ventricular repolarization on the surface ECG. During 
the first minutes of coronary arterial occlusion (Dressler et al., 1947), the earliest ECG 
changes are represented by an increase in the amplitude of the T-wave, the so-called 
“Hyperacute T-waves” (Figure 1B,C). The morphologic characteristic of hyperacute T-wave 
are typical of ischemic event: they are asymmetric with a broad base and generally 
associated with reciprocal ST segment depression. In the evolving STEMI the hyperacute T-
waves turn into giant R wave (Figure 1E). Hyperacute T-waves represent the 
electrocardiographic expression of ischemia before the beginning of necrosis; for this reason 
they are considered as the most significant phase during which the reperfusion therapy may 
achieve the greatest benefit in term of myocardial salvage (Lee et al., 1995). Prominent T-
waves, however, are also associated with other diagnoses, including hyperkalemia, early 
repolarization end left ventricular hypertrophy (Somers et al., 2002). Thus in the differential 
diagnosis, the clinicians must consider additional features related to patient, including age, 
comorbidity and current medical status. 
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A Normal: Normal ST-segment and T-wave; B Early, Hyper-acute T wave: Development of Prominent 
T Wave; C Hyper-acute T Wave: Prominent T-wave with early ST-segment elevation; D ST-segment 
elevation: Progressive ST-segment elevation with persistent prominent T-wave; E  Giant R Wave: ST -
segment elevation continues with development of giant R-wave. F  ST-segment Elevation: ST-segment 
elevation with oblique morphology. 
Fig. 1. Evolving ECG changes occurring in the early phase of ST-elevation myocardial 
infarction  
2.2 ST-segment elevation  
The ST-segment, defined as the segment beginning at the J point and ending at the apex of 
the T-wave, represents the electrocardiographic period between ventricular depolarization 
(QRS) and repolarization (T-wave) (Figure 1A). The ST-segment changes on the standard 
ECG that are associated with infarction are due to flow of current across the boundary 
between the ischemic and nonischemic zones. ST-segment elevation generally occurs with 
reciprocal ST depression in ECG leads in which the axis is opposite in direction from those 
with ST elevation (Figure 1D). The best criteria to classify abnormally elevated ST-segment 
are resumed in the Minnesota code 9-2 and are defined as ST-segment elevation of 1 mm in 
at least 1 peripheral lead, or 2 mm elevation in at least 1 precordial lead. These criteria have 
94% of specificity for STEMI with a sensitivity of 56% in STEMI diagnosis (Menown  et al., 
2000). The threshold values results from recognition that some elevation of the junction of 
the QRS complex and the ST-segment (J-point) is a normal finding. Indeed, these are 
 
ECG in Acute Myocardial Infarction in the Reperfusion Era 
 
115 
dependent on gender, age, and ECG lead. Thus, the current thresholds recommended by the 
American Heart Association Electrocardiography and Arrhythmias, the Amrican College of 
Cardiology vary according to age, gender, and ECG lead (Table 1). 
 
Men 40 years old of age 
and older 
The threshold value for abnormal J-point elevation should be 
0.2 mV (2 mm) in leads V2 and V3 and 0.1 mV (1 mm) in all 
other leads.  
Men less than 40 years of 
age 
The threshold value for abnormal J-point elevation in V2 and 
V3 should be 0.25 mV (2.5 mm). 
Women of all ages The threshold value for abnormal J-point elevation should be 
0.15 mV (1.5 mm) in leads V2 and V3 and greater than 0.1 mV 
(1 mm) in all other leads. 
Men and women of all 
ages 
The threshold for abnormal J-point elevation V3R and V4R 
should be 0.05 mV (0.5 mm), except for males less than 30 
years of age, for whom 0.1 mV (1 mm) is more appropriate. 
Men and women of all 
ages 
The threshold value for abnormal J-point elevation in V7 
through V9 should be 0.05 mV (0.5 mm). 
Men and women of all 
ages 
The threshold value for abnormal J-point depression should 
be – 0.05 mV (-0.5 mm) in leads V2 and V3 and – 0.1 mV (- 1 
mm) in all other leads. 
Table 1. Threshold values for ST-segment elevation according to age, gender, and ECG 
leads. Adapted from AHA/ACCF/HRS (2009) Recommendations for standardization and 
interpretation of the electrocardiogram . J Am Coll Cardiol, Vol. 53, No. 11, pp. 1003-10011, 
ISSN  0735-1097/09/ 
However, ST-segment elevation can also attributed to other causes, different from acute 
myocardial infarction: a normal variant, frequently referred as early repolarization, commonly 
characterized by J-point elevation and rapidly upsloping or normal ST-segment; ventricular 
dyskinesis, often characterized by a small ST elevation; pericarditis, in which usually the ST 
elevation can be detected in more than one discrete region, as the inflammation involves a 
large portion of the epicardial surface, and reciprocal ST-depression is absent; elevated 
serum potassium; acute myocarditis; cardiac tumors or intra-thoracic mass. An additional 
ECG criteria in diagnosis of evolving STEMI is represented by the morphology of ST-
segment elevation. In fact, two patterns of ST-segment morphology can be distinguish, 
according to the direction of the ST slope: a concave morphology and a convex morphology 
(Figure 2A,B). The concave morphology (Figure 2A) is hardly consistent with STEMI 
diagnosis, and rather related to other conditions, such as benign early repolarization, acute 
pericarditis. On the other hand, the convex morphology is usually associated with STEMI 
(Brady et al., 2001) (Figure 2B). The assessment of ST-segment elevation during STEMI is 
also useful to evaluate the extension of the myocardial at risk, and then the prognosis. In fact 
the number of leads with ST segment elevation and the sum of the total ST deviation have 
been related to the extension of area of myocardium at risk, defined as the extent of 
jeopardize ischemic myocardium, and consequently to the extent of necrotic area if 
reperfusion is not undertaken (Aldrich et al., 1988). 
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dependent on gender, age, and ECG lead. Thus, the current thresholds recommended by the 
American Heart Association Electrocardiography and Arrhythmias, the Amrican College of 
Cardiology vary according to age, gender, and ECG lead (Table 1). 
 
Men 40 years old of age 
and older 
The threshold value for abnormal J-point elevation should be 
0.2 mV (2 mm) in leads V2 and V3 and 0.1 mV (1 mm) in all 
other leads.  
Men less than 40 years of 
age 
The threshold value for abnormal J-point elevation in V2 and 
V3 should be 0.25 mV (2.5 mm). 
Women of all ages The threshold value for abnormal J-point elevation should be 
0.15 mV (1.5 mm) in leads V2 and V3 and greater than 0.1 mV 
(1 mm) in all other leads. 
Men and women of all 
ages 
The threshold for abnormal J-point elevation V3R and V4R 
should be 0.05 mV (0.5 mm), except for males less than 30 
years of age, for whom 0.1 mV (1 mm) is more appropriate. 
Men and women of all 
ages 
The threshold value for abnormal J-point elevation in V7 
through V9 should be 0.05 mV (0.5 mm). 
Men and women of all 
ages 
The threshold value for abnormal J-point depression should 
be – 0.05 mV (-0.5 mm) in leads V2 and V3 and – 0.1 mV (- 1 
mm) in all other leads. 
Table 1. Threshold values for ST-segment elevation according to age, gender, and ECG 
leads. Adapted from AHA/ACCF/HRS (2009) Recommendations for standardization and 
interpretation of the electrocardiogram . J Am Coll Cardiol, Vol. 53, No. 11, pp. 1003-10011, 
ISSN  0735-1097/09/ 
However, ST-segment elevation can also attributed to other causes, different from acute 
myocardial infarction: a normal variant, frequently referred as early repolarization, commonly 
characterized by J-point elevation and rapidly upsloping or normal ST-segment; ventricular 
dyskinesis, often characterized by a small ST elevation; pericarditis, in which usually the ST 
elevation can be detected in more than one discrete region, as the inflammation involves a 
large portion of the epicardial surface, and reciprocal ST-depression is absent; elevated 
serum potassium; acute myocarditis; cardiac tumors or intra-thoracic mass. An additional 
ECG criteria in diagnosis of evolving STEMI is represented by the morphology of ST-
segment elevation. In fact, two patterns of ST-segment morphology can be distinguish, 
according to the direction of the ST slope: a concave morphology and a convex morphology 
(Figure 2A,B). The concave morphology (Figure 2A) is hardly consistent with STEMI 
diagnosis, and rather related to other conditions, such as benign early repolarization, acute 
pericarditis. On the other hand, the convex morphology is usually associated with STEMI 
(Brady et al., 2001) (Figure 2B). The assessment of ST-segment elevation during STEMI is 
also useful to evaluate the extension of the myocardial at risk, and then the prognosis. In fact 
the number of leads with ST segment elevation and the sum of the total ST deviation have 
been related to the extension of area of myocardium at risk, defined as the extent of 
jeopardize ischemic myocardium, and consequently to the extent of necrotic area if 
reperfusion is not undertaken (Aldrich et al., 1988). 
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Fig. 2. Patterns of ST-segment elevation at ECG 
Moreover , the analysis of the electrocardiographic leads revealing ST-segment elevation as 
well as of those showing ST depression, permits an almost accurate identification of the 
occluded coronary artery and also the proximal or distal location of the occlusion within 
that artery (Wagner et al., 2009). Anterior wall ischemia/infarction is invariably due to 
occlusion of the left anterior descending coronary artery and results in the spatial vector of 
the ST segment being directed to the left and laterally. This will be expressed as ST elevation 
in some or all of leads V1 through V6. The location of the occlusion within the left anterior 
descending coronary artery, that is, whether proximal or distal, is suggested by the chest 
leads in which the ST-segment elevation occurs and the presence of ST-segment elevation or 
depression in other leads. Occlusion of the proximal left anterior descending coronary artery 
above the first septal and first diagonal branches results in involvement of the basal portion 
of the left ventricle, as well as the anterior and lateral walls and the interventricular septum. 
This will result in the ST-segment spatial vector being directed superiorly and to the left and 
will be associated with ST-segment elevation in leads V1 through V4, I, aVL, and often aVR. 
It will also be associated with reciprocal ST-segment depression in the leads whose positive 
poles are positioned inferiorly, that is, leads II, III, aVF, and often V5 (Birnbaum et al., 1993). 
When the occlusion is located between the first septal and first diagonal branches, the basal 
interventricular septum will be spared, and the ST segment in lead V1 will not be elevated. 
In that situation, the ST-segment vector will be directed toward aVL, which will be elevated, 
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and away from the positive pole of lead III, which will show depression of the ST segment. 
When the occlusion is located more distally, that is, below both the first septal and first 
diagonal branches, the basal portion of the left ventricle will not be involved, and the ST-
segment vector will be oriented more inferiorly. Thus, the ST segment will not be elevated in 
leads V1, aVR, or aVL, and the ST segment will not be depressed in leads II, III, or aVF. 
Indeed, because of the inferior orientation of the ST-segment vector, elevation of the ST 
segment in leads II, III, and aVF may occur. In addition, ST-segment elevation may be more 
prominent in leads V3 through V6 and less prominent in V2than in the more proximal 
occlusions (Engelen et al., 1999). Inferior wall infarction that results in ST-segment elevation 
in only leads II, III, and aVF may be the result of occlusion of either the right coronary artery 
or the left circumflex coronary artery, depending on which provides the posterior 
descending branch, that is, which is the dominant vessel. When the right coronary artery is 
occluded, the spatial vector of the ST segment will usually be directed more to the right than 
when the left circumflex is occluded. This will result in greater ST-segment elevation in lead 
III than in lead II and will often be associated with ST-segment depression in leads I and 
aVL, leads in which the positive poles are oriented to the left and superiorly. However, 
recently these criteria resulted less accurate in patients with electrocardiographic small 
inferior myocardial infarction (Verouden et al., 2009). Indeed, when the RCA is occluded in 
its proximal portion, ischemia/infarction of the right ventricle may occur, which causes the 
spatial vector of the ST-segment shift to be directed to the right and anteriorly, as well as 
inferiorly. This will result in ST-segment elevation in leads placed on the right anterior 
chest, in positions referred to as V3R and V4R, and often in lead V1 (Correale et al., 1999). 
Lead V4R is the most commonly used right-sided chest lead. It is of great value in 
diagnosing right ventricular involvement in the setting of an inferior wall infarction and in 
making the distinction between right coronary artery and left circumflex coronary artery 
occlusion and between proximal and distal right coronary artery occlusion. It is important to 
recognize that the ST elevation in the right-sided chest leads associated with right 
ventricular infarction persists for a much shorter period of time than the ST elevation 
connoting inferior wall infarction that occurs in the extremity leads. For this reason, leads 
V3R and V4R should be recorded as rapidly as possible after the onset of chest pain. ST-
segment depression in leads V1, V2, and V3 that occurs in association with an inferior wall 
infarction may be caused by occlusion of either the right coronary or the left circumflex 
artery. This ECG pattern has been termed posterior or posterolateral ischemia since the early 
reports based on anatomic and pathological studies of ex vivo. However, recent in vivo 
imaging studies, including magnetic resonance imaging, have demonstrated that the region 
referred to as the posterior wall was lateral rather than posterior since the oblique position 
of the heart within the thorax: correlating the ECG patterns of healed myocardial infarctions 
to their anatomic location as determined by magnetic resonance imaging, the most frequent 
cause of abnormally tall and broad R waves in leads V1 and V2 was involvement of the 
lateral and not the posterior wall of the left ventricle (Bayes de Luna et al., 2006a). On these 
basis it has been proposed that the term posterior be replaced by the designation lateral 
(Cerqueira et al., 2002). Therefore, the terms posterior ischemia and posterior infarction be 
replaced by the terms lateral, inferolateral, or basal-lateral depending on the associated 
changes in II, III, aVF, V1, V5, and V6. Such terminology has been endorsed by the 
International Society for Holter and Noninvasive Electrocardiography (Bayes de Luna A et 
al., 2006b). It is not possible to determine whether the right coronary artery or left circumflex 
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in some or all of leads V1 through V6. The location of the occlusion within the left anterior 
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This will result in the ST-segment spatial vector being directed superiorly and to the left and 
will be associated with ST-segment elevation in leads V1 through V4, I, aVL, and often aVR. 
It will also be associated with reciprocal ST-segment depression in the leads whose positive 
poles are positioned inferiorly, that is, leads II, III, aVF, and often V5 (Birnbaum et al., 1993). 
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interventricular septum will be spared, and the ST segment in lead V1 will not be elevated. 
In that situation, the ST-segment vector will be directed toward aVL, which will be elevated, 
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and away from the positive pole of lead III, which will show depression of the ST segment. 
When the occlusion is located more distally, that is, below both the first septal and first 
diagonal branches, the basal portion of the left ventricle will not be involved, and the ST-
segment vector will be oriented more inferiorly. Thus, the ST segment will not be elevated in 
leads V1, aVR, or aVL, and the ST segment will not be depressed in leads II, III, or aVF. 
Indeed, because of the inferior orientation of the ST-segment vector, elevation of the ST 
segment in leads II, III, and aVF may occur. In addition, ST-segment elevation may be more 
prominent in leads V3 through V6 and less prominent in V2than in the more proximal 
occlusions (Engelen et al., 1999). Inferior wall infarction that results in ST-segment elevation 
in only leads II, III, and aVF may be the result of occlusion of either the right coronary artery 
or the left circumflex coronary artery, depending on which provides the posterior 
descending branch, that is, which is the dominant vessel. When the right coronary artery is 
occluded, the spatial vector of the ST segment will usually be directed more to the right than 
when the left circumflex is occluded. This will result in greater ST-segment elevation in lead 
III than in lead II and will often be associated with ST-segment depression in leads I and 
aVL, leads in which the positive poles are oriented to the left and superiorly. However, 
recently these criteria resulted less accurate in patients with electrocardiographic small 
inferior myocardial infarction (Verouden et al., 2009). Indeed, when the RCA is occluded in 
its proximal portion, ischemia/infarction of the right ventricle may occur, which causes the 
spatial vector of the ST-segment shift to be directed to the right and anteriorly, as well as 
inferiorly. This will result in ST-segment elevation in leads placed on the right anterior 
chest, in positions referred to as V3R and V4R, and often in lead V1 (Correale et al., 1999). 
Lead V4R is the most commonly used right-sided chest lead. It is of great value in 
diagnosing right ventricular involvement in the setting of an inferior wall infarction and in 
making the distinction between right coronary artery and left circumflex coronary artery 
occlusion and between proximal and distal right coronary artery occlusion. It is important to 
recognize that the ST elevation in the right-sided chest leads associated with right 
ventricular infarction persists for a much shorter period of time than the ST elevation 
connoting inferior wall infarction that occurs in the extremity leads. For this reason, leads 
V3R and V4R should be recorded as rapidly as possible after the onset of chest pain. ST-
segment depression in leads V1, V2, and V3 that occurs in association with an inferior wall 
infarction may be caused by occlusion of either the right coronary or the left circumflex 
artery. This ECG pattern has been termed posterior or posterolateral ischemia since the early 
reports based on anatomic and pathological studies of ex vivo. However, recent in vivo 
imaging studies, including magnetic resonance imaging, have demonstrated that the region 
referred to as the posterior wall was lateral rather than posterior since the oblique position 
of the heart within the thorax: correlating the ECG patterns of healed myocardial infarctions 
to their anatomic location as determined by magnetic resonance imaging, the most frequent 
cause of abnormally tall and broad R waves in leads V1 and V2 was involvement of the 
lateral and not the posterior wall of the left ventricle (Bayes de Luna et al., 2006a). On these 
basis it has been proposed that the term posterior be replaced by the designation lateral 
(Cerqueira et al., 2002). Therefore, the terms posterior ischemia and posterior infarction be 
replaced by the terms lateral, inferolateral, or basal-lateral depending on the associated 
changes in II, III, aVF, V1, V5, and V6. Such terminology has been endorsed by the 
International Society for Holter and Noninvasive Electrocardiography (Bayes de Luna A et 
al., 2006b). It is not possible to determine whether the right coronary artery or left circumflex 
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vessel is occluded when changes of inferior wall ischemia/infarction are accompanied by 
depression of the ST-segment in leads V1, V2, and V3; however, the absence of such changes 
is more suggestive of right coronary than left circumflex artery occlusion. When the left 
circumflex is occluded, the spatial vector of the ST-segment in the frontal plane is more 
likely to be directed to the left. For this reason, the ST-segment may be elevated to a greater 
extent in lead II than in lead III and may be isoelectric or elevated in leads I and aVL (Bairey  
et al., 1987). Conversely, when a dominant right coronary artery is occluded proximally, left 
posterolateral and right ventricular wall involvement will be present, and the posteriorly 
directed ST-segment vector associated with this involvement may cancel the ST-segment 
elevation in lead V1 anticipated by right ventricular involvement and vice versa. The 
American College of Cardiology (ACC)/American Heart Association (AHA) guidelines for 
the management for patients with acute myocardial infarction (ACC/AHA, 2009) note the 
presence of electrocardiographic ST-segment elevation of greater than 0.1 mV in two 
anatomically contiguous leads; they suggest that such a finding is a Class I indication for 
urgent reperfusion therapy in the patient presumed to have STEMI.  However, in few 
patients the presence of a left bundle branch block make the ECG less specific for the 
diagnosis of STEMI, because LBBB resembles STEMI changes. In this setting, the presence of 
suggestive symptoms and/or the certainty of the new-onset of conduction disorders may be 
helpful in diagnosis. Nevertheless, when these are not conclusive for diagnosis, the presence 
of some ECG criteria, pertaining the ST shift in relation to QRS vectors, may still indicate the 
diagnosis. To this regard, the ECG should be interpreted using the “rule of appropriate 
discordance”, described by Sgarabossa and colleagues (Sgarbossa, 1996, 1998). They 
identified three independent electrocardiographic criteria suggesting for STEMI diagnosis in 
presence of LBBB: ST-segment elevation of at least 1mm that is concordant with the QRS 
complex; ST-segment depression of at least 1mm in leads V2 and V3; and ST-segment 
elevation of at least 5 mm that is discordant with the QRS complex. The Sgarbossa criteria 
provide a simple and practical diagnostic approach to identify STEMI in presence of LBBB, 
contributing to better address risk stratification and to optimize the risk-benefit ratio of 
reperfusion therapy in this challenging and high-risk population. In fact, the presence of 
LBBB in patients with acute myocardial infarction is usually related to large necrosis and 
consequently to high risk of complications and death. In fact, the new onset LBBB is related 
to the occlusion of the proximal left anterior descending artery and a large amount of 
jeopardized myocardium (Opolski et al., 1986). On the other hand, a pre-existing left bundle 
branch block is a powerful marker of depressed left ventricular systolic function, and any 
additional loss of myocardium is likely to result in large infarction and cardiogenic shock 
(Hamby et al., 1983) 
2.3 Abnormal Q-wave 
Q-wave are commonly present in normal ECG. Abnormal Q-wave suggesting myocardial 
necrosis have grater negative deflection and longer duration. Pathologic Q-wave typically 
appear within the first 9 hours of infarction, with a wide interval, ranging from few minutes 
to 24 hours (Perera, 2004; Goldberger, 1991). In particular in the evolution of non-reperfused 
myocardial infarction, Q-wave usually appear within 9 hours from coronary occlusion (Bär 
et al., 1996). However, it is not infrequent to observe Q-wave early after symptom onset. 
Abnormal Q-wave may be related to ischemia of the conduction system (Raitt at al., 1995; 
Smith & Whitwam, 2006). Thus, Q-wave should not be used exclusively as a marker of late 
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presentation of acute coronary occlusion, denying patients potentially beneficial reperfusion 
therapy. It is important to note that, in the Global Utilization of Streptokinase and Tissue 
Plasminogen Activator for Occluded Coronary Arteries (GUSTO-I) trial patients who did 
not develop Q-wave after fibrinolysis for STEMI had a lower mortality rate when compared 
to those who did develop Q wave at 30 days post infarction and 1 year post infarction 
(Bargelata et al., 1997). Thus, the absence of Q-wave after reperfusion therapy is a powerful 
marker of non-transmural necrosis and then of favorable prognosis. 
2.4 T-wave inversion 
In healthy patients, T-wave are normally upright in the left-sided leads (I, II, V3-V6). Within 
hours to days, an evolving STEMI will typically demonstrate T-wave inversion (Goldberger, 
1991).The inverted T-wave appear generally in the same leads showing ST-segment 
elevation (Oliva et al., 1993). The morphology of inverted T-wave tends to be symmetric 
(Goldschlager & Goldman,1989). In the course of an evolving STEMI, T-wave inversion 
occurs when ischemia involves the epicardium. T-wave inversion is hypothesized by 
Mandel et al. to occur because of delayed depolarization in ischemic tissue (Mandel et al., 
1968). In normal hearts, the epicardium is the first to depolarize, whereas the endocardium 
is the last. Delayed repolarization of the epicardium during ischemia reverses the direction 
of the ventricular repolarization current. With repolarization moving in the direction of 
endocardium to epicardium, the repolarization vector also reverses, causing a downward 
deflection of the T-wave (Smith & Whitwam, 2005). T-wave inversion occurs in 
approximately 3/4 of all patients with a completed myocardial necrosis (Goldschlager & 
Goldman,1989). Presence of T-wave inversion in precordial leads, of at least 2 mm, has a 
positive predictive value of 86% for left anterior descending artery stenosis (Haines et al., 
1983). Indeed, a deepening T-wave soon after fibrinolysis may then determine successful 
reperfusion. However, normalization of T-waves may also predict a lower morbidity 
months after STEMI. One study by Tamura et al. found that patients with T-wave 
normalization within 6 months of infarction had higher left ventricular ejection fraction than 
those who did not, indicating that patients with normalization of inverted T waves had 
improved myocardial recovery (Tamura et al., 1999). The morphology of the T-wave 
inversion may help to differentiate between these other causes of T-wave inversion. 
Pacemaker T wave, in other words T wave inversion related to permanent ventricular 
pacemakers, tend to be broader than the narrower infarction T waves. A prolonged QTc 
distinguishes long QT syndrome. In mitral valve prolapse, T wave may be flattened or even 
inverted in inferior or lateral leads (Goldberger, 1991). In stroke, T waves tend to be very 
wide and the QT interval prolonged (Cropp & Manning, 1960). 
2.5 Normalization of the ST segment 
In not-reperfused STEMI, after a peak elevation approximately 1 hour after the onset of 
chest pain, the ST segment reaches a plateau at about 12 hours (Essen et al., 1979), and a 
complete resolution within 2 weeks in 95% of patients with inferior STEMI and 40% of 
patients with anterior STEMI (Mills et al., 1975). Even if the resolution of the ST-segment 
elevation may rarely  occur from spontaneous reperfusion (Parikh & Shah, 1997), nowadays 
the normalization of the ST-segment can be observed in the majority of patients as result of 
successful reperfusion therapy. In fact, after successful fibrinolysis or mechanical reopening 
of infarct-related artery, abrupt changes occur in ECG as result of recovery in depolarization 
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vessel is occluded when changes of inferior wall ischemia/infarction are accompanied by 
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presentation of acute coronary occlusion, denying patients potentially beneficial reperfusion 
therapy. It is important to note that, in the Global Utilization of Streptokinase and Tissue 
Plasminogen Activator for Occluded Coronary Arteries (GUSTO-I) trial patients who did 
not develop Q-wave after fibrinolysis for STEMI had a lower mortality rate when compared 
to those who did develop Q wave at 30 days post infarction and 1 year post infarction 
(Bargelata et al., 1997). Thus, the absence of Q-wave after reperfusion therapy is a powerful 
marker of non-transmural necrosis and then of favorable prognosis. 
2.4 T-wave inversion 
In healthy patients, T-wave are normally upright in the left-sided leads (I, II, V3-V6). Within 
hours to days, an evolving STEMI will typically demonstrate T-wave inversion (Goldberger, 
1991).The inverted T-wave appear generally in the same leads showing ST-segment 
elevation (Oliva et al., 1993). The morphology of inverted T-wave tends to be symmetric 
(Goldschlager & Goldman,1989). In the course of an evolving STEMI, T-wave inversion 
occurs when ischemia involves the epicardium. T-wave inversion is hypothesized by 
Mandel et al. to occur because of delayed depolarization in ischemic tissue (Mandel et al., 
1968). In normal hearts, the epicardium is the first to depolarize, whereas the endocardium 
is the last. Delayed repolarization of the epicardium during ischemia reverses the direction 
of the ventricular repolarization current. With repolarization moving in the direction of 
endocardium to epicardium, the repolarization vector also reverses, causing a downward 
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Goldman,1989). Presence of T-wave inversion in precordial leads, of at least 2 mm, has a 
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those who did not, indicating that patients with normalization of inverted T waves had 
improved myocardial recovery (Tamura et al., 1999). The morphology of the T-wave 
inversion may help to differentiate between these other causes of T-wave inversion. 
Pacemaker T wave, in other words T wave inversion related to permanent ventricular 
pacemakers, tend to be broader than the narrower infarction T waves. A prolonged QTc 
distinguishes long QT syndrome. In mitral valve prolapse, T wave may be flattened or even 
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In not-reperfused STEMI, after a peak elevation approximately 1 hour after the onset of 
chest pain, the ST segment reaches a plateau at about 12 hours (Essen et al., 1979), and a 
complete resolution within 2 weeks in 95% of patients with inferior STEMI and 40% of 
patients with anterior STEMI (Mills et al., 1975). Even if the resolution of the ST-segment 
elevation may rarely  occur from spontaneous reperfusion (Parikh & Shah, 1997), nowadays 
the normalization of the ST-segment can be observed in the majority of patients as result of 
successful reperfusion therapy. In fact, after successful fibrinolysis or mechanical reopening 
of infarct-related artery, abrupt changes occur in ECG as result of recovery in depolarization 
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currents  across the myocites membrane. Thus a prompt decrease in ST-segment elevation is 
a powerful predictor of reperfusion (Richardson et al., 1988), whereas the persistence of ST-
segment elevation represent a marker of unsuccessful reperfusion therapy and is an 
independent determinant of major adverse cardiac event (Claeys et al., 1999). Interestingly, a 
decrease in ST-segment elevation by at least 50% seems to be associated with 94% positive 
predictive value for complete reperfusion (Krucoff et al., 1993). Indeed, studies have also 
found that even after a complete and sustained patency of epicardial infarct-related artery 
obtained by pharmacological or mechanical recanalization, about one-third of patients still 
show a persistent ST- segment elevation, as result of unsuccessful reperfusion of the 
microvasculature (De Lemos & Brunwald, 2001). This condition is known as a no-reflow 
phenomenon, and has been related to a higher mortality and worse clinical outcome after 
myocardial infarction (Poli et al., 2002). Thus it is important to remark that normalization of 
the ST-segment indicates adequate perfusion throughout the myocardial microvasculature 
rather than epicardial coronary patency.  
3. Choice of reperfusion strategy 
Primary percutaneous coronary intervention and thrombolysis remain therapies of choice 
for patients presenting with evolving STEMI. However, clinical outcome after  STEMI is 
mainly related to complete and sustained myocardial reperfusion, but strongly influenced 
by delay in achieving reperfusion. In fact, the extension of necrosis is time dependent, with a 
wave front developing from the subendocardium and extending transmurally to the 
epicardium over time. For every 30 minutes duration of ischemia, there is an 8-10% increase 
in mortality (Pinto et al., 2006). Reperfusion therapy, with dissolution or removal of the 
intracoronary thrombus, provides the best chance for mortality reduction. The Focused 
Update gives primary percutaneous coronary intervention (P-PCI) a Class IA 
recommendation for reperfusion, as long as it can be accomplished with a first medical 
contact to balloon inflation time of 90 minutes or less (Antman et al., 2008). Fibrinolysis, 
which is less effective than P-PCI in head-to-head trials, is given a Class IB rating as an 
alternative to P-PCI, as long as P-PCI can’t be accomplished within 90 minutes. Although P-
PCI is commonly more effective than thrombolytic therapy (TT) for the treatment of patients 
with STEMI, the mortality benefit of P-PCI over TT is risk and time-dependent (Antman et 
al., 2008; Keeley et al., 2003; Tarantini et al., 2005; Thune et al., 2005; Cannon et al., 2000; De 
Luca et al., 2003). As the time delay for performing P-PCI increases, the mortality benefit of 
P-PCI compared with fibrinolysis decreases. The P-PCI strategy may not reduce mortality 
when the delay is 60 min compared with immediate administration of a fibrin-specific lytic 
agent (Nallamothu & Bates, 2003). However, the value of 60 min is still controversial and 
should not be stated so categorically; other authors, for example, found that longer P-PCI-
related delays do not negate the survival benefit of PPCI even when the delay is up to 3 h 
(Boersma et al., 2006; Stenestrand et al., 2006; Betriu & Masotti, 2005).  Moreover, a recent 
evaluation of registry data has shown that the acceptable P-PCI-related delay depends upon 
the risk of the patient (Pinto et al., 2006). It has been explored the relationship between risk 
and P-PCI delay, adjusted for the delay at presentation, which leads to equivalent 30-day 
mortality between P-PCI and fibrin-specific thrombolytic therapy. Baseline mortality risk of 
STEMI patients is a major determinant of the acceptable time delay to choose the most 
appropriate therapy. Although a longer delay lowers the survival advantage of P-PCI, a 
longer P-PCI-related delay could be acceptable in high-risk STEMI patients (Tarantini et al., 
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2010). Generally factors which preclude “waiting for PCI” include young age, anterior MI, 
and early (<3 hrs of pain) presentation. Factors which make delayed P-PCI the preferred 
strategy include contraindications to fibrinolysis, cardiogenic shock, advanced age, inferior 
MI, and delayed presentation (Antman et al., 2004). Whichever reperfusion strategy is 
chosen, it is important to maximize the effectiveness of that therapy by applying not only 
prompt, but also appropriate anti-platelet and anti-thrombin adjuncts. The 
recommendations for these therapies differ with the reperfusion method chosen. 
Appropriate protocol development demands maximization of the effectiveness of anti-
platelet and anti-thrombin agents with each reperfusion choice. 
4. Arrhythmias and conduction disturbances in the acute phase 
Ventricular tachycardia (VT), Ventricular Fibrillation (VF) and complete atrio-ventricular 
(BAVC) block, may be the first manifestation of ischemia and requires immediate correction, 
since these arrhythmias may cause sudden cardiac death. VF and VT have been reported up 
to 20% of patients with STEMI (Henkel et al., 2006). Often arrhythmias are the manifestation 
of a serious underlying disorder, such as persisting ischemia, severe pump failure, or 
endogenous factors such as abnormal potassium levels, autonomic imbalances, hypoxia, and 
acid-base disturbances, that may require corrective measures.  The need for arrhythmias 
treatment depends mainly upon the hemodynamic impact of the rhythm disorder. 
4.1 Ventricular arrhythmias 
VF occurring within 48 hours of the onset of STEMI has been related to higher in-hospital 
mortality, but not to long-term mortality. The major determinants of risk of sudden death 
are related more to the severity of the cardiac disease and less to frequency of classification 
of ventricular arrhythmias (Huikuri et al., 2001).  
4.2 Ventricular ectopic rhythms 
Ventricular ectopic beats are common during the initial phase of STEMI. Irrespective of their 
complexity (multiform QRS complex beats, short runs of ventricular beats or the R-on-T 
phenomenon) their value, as predictor of VF, is questionable.  
4.3 Ventricular tachycardia and Ventricular fibrillation 
Either not sustained VT (lasting <30s) not accelerated idioventricular rhythm (usually a 
harmless consequence of reperfusion with a ventricular rate<120beats), occurring in the 
setting of STEMI, serve as a reliably predictive marker of early VF. Sustained and/or 
haemodinamically compromising VT (occurring in 3%) requires suppressive therapy, and 
outlined in the guidelines for ventricular arrythmias (Zipes et al., 2006). Pulsless VT and VF 
should be managed according to the resuscitation guidelines.  
4.4 Supraventricular arrhythmias  
Atrial fibrillation (AF), which complicates 10-20% of STEMI is more prevalent in older 
patients and in those with severe LV damage and heart failure. AF is associated with 
increased in-hospital mortality (Fuster et al., 2006). In many cases this arrhythmia is well 
tolerated and no specific treatment is required. In other instances, the high ventricular 
response contributes to heart failure and prompt treatment is needed. 
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4.5 Sinus bradycardia and heart block 
Sinus bradicardya: is common (9-25%) in the first hour, particularly in inferior infarction 
(Goldestein et al 2005). If associated with hemodynamic compromise it should be treated. 
AV block: Data from four large, randomized trials suggest that AV block occurs in almost 7% 
(Meine et al., 2005) and persistent LBBB in up to 5.3% of cases of STEMI (Newby et al., 1996). 
Patients with peri-infarction AV block have an higher in hospital mortality than those with 
preserved AV conduction (Meine et al., 2005). The increased mortality seems related to the 
extensive myocardial damage required to develop heart block rather than to heart block 
itself. AV block associated with inferior wall infarction is usually transient, whereas AV 
block related to anterior wall infarction is more often located below the AV node and 
associated with an unstable, wide QRS escape rhythm due to extensive myocardial necrosis. 
A new LBBB usually indicated extensive anterior infarction with high probability to develop 
complete AV block and pump failure. The preventive placement of a temporary pacing 
electrode may be warranted. Raccomandations for permanent cardiac pacing for persistent 
conduction disturbances (>14 days) due to STEMI are outlined in the ESC Guidelines for 
cardiac pacing.   
5. ECG in pharmacological reperfusion - implications for adjunctive therapies 
As a tool to identify epicardial reperfusion all methods of ST resolution, assessed by either 
continuous monitoring or static ECG recording, have the limitation that ST-segment changes 
integrate both epicardial and myocardial reperfusion. A resolution of ST-segment elevation 
of more than 70% of the initial value at 60 to 90 minutes after the initiation of therapy, is a 
powerful predictor of successful myocardial reperfusion and is therefore associated with 
enhanced recovery of LV function, reduced infarct size, and improved prognosis (de Lemos 
et al., 2000; Zeymer et al., 2001). Thus patients with complete ST-resolution at 90 minutes 
after fibrinolysis have a  > 90% probability of a patent infarct-related artery associated with a 
successful reperfusion at the microvascular level. However, approximately 50% of patients 
with no ST-segment resolution after fibrinolysis still show a patent epicardial infarct artery. 
In fact in these patients the lack of ST resolution is caused by the failure of reperfusion at the 
level of microvasculature rather than at epicardial vessel. Thus, ST resolution represents a 
powerful predictor of infarct-related artery patency, but it is less accurate for predicting the 
persistence of epicardial vessel occlusion after fibrinolysis (Schröder et al., 2004). Therefore, 
in order to judge the need for adjunctive mechanical reopening of the infarct-related artery 
after failed fibrinolysis, by the so called “rescue angioplasty”, it is important to integrate 
clinical and ECG data. According to the ACC/AHA guidelines, it is reasonable to monitor 
the pattern of ST-segment elevation, cardiac rhythm, and clinical symptoms during the 60 to 
90 minutes after the initiation of fibrinolytic therapy. Non-invasive findings suggesting for a 
successful reperfusion include relief of symptoms, maintenance or restoration of 
hemodynamic and electrical stability, and a reduction of at least 50% in the initial ST-
segment elevation. In this scenario, the presence of particular arrhythmias, such as not rapid 
ventricular tachycardia, idioventricular rhythm or not-sustained bradycardia, early after 
fibrinolytic administration, represents a highly specific marker of reperfusion. Otherwise, 
persistence of  ischemic chest pain, absence of resolution of the qualifying ST-segment 
elevation, and hemodynamic or electrical instability are generally predictors of failed 
pharmacological reperfusion, needing rescue angioplasty. 
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6. ECG in mechanical reperfusion - implication for prognosis 
Many studies, evaluating the outcomes of primary angioplasty in STEMI, found that 
persistent ST-segment elevation after coronary flow restoration, is one of the independent 
determinant of adverse cardiac event (Schröder et al., 1994; de Lemos & Braunwald, 2001). 
In fact, patients with persistent ST-segment elevation, even after a successful restoration of 
normal antegrade coronary flow in the epicardial artery, show absent or inadequate flow at 
level of microvasculature (van’t Hof et a., 1997). This phenomenon, known as a no-reflow 
phenomenon, has been described in animal and clinical studies, involving about one third of 
patients who underwent successful recanalization of the infarct-related artery. This 
condition, has been related to larger necrosis, adverse ventricular remodeling and higher 
morbidity/mortality at short and long-term follow-up. Otherwise, a resolution of ST-
segment elevation by at least 50% is associated with a high positive predictive value for 
successful myocardial reperfusion. In this setting, the analysis of ST-segment evolution 
during and after coronary recanalization represents an useful tool to guide further 
pharmacological treatments, as well as more aggressive management of these patients. 
Different methods, cut-offs, and timing have been proposed to evaluate ST-segment 
resolution. In most studies, resolution of ST-segment elevation has been expressed as 
percentage of resolution of the sum of ST-segment elevation in all leads (van’t Hof et a., 
1997; Schröder et al., 1994; de Lemos JA & Braunwald, 2001;  Zeymer et al., 2003). To this 
purpose, ST sum should take into account not only the ST shift in all leads showing ST 
elevation, but also the reciprocal ST deviation in leads showing ST depression. However, 
measuring ST resolution from all leads is time consuming and may be influenced by 
patient’s position and by changes in position of lead electrodes. In order to simplify ST 
resolution assessment, other authors have proposed an alternative method based on 
measurement of ST resolution in only the single lead showing the maximum deviation 
before reperfusion: “the single lead ST resolution” (Schröder et al.,  2001). In the single lead 
method, ST resolution is measured by comparing one ECG lead with the most prominent 
ST-segment shift at baseline and at a given time-point after reperfusion therapy, irrespective 
of the ECG lead measure at baseline. This method resulted as simple as accurate when 
compared to conventional model of sum ST resolution model. The optimal cut-off for 
defining reperfusion effectiveness and then mortality risk groups were assessed by 
statistical methods. Applying 2 cut-offs provides the most powerful stratification of high 
and low mortality risk group. To this purpose sum ST resolution is conventionally 
categorized as complete (≥ 70%), partial (<70% to 30%), and no (≤ 30%) ST-segment 
elevation resolution (Schroder et al., 1994). Although different time points have been 
reported across the studies evaluating the relationship between ST resolution and outcome, 
such as 30, 60, or even 90 minutes after reperfusion therapy, no significant differences 
between various time points were found, and the ideal time of measuring ST resolution 
remains unclear. However, these studies were mostly conducted in patients receiving 
fibrinolytic therapy, and may not directly applicable when assessing success of primary 
angioplasty. In fact, after fibrinolysis for STEMI the ECG for measuring ST resolution is 
usually taken 60 to 90 minutes after the onset of therapy, in order to detect by means of non-
invasive tool the patency of epicardial vessel, rather than the reperfusion at microvascular 
level. In studies assessing the ST resolution on ECG, the timing of ECG after primary 
angioplasty was highly variable, ranging from 30 minutes after angioplasty to 60 minutes, or 
even several hours later. Strong evidences showed that ST resolution as evaluated 30 
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minutes after angioplasty correlated better with other markers of myocardial perfusion than 
ST resolution at 60 to 90 minutes. Indeed, recent evidences have shown that early complete 
ST recovery, as assessed immediately after last contrast injection in the catheterization 
laboratory, have a better preserved left ventricular ejection fraction and smaller infarct at 
magnetic resonance than patients showing ST resolution at 30 minutes or later (Haeck et al., 
2011). These findings are not only consistent with the hypothesis that ST resolution implies 
effective microvascular and tissue reperfusion, but also relate the recovery of 
electrocardiografic changes to salvage of viable myocardium. Indeed, early assessment of ST 
recovery may represents the appropriate time to identify patients at higher risk of adverse 
events potentially benefit from additional novel therapies, ideally starting already at the 
catheterization laboratory. 
7. ECG in stabilized myocardial infarction 
The ECG in the stabilized phase of STEMI, after reperfusion therapy, represents a simply 
and universally applicable diagnostic tool to understand the prognosis and to guide further 
interventions. One method for determining the presence of  pathological Q-waves related to 
myocardial infarction has been the Minnesota Code (Blackburn et a., 1960). This method was 
developed for diagnosis of infarction rather than the quantification of its size and correlates 
poorly with anatomically measured infarct size (Pahlm et al., 1998). An improved 
correlation of changes in the QRS complex with infarct size was the development of a QRS 
scoring system by Selvester et al. The Selvester QRS scoring system included 54 criteria from 
the QRS complexes in 10 of the standard leads, which totaled 32 points, each equivalent to 
approximately 3% of the left ventricular wall (Startt-Selvester et al., 1989). Recently, studies 
using cardiac magnetic resonance have show that Q-wave predict the location and size of 
myocardial infarction (Wu E et al., 2001.). Historically  the presence of Q-wave on ECG after 
myocardial infarction has been used in clinical practice to stratify patients in Q-wave and 
non-Q-wave myocardial infarction, according to larger necrosis and worse outcome 
discovered in Q-wave infarctions (Stone PH et al., 1988). On these basis, for many years after 
the original report by Prinzmetal in animal model (Prinzmetal et al., 1954), the presence of 
Q-wave has been related to transmural infarction, whereas its absence was categorize as 
non-transmural infarction. Recently, studies based on cardiac magnetic resonance have 
clarified that, even if this distinction still appears useful to stratify the risk after myocardial 
infarction,  the presence of Q-wave on surface ECG is determined by the total size of 
necrosis rather than transmural extent of underlying myocardial infarction (Moon et al., 
2004). A relative small number of patients after myocardial infarction still show persistence 
of ST-segment elevation even days and month after the acute event. Historically, this late 
persistence of ST-segment elevation has been ascribed to left ventricular aneurysm or 
impending rupture of free wall or ventricular septum, identifying patients at very high risk 
for heart failure and death (Chon et al., 1967 ). However, this association is among the most 
controversial in electrocardiography, since previous studies, including echocardiography 
and angiography, clearly showed a more severe systolic dysfunction and wall motion 
abnormalities in patients with persistent STE, but failed to demonstrate a definite 
relationship between this electrocardiographic pattern and left ventricular aneurysm. 
Moreover, the explanation of the underlying mechanism of persistent STE and its 
pathological correlates are still unclear (Bar et al., 1984 & Lidsay J et al., 1984 ; Bhatnagar, 
1994). Recently, using cardiac magnetic resonance, correlations between this ECG pattern 
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and type of myocardial damage have been reported. Particularly, the presence of persisting 
ST-elevation seems related to the presence of large microvascular damage in the context of 
transmural necrosis (Figure 3). These findings suggest that in this scenario late persistence of 
ST elevation indicates not only, as predictable, a greater extent of myocardial necrosis, but 
also, and more interestingly, the presence of severe microvascular damage as shown by 
cardiac magnetic resonance. Patients exhibiting persistent ST elevation showed more 
frequently left ventricular aneurysm, even though this difference did not achieve a statistical 
significance. Taking into account the findings of previous studies, these observations lead to 
the criticism about wall motion abnormalities as mechanism of electrocardiographic 
alterations. Recently, Li et al provided direct evidence in animals that opening of 
sarcolemmal KATP channels underlies ST elevation during ischemia (Li RA et al., 2000). It 
has also been demonstrated in a swine model that mechanical stimuli can induce marked ST 
elevation , by producing the stretching activation of KATP channel (Link et al., 1999). On 
these basis it has been hypothesized that outward bulging of myocardial necrotic wall, 
producing an abnormal stretch on the adjacent tissue, may alter cellular activity, generating 
injury currents at this level responsible for the ST elevation (Gussak et al., 2000). Thus 
patients exhibiting persistence of ST elevation had not only more severe myocardial  
 
 
Panel A: ECG shows neither ST-segment elevation nor pathological Q-wave; the ce-MRI detects non-
trasmural necrosis (middle and apical segments) of anterolateral wall, without either persistent 
microvascular obstruction or left ventricular aneurysm. Panel B: ECG shows pathological Q-wave in 
leads V4 to V6, with persistent ST elevation; the corresponding ce-MRI shows transmural necrosis of the 
septum, anterolateral wall  (middle and apical segments), and apex, with evidence of persistent 
microvascular obstruction in the setting of necrotic core, without aneurysm. Panel C : ECG shows Q-
wave in leads V1 through V6, DI, aVL, and STE in leads V1 through V6. The corresponding ce-MRI 
shows a large trasmural necrosis in the septum and anterolateral wall (middle and apical segments), 
and of the apical segments of inferior wall, with evidence of persistent microvascular obstruction in the 
necrotic core. 
Fig. 3. Different patterns of myocardial structural abnormalities detected by contrast-
enhanced magnetic resonance imaging (ce-MRI) and corresponding 12-leads 
electrocardiogram (ECG). 
 
Advances in Electrocardiograms – Clinical Applications 
 
124 
minutes after angioplasty correlated better with other markers of myocardial perfusion than 
ST resolution at 60 to 90 minutes. Indeed, recent evidences have shown that early complete 
ST recovery, as assessed immediately after last contrast injection in the catheterization 
laboratory, have a better preserved left ventricular ejection fraction and smaller infarct at 
magnetic resonance than patients showing ST resolution at 30 minutes or later (Haeck et al., 
2011). These findings are not only consistent with the hypothesis that ST resolution implies 
effective microvascular and tissue reperfusion, but also relate the recovery of 
electrocardiografic changes to salvage of viable myocardium. Indeed, early assessment of ST 
recovery may represents the appropriate time to identify patients at higher risk of adverse 
events potentially benefit from additional novel therapies, ideally starting already at the 
catheterization laboratory. 
7. ECG in stabilized myocardial infarction 
The ECG in the stabilized phase of STEMI, after reperfusion therapy, represents a simply 
and universally applicable diagnostic tool to understand the prognosis and to guide further 
interventions. One method for determining the presence of  pathological Q-waves related to 
myocardial infarction has been the Minnesota Code (Blackburn et a., 1960). This method was 
developed for diagnosis of infarction rather than the quantification of its size and correlates 
poorly with anatomically measured infarct size (Pahlm et al., 1998). An improved 
correlation of changes in the QRS complex with infarct size was the development of a QRS 
scoring system by Selvester et al. The Selvester QRS scoring system included 54 criteria from 
the QRS complexes in 10 of the standard leads, which totaled 32 points, each equivalent to 
approximately 3% of the left ventricular wall (Startt-Selvester et al., 1989). Recently, studies 
using cardiac magnetic resonance have show that Q-wave predict the location and size of 
myocardial infarction (Wu E et al., 2001.). Historically  the presence of Q-wave on ECG after 
myocardial infarction has been used in clinical practice to stratify patients in Q-wave and 
non-Q-wave myocardial infarction, according to larger necrosis and worse outcome 
discovered in Q-wave infarctions (Stone PH et al., 1988). On these basis, for many years after 
the original report by Prinzmetal in animal model (Prinzmetal et al., 1954), the presence of 
Q-wave has been related to transmural infarction, whereas its absence was categorize as 
non-transmural infarction. Recently, studies based on cardiac magnetic resonance have 
clarified that, even if this distinction still appears useful to stratify the risk after myocardial 
infarction,  the presence of Q-wave on surface ECG is determined by the total size of 
necrosis rather than transmural extent of underlying myocardial infarction (Moon et al., 
2004). A relative small number of patients after myocardial infarction still show persistence 
of ST-segment elevation even days and month after the acute event. Historically, this late 
persistence of ST-segment elevation has been ascribed to left ventricular aneurysm or 
impending rupture of free wall or ventricular septum, identifying patients at very high risk 
for heart failure and death (Chon et al., 1967 ). However, this association is among the most 
controversial in electrocardiography, since previous studies, including echocardiography 
and angiography, clearly showed a more severe systolic dysfunction and wall motion 
abnormalities in patients with persistent STE, but failed to demonstrate a definite 
relationship between this electrocardiographic pattern and left ventricular aneurysm. 
Moreover, the explanation of the underlying mechanism of persistent STE and its 
pathological correlates are still unclear (Bar et al., 1984 & Lidsay J et al., 1984 ; Bhatnagar, 
1994). Recently, using cardiac magnetic resonance, correlations between this ECG pattern 
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and type of myocardial damage have been reported. Particularly, the presence of persisting 
ST-elevation seems related to the presence of large microvascular damage in the context of 
transmural necrosis (Figure 3). These findings suggest that in this scenario late persistence of 
ST elevation indicates not only, as predictable, a greater extent of myocardial necrosis, but 
also, and more interestingly, the presence of severe microvascular damage as shown by 
cardiac magnetic resonance. Patients exhibiting persistent ST elevation showed more 
frequently left ventricular aneurysm, even though this difference did not achieve a statistical 
significance. Taking into account the findings of previous studies, these observations lead to 
the criticism about wall motion abnormalities as mechanism of electrocardiographic 
alterations. Recently, Li et al provided direct evidence in animals that opening of 
sarcolemmal KATP channels underlies ST elevation during ischemia (Li RA et al., 2000). It 
has also been demonstrated in a swine model that mechanical stimuli can induce marked ST 
elevation , by producing the stretching activation of KATP channel (Link et al., 1999). On 
these basis it has been hypothesized that outward bulging of myocardial necrotic wall, 
producing an abnormal stretch on the adjacent tissue, may alter cellular activity, generating 
injury currents at this level responsible for the ST elevation (Gussak et al., 2000). Thus 
patients exhibiting persistence of ST elevation had not only more severe myocardial  
 
 
Panel A: ECG shows neither ST-segment elevation nor pathological Q-wave; the ce-MRI detects non-
trasmural necrosis (middle and apical segments) of anterolateral wall, without either persistent 
microvascular obstruction or left ventricular aneurysm. Panel B: ECG shows pathological Q-wave in 
leads V4 to V6, with persistent ST elevation; the corresponding ce-MRI shows transmural necrosis of the 
septum, anterolateral wall  (middle and apical segments), and apex, with evidence of persistent 
microvascular obstruction in the setting of necrotic core, without aneurysm. Panel C : ECG shows Q-
wave in leads V1 through V6, DI, aVL, and STE in leads V1 through V6. The corresponding ce-MRI 
shows a large trasmural necrosis in the septum and anterolateral wall (middle and apical segments), 
and of the apical segments of inferior wall, with evidence of persistent microvascular obstruction in the 
necrotic core. 
Fig. 3. Different patterns of myocardial structural abnormalities detected by contrast-
enhanced magnetic resonance imaging (ce-MRI) and corresponding 12-leads 
electrocardiogram (ECG). 
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damage, but also more frequently coexistence of microvascular damage within it, that could 
account for diffuse alterations in myocardial skeletal favoring myocardial bulging and 
mechanical activation of KATP channels in the adjacent tissue. Finally, these findings may 
also explain the temporal discrepancy between developing of aneurysm and ECG 
alterations.  
8. Conclusion 
The ECG is the most important diagnostic tool in the diagnosis of evolving ST-segment 
elevation myocardial infarction, influencing therapeutic strategies and management. 
Moreover, ECG remains a simple but valuable method to estimate the risk of STEMI 
patients either before and after reperfusion therapy. Finally the value of ECG in the 
prognostic stratification after stabilized STEMI have still a role in current management of 
these patients.  
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Of various functional impairments of electrical events in the heart, ventricular arrhythmias 
underlie the majority of deaths in patients with left ventricular dysfunction and heart failure 
after myocardial ischemia and infarction. As heart failure develops, pathophysiological 
remodeling of cardiac function occurs at multiple levels, spanning the spectrum from 
molecular and subcellular changes to those occurring at the organ system levels (Jin et al., 
2008). 
Although advances in anti-arrhythmic agents and implantation of direct-current 
defibrillator have resulted in improved prevention of death due to arrhythmia in 
myocardial infarction, morbidity and mortality due to arrhythmias are still high in all over 
the world. In addition, in patients with severe congestive heart failure, ventricular 
arrhythmia is also a critical determinant of prognosis, because conservative anti-arrhythmia 
therapies are not very effective. Therapeutic strategies for arrhythmias have been focused 
mainly on electrophysiological aspects with little consideration of structural or cellular bases 
for arrhythmogenesis. Thus, the exact cellular mechanism underlying lethal arrhythmias is 
undetermined. Identification of arrhythmogenic substrates from viewpoints other than 
electrophysiological ones is essential (Takamatsu, 2008). 
Despite decades of investigation, the precise mechanisms that underlie the 
electrophysiological abnormality remain elusive. In this chapter we therefore focus on three 
main issues with an emphasis on the mechanisms responsible for these adaptations: 
sympathetic neural remodeling, electrical remodeling and gap junction remodeling. 
2. Cardiac sympathetic neural remodeling 
2.1 The sympathetic nervous system in the heart 
Cardiac innervation comes from both extrinsic and intrinsic sources. The extrinsic 
sympathetic innervation arises from the stellate ganglia and paravertebral sympathetic 
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Cardiac innervation comes from both extrinsic and intrinsic sources. The extrinsic 
sympathetic innervation arises from the stellate ganglia and paravertebral sympathetic 
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ganglia. The vagal nerves are sources of extrinsic parasympathetic nerves that innervate the 
heart. In addition to the extrinsic cardiac nervous system, there is also an extensive intrinsic 
cardiac nervous system that includes collections of ganglionated plexuses (Armour, 2010). 
The major neurotransmitter mediating sympathetic response is norepinephrine; of note, 
epinephrine release during activation is negligible (Fig 1) (Esler et al., 1990).  
 
 
Fig. 1. Cardiac sympathetic control. NE, norepinephrine; Ach, acetylcholine; E, epinephrine 
(Esler et al., 1990). 
Each ganglionated plexuses contains both sympathetic and parasympathetic neurons that are 
associated with complex synaptology. The sympathetic innervation to the ventricles follows a 
course along the common pulmonary artery into the plexus supplying the main left coronary 
artery. The sympathetic nerves are distributed to the myocardium in superficial epicardial 
layers. They penetrate the myocardium along with the coronary arteries (Figure 2) (Zipes, 
1990). Immunocytochemical techniques have allowed investigators to stain many nerve cells 
and nerve tissues including the Schwann cells and autonomic nerves using different 
antibodies with different stains (Oki et al., 1995; Gulbenkian et al., 1993; Chow et al., 1998).  
 
 
Fig. 2. Schematic of sagittal view of left ventricular wall showing pathways of vagal and 
sympathetic afferent and efferent nerves. Postganglionic sympathetic axons are located 
superficially in periadventia of coronary arteries; postganglionic vagal axons cross the 
atrioventricular groove in subepicardium but are located in subendocardium. Cx, circumflex 
coronary artery; LAD, left ventricular descending coronary artery (Zipes, 1990). 
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2.2 Sympathetic neural remodeling after myocardial infarction 
In ischemic hearts, regional heterogeneity of sympathetic innervation usually occurs as a result 
of ischemia- or infarction-induced neural axons necrosis and nerve sprouting (Zipes, 1990). 
Sympathetic neural remodeling characterized by heterogeneous cardiac nerve sprouting and 
sympathetic hyperinnervation was also observed; see Figure 3 (Cao et al., 2000).  
 
 
Fig. 3. Neural remodeling and nerve sprouting (Cao et al., 2000). 
The density of nerve fibers immunopositive for Growth-associated protein-43 upregulated 
after myocardial infarction at different periods, indicating nerve fibers undergoing sprouting 
activity shortly after myocardial infarction (Oh et al., 2006; Zhou et al., 2004). However, 
sprouting nerve fibers may regress unless nerve terminals can form synaptic contacts with 
target cells. Therefore, the density of growth-associated protein-43 positive nerve fibers is a 
measurement for nerve sprouting activity instead of a measurement for stable innervation. 
Myocardial infarction induced nerve sprouting activity in both peri-infarct and remote 
areas. Nerve sprouting, which resulted in sympathetic (but not parasympathetic) 
hyperinnervation, was greater in the outer loop of the heart. The difference in the outer and 
inner loops started within 3 hours and persisted for 2 months after myocardial infarction 
(Figure 4) (Oh et al., 2006). 
 
 
Fig. 4. Nerve fiber densities in the outer versus the inner loop of normal mouse heart. A, 
Cross-section of a normal mouse ventricle. The fiber orientation in the inner loop is roughly 
perpendicular, whereas the outer loop fibers are parallel to the circumference of the 
ventricles. B, C: Growth-associated protein-43 immunopositive nerves in the inner and outer 
loops, respectively. More nerve fibers are present in the outer loop than the inner loop. 
Arrows point to brown nerve twigs (20×objective) (Oh et al., 2006). 
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Necrotic injury to the rat myocardium results in denervation followed by proliferative 
regeneration of schwann cells and axons (Nori et al., 1995). Abnormal patterns of 
neurilemma proliferation have been documented in infarsitescted human and rat hearts 
(Vracko, 1990, 1991). Rencently, Huazhi et al (Huazhi et al., 2010) showed that sympathetic 
nerve sprouting at the peri-infarct zone in infarcted hearts at 8 weeks post myocardial 
infarction was more excessive and heterogeneous than that in the corresponding zone in 
normal hearts. Excessive nerve sprouting may result in abnormal patterns of myocardial 
innervation and may potentially increase cardiac arrhythmia. Wei et al (Wei et al., 2004) 
identified a number of changes, including substantial denervation of the left ventricular and 
areas of apparent hyperinnervation at the border of innervated and denervated 
myocardium after myocardial infarction. 
2.3 Mechanisms of sympathetic neural remodeling after myocardial infarction 
The sympathetic innervation of the heart regulates cardiac function by stimulating heart 
rate, contractility, and conduction velocity through the release of norepinephrine and the 
activation of cardiac β1-adrenergic receptors. Sympathetic innervation of the heart is 
sculpted during development by chemoattractive and chemorepulsive factors (Ieda et al., 
2007). For example, nerve growth factor supports sympathetic neuron survival and 
promotes cardiac axon outgrowth during development (Crowley et al., 1994), whereas the 
chemorepulsive factorsemaphorin 3a (Sema3a) attenuates sympathetic axon extension in the 
heart (Ieda et al., 2007) and in the peripheral vasculature (Long et al., 2009). 
The nerve fiber regeneration process is triggered by up-regulation of nerve growth factor or 
other neurotrophic factor genes in the non-neuronal cells around the site of injury. Up-
regulation of nerve growth factor was more prominent in the area near the infarct than in 
the area remote to the infarct (Oh et al., 2006). Nerve growth factor mRNA was significantly 
up-regulated within 3 hours after myocardial infarction and persisted for 1 month in both 
the infarcted myocardium and the noninfarcted left ventricular free wall (Oh et al., 2006; 
Zhou et al., 2004).  
Neurotrophins such as nerve growth factor act through two distinct types of receptors: 
tropomyosin-related tyrosine kinase (Trk) receptors and the lower-affinity p75 neurotrophin 
receptor (p75NTR) (Kuruvilla et al., 2004; Kaplan & Miller, 2003). Nerve growth factor acts 
through TrkA to promote the extension of sympathetic axons into the heart (Kuruvilla et al., 
2004), whereas p75NTR modulates signaling by coreceptors that can either stimulate or 
inhibit axon outgrowth (Kaplan & Miller, 2003). p75NTR has a great functional impact on the 
cardiovascular system and cardiac rhythm stability (Christina et al., 2010), which were 
particularly relevant to myocardial infarction and heart failure where heterogeneous 
sympathetic innervation was correlated with altered neurotrophin expression and the 
development of ventricular arrhythmias (Rubart & Zipes, 2005).  
In addition to nerve growth factor, other neurotrophic factors are also up-regulated after 
myocardial infarction. For example, Leukemia inhibitory factor protein was increased by 
40% at 48 hours after myocardial infarction in mice (Fuchs et al., 2003). IL-1α was increased 
after myocardial infarction, primarily at peri-infarct sites. And IL-1, IL-1β, and IL-6 were 
increased at only one time point after myocardial infarction (Oh et al., 2006; Nian et al., 
2004). IL-6 mRNA was induced in myocytes at the viable border zone in dogs subjected to 
ischemia-reperfusion (Gwechenberger et al., 1999). Table 1 describes detailly neurotrophic 
factors gene expression in the myocardium after myocardial infarction.  
Electrophysiological Abnormality: 




Table 1. Neurotrophic factors gene expression in the myocardium after myocardial 
infarction Numbers indicate ratio to normal control. Bold numbers indicate those＞3×of 
control in at least two consecutive time points. Bold numbers in parentheses are obtained 
with quantitative reverse-transcriptase polymerase chain reaction. Other numbers are 
obtained using DNA microarray. BDNF = brain-derived neurotrophic factor; EGF = 
epidermal growth factor; FGF = fibroblast growth factor; GDNF = glial cell-derived 
neurotrophic factor; IGF = insulin-like growth factor; IL = interleukin; LIF = leukemia 
inhibitory factor; NT-3 = neutrophin-3; NGF, nerve growth factor; TGF = transforming 
growth factor; TNF = tumor necrosis factor (Oh et al., 2006). 
Increase of neurotrophic factors sometimes can be injurious. Thus, both exogenous and 
endogenous nerve growth factor can induce cardiac nerve sprouting, but they also can 
increase the incidence of ventricular arrhythmias and sudden death in canine models (Cao 
et al., 2000a). Increased neurotrophic factor expression and heterogeneous innervation also 
could induce side effects that contribute to the increased risk for sudden death after 
myocardial infarction (Luisi et al., 2002; Canty et al., 2004). 
2.4 The interaction between sympathetic neural remodeling and electrical remodeling 
Regional heterogeneity of sympathetic innervation is also closely related to electrical 
inhomogeneity. Previous study revealed that electrical heterogeneity is exacerbated after 
initial nerve injury by sympathetic nerve sprouting and subsequent regional myocardial 
hyperinnervation (Figure 6) (Rubart & Zipes, 2005). The enhanced spatial inhomogeneity in 
cardiac sympathetic innervation could amplify the spatial inhomogeneity of these 
electrophysiological properties and therefore facilitate the initiation of ventricular 
arrhythmias (Cao et al., 2000b).  
Nerve growth factor overexpression and nerve sprouting affected the expressions and 
functions of certain potassium channels and thus increases the susceptibility to ventricular 
tachyarrhythmia. Nerve sprouting suppressed the expressions and functions of myocardial 
transient outward current (Ito) and inward rectifier current (IK1) channels. Myocardial necrotic 
injury plus intensified sympathetic nerve sprouting further decreased Kir2.1 expression and 
IK1 current density. All of these changes affected the repolarization of myocardial cells and 
hence increased the vulnerability to ventricular arrhythmia (Ren et al., 2008). 
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Fig. 6. Factors contributing to arrhythmogenesis in hearts with heterogeneous sympathetic 
innervation (Rubart & Zipes, 2005). 
Besides, the coexistence of sympathetic denervation zones (infarct zones), sympathetic 
reinnervation zones (ischemic zones) and sympathetic normal zones in the ischemic heart 
could increase the heterogeneity of electrical communication which is facilitative to the 
abnormality of cardiac autorhythmicity and triggered activity. Sympathetic neural remodeling 
can raises the norepinephrine concentration, which encourage the early afterdepolarization 
(EAD) and delayed afterdepolarization (DAD) by affect the calcium influx and repolarization 
potassium current, and then trigger arrhythmia. Neurotransmitters such as norepinephrine 
can cause focal vasoconstriction and myocardial ischemia which is facilitative to the 
arrhythmogenesis.  
2.5 Relationship between sympathetic neural remodeling and ventricular arrhythmia 
The initiation of lethal arrhythmias needs a substrate and a trigger. Myocardial remodeling 
(structural and/or functional) is considered the substrate. In recent years, the concept “cardiac 
nerve remodeling” and its potentiality as a trigger for lethal arrhythmia have entered the scope 
of arrhythmia research (Ren et al., 2008). Abnormally increased post-injury sympathetic nerve 
density may be in part responsible for the occurrence of ventricular arrhythmia and sudden 
cardiac death in patients with severe heart failure (Cao et al., 2000b). Cardiac nerve sprouts 
detering occured after myocardial infarction even without exogenous nerve growth factor. 
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Infusion of nerve growth factor accelerated and intensified the magnitude of nerve sprouting, 
resulting in a high incidence of sudden cardiac death (Cao et al., 2000a).  
The left stellate ganglion is known to be important in cardiac arrhythmogenesis (Schwartz & 
Stone, 1980). Left cardiac sympathetic denervation, including left stellate ganglion resection, 
decreases the incidence of ventricular arrhythmia in patients with myocardial infarction 
(Schwartz et al., 1992). Increased sympathetic tone is important in the generation of ventricular 
arrhythmia and sudden cardiac death (Rubart & Zipes, 2005). In dogs with both complete 
atrioventricular block and myocardial infarction, high-amplitude spiky discharges frequently 
cause premature ventricular contractions or even ventricular tachycardia (Figure 7). These 
findings suggest that high-amplitude spiky discharges is highly arrhythmogenic in diseased 
hearts. However, because high-amplitude spiky discharges is also present in normal hearts, 
the presence of these types of discharge by itself is not pathological (Zhou S, et al., 2008).  
 
 
Fig. 7. A, Electrical stimulation of left stellate ganglion lengthened the corrected QT (QTc) 
from 325 to 402 ms and the corrected Tpe (Tpec) from 45 to 82 ms (at 10 mA). B, Left stellate 
ganglion stimulation induced ventricular tachycardia (VT); C, ventricular fibrillation (VF) in 
the experimental group. Afterdischarges were present in left stellate ganglion recordings 
after electrical stimulation. BP = blood pressure; SGNA = stellate ganglion nerve activity 
(Zhou S, et al., 2008). 
2.6 Therapeutic implications of sympathetic neural remodeling after myocardial 
infarction 
As sympathetic tone was known to be increased in cardiomyopathy patients, interventions 
that aim to reduce sympathetic tone could reduce the risk of sudden cardiac death and 
ventricular tachyarrhythmias (Fig 8，Marmar & Kalyanam, 2008). 
Selective sympathetic blockade was an effective theraty， which was applied in animal 
models and human during myocardial ischemia (Issa et al., 2005; Nademanee et al., 2000). In 
a canine model, intrathecal clonidine, when delivered via a catheter at T2–T4 spinal 
segments, significantly reduced the occurrence of ventricular tachycardia and fibrillation 
during transient myocardial ischemia (Issa et al., 2005). Electrical storm, defined as recurrent 
multiple ventricular fibrillation (VF) episodes, often occurs in patients with recent 
myocardial infarction. Sympathetic blockade was proved to be superior to the 
antiarrhythmic therapy in treating electrical storm patients, and sympathetic blockade - not 
class 1 antiarrhythmic drugs - should be the treatment of choice for electrical storm 
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(Nademanee et al., 2000). Successful treatment of recurrent ventricular tachycardia, 
refractory to antiarrhythmic therapy, can be achieved by neuraxial modulation at the level 
of the spinal cord. The benefit of thoracic epicardial anesthesia was reported in a patient 
with ischemic cardiomyopathy and recurrent ventricular arrhythmia refractory to 
intubation and sedation, with the use of 0.25% Bupicavaine at T1–T2 interspace, reducing 
the number of ICD shocks from 86 in 48 hours to zero (Mahajan et al., 2005). 
 
 
Fig. 8. Structural and functional basis of ventricular tachycardia and fibrillation (Marmar & 
Kalyanam, 2008). 
β-blockers, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, 
aldosterone antagonists (Cittadini et al., 2003), statins (Gao et al., 2005), and fish oil have 
been shown to decrease risk of sudden cardiac death in ischemic cardiomyopathy and 
significantly improve mortality through modulating the autonomic nervous system to 
decrease sympathetic tone (Marmar & Kalyanam,2008). In a recent study, carvedilol 
ameliorated electrical remodeling at peri-infarct zones after myocardial infarction by 
improving the spatial distribution of the sympathetic nerve reinnervation (Huazhi et al., 
2010). Moreover, attenuation of oxidative stress and inflammatory response after resveratrol 
treatment, a naturally occurring compound, significantly inhibited nerve growth factor 
expression, and protected against sympathetic neural remodeling (Ping et al., 2010). Ghrelin, 
a novel growth hormone-releasing peptide, which was showed to inhibite neural 
remodeling in rats with myocardial infarction, likely mediated through nerve growth factor 
suppression, might be used as a new potential way to treat and prevent sudden cardiac 
death after myocardial infarction (Ming-Jie et al., 2009).  
3. Myocardial electrical remodelling 
3.1 The cardiac action potential 
The normal sequence and synchronous contraction of the atria and ventricles require the 
rapid activation of groups of cardiac cells. An activation mechanism must enable rapid 
changes in heart rate and also respond to the changes in autonomic tone. The propagating 
cardiac action potential fulfils these roles. The action potential is a key determinant of 
cardiac electrical activity and is shaped by underlying ionic currents and transporters 
(Nerbonne & Kass 2005). A schematic representation of a cardiac action potential and the 
principal currents involved in its various phases are shown in Figure 9A (Nattel & Carlsson 
2006). The action potentials of pacemaker cells in the sinoatrial (SA) and atrioventricular 
(AV) nodes are significantly different from those in working myocardium. Figure 9B depicts 
action potential characteristics in different regions of the heart (Michael et al., 2009).  
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The average duration of the ventricular action potential duration is reflected in the QT interval 
in the ECG. Factors that prolong the action potential duration (eg, a decrease in outward K+ 
currents or an increase in inward late Na+ current) prolong the action potential duration and 
the QT interval in the ECG. The QT interval of males and females is equal during early 
childhood. However, at puberty the interval of males shortens (Rautaharju et al., 1992). 
 
 
Fig. 9. A, Membrane currents that generate the normal action potential duration. Resting (4), 
upstroke (0), early repolarization (1), plateau (2), and final repolarization are the 5 phases of 
the action potential. A decline of potential at the end of phase 3 in pacemaker cells, such as 
the sinus node, is shown as a broken line. The inward currents, INa, ICa, and If, are shown in 
yellow boxes; the sodium-calcium exchanger (NCX) is also shown in yellow. It is 
electrogenic and may generate inward or outward current. IKAch, IK1, Ito, IKur, IKr, and IKs are 
shown in gray boxes. The action potential duration is approximately 200ms. B, Various 
specialized tissues in the heart and typical corresponding action potentials. The short 
vertical lines indicate the time of onset of activity in the sinus atrial node for one beat. 
Green, slow-channel tissue (nodes); violet, fast-channel tissues (Nattel & Carlsson 2006). 
3.2 General properties of ion channels 
Ion channels have two fundamental properties, ion permeation and gating (Hille, 1978). Ion 
permeation describes the movement through the open channel. The selective permeability of 
ion channels to specific ions is a basis of classification of ion channels (eg, Na+, K+, and Ca2+ 
channels). Size, valency, and hydration energy are important determinants of selectivity 
(Augustus, 2009). Ion channels provide multiple binding sites for ions as they traverse the 
membrane. Like an enzyme-substrate interaction, the binding of the permeating ion is 
saturable. Most ion channels are singly occupied during permeation; certain K+ channels 
may be multiply occupied (Augustus, 2009). 
Gating is the mechanism of opening and closing of ion channels and is their second major 
property. Ion channels are also subclassified by their mechanism of gating: 
voltagedependent, ligand-dependent, and mechano-sensitive gating. Voltage-gated ion 
 
Advances in Electrocardiograms – Clinical Applications 
 
140 
(Nademanee et al., 2000). Successful treatment of recurrent ventricular tachycardia, 
refractory to antiarrhythmic therapy, can be achieved by neuraxial modulation at the level 
of the spinal cord. The benefit of thoracic epicardial anesthesia was reported in a patient 
with ischemic cardiomyopathy and recurrent ventricular arrhythmia refractory to 
intubation and sedation, with the use of 0.25% Bupicavaine at T1–T2 interspace, reducing 
the number of ICD shocks from 86 in 48 hours to zero (Mahajan et al., 2005). 
 
 
Fig. 8. Structural and functional basis of ventricular tachycardia and fibrillation (Marmar & 
Kalyanam, 2008). 
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3.1 The cardiac action potential 
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action potential characteristics in different regions of the heart (Michael et al., 2009).  
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The average duration of the ventricular action potential duration is reflected in the QT interval 
in the ECG. Factors that prolong the action potential duration (eg, a decrease in outward K+ 
currents or an increase in inward late Na+ current) prolong the action potential duration and 
the QT interval in the ECG. The QT interval of males and females is equal during early 
childhood. However, at puberty the interval of males shortens (Rautaharju et al., 1992). 
 
 
Fig. 9. A, Membrane currents that generate the normal action potential duration. Resting (4), 
upstroke (0), early repolarization (1), plateau (2), and final repolarization are the 5 phases of 
the action potential. A decline of potential at the end of phase 3 in pacemaker cells, such as 
the sinus node, is shown as a broken line. The inward currents, INa, ICa, and If, are shown in 
yellow boxes; the sodium-calcium exchanger (NCX) is also shown in yellow. It is 
electrogenic and may generate inward or outward current. IKAch, IK1, Ito, IKur, IKr, and IKs are 
shown in gray boxes. The action potential duration is approximately 200ms. B, Various 
specialized tissues in the heart and typical corresponding action potentials. The short 
vertical lines indicate the time of onset of activity in the sinus atrial node for one beat. 
Green, slow-channel tissue (nodes); violet, fast-channel tissues (Nattel & Carlsson 2006). 
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Advances in Electrocardiograms – Clinical Applications 
 
142 
channels change their conductance in response to variations in membrane potential. 
Voltage-dependent gating is the commonest mechanism of gating observed in ion channels. 
A majority of ion channels open in response to depolarization. The pacemaker current 
channel (If channel) opens in response to membrane hyperpolarization. The steepness of the 
voltage dependence of opening or activation varies between channels (Hille, 1978). 
Ion channels have two mechanisms of closure. Certain channels like the Na+ and Ca2+ 
channels enters a closed inactivated state during maintained depolarization. To regain their 
ability to open, the channel must undergo a recovery process at hyperpolarized potentials. 
The inactivated state may also be accessed from the closed state. Inactivation is the basis for 
refractoriness in cardiac muscle and is fundamental for the prevention of premature 
reexcitation (Hille, 1978; Leblanc & Hume, 1990).  
Ligand-dependent gating is the second major gating mechanism of cardiac ion channels. 
The acetylcholine (Ach)-activated K+ channel, an inward-rectifying K+ channel (IKAch), is one 
of this class. IKAch channels are most abundant in the atria and the sinus atrial and 
atrioventricular nodes. The ATP-sensitive K+ channel, also termed the ADP-activated K+ 
channel, is a ligand-gated channel distributed abundantly in all regions of the heart. Energy 
depletion during ischemia increases the [ADP]/ [ATP] ratio, activates IKATP, and abbreviates 
the action potential. The abbreviated action potential results in less force generation and 
may be cardioprotective. This channel also plays a central role in ischemic preconditioning 
(Hille, 1978).  
3.3 Significance and arrhythmic consequences of Ionic currents remodeling 
associated with myocardial infarction 
Myocardial infarction refers to the death of cardiac tissue, most often caused by critical 
decreases in coronary artery blood flow induced by obstructive coronary artery disease.  
Several mechanisms, including reentry and triggered activity due to early and delayed 
afterdepolarizations, contribute to ventricular tachyarrhythmia (Janse & Wit, 1989; Qin et al., 
1996). Remodeling of ion-channel and transport processes cause important changes in 
cellular electrical activity and impulse propagation over days and weeks following acute 
infarction (Friedman et al., 1975; Spear et al., 1977). 
Generally, by 24–48h after total coronary artery occlusion the action potentials and maximal 
action potential upstroke velocity (Vmax) decreased, as well as an increase in total time of 
repolarization. On the other hand, the cells of the epicardial border zone of the canine 
infarction model show a reduction in Vmax, and a shortening and triangularization of the 
action potential by 5 days after total artery occlusion. By 14 days post occlusion further 
shortening of the action potential occurs. Then by the time of the healed infarct (2 months), 
action potential voltage profiles have returned to nearly normal suggesting the presence of a 
process that might be termed ‘reverse remodeling’ (Figure 10) (Ursell et al., 1985). We found 
that the PR, QRS, QT and QTc intervals in myocardial infarction mice were significantly 
longer than normal mice after 4, 8, and 12 weeks (LI et al., 2009c). 
These abnormalities cause severe conduction disturbances that strongly promote reentry. A 
particularly important arrhythmia mechanism is anisotropic reentry in the peri-infarction 
border zone (Dillon et al., 1988; Restivo et al., 1990). Acute myocardial infarction causes 
longer term (remodeling) changes over days to weeks, as well as important very early 
(within minutes to hours) functionally based ion-channel abnormalities. Figure 11 illustrates 
how different forms of ionchannel remodeling contribute to anisotropic reentry in the 
presence of a healed myocardial infarction (Nattel S et al., 2007). 
Electrophysiological Abnormality: 




Fig. 10. Changes in action potential duration measured to 50% (above left) and 90% 
repolarization (below left) of epicardial muscle fibers with increasing time after coronary 
artery occlusion. Asterisks denote values significantly different from control. At the right are 
shown representative transmembrane potential recordings; A, normal; B, 1 day; C, 5 days; 
D, 2 weeks; E, 2 months. Note that action potentials in the 1- and 5-day-old infarcts show 
loss of the plateau phase during repolarization. Action potential duration is decreased more 
in 5-day-old than in 1-day-old infarcts (Ursell et al., 1985). 
3.4 Alterations in K+ currents 
Cardiac K+ channels fall into three broad categories: Voltagegated (Ito, IKur, IKr, and IKs), 
inward rectifier channels (IK1, IKAch, and IKATP), and the background K+ currents (TASK-1, 
TWIK-1/2). Voltage-gated K+ channels consist of principal α-subunits and multiple β-
subunits. The channel functional units also include the complementary proteins KV-channel 
associated protein, KChAP, and the KV channel interacting protein, KChIP. The major 
subfamilies ofα-subunits include KVN.x (n=1 to 4), the HERG channel (gene KCNH2), and 
KvLQT1 (gene KCNQ1). They are important in generating outward current in the heart 
(Augustus, 2009). Myocardial infarction causes substantial changes in K+ current expression, 
density, and function (Janse & Wit, 1989).  
3.4.1 Changed K+ current function in surviving border-zone cells 
A variety of K+ currents are downregulated in border-zone cells. Background K+ 
conductance is reduced in surviving canine subendocardial Purkinje fibers (Boyden et al., 
1989), due to reduced IK1 and altered delayed-rectifier currents (Pinto & Boyden, 1998). 
Border-zone left ventricular cardiomyocytes show reduced Ito (Lue & Boyden, 1992). Ito 
decreases are most prominent within days of acute infarction and tend to resolve over the 
subsequent 2 months (Dun et al., 2004). The expression of subunits encoding IKr (ERG) and 
IKs (KvLQT1 and minK) is downregulated in 2-day postinfarction border-zone cells (Dun & 
Boyden, 2005; Jiang et al., 2000). Overall, the multiple forms of K+-channel dysfunction 
postinfarction impair repolarization and lead to early afterdepolarizations. 
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channels change their conductance in response to variations in membrane potential. 
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shortening of the action potential occurs. Then by the time of the healed infarct (2 months), 
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process that might be termed ‘reverse remodeling’ (Figure 10) (Ursell et al., 1985). We found 
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longer than normal mice after 4, 8, and 12 weeks (LI et al., 2009c). 
These abnormalities cause severe conduction disturbances that strongly promote reentry. A 
particularly important arrhythmia mechanism is anisotropic reentry in the peri-infarction 
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longer term (remodeling) changes over days to weeks, as well as important very early 
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how different forms of ionchannel remodeling contribute to anisotropic reentry in the 
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Fig. 11. Contributors to anisotropic reentry in myocardial infarction. A principal mechanism 
underlying potentially lethal ventricular tachyarrhythmias post-myocardial infarction is 
anisotropic reentry, represented schematically by the black activation map in the central 
part of the figure (Peters et al., 1997). The numbers indicated on the map are times of 
electrical activation, and the curved lines (isochrones) indicate zones of tissue activated 
within 10 ms of each other. Crowded isochrones denote very slow conduction. Thicker black 
lines show lines of functional conduction block parallel to fiber orientation, due to the 
impaired transverse conduction (increased anisotropy) post-myocardial infarction. The 
impulse travels slowly in two parallel streams (thick arrows) around the lines of block, 
which come together to conduct through the central corridor (thinner arrows) of the 
reentrant pathway. The ways in which ion-channel remodeling post-myocardial infarction 
lead to this arrhythmia mechanism are indicated by the red points, organized into groups of 
dysfunction categories (blue underlined headings). Increased tissue anisotropy, which 
causes the unidirectional block needed for reentry initiation, arises because of connexin 
downregulation, reduced gap junction number and size, fewer side-to-side connections, and 
tissue fibrosis around muscle bundles. Unidirectional block is also favored by refractoriness 
heterogeneity due to spatially heterogeneous K+ channel downregulation coupled with 
postrepolarization refractoriness. Slowed conduction, which allows enough time for the 
proximal part of the central corridor to recover excitability when the reentering impulse 
returns, is caused by connexin downregulation, INa decreases, and reduced ICaL (ICaL is 
particularly important for conduction in conditions of impaired coupling). Finally, the ectopic 
complexes needed to engage spatially variable refractoriness and initiate reentry are provided 
by early afterdepolarizations promoted by K+ current downregulation and delayed 
afterdepolarizations caused by spontaneous diastolic Ca2+ releases (Nattel S et al., 2007). 
3.4.2 Changes in K+ currents in normal zones of hearts with prior myocardial 
infarction 
Action potential duration increases and ventricular arrhythmias are features of normal-zone 
tissues from postinfarction rat (Perrier et al., 2004) and rabbit (Liu et al., 2004) hearts. Both 
reentries associated with spatial refractoriness heterogeneity and triggered activity is 
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involved (Liu et al., 2004). Decreases in Ito, IK1, and total delayed-rectifier current (IK) occur 
in rabbit hearts (Liu et al., 2004). In rats, Ito decreases correlate most closely with 
downregulation of Kv4.2 subunits (Perrier et al., 2004). There may be compensatory 
upregulation of Kv1.4 subunits (Kaprielian et al., 2002), although downregulation of Kv1.4 
has also been reported (Gidh-Jain et al., 1996). Decreases in rat IK correlate with 
downregulation of the putative α-subunit Kv2.1 (Huang et al., 2001b). The effects of 
postinfarction remodeling on spatial dispersion of electrophysiological properties in 
noninfarcted tissues are controversial, with one study showing increases in dispersion 
(Huang et al., 2001b) and another decreased spatial heterogeneity (Kaprielian et al., 2002). 
3.5 Alterations in Ca2+ currents and cellular Ca2+ handling 
Calcium ions are the principal intracellular signaling ions. They regulate excitation- 
contraction coupling, secretion, and the activity of many enzymes and ion channels. 
[Ca2+]i is highly regulated despite its marked fluctuation between systole and diastole. 
Calcium channels are the principal portal of entry of calcium into the cells; a system of 
intracellular storage sites, and transporters such as the sodium-calcium exchanger, also 
play important roles in [Ca2+]i regulation. In cardiac muscle, two types of Ca2+ channels, 
the L- (low threshold type) and T-type (transient-type), transport Ca2+ into the cells. The 
L-type channel is found in all cardiac cell types. The T-type channel is found principally 
in pacemaker, atrial, and Purkinje cells. The unqualified descriptor Ca2+ channel refers to 
the L-type channel. Table 2 contrasts the properties of the two types of channels 




Table 2. A comparisons of the L-type and T-type Ca2+ channels (Augustus, 2009). 
3.5.1 Changes in Ca2+ current 
ICaL is diminished in border-zone cells of dogs (Dun et al., 2004), sheep (Kim et al., 2002), cats 
(Pinto et al., 1997), and rabbits (Litwin et al., 2000). ICaL kinetic properties also change, with 
slowed recovery (Dun et al., 2004) and hyperpolarizing shifts in inactivation voltage 
dependence (Pinto et al., 1997). The ICaL response to dihydropyridine agonists (Pu et al., 
1999) and tyrosine kinase inhibitors (Yagi & Boyden, 2002) is preserved in the border zone. 
T-type Ca2+ current (ICaT) varies over time, being unchanged 5 days postinfarction 
(Aggarwal & Boyden, 1995) and increasing thereafter (Dun et al., 2004). In surviving 
subendocardial Purkinje cells, both ICaL and ICaT are reduced (Boyden & Pinto, 1994). 
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involved (Liu et al., 2004). Decreases in Ito, IK1, and total delayed-rectifier current (IK) occur 
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3.5.2 Changes in cellular Ca2+ handling 
Ca2+ transients in border-zone cells are decreased in amplitude and show slowed recovery 
and decay (Kim et al., 2002). SERCA2A, the sarcoplasmic reticulum Ca2+ ATPase, is 
downregulated (Kim et al., 2002). The diminished and slowed Ca2+ transients are due to 
impaired spatial coordination of quantal Ca2+ releases, or sparks (Litwin et al., 2000). Na+-
Ca2+ exchange function is unaltered, and action potential abnormalities are not responsible 
for Ca2+ handling abnormalities (Pu et al., 2000). Surviving subendocardial Purkinje cells 
show marked abnormalities in subcellular Ca2+ release events, with spontaneous and 
spatiotemporally nonuniform microreleases that can trigger arrhythmic episodes (Boyden et 
al., 2003). Drugs that suppress Ca2+ microreleases by either inhibiting sarcoplasmic 
reticulum Ca2+ release channels or inositol trisphosphate receptors may constitute a novel 
antiarrhythmic approach postinfarction (Boyden et al., 2004). 
3.6 Alterations in Na+ current 
The human cardiac sodium channel hNaV1.5 is a member of the family of voltage-gated 
sodium channels (hNaV1 to 9). The channel consists of a primary α-and multiple secondary 
β-subunits. The sodium channel consists of 4 homologous domains, DI through DIV (Noda 
et al., 1984) arranged in a 4-fold circular symmetry to form the channel (Figure 12) (Herbert 
& Chahine, 2006).  
 
 
Fig. 12. Putative transmembrane organization of the sodium channel. The channel consists 
of 4 homologous domains, DI through DIV. The amino and carboxyl termini are 
intracellular. (Herbert & Chahine, 2006).  
Each sodium channel opens very briefly (<1ms) during more than 99% of depolarizations 
(Patlak & Ortiz, 1985). The channel occasionally shows alternative gating modes consisting 
of isolated brief openings occurring after variable and prolonged latencies and bursts of 
openings during which the channel opens repetitively for hundreds of milliseconds. The 
isolated brief openings are the result of the occasional return from the inactivated state. The 
bursts of openings are the result of occasional failure of inactivation (Patlak & Ortiz, 1985). 
The cardiac sodium channel has consensus sites for phosphorylation by protein kinase, 
protein kinase C, and Ca-calmodulin kinase (Frohnwieser et al., 1997). 
3.6.1 Na+ current changes 
Surviving border-zone tissue is characterized by reduced phase 0 amplitude and upstroke 
velocity (dV/dtmax), suggestive of reduced INa (Spear et al., 1979). These abnormalities in 
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excitability favor unidirectional block and reentry (Janse & Wit, 1989). Isolated border-zone 
cardiomyocytes also have reduced dV/dtmax (Lue & Boyden, 1992) and marked 
abnormalities in INa, including reduced current density, accelerated inactivation, and slowed 
reactivation (Pu & Boyden, 1997). Computer simulations suggest that both INa and ICaL 
abnormalities contribute to conduction abnormalities in the reentry circuit (Baba et al., 2005), 
in keeping with the key role of ICaL in the context of reduced coupling (Shaw & Rudy, 1997). 
Protein kinase A activators partially improve INa in peri-infarct zone cells, and the response to 
phosphatase inhibitors suggests that INa is hyperphosphorylated (Baba et al., 2004). In late 
postinfarction rat cardiomyocytes, changes in INa properties and in ion-channel subunit 
expression suggest the appearance of atypical INa isoforms (Huang et al., 2001a); these changes 
may be due to generalized cardiac hypertrophy/dysfunction rather than infarction per se. 
3.6.2 Functional consequences 
Oxidative stress in postinfarction tissues produces reactive intermediates that alter INa in a 
fashion similar to arrhythmogenic Nav1.5 subunit mutations and potentiate the effects of 
Na+ channel-blocking drugs (Fukuda et al., 2005). The INa blocker lidocaine differentially 
affects peri-infarct zone cardiomyocytes (Pu et al., 1998). These differential effects may 
contribute to the tendency of INa blockers to cause malignant ventricular tachyarrhythmias 
postinfarction (Ranger & Nattel, 1995). These paradoxical “proarrhythmic” effects of INa-
blocking antiarrhythmic drugs on myocardial infarction tissues contribute to a mortality-
enhancing potential (Cardiac Arrhythmia Suppression Trial (CAST) Investigators, 1989). 
3.7 Therapeutic implications of ionic current and transporter remodeling 
3.7.1 Remodeling-induced modification of the response to therapeutic interventions 
Myocardial infarction greatly increases the risk of arrhythmic death, and associated 
remodeling sensitizes patients to the proarrhythmic effects of a variety of drugs. The risk of 
drug-induced Torsades de Pointes arrhythmias caused by early afterdepolarizations is 
approximately increased by myocardial infarction (Stanley et al., 2007). Drugs like β-
adrenergic agonists and phosphodiesterase inhibitors, which increase cardiac contractility 
by increasing intracellular cAMP concentrations, Ca2+ loading and Ca2+-induced Ca2+ 
release, have been used extensively to improve cardiac function in patients with severe 
cardiac dysfunction. Unfortunately, in the longer term they have arrhythmogenic actions 
and increase mortality (Gardner et al., 1985; Hagemeijer, 1993; Lubbe et al., 1992). Ionic 
remodeling likely contributes to these adverse responses.  
Many of the changes responsible for adverse effects of antiarrhythmic drugs are caused by 
postinfarction myocardial remodeling: increased action potential duration, localized 
conduction slowing, downregulation of K+ channels, abnormal diastolic Ca2+ handling, and 
impaired connexin function. Myocardial infarction predisposes to the proarrhythmic actions 
of Na+ channel blocking drugs (Cardiac Arrhythmia Suppression Trial (CAST) Investigators, 
1989; Ranger & Nattel, 1995) and IKr blocking agents (Waldo et al., 1996). Responses to IKr 
blocking drugs may be reduced in postinfarction cells, perhaps because of IKr 
downregulation (Yuan et al., 1999). 
3.7.2 Ionic remodeling as a target for novel therapeutic approaches 
Much less work has been done to study interventions targeting ion-handling processes 
postinfarction. An angiotensin-converting enzyme inhibitor attenuated increases in 
refractoriness heterogeneity and prevented afterdepolarization formation in normal zones of 
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3.5.2 Changes in cellular Ca2+ handling 
Ca2+ transients in border-zone cells are decreased in amplitude and show slowed recovery 
and decay (Kim et al., 2002). SERCA2A, the sarcoplasmic reticulum Ca2+ ATPase, is 
downregulated (Kim et al., 2002). The diminished and slowed Ca2+ transients are due to 
impaired spatial coordination of quantal Ca2+ releases, or sparks (Litwin et al., 2000). Na+-
Ca2+ exchange function is unaltered, and action potential abnormalities are not responsible 
for Ca2+ handling abnormalities (Pu et al., 2000). Surviving subendocardial Purkinje cells 
show marked abnormalities in subcellular Ca2+ release events, with spontaneous and 
spatiotemporally nonuniform microreleases that can trigger arrhythmic episodes (Boyden et 
al., 2003). Drugs that suppress Ca2+ microreleases by either inhibiting sarcoplasmic 
reticulum Ca2+ release channels or inositol trisphosphate receptors may constitute a novel 
antiarrhythmic approach postinfarction (Boyden et al., 2004). 
3.6 Alterations in Na+ current 
The human cardiac sodium channel hNaV1.5 is a member of the family of voltage-gated 
sodium channels (hNaV1 to 9). The channel consists of a primary α-and multiple secondary 
β-subunits. The sodium channel consists of 4 homologous domains, DI through DIV (Noda 
et al., 1984) arranged in a 4-fold circular symmetry to form the channel (Figure 12) (Herbert 
& Chahine, 2006).  
 
 
Fig. 12. Putative transmembrane organization of the sodium channel. The channel consists 
of 4 homologous domains, DI through DIV. The amino and carboxyl termini are 
intracellular. (Herbert & Chahine, 2006).  
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Surviving border-zone tissue is characterized by reduced phase 0 amplitude and upstroke 
velocity (dV/dtmax), suggestive of reduced INa (Spear et al., 1979). These abnormalities in 
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excitability favor unidirectional block and reentry (Janse & Wit, 1989). Isolated border-zone 
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rats with prior infarctions (Li et al., 2004). The combined α- and β-adrenoceptor antagonist 
carvedilol suppresses downregulation of both Na+ (Maltsev et al., 2002) and L-type Ca2+ (Li 
et al., 2005) currents following myocardial infarction. Protein kinase A activators can 
partially restore suppressed INa in the infarct border zone (Baba et al., 2004). 
Advances in molecular cardiology have identified several potential targets for gene therapy. 
In a porcine model, focal gene transfer in the border zone of myocardial infarction to silence 
the KCNH2 potassium channel has been shown to abolish ventricular arrhythmias (Sasano 
et al., 2006). Furthermore, overexpression of the HERG potassium channel in isolated rabbit 
ventricular myocytes shortens action potential duration and reduces the frequency of early 
after-depolarizations (Nuss et al., 1999). Additional investigation is needed to confirm the 
safety and efficacy of targeted gene therapy in human. However, successful transition of 
gene therapy into clinical therapies will require the development of safe and efficient 
transgene vectors and delivery systems. 
4. Cardiac gap junction remodeling 
4.1 Gap junction structure, permeability and regulation 
The gap junction, a type of cell-to-cell junction, is composed of low-resistance intercellular 
pathways and mediates electrical and metabolic coupling between adjacent cells. Each gap 
junction channel is formed by two end-to-end connected hemichannels (also known as 
connexons) contributed by each of the two adjacent cells. In chordates, hemichannels are 
hexameric structures formed by six connexins (Cx). Connexins have four transmembrane 
domains with two extracellular loops and with the N-terminal and C-terminal domains in 
the cytoplasm (Harris, 2001; Sosinsky, 2000). Twenty different connexin types have been 
identified in mouse and 21 in man (Sohl & Willecke, 2004). Cells can usually express a 
variety of connexins, and the six connexins forming a hemichannel may not be identical (for 
example Cx43 and Cx40), thus forming a heteromeric hemichannel. Although not all 
combinations are possible (Harris, 2001), hemichannels formed by a particular connexins 
can dock to hemichannels with a different composition (Harris, 2001). A principal 
ultrastructural feature of the intercalated disk and gap junction was illustrated in Figure 13 
 
 
Fig. 13. Principal ultrastructural features of the intercalated disk and gap junction. A, Thin-
section electron micrograph showing the appearance of the 3 types of cell-cell junction, the 
gap junction (GJ), fascia adherens (FA), and desmosome (D). B, Higher magnification thin-
section of a gap junction. C, Structure of gap junction as revealed by freeze-fracture electron 
microscopy. The gap junction is seen as a cluster of particles. Each particle represents a 
connexon hemichannel. (a) ×36,250; (b) ×350,000; (c) ×98,000 (Severs et al., 1993). 
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(Severs et al., 1993). Gap junction are permeable to relatively large molecules (Harris, 2001). 
Depending on the connexins type, pore diameter ranges between approximately 6.5 and 
15A °(Harris, 2001), which is wide enough to allow the passage of water, all relevant cations 
and anions, including Na+, K+, and Ca2+ and most second messengers as IP3, cAMP, and 
cGMP (Figure 14) (Harris, 2001; Wong et al., 2008). 
 
 
Fig. 14. Organisation of connexins into gap junctions and molecules capable of diffusing 
through gap junctions (Wong et al., 2008). 
The mechanisms by which gap junction channel close or open are not fully elucidated. 
Gating can take place in at least two independent ways: a rapid, voltage-driven mechanism 
that can change the channel conformation between a fully open and a nearly completely 
closed state within a few ms (voltage gating), and a slower (up to 30 ms) mechanism (Harris, 
2001; Moreno et al., 2002a). Phosphorylation alters the probability of the different 
conductance states as well as intracellular trafficking and assembly of connexins depending 
on the connexins type, the phosphorylation site and, possibly, the biochemical environment 
(Van et al., 2001). The half-life of connexins is relatively short (less than 2h for Cx43) (Laing 
& Beyer, 2000) so that changes in the rates of synthesis or degradation are rapidly translated 
into changes in the number of operative gap junction channel. 
4.2 Diversity of connexin expression in the normal heart 
Three principal connexins are expressed in cardiac myocytes, Cx43, Cx40, and Cx45. 
Although Cx43 predominates in the heart as a whole, it is typically co-expressed in 
characteristic combinations and relative quantities with Cx40 and/or Cx45 in a chamber-
related and myocyte-type-specific manner (Vozzi et al., 1999). Although a few other 
connexins have been reported in cardiac tissue, these are minor components, species 
variants, or not been confirmed. Figure 15 gives an overview of the typical connexin 
expression patterns of the normal adult mammalian heart (Severs et al., 2008). 
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expression patterns of the normal adult mammalian heart (Severs et al., 2008). 
 




Fig. 15. Summary of the typical connexin expression patterns of the mammalian heart 
(Severs et al., 2008). 
The working cardiomyocytes of the ventricle are extensively interconnected by clusters of 
connexin43-containing gap junctions located at the intercalated disks (Figure 16) (Severs et 
al., 2004). The intercalated disks of working ventricular myocardium have a step-like 
configuration, with the gap junctions situated predominantly in the membrane segments 
that lie parallel with the long axis of the cell (Severs, 1990), with larger gap junctions 
typically circumscribing the disk periphery (Gourdie et al., 1991). This and other features of 
gap junction organization and aspects of tissue architecture such as the size and shape of the 
cells combine to ensure preferential propagation of the impulse in the longitudinal axis and 




Fig. 16. An isolated ventricular myocyte labelled for Cx43 (green) illustrating localization of 
the gap junctions in clusters at the intercalated disks (Severs et al., 2004).  
The gap junctions of atrial myocytes contain abundant Cx40 (Vozzi et al., 1999; Dupont et 
al., 2001), co-localized with Cx43 within the same individual gap-junctional plaques (Severs 
et al., 2001). Working ventricular myocytes, by contrast, normally lack detectable Cx40. In 
both ventricular and atrial working myocardium, Cx45 is present in very low quantities 
(Vozzi et al., 1999; Dupont et al., 2001). The specialized cardiomyocytes of the impulse 
generation and conduction system are distinct from the working ventricular and atrial cells 
both in terms of general morphology (Severs, 1989) and connexin expression profiles 
(Figure 17) (Coppen et al., 1999). 
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Fig. 17. Expression patterns of Cx43, Cx40 and Cx45 in different cardiomyocyte sub-types. 
This triple-labelled confocal montage shows part of the conduction system (common bundle 
and right bundle branch) which expresses Cx40 and Cx45). These two connexins are not 
detected in the adjacent working ventricular myocytes of the septum, which instead express 
Cx43. This example comes from rat heart (Coppen et al., 1999).  
4.3 Gap junction remodeling in myocardial infarction 
4.3.1 Connexin 43 remodeling in myocardial infarction 
Two principal gap junction-related alterations have been reported in the diseased ventricle: 
disturbances in the distribution of gap junctions and reduced levels of their major 
component, Cx43. “Lateralization”of Cx43 gap junction label is a prominent feature of the 
border zone of surviving myocytes around infarct scar tissue in the human ventricle (Smith 
et al., 1991). Electron microscopy reveals that both laterally disposed gap junctions 
connecting adjacent cells, and internalized (non-functional) gap junctional membrane, 
contribute to this abnormal pattern (Smith et al., 1991). 
By 6–12h after ligation, the normal distribution was lost for Cx43, desmoplakin, and 
cadherin at the intercalated disks in the infarct zone. By 24–48 h after ligation, the expression 
of Cx43 markedly decreased, to 5% of the levels of shamoperated hearts (Figure 18) 
(Takamatsu, 2008). At 4 days post-infarction in a dog model, lateral gap junction label in the 
extended infarct border zone has been correlated spatially with electrophysiologically 
identified figure-of-eight re-entrant circuits (Peters et al., 1997).  
Gap junctional changes distant from the infarct scar tissue, in particular reduction in the size 
and the number of gap junctions per unit length of intercalated disc, and fewer side-to-side 
connections between myocytes, have been described as longer term remodelling events in 
dog myocardium (Kostin et al., 2003). Our study showed that Cx43 mRNA and Cx43 protein 
reduced significantly at ischemic zone at 4, 8 and 12 weeks of myocardial infarction mice 
(Figure 19) (LI et al., 2010; Zhao et al., 2009). 
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Fig. 18. Remodeling process of cell–cell and cell–extracellular matrix (cell–ECM) interactions 
at the stump of myocardial infarction. (a) Normal; (b) 24–48 h. At early phase after ligation 
(to 48 h), borderline cardiomyocytes facing the infarct lose neighboring cells and form blunt-
ended stumps while maintaining some desmoplakin, and cadherin loses Cx43. (c) 48 h–day 
3. By day 3, integrins such as b1-integrin cluster at stumps where basement membranes are 
partially formed. The formation of intracellular junctions composed of desmoplakin and 
cadherin is initiated between cell processes. (d) Days 3–4; (e) days 8–15, After day 3, stumps 
change into fine cytoplasmic processes toward the infarct. Cx43 expression between cell 
processes forms intracellular junctional complexes with desmoplakin and cadherin, similar 
to those of typical intercalated disks. Cx43 expression is also observed at transverse cell 
boundaries of borderline and vicinity cardiomyocytes. (f) In the chronic phase (days 60–90), 
integrin–ECM couplings at the tips of cell processes and collagen accumulation around the 
processes increase as wound healing proceeds. Cell processes fuse together, and the 
intercalated disk-like structures diminish (Takamatsu, 2008). 
 
 
Fig. 19. A, Cx43 expression at normal zones in myocardial infarction mice after 4 weeks; B, 
Cx43 expression at ischemic zones in myocardial infarction mice after 4 weeks; C, Cx43 
expression at infarcted zones in myocardial infarction mice after 4 weeks (×400) (LI et al., 
2010).  
Apart from alterations in connexin43 level, rapid dephosphorylation of Cx43 and 
translocation of Cx43 from gap junctions into the cytosol has been reported when electrical 
uncoupling is induced by acute ischaemia in the Langendorff-perfused rat heart (Beardslee 
et al., 2000). These processes are reversible upon reperfusion and substantially reduced with 
ischemic preconditioning (LI et al., 2009a). Dephosphorylated Cx43 is associated with the 
laterally distributed gap junction label, while those gap junctions that remain in the classic, 
polar intercalated disc orientation contain phosphorylated Cx43 (Lampe et al., 2006). 
A rather different form of gap junction remodelling is associated with ‘hibernating 
myocardium’ in patients with ischemic heart disease (Kaprielian et al., 1998). The term 
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‘hibernating myocardium’ refers to regions of ventricular myocardium that do not contract 
properly but which recover after normal blood flow is restored following coronary artery by-
pass surgery. In hibernating myocardium, the large Cx43 gap junctions typically found at the 
periphery of the intercalated disc are smaller in size, and the overall amount of 
immunodetectable Cx43 per intercalated disc is reduced, compared with normally perfused 
myocardial regions of the same heart (Kaprielian et al., 1998). These findings were the first 
indication that Cx43 gap junction remodelling contributes to impaired ventricular contraction, 
in addition to arrhythmia, in human ischemic heart disease (Kaprielian et al., 1998).  
4.3.2 Connexin 45 remodeling in myocardial infarction 
Because Cx45 is not expressed widely in working ventricular myocytes in the normal adult 
heart, there is no report on the alternation of distribution and expression of Cx45 after 
myocardial infarction. However, previous study showed that expression of Cx45 in the 
failing human ventricle was up-regulated, alongside the reduction in Cx43, thus 
significantly altering the Cx43: Cx45 ratio (Yamada et al., 2003). Our datas showed that Cx45 
mRNA and Cx45 protein increased significantly at ischemic zone at 4, 8 and 12 weeks in 
myocardial infarction mice (Figure 20) (Zhao et al., 2009). Up-regulation of Cx45 in 
myocardial infarction hearts inplicates a novel mechanism whereby connexin remodeling 
may promote arrhythmogenesis.  
 
 
Fig. 20. Ratio change of connexin 45/β-actin for myocardial infarction mice after 4, 8 and 12 
weeks MSCs, bone marrow mesenchymal stem cells; aP < 0.01, vs. the normal area in the 
same group; bP < 0.01, vs. the ischemic zone in the same group; cP < 0.01, vs. myocardial 
infarction group (Zhao et al., 2009).  
4.3.3 Possibility of formation of heteromeric gap junction channels in myocardial 
infarction 
Expression of multiple connexin isoforms induces the formation of hetero-multimeric gap 
junction channels with distinct gating and permeability properties than their homo-
multimeric counterparts. Cx43 and Cx45 can form heterotypic channels that have unitary 
conductances lower than those of homotypic Cx43 channels and that fail to pass the 
fluorescent dye Lucifer yellow (Zhong et al., 2002; Moreno et al., 2002b; Moreno et al., 1995). 
When Cx43-expressing ROS cells are transfected to coexpress Cx45, electrical coupling is 
reduced even though Cx43 abundance, phosphorylation, and localization do not change 
(Koval et al., 1995). Coexpression of Cx45 with Cx43 in HeLa cells reduced the number of 
neighboring cells that were chemically coupled. Thus, increased Cx45 expression may 
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cadherin is initiated between cell processes. (d) Days 3–4; (e) days 8–15, After day 3, stumps 
change into fine cytoplasmic processes toward the infarct. Cx43 expression between cell 
processes forms intracellular junctional complexes with desmoplakin and cadherin, similar 
to those of typical intercalated disks. Cx43 expression is also observed at transverse cell 
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Fig. 19. A, Cx43 expression at normal zones in myocardial infarction mice after 4 weeks; B, 
Cx43 expression at ischemic zones in myocardial infarction mice after 4 weeks; C, Cx43 
expression at infarcted zones in myocardial infarction mice after 4 weeks (×400) (LI et al., 
2010).  
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translocation of Cx43 from gap junctions into the cytosol has been reported when electrical 
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A rather different form of gap junction remodelling is associated with ‘hibernating 
myocardium’ in patients with ischemic heart disease (Kaprielian et al., 1998). The term 
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‘hibernating myocardium’ refers to regions of ventricular myocardium that do not contract 
properly but which recover after normal blood flow is restored following coronary artery by-
pass surgery. In hibernating myocardium, the large Cx43 gap junctions typically found at the 
periphery of the intercalated disc are smaller in size, and the overall amount of 
immunodetectable Cx43 per intercalated disc is reduced, compared with normally perfused 
myocardial regions of the same heart (Kaprielian et al., 1998). These findings were the first 
indication that Cx43 gap junction remodelling contributes to impaired ventricular contraction, 
in addition to arrhythmia, in human ischemic heart disease (Kaprielian et al., 1998).  
4.3.2 Connexin 45 remodeling in myocardial infarction 
Because Cx45 is not expressed widely in working ventricular myocytes in the normal adult 
heart, there is no report on the alternation of distribution and expression of Cx45 after 
myocardial infarction. However, previous study showed that expression of Cx45 in the 
failing human ventricle was up-regulated, alongside the reduction in Cx43, thus 
significantly altering the Cx43: Cx45 ratio (Yamada et al., 2003). Our datas showed that Cx45 
mRNA and Cx45 protein increased significantly at ischemic zone at 4, 8 and 12 weeks in 
myocardial infarction mice (Figure 20) (Zhao et al., 2009). Up-regulation of Cx45 in 
myocardial infarction hearts inplicates a novel mechanism whereby connexin remodeling 
may promote arrhythmogenesis.  
 
 
Fig. 20. Ratio change of connexin 45/β-actin for myocardial infarction mice after 4, 8 and 12 
weeks MSCs, bone marrow mesenchymal stem cells; aP < 0.01, vs. the normal area in the 
same group; bP < 0.01, vs. the ischemic zone in the same group; cP < 0.01, vs. myocardial 
infarction group (Zhao et al., 2009).  
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junction channels with distinct gating and permeability properties than their homo-
multimeric counterparts. Cx43 and Cx45 can form heterotypic channels that have unitary 
conductances lower than those of homotypic Cx43 channels and that fail to pass the 
fluorescent dye Lucifer yellow (Zhong et al., 2002; Moreno et al., 2002b; Moreno et al., 1995). 
When Cx43-expressing ROS cells are transfected to coexpress Cx45, electrical coupling is 
reduced even though Cx43 abundance, phosphorylation, and localization do not change 
(Koval et al., 1995). Coexpression of Cx45 with Cx43 in HeLa cells reduced the number of 
neighboring cells that were chemically coupled. Thus, increased Cx45 expression may 
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reduce coupling and slow conduction or create microheterogeneities in coupling without 
slowing macroscopic conduction (Yamada et al., 2003). 
Previos studies showed that heterotypic combination of Cx45 and Cx43 in mammalian cell 
lines impairs voltage gating of Cx43 and alters residual conductances, suggesting that 
connexon interactions may play a distinct role in modulation of intercellular communication 
(Elenes et al., 2001; Thomas et al., 2004). Cx43 and Cx45 formed heteromeric channels that 
exhibit reduced single channel conductance compared with Cx43 homomeric channels  
(Martinez et al., 2002). Our datas demonstrated colocalization of Cx45 and Cx43 in both 
control and ischemic ventricular myocardium (Figure 21).  
Not only do Cx45 and Cx43 form hybrid channels in vitro, colocalization of these connexins 
in ventricular myocyte gap junctions provides and opportunity for hybrid channel 
formation in vivo, where interaction between Cx45 and Cx43 in hybrid channels could alter 
conductance states and gating responsiveness relative to the biophysical properties of 
homotypic channels (Yamada et al., 2003; Moreno et al., 2004). Our dates further suggested 
that enhanced expression of Cx45 in the ischemic heart occurs in junctions containing 
reduced levels of Cx43, raising the intriguing possibility that the relative stoichiometries of 
Cx45 and Cx43 within gap junctional plaques may be dramatically altered in the ischemic 
heart (Zhao et al., 2009). The limitation for our study is that the colocalization data are 
qualitative. In the absence of technological support of electrophysiologic confirmation of 
hybrid gap junction channels connecting ventricular myocytes in vivo, we can only 
speculate on the functional effects of increased Cx45 in the myocardial infarction heart. 
 
 
Fig. 21. Colocalizations (white arrows) of Cx45 and Cx43 in ischemic ventricular 
myocardium after 12 weeks in myocardial infarction mice by confocal microscopy 
examination (Scale bar = 20μm). 
4.3.4 Mitochondrial Cx43 in myocardial infarction 
Although it is generally assumed that Cx43 is exclusively localized at the sarcolemma, Cx43 
has been found recently at cardiomyocyte mitochondria linner and outer membrane (Boengler 
et al., 2005; Rodriguez-Sinovas et al., 2006; Goubaeva et al., 2007). Boengler et al (Boengler et 
al., 2005) presented evidence at first for the presence of Cx43 in mitochondria from mouse, rat, 
pig and human left ventricular myocardium obtained from fluorescence-activated cell sorting 
and western blot analyses, as well as confocal and immunoelectron microscopy (Figure 22).  
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Fig. 22. Cultured mice atrial HL-1 cardiomyocytes were stained with antibodies against 
Cx43 (red) and mitochondria (Ox-Phos Com plex II, green) and analyzed by confocal laser 
scan microscopy. Merged image demonstrates colocalization as yellow po ints (arrows). 
Additional ly, the phase contrast image was shown (Boengler et al., 2005). 
 
 
Fig. 23. Cx43 and translocase of the outer membrane 20 (Tom20) protein level in mitochondria 
isolated from left ventricular mycardium from young and aged mice. A: Western blot analysis 
was performed on mitochondrial protein extracts from young (< 3 mo) and aged (> 13mo) 
mice and on total right ventricular proteins (< 3 mo) for Na-K-ATPase and Cx43. Ponceau S 
staining demonstrates equal protein loading. B: Western blot analysis was performed for 
Tom20 on mitochondrial protein extracts from young and aged mice and on total right 
ventricular proteins. Ponceau S staining demonstrates equal protein loading. C: quantification 
of the Cx43 and Tom20 immunoreactivity in mitochondria of young (<3 mo, n = 14) and aged 
(> 13 mo, n = 10) mice normalized to Ponceau S staining. *P<0.05 vs. <3 mo (Boengler et al., 2007). 
In Antonio et al (Rodriguez-Sinovas et al., 2006) study, treatment of isolated mitochondria 
with digitonin resulted in a marked reduction of voltage dependent anion channel 
immunoreactivity (VDA), whereas an adenine nucleotide transporter (ANT) specific signal 
was detected by confocal laser scan microscopy. An observations, by using western blotting 
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and immunofluorescence with anti-VDAC as a marker for the outer mitochondrial 
membrane and with anti-ANT as a marker for the inner mitochondrial membrane, 
confirmed that Cx43 was not only present in the inner and outer mitochondrial membrane, 
but the mitochondrial Cx43 is phosphorylated (Goubaeva et al., 2007). Furthermore, with 
progressing age, GJ and mitochondrial levels of Cx43 in ventricular and atrial tissue 
homogenates are reduced. In mice hearts, sarcolemmal Cx43 content was reduced in aged (> 
13 month) com pared with young (< 3 month). Also in mitochondria isolated from aged 
mice left ventricular myocardium, western blot analysis indicated a 40% decrease in Cx43 
content compared with mitochondria isolated from young mice hearts. The reduced levels 
of Cx43 may contribute to the age-related loss of cardioprotection (Figure 23) (Boengler et 
al., 2007). 
There is very little research on the relationship between mitochondria connexin and 
myocardial infarction until now, and Cx43 is the only connexin that has been found at 
cardiomyocyte mitochondria. Recentlly, our data showed that Heptanol (a GJ blocker) 
preconditioning protects myocardium from ischemia-reperfusion injury. The mechanism 
may be related to increasing in mitochondrial membrane potential and attenuating the 




Fig. 24. Western blotting (30 μg total protein / lane) shows the increase of Cx43 protein in 
myoca rdial mitochondria in heptanol preconditioning on myocardial isehemia/reperfusion 
injury of rabbits. A: expression of Cx43 protein detected by Western blotting; B: results of 
the relative density of Cx43 protein; n = 3. P<0.05 vs IR; *P< 0.05 vs sham (HE, 2009, 2010). 
4.4 Electrophysiological consequences of gap junction remodeling 
Reductions in intercellular coupling lead to slowing of impulse propagation and 
amplification of the normal electrical heterogeneity within the ventricular myocardium. 
Individually, each of these electrophysiological effects of uncoupling are predicted to favor 
reentry, and together they may very well synergistically enhance arrhythmic risk (Kleber & 
Rudy, 2004). 
Anatomic evidence of GJ remodeling, typically documented by immunohistochemical 
means, has been correlated with functional measures of aberrant cell-cell coupling such as 
slowing of impulse propagation and changes in anisotropy, as well as arrhythmogenicity 
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(Fishman, 2005). In the healing canine infarct model, areas of GJ remodeling characterized 
by redistribution of Cx43 to lateral cell borders, correlates with the location of the central 
common pathway of figure-of-eight reentrant circuits (Peters et al., 1997). Additionally, 
junctional conductance of side-to-side coupled cells from the epicardial border zone is 
markedly diminished (Yao et al., 2003). 
What needs to be noted is that dysregulated connexin expression occurs as but one element 
of a widespread remodeling process - one that in volves many of the ion-handling proteins 
that regulate cardiac excitability (Fishman, 2005). Cardiac-specific Cx43 gene-targeted 
mutant mice showed significant slowing of impulse propagation and despite the relatively 
small mass of the murine ventricle, they all succumb to spontaneous or easily inducible 
sustained ventricular tachyarrhythmias (Fishman, 2005). Moreover, optical mapping studies 
suggest that most, if not all of these arrhythmias are due to reentry (Gutstein et al., 2001). 
On the other hand, studies of several additional genetic models in which Cx43 expression is 
modified are instructive, including the heteryzygous (Cx43+/-) germline knockout mice, 
chimeric (Cx43-/-/Cx43+/+) mice, as well as the recently described Cx43 O-CKO mice 
(Guerrero et al., 1997). Taken together, data from these murine models suggest that in the 
absence of additional pathologic stimuli, less widespread or more modest reductions in cell-
cell coupling are insufficient to support sustained ventricular arrhythmias (Fishman, 2005). 
For example, Cx43 germline heterozygous mice subjected to myocardial infarction 
reportedly have no increase in the frequency of spontaneous or inducible arrhythmias 
compared to wildtype mice with infarcts (Betsuyaku, 2004). Moreover, the imposition of 
ischemia in isolated-perfused hearts from Cx43+/- mice provokes only non-sustained 
ventricular tachycardia (Lerner et al., 2000). Cx43 chimeric mice, which have relatively large 
foci of uncoupled myocytes within the ventricle, display a substantial increase in 
spontaneous PVCs and short runs of VT (Gutstein et al., 2005). The O-CKO mice only 
develop inducible or spontaneous sustained VT when the anatomic extent of knockout is 
marked, encompassing more than 60% of the myocardium (Danik et al., 2004). Thus, the 
spatial extent and magnitude of uncoupling of Cx43 is likely to be insufficient to support the 
development of sustained ventricular tachyarrhythmias in the absence of additional 
pathologic pro-arrhythmic”hits” (Fishman, 2005). 
4.5 Therapeutic Implications of gap junction remodeling after myocardial infarction 
4.5.1 Pharmacological therapeutic implications 
Pharmacology of GJ intercellular communication is still at its beginnings. Figure 26 shows a 
schematic view of a gap junction channel as a target of pharmacology (Salameh & Dhein, 
2005). Potential mechanisms controlling the level of intercellular communication in the heart 
include regulation of connexin turnover (synthesis and degradation), cellular distribution 
and phosphorylation. There are numerous data showing that some compounds can up-
regulate Cx43 via modulation either synthesis or degradation and enhance gap junctional 
communication (Salameh & Dhein, 2005). Although many substances have effects on Gap 
junction-mediated intercellular communication (GJMIC), there is a lack of powerful and 
specific GJ blockers (Dhein, 1998, 2005). 
Substances, such as AAP10 (Weng et al., 2002) or its derivative ZP123 (Xing et al., 2003), that 
increase intercellular coupling have presented themselves as valuable new tools to 
investigate the role of intercellular coupling in physiology and pathophysiology. It has been 
shown that uncoupling correlates with the development of some types of arrhythmias, and 
in several cases application of drugs that increase coupling has confirmed this role (Axelsen 
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Fig. 26. Schematic view of a gap junction channel and its constituent component, the 
connexin, as a target of pharmacology (Salameh & Dhein, 2005). 
 et al., 2007). Two recent studies showed (Haugan et al. 2005, Axelsen et al. 2007 (Haugan et 
al., 2005; Axelsen et al., 2007) that an increase of gap junctional conductance by specific 
peptide, rotigaptide, can prevent atrial conduction slowing or re-entrant ventricular 
tachycardia in ischemic heart. Suppression of ischemia-induced dephosphorylation of 
connexin seems to be one of the mechanisms involved. This mechanism was thought to be 
involved in the antiarrhythmic effects of ischemic preconditioning (Schulz et al., 2007). On 
the other hand, the reduction in gap junction communication that takes place during 
ischemia has been regarded as a beneficial and protective measure (Garcia-Dorado et al., 
2004). Several investigators have examined the role of uncoupling GJ communication on 
myocardial infarct size. Thus, pharmacological uncoupling of GJ communication with 
nonselective uncouplers of GJ communication has been reported to reduce infarct size in 
animal experiments. Addition of the GJ blocker heptanol at concentration has a marked 
protective effect when applied at the time of reperfusion (Garcia-Dorado et al., 1997). Recent 
studies analyzing the effect of GJ uncouplers when administered during reoxygenation or 
reperfusion have consistently documented a reduction of necrosis (enzyme release or infarct 
size) (Saltman et al., 2002; Sebbag et al., 2003). Besides, electrical uncoupling by heptanol 
significantly lowers defibrillation threshold and dispersion of ventricular fibrillation cycle 
length without altering refractoriness (Qi et al., 2003). Although the beneficial and protective 
effort of GJ uncouplers delighted our researches, an important limitation is the lack of 
specific, rapid, reversible, and safe inhibitors of GJ intercellular communication. 
Modulation of GJ intercellular coupling may open interesting new therapeutic approaches 
for a large number of diseases including myocardial infarction. However, in many respects, 
we have not completely understood the complex networking and its long-term regulation. 
This again underlines the need for in vivo and organbased models to evaluate the 
possibilities of pharmacological approaches towards an acute or chronic modulation of gap 
junctions. Moreover, the development of connexin- or organ specific gap junction modulator 
drugs is a challenging task for pharmacologists. 
4.5.2 Stem cell therapy 
Stem cell transplantation has emerged as a potential treatment strategy for heart failure 
secondary to acute or chronic ischaemic heart disease (Laflamme & Murry, 2005). But 
currently two autologous cell types, namely bone marrow (BM) cells and skeletal myoblasts 
(SMs), which were used in clinical trials in patients after myocardial infarction (Murry et al., 
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2005), seem to provide only modest improvement of contractile heart function (Janssens et al., 
2006) because neither BM cells (Murry et al., 2004) nor SMs (Reinecke et al., 2002) adopt a 
cardiac cell fate or couple electrically with the host myocardium (Leobon et al., 2003; Murry et 
al., 2004). Moreover, VT has been reported in several of the patients transplanted with SMs 
(Hagege et al., 2006), raising concerns as to whether engraftment of cells enhances the risk of 
VT, the most frequent cause of sudden death after myocardial infarction (Solomon et al., 2005; 
Henkel et al., 2006). So it is very important to fully answer these two questions before cell or 
stem cell therapy was proposed widely in clinic: whether cell or stem cell can differenciate into 
cardiomyocytes? Whether cell or stem cell can form functional coupling with the host, which is 
important for the physiological communication between cardiac myocytes?  
A study (Virginijus et al., 2004) showed that human mesenchymal stem cells (hMSCs) can 
express connexins and couple to one another via Cx43 and Cx40. In addition, they formed 
functional gap junction channels with cells tranfected with Cx43, Cx40 or Cx45 as well as 
canine ventricular cardiomyocytes. Those are the foundermantal conditions for mesenchymal 
stem cells therapy for heart disease including myocardial infarction (see Figure 27).  
Besides, another study (Wilhelm et al., 2007) showed that cardiomyocyte transplantation has 
the potential to impart electrical stability to the injured heart, thereby markedly reducing the 
major factor leading to sudden death. This protective effect was independent of the 
documented modest augmentation of left ventricular function and was associated with 
improved electrical coupling within the infarct by the engraftment of Cx43-expressing 
embryonic cardiomyocytes (eCMs). This enhanced coupling reduced vulnerability to VT by 
decreasing the incidence of conduction block within the infarct and/or by a modulatory 
effect on border-zone cardiomyocytes. This study also found that expression of the cardiac 
gap-junction protein Cx43 is the critical factor underlying augmented intercellular electrical 
conduction and protection from arrhythmia, because engraftment of Cx43-expressing SMs  
 
 
Fig. 27. Identification of connexins in gap junctions of hMSCs Immunostaining of Cx43 (A), 
Cx40 (B) and Cx45 (C). D, immunoblot analysis of Cx43 in canine ventricular myocytes and 
hMSCs. Whole cell lysates (120μg) from ventricular cells or hMSCs were resolved by SDS, 
transferred to membrans, and blotted with Cx43 antibodies. Migration of molecular weight 
markers is indicated to the right of the blot (Virginijus et al., 2004).  
 





Fig. 26. Schematic view of a gap junction channel and its constituent component, the 
connexin, as a target of pharmacology (Salameh & Dhein, 2005). 
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(SMs), which were used in clinical trials in patients after myocardial infarction (Murry et al., 
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2005), seem to provide only modest improvement of contractile heart function (Janssens et al., 
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al., 2004). Moreover, VT has been reported in several of the patients transplanted with SMs 
(Hagege et al., 2006), raising concerns as to whether engraftment of cells enhances the risk of 
VT, the most frequent cause of sudden death after myocardial infarction (Solomon et al., 2005; 
Henkel et al., 2006). So it is very important to fully answer these two questions before cell or 
stem cell therapy was proposed widely in clinic: whether cell or stem cell can differenciate into 
cardiomyocytes? Whether cell or stem cell can form functional coupling with the host, which is 
important for the physiological communication between cardiac myocytes?  
A study (Virginijus et al., 2004) showed that human mesenchymal stem cells (hMSCs) can 
express connexins and couple to one another via Cx43 and Cx40. In addition, they formed 
functional gap junction channels with cells tranfected with Cx43, Cx40 or Cx45 as well as 
canine ventricular cardiomyocytes. Those are the foundermantal conditions for mesenchymal 
stem cells therapy for heart disease including myocardial infarction (see Figure 27).  
Besides, another study (Wilhelm et al., 2007) showed that cardiomyocyte transplantation has 
the potential to impart electrical stability to the injured heart, thereby markedly reducing the 
major factor leading to sudden death. This protective effect was independent of the 
documented modest augmentation of left ventricular function and was associated with 
improved electrical coupling within the infarct by the engraftment of Cx43-expressing 
embryonic cardiomyocytes (eCMs). This enhanced coupling reduced vulnerability to VT by 
decreasing the incidence of conduction block within the infarct and/or by a modulatory 
effect on border-zone cardiomyocytes. This study also found that expression of the cardiac 
gap-junction protein Cx43 is the critical factor underlying augmented intercellular electrical 
conduction and protection from arrhythmia, because engraftment of Cx43-expressing SMs  
 
 
Fig. 27. Identification of connexins in gap junctions of hMSCs Immunostaining of Cx43 (A), 
Cx40 (B) and Cx45 (C). D, immunoblot analysis of Cx43 in canine ventricular myocytes and 
hMSCs. Whole cell lysates (120μg) from ventricular cells or hMSCs were resolved by SDS, 
transferred to membrans, and blotted with Cx43 antibodies. Migration of molecular weight 
markers is indicated to the right of the blot (Virginijus et al., 2004).  
 




Fig. 28. d, Ventricular burst stimulation does not induce VT. Upper trace, surface ECG; 
lower trace, His-level electrogram. e, EGFP-positive eCMs integrate into the infarct. f, EGFP 
positive eCMs are striated (α-actinin staining, red) and are in direct contact with EGFP-
negative host cardiomyocytes. g, Cx43 staining (red) illustrates gap-junction formation 
between engrafted EGFP-positive eCMs (arrows) and with native cardiomyocytes 
(arrowheads). h, Summary of VT inducibility. Note strongly elevated susceptibility to VT 
induction in shaminjected group (Sh) compared with control group; eCM engraftment 
reduces VT inducibility compared with sham injection. Conversely, VT remains frequent 
after transplantation of SMs, BM and cardiac myofibroblasts (cFib). i, Improvement of left 
ventricular ejection fraction after eCM or SM transplantation. Numbers above bars indicate 
n; error bars show s.d. Scale bar, 60 mm (e), 5 mm (f), and 11mm (g). 
protected against VT induction (see Figure 28). Thus, cell therapy including stem cell 
therapy in combination with Cx43 gene transfer represents a promising therapeutic strategy 
to decrease the risk of potentially fatal arrhythmias in injured heart. 
In our recently study on mice, Laser Scanning Confocal Microscope examination found that 
DAPI-labeled MSCs distributed widely at the host ischemic zone and expressed Cx43. 
Fluorescence PCR, Immunohistochemistry, Immunofluorescence and immuno-electron 
microscope studies showed that Cx43 mRNA and Cx43 protein exprssions were statistically 
higher in MSCs group compared to MI group; Cx45 mRNA and Cx45 protein expressions 
were statistically lower in MSCs group compared to MI group (see Figure 29). We concluded 
that MSCs transplantation, which could survive at the host ischemic zone and express Cx43, 
can modulate the electrophysiological abnormality of myocardial infarction by up-regulating 
Cx43 and down-regulating Cx45 both at Protein and mRNA levels. In a word, MSCs have the 
plasticity of differentiating into cardiac muscle cell-like cells, which can modulate the 
electrophysiological abnormality via regulation of Cx43 and Cx45 remodeling following with 
myocardial infarction (Li et al., 2009b, 2010; Zhao et al., 2009, 2010). 
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Fig. 29. A, Cx43 staining by FITC (green) at normal zones of ventricular myocardium. B, 
Cx43 staining by FITC at ischemic zones of ventricular myocardium. C, Cx43 staining by 
FITC at ischemic zones of ventricular myocardium after MSCs transplantation. D, Cx45 
staining by TR (red) at normal zones of ventricular myocardium. E, Cx45 staining by TR at 
ischemic zones of ventricular myocardium. F, Cx45 staining by TR at ischemic zones of 
ventricular myocardium after MSCs transplantation. 
5. Conclusions and perspective 
In this chapter, we have presented mechanisms of sympathetic neural remodeling, electrical 
remodeling and gap Junction remodeling, which closely relate to the electrophysiological 
abnormality after myocardial infarction. Pathophysiological remodeling in myocardial 
infarction is multifactorial and complex, which involves changes in the structure and function 
of the myocardium. Although we anthropogenically divided the arrhythogenic mechamism of 
myocardial infarction into three parts, we have emphasized the importance of 
interrelationship among them which occurs at the cellular and molecular levels. Elucidating 
the role of myocardial remodeling and its molecular underpinnings present opportunities for 
the development of novel gene- and cell-based strategies as well as more pharmacotherapies. 
Besides, the localization of Cx43 at mitochondria opens a new door for us to reveal the 
cardioprotection against myocardial infarction. Stem cells, especially MSCs, give us a new 
hope on the potential treatment strategy for reducing life-threatening post-infarct arrhythmias 
and for heart failure secondary to acute or chronic ischaemic heart disease. 
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1. Introduction 
Cardiovascular diseases, the first killer for human being, constitute the global economic 
burden. The updated data from World Health Organization (WHO) addresses that the 
mortality rank of myocardial infarction will increase from No.5 in 2000 to Top One till 2020. 
And 30 percent of overall mortality is due to the cardiovascular diseases. Their prevalence has 
severely affected patients’ healthy conditions. Therefore, it is the priority for us to enforce the 
research on the mechanisms of pathogenesis and treatment of cardiovascular diseases. 
Heart attacks are most commonly caused by a fatty “plaque” dislodging from the blood 
vessel wall. Inflammation in vessels and heart also plays an important role in this process. 
This provokes tiny cells in the bloodstream known as platelets to clump together and block 
the blood circulation to important organs. To elucidate the exact mechanism of the 
mentioned process, researchers need to develop various pre-clinical approaches to simulate 
the clinical presentation in animal models, cell strains, or even in tube reactions. Among 
those methodologies, animal model are more acceptable than the others due to its easily 
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1. Introduction 
Cardiovascular diseases, the first killer for human being, constitute the global economic 
burden. The updated data from World Health Organization (WHO) addresses that the 
mortality rank of myocardial infarction will increase from No.5 in 2000 to Top One till 2020. 
And 30 percent of overall mortality is due to the cardiovascular diseases. Their prevalence has 
severely affected patients’ healthy conditions. Therefore, it is the priority for us to enforce the 
research on the mechanisms of pathogenesis and treatment of cardiovascular diseases. 
Heart attacks are most commonly caused by a fatty “plaque” dislodging from the blood 
vessel wall. Inflammation in vessels and heart also plays an important role in this process. 
This provokes tiny cells in the bloodstream known as platelets to clump together and block 
the blood circulation to important organs. To elucidate the exact mechanism of the 
mentioned process, researchers need to develop various pre-clinical approaches to simulate 
the clinical presentation in animal models, cell strains, or even in tube reactions. Among 
those methodologies, animal model are more acceptable than the others due to its easily 
“from bench to bed” translational property. The use of appropriate large-animal models is 
essential if some new therapeutic strategies are to be critically evaluated in a preclinical 
setting before their use in humans. 
Over the past decade, swine have been increasingly used in studies of myocardial ischemia 
because of their numerous similarities to humans, including minimal preexisting coronary 
collaterals as well as similar coronary anatomy and physiology. In this chapter, the author 
will consequently review the most commonly used swine models of myocardial ischemia 
with special attention to regional myocardial blood flow and function and critically 
evaluates the strengths and weaknesses of each model in terms of utility for preclinical 
trials. 
Also in this part, several porcine models of myocardial ischemia/infarction developed in 
our department will be summarized briefly regarding with the technical progress. We 
would also like to share our experiences about new adventures in the field of 
electrocardiogram mapping using multiple electrodes. 
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2. Animal models of myocardial ischemia/infarction 
2.1 Myocardial ischemic or infarction models 
High mortality and morbidity associated with myocardial ischemia or even the infarction 
necessitates modelling the process in animal. In a hospital setting, because the primary 
concern is resuscitation and maintaining of the patient's life, but not research in the 
underlying mechanism of the diseases. To study the pathophysiological changes associated 
with myocardial ischemic injury and how they lead to the establishment of cardiac cell 
death and regional infarction, animal models of clinical pathophysiology should gain our 
serious concern to overcome the limitations of clinical studies and to play an invaluable role 
in advancing mechanistic insight. Animal model studies will considerably provided new 
ideas and hypotheses that have been tested in clinical studies and have thus increased the 
level of knowledge regarding cardioprotection in the ischemic milieu. 
Moreover, the use of experimental models of heart diseases in animals is an obligatory step 
for the understanding of mechanisms involved in pathologies consecutive to cardiac 
metabolic or functional disorders. As for any kind of therapeutic approach, to demonstrate 
its efficacy and safety there is also a need for animal models. Among factors of importance, 
there are animal species, coronary thrombosis induction method, thrombus composition and 
site of formation. 
2.1.1 Acute ischemic and reperfusion animal models 
Based on the clinical profiles of the sudden heart attach, people firstly sought for the mimic 
method to study myocardial ischemic condition by ligation of one of the three main arteries 
in heart. Back to 1975, myocardial ischemia was induced in swine by ligation of the anterior 
descending coronary artery for periods of 30 minutes to six hours. Electron microscopy was 
used to monitor normal and ischemic myocardium (Lichtig et al., 1975). Scientists from our 
institute did contribute quite a lot to this model, not in swine, but in dogs. The dog’s heart 
was exposed by opening the chest. The acute ischemia models were prepared by ligating left 
anterior descending (LAD) artery. Meanwhile, timed monitoring hemodynamics and blood 
flow were determined by physiological polygraph and electromagnetic flow meter, 
respectively (Li, 1978). In another research group, the diagonal branches of the left anterior 
descending coronary artery in pigs were ligated for 5, 15, 30, 60 and 120 minutes. By using 
transmission electron microscopy, morphological observations indicated that initial 
leukocyte infiltration and inflammation during myocardial ischemia (Park et al., 1985). 
These kinds of open-chest model were widely accepted during 1990s and were still 
prevalent in 2000s. With development of the diagnostic methods, more and more advanced 
technologies were employed in the research of heart diseases and animal modelling. In one 
of representative works, nine open-chest swine undergoing myocardial ischemia were 
instrumented for measurement of regional myocardial blood flow (microsphere method), 
contractile function (sonomicrometry), and hemodynamics. L-[1-14C] Lactate or L-[U-13C] 
lactate was infused intravenously using a primed continuous infusion technique to quantify 
regional myocardial lactate release. A close inverse relation between regional myocardial 
lactate release and regional subendocardial blood flow during graded ischemia was 
revealed (Guth et al., 1990). When researcher evaluated the utility of transplanting bone 
marrow stromal cells in a porcine myocardial infarction model, a myocardial infarction was 
created by occluding the distal left anterior descending artery in pigs with coils and 
Gelfoam sponge (Tomita et al., 2002). In this study, sestamibi technetium single-photon 
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emission computed tomographic scans were performed to compare the stroke volume, 
regional perfusion, and wall motion in different treatment group.  
Most of these myocardial infarction animal models using dogs or pigs is created by coronary 
artery ligation after surgical opening of the chest and exposure of the heart. Hereby, 
numerous disadvantages and experimental limitations may be associated with this 
technique: There is evidence suggesting that normal cardiac mechanics are disturbed in 
acute models after thoracotomy. Opening the chest and pericardium have both been 
suspected and reported to influence the pattern of left ventricular remodeling in chronic 
models (Kraitchman et al., 2000; Ludemann et al., 2007). Furthermore, the surgical trauma 
may cause a high rate of complications, resulting in high mortality. In addition, the trauma 
may render successful recovery from anesthesia in models of myocardial infarction more 
difficult, compared with closed chest procedures. 
Besides, to date, there are various myocardial ischemic animal models, such as ligating the 
coronary artery (Takahashi et al., 2005), placing constrictors on the coronary artery (Laham 
et al., 2000), putting microembolus into the coronary artery (Huang et al., 2004), or injecting 
ferric chloride via the vein (Dogne et al., 2005).  However, operations in these methods lead 
to much damage in animals, and channelization can not be restored in the obstructed 
coronary artery. More considerably, the mimic pathophysiological alterations deviate from 
clinical data, especially autopsy. Nowadays, cardiovascular medicine research requires the 
availability of appropriate experimental animal models that are as close to humans as 
feasible. 
2.1.2 Mechanically chronic ischemic animal models 
The most widely used porcine model of chronic ischemia has been the ameroid constrictor. 
Originally described by Litvak and colleagues in 1957, these constrictors are constructed of 
the hygroscopic material casein encased within a steel sleeve. When the device is implanted 
around an artery, the constrictor absorbs water and swells, compressing the artery and 
producing total coronary occlusion over a period of 14-30 or more days (Elzinga, 1969). The 
major advantage of the ameroid constrictor model is its simplicity. Inherent limitations to 
the use of these occluders include an inability to control the rate or degree (sometimes 
incomplete) of coronary occlusion (Inou et al., 1980).  
Another large-animal model of chronic ischemia has involved placing an adjustable 
hydraulic occluder around an epicardial coronary artery to produce a fixed degree of 
coronary stenosis (Bolukoglu et al., 1992). This model is similar to the fixed stenosis model 
in that the coronary artery is reduced in diameter by an external device, although with this 
latter model the occluder is typically placed either proximal or distal to a myocardial flow 
probe. Another famous study using this animal is about the relationship between 
hibernating myocardium and cell autophage (Yan et al., 2005). Chronically instrumented 
pigs were studied with repetitive myocardial ischemia produced by coronary hydraulic 
stenosis. Autophagy, triggered by ischemia, could be a homeostatic mechanism, by which 
apoptosis is inhibited and the deleterious effects of chronic ischemia are limited (Yan et al., 
2006).  
2.1.3 Swine models with thrombosis formation in coronary artery 
Coronary artery thrombosis is widely accepted as a major cause of myocardial infarction 
(MI). The abrupt transition from a stable, often clinically silent, disease to a symptomatic 
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life-threatening condition results from endothelial injury or plaque disruption followed by 
thrombosis (Falk et al., 1995). Because of this acute intracoronary thrombotic occlusion, the 
primary goal of therapy is rapid, complete, and sustained restoration of infarct-related 
artery blood flow. In this case, the choice of the animal model of thrombosis to evaluate the 
efficiency of antiplatelet, antithrombotic or thrombolytic drugs in preclinical studies is 
crucial. Numerous animal models of thrombosis-induced MI have been proposed in the last 
decades (Leadley et al., 2000). Another example was from porcine model of myocardial 
infarction induced by topical application of ferric chloride to the LAD coronary artery, 
which was validated to quite close to clinical pathophysiological conditions, such as 
thrombus formation occurring after atherosclerotic plaque rupture (Dogne et al., 2005). 
In dogs, left circumflex coronary artery (LCx) thrombosis was induced by vascular 
electrolytic injury (Hennan et al., 2001; Romson et al., 1980). After a flow probe and stenosis 
had been placed around the LCx, an intracoronary electrode was inserted through the LCx 
arterial wall, with the uninsulated portion positioned against the endothelial surface. An 
anodal current of 150 µA was applied to the endothelial surface to initiate the experiment. 
This operation is relatively difficult to master or needs much more practice, since the 
electrode is introduced into coronary artery. Another shortcoming is bleeding due to artery 
injury during procedure, especially the introduction of electrode. 
In our department, to evaluate the thrombolytic effects of heparin-like drugs, swine’s 
endoarterium was injuried and coronary thrombi were formed gradually through direct 
electrical stimulation on the coronary artery of animals (Liu et al., 2002). However, some 
limitations of this model should be pointed out. First, we are aware of the fact that the 
maintenance of pigs is expensive and difficult, and requires special facilities that are beyond 
the capabilities of most laboratories. Secondly, the pig presents a high myocardial sensitivity 
to hypoxia. Acute reduction of coronary blood flow can easily induce paroxystic ventricular 
fibrillation which may then requires the use of prophylactic antiarrythmic agents.  
2.1.4 Making myocardial ischemic animal models via interventional techniques 
Most models listed above in the pig, with or without subsequent reperfusion need 
thoracotomy. The majority of these employ surgical techniques of coronary occlusion 
following thoracotomy. During these complex operations, the subtle enviorment inside of 
the chest will be somewhat disturbed. The endovascular and minimal invasion techniques 
offer a series of advantages over the surgical technique such as a lower incidence of 
infections and of related complications which can compromise the survival of the animal 
and the validity of the results.  
These disadvantages raise the demand for closed-chest models for myocardial infarction in 
large animals. To facilitate the surgical operation, we introduced the intervention technique 
and selective coronary angiography into our study. One ischemic model we used was 
developed in Chinese miniature swine, where myocardial ischemia was performed by 
injecting self-embolus into the middle segment of the left anterior descending (LAD) 
without thoracotomy (Liu et al., 2007b; Yu et al., 2007b). Embolization occurred in the LAD 
coronary artery of the Chinese miniature swine injected by self-embolus. There were 
significant myocardial ischemia and large cardiac muscle infarction in the Chinese miniature 
swine, which were accompanied with increased Body surface ECG (BS-ECG) (Liu et al., 
2007b), decreased hemodynamic indexes of the cardiac output, cardiac index, left cardiac 
work and left cardiac work index, and increased systemic vascular resistance index. 
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Pathohistological analysis revealed myocardial degeneration, necrosis, fibrosis, 
inflammatory cell infiltration and granulation tissue hyperblastosis. Our data showed that 
myocardial ischemia induced by injecting self-embolus into the LAD coronary artery in 
Chinese miniature swine is quite close to clinical pathophysiological conditions. (Fig. 1.) 
 
 
Fig. 1. Changes of coronary embolism were disclosed by the coronary angiography. (A) the 
LAD of the model group was normal at pre-operation; (B) the LAD of the model group was 
completely and instantly embolized, post-operation. 
In other lab, injection of thrombogenic material, such as microcoils or thrombin fibrinogen 
mixtures, have also been proposed and explored (Koning et al., 1993; Naslund et al., 1992). 
In these studies, after injection into a coronary artery, the blood flow transports these 
materials downstream until their size matches the diameter of the coronary artery. 
Standardization of the infarction size is not possible because there is physiologic variation of 
the diameter of the coronary arteries between individual animals of similar body weight. 
Furthermore, with these approaches, either reperfusion is not possible or occurs after 
spontaneous lysis of the occluding material. This approach does not allow for controlling 
the duration of the occlusion.  
On the other hand, X-ray-guided placement of a balloon catheter in the coronary artery and 
inflation of the balloon for coronary artery occlusion avoids extensive surgery and allows 
the control of both the location and the time of occlusion. This approach has been used in 
several studies. Balloon occlusion of the LAD can successfully be performed in pigs to create 
reperfused or occlusive myocardial infarction. The technique allows for a relatively short 
preparation time compared with open-chest surgery, control over the duration of ischemia, 
and standardization the location of the occlusion and infarcts size. The resulting changes of 
the myocardial function are solely due to the ischemic injury. This renders results obtained 
 
Advances in Electrocardiograms – Clinical Applications 
 
178 
life-threatening condition results from endothelial injury or plaque disruption followed by 
thrombosis (Falk et al., 1995). Because of this acute intracoronary thrombotic occlusion, the 
primary goal of therapy is rapid, complete, and sustained restoration of infarct-related 
artery blood flow. In this case, the choice of the animal model of thrombosis to evaluate the 
efficiency of antiplatelet, antithrombotic or thrombolytic drugs in preclinical studies is 
crucial. Numerous animal models of thrombosis-induced MI have been proposed in the last 
decades (Leadley et al., 2000). Another example was from porcine model of myocardial 
infarction induced by topical application of ferric chloride to the LAD coronary artery, 
which was validated to quite close to clinical pathophysiological conditions, such as 
thrombus formation occurring after atherosclerotic plaque rupture (Dogne et al., 2005). 
In dogs, left circumflex coronary artery (LCx) thrombosis was induced by vascular 
electrolytic injury (Hennan et al., 2001; Romson et al., 1980). After a flow probe and stenosis 
had been placed around the LCx, an intracoronary electrode was inserted through the LCx 
arterial wall, with the uninsulated portion positioned against the endothelial surface. An 
anodal current of 150 µA was applied to the endothelial surface to initiate the experiment. 
This operation is relatively difficult to master or needs much more practice, since the 
electrode is introduced into coronary artery. Another shortcoming is bleeding due to artery 
injury during procedure, especially the introduction of electrode. 
In our department, to evaluate the thrombolytic effects of heparin-like drugs, swine’s 
endoarterium was injuried and coronary thrombi were formed gradually through direct 
electrical stimulation on the coronary artery of animals (Liu et al., 2002). However, some 
limitations of this model should be pointed out. First, we are aware of the fact that the 
maintenance of pigs is expensive and difficult, and requires special facilities that are beyond 
the capabilities of most laboratories. Secondly, the pig presents a high myocardial sensitivity 
to hypoxia. Acute reduction of coronary blood flow can easily induce paroxystic ventricular 
fibrillation which may then requires the use of prophylactic antiarrythmic agents.  
2.1.4 Making myocardial ischemic animal models via interventional techniques 
Most models listed above in the pig, with or without subsequent reperfusion need 
thoracotomy. The majority of these employ surgical techniques of coronary occlusion 
following thoracotomy. During these complex operations, the subtle enviorment inside of 
the chest will be somewhat disturbed. The endovascular and minimal invasion techniques 
offer a series of advantages over the surgical technique such as a lower incidence of 
infections and of related complications which can compromise the survival of the animal 
and the validity of the results.  
These disadvantages raise the demand for closed-chest models for myocardial infarction in 
large animals. To facilitate the surgical operation, we introduced the intervention technique 
and selective coronary angiography into our study. One ischemic model we used was 
developed in Chinese miniature swine, where myocardial ischemia was performed by 
injecting self-embolus into the middle segment of the left anterior descending (LAD) 
without thoracotomy (Liu et al., 2007b; Yu et al., 2007b). Embolization occurred in the LAD 
coronary artery of the Chinese miniature swine injected by self-embolus. There were 
significant myocardial ischemia and large cardiac muscle infarction in the Chinese miniature 
swine, which were accompanied with increased Body surface ECG (BS-ECG) (Liu et al., 
2007b), decreased hemodynamic indexes of the cardiac output, cardiac index, left cardiac 
work and left cardiac work index, and increased systemic vascular resistance index. 
Novel Porcine Models of Myocardial Ischemia/Infarction 
– Technical Progress, Modified Electrocardiograms Validating, and Future Application 
 
179 
Pathohistological analysis revealed myocardial degeneration, necrosis, fibrosis, 
inflammatory cell infiltration and granulation tissue hyperblastosis. Our data showed that 
myocardial ischemia induced by injecting self-embolus into the LAD coronary artery in 
Chinese miniature swine is quite close to clinical pathophysiological conditions. (Fig. 1.) 
 
 
Fig. 1. Changes of coronary embolism were disclosed by the coronary angiography. (A) the 
LAD of the model group was normal at pre-operation; (B) the LAD of the model group was 
completely and instantly embolized, post-operation. 
In other lab, injection of thrombogenic material, such as microcoils or thrombin fibrinogen 
mixtures, have also been proposed and explored (Koning et al., 1993; Naslund et al., 1992). 
In these studies, after injection into a coronary artery, the blood flow transports these 
materials downstream until their size matches the diameter of the coronary artery. 
Standardization of the infarction size is not possible because there is physiologic variation of 
the diameter of the coronary arteries between individual animals of similar body weight. 
Furthermore, with these approaches, either reperfusion is not possible or occurs after 
spontaneous lysis of the occluding material. This approach does not allow for controlling 
the duration of the occlusion.  
On the other hand, X-ray-guided placement of a balloon catheter in the coronary artery and 
inflation of the balloon for coronary artery occlusion avoids extensive surgery and allows 
the control of both the location and the time of occlusion. This approach has been used in 
several studies. Balloon occlusion of the LAD can successfully be performed in pigs to create 
reperfused or occlusive myocardial infarction. The technique allows for a relatively short 
preparation time compared with open-chest surgery, control over the duration of ischemia, 
and standardization the location of the occlusion and infarcts size. The resulting changes of 
the myocardial function are solely due to the ischemic injury. This renders results obtained 
 
Advances in Electrocardiograms – Clinical Applications 
 
180 
with this model more easily interpretable. Furhtermore, this model is advantageous for MRI 
studies because the heart is not exposed, so that susceptibility artifacts that arise from the 
myocardium-air border in open chest-models are avoided (Krombach et al., 2005). 
2.1.5 Coronary atherosclerosis in swine 
Recently, advanced coronary atherosclerosis in swine was produced by combination of 
balloon-catheter injury and cholesterol feeding (Li et al., 2009). In this study, twelve Chinese 
experimental miniature swine (CEMS) were randomly divided into Control and Model 
groups.  In the model, fed with high fat diet for 2 weeks, the pigs underwent left coronary 
angiography and balloon over dilation in left anterior descending artery (LAD) followed by 
continuous feeding with high fat diet for 8 weeks. At the end of 10 weeks, an IVUS catheter 
was guided to the LAD artery. Intravascular ultrasound and virtual histology (IVUS-VH) 
data analysis was based on border contour calculation from gray scale. Coronary 
angiography with (IVUS) and virtual histology (VH) will help us to detect the process of 
coronary atherosclerosis during coronary heart disease (CHD). IVUS classified the plaque as 
concentric, with fibrous 62.8%, fibro-lipidic 12.7%, necrotic 15.5%, and calcific 8.9% tissue. In 
vitro histopathology correctly identified the different presence of fibrous tissue, and 
different extent of stenosis, which was consistently correlative to the result of IVUS-VH (Fig. 
2.). These models provide essential help for researchers to better understand the 
pathophysiological implications of the heart diseases, from endothelium injury to plaque 
stability, from marker protein expressions to cell death pattern. All these findings will not 
only present one of the scientific answers to the pathogenesis of model animals with 
coronary atherosclerotic heart diseases (coronary heart disease, CHD), but also will facilitate 
to interpret the scientific insights of prevention and therapeutic strategy. 
 
 
Fig. 2. LAD angiography and IVUS-VH after balloon injury in swine fed with high-fat diet 
for different time (1, 2, 8w). (A, C, E) LAD angiography; (B, D, F) IVUS-VH. 
2.1.6 Transgenic animal models for cardiovascular diseases 
For economic reasons and with the help of genetically targeted mouse manipulated in the 
laboratory, considerable basic and applied cardiovascular experimentation has been 
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performed in mice and rats; on the assumption that the results can be translated to humans. 
Transgenic mice are widely accepted and used in many labs. To delve the roles of 
prostaglandin H synthase-1 and prostaglandin H-synthase-2, known colloquially as COX-1 
(target of aspirin: first level heart disease prevention drug) and COX-2 (target of many anti-
inflammatory drugs), in cardiovascular systems, Four different strains of mice were 
successfully generated and characterized including: (i) genetic knockdown of COX-1 (80-
97% reduction) (Yu et al., 2005); (ii) genetic knockdown of COX-2 (80-95 % reduction) (Seta 
et al., 2009); (iii) knock-in of a point mutation at the COX-2 active site to abolish 
cyclooxygenase activity and leave peroxidase activity intact Ptgs2Y385F (Yu et al., 2006); and 
(iv) exchange of COX-1 into the COX-2 locus (Yu et al., 2007a). But before we head to set up 
more transgenic knock-in and/or knock-out mice, we should keep our own brain cool to 
think over the necessity and specific characters in each animal model.  
Tiny mouse’s heart muscle mass (<100 mg) as compared to about 500 g in the human heart 
presents problems of magnitude and architectural complexity. This may partially explain 
why so many effective investigational new drugs withdraw market after phase 3 clinical 
trials even they have show promising pharmacological effects in experimental animal 
models. Scientist resorted to another popular rodent animal: rat. But hampered by lacking 
specific techniques to manipulate the rat stem cells which have been working very well in 
mice, rats were kicked out of the transgenic game for a long time. Zinc-Finger Nucleases 
(ZFN) technology to generate knock-in rats in which foreign genes have been inserted, or 
‘knocked-in’, into the rat genome in a precisely targeted manner (Geurts et al., 2009). This 
breakthrough achievement represents a major step forward in the creation of a transgenic 
animal, which may serve as more predictive models of human disease, especially in 
cardiovascular diseases. For example, first rat knockout in the renin-angiotensin system has 
demonstrated the efficacy of the ZFN technology for creating knockout rats for 
cardiovascular disease on any genetic background (Moreno et al., 2011). 
2.1.7 Computer-based simulation of ischemia and reperfusion model 
Experimental models, however, have their own set of limitations that hamper the 
comprehensive evaluation of heart functional mechanisms. At the end of the last century, 
some scientists pursued to develop a biochemically and biophysically detailed model that 
could provide a novel approach to studying myocardial ischaemia and reperfusion (Ch'en et 
al., 1998). Over the last decade, analysis of electrophysiological phenomena following 
coronary occlusion has been significantly augmented and advanced by the use of 
mathematical modeling and computer simulations, from the ionic channel to the whole 
organ. One of the major contributions of computational research in electrophysiology has 
been the ability of mathematical models to dissect various effects and to tease out important 
relations between electrophysiological parameters. This part has been well reviewed by 
others (Rodriguez et al., 2006). 
2.2 Evaluation of myocardial ischemia and infarction 
Conventional 12-lead electrocardiography (ECG) as well as analysis of serum markers still 
play a non-replaceable role clinically and even in the animal model research. In addition, a 
number of special techniques such as echocardiography, nuclear magnetic resonance 
imaging (MRI) (Wright et al., 2009), computed tomography (CT) (Baks et al., 2006; Buecker 
et al., 2005; Mahnken et al., 2005), single photon emission computed tomography (SPECT), 
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with this model more easily interpretable. Furhtermore, this model is advantageous for MRI 
studies because the heart is not exposed, so that susceptibility artifacts that arise from the 
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pathophysiological implications of the heart diseases, from endothelium injury to plaque 
stability, from marker protein expressions to cell death pattern. All these findings will not 
only present one of the scientific answers to the pathogenesis of model animals with 
coronary atherosclerotic heart diseases (coronary heart disease, CHD), but also will facilitate 
to interpret the scientific insights of prevention and therapeutic strategy. 
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performed in mice and rats; on the assumption that the results can be translated to humans. 
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(target of aspirin: first level heart disease prevention drug) and COX-2 (target of many anti-
inflammatory drugs), in cardiovascular systems, Four different strains of mice were 
successfully generated and characterized including: (i) genetic knockdown of COX-1 (80-
97% reduction) (Yu et al., 2005); (ii) genetic knockdown of COX-2 (80-95 % reduction) (Seta 
et al., 2009); (iii) knock-in of a point mutation at the COX-2 active site to abolish 
cyclooxygenase activity and leave peroxidase activity intact Ptgs2Y385F (Yu et al., 2006); and 
(iv) exchange of COX-1 into the COX-2 locus (Yu et al., 2007a). But before we head to set up 
more transgenic knock-in and/or knock-out mice, we should keep our own brain cool to 
think over the necessity and specific characters in each animal model.  
Tiny mouse’s heart muscle mass (<100 mg) as compared to about 500 g in the human heart 
presents problems of magnitude and architectural complexity. This may partially explain 
why so many effective investigational new drugs withdraw market after phase 3 clinical 
trials even they have show promising pharmacological effects in experimental animal 
models. Scientist resorted to another popular rodent animal: rat. But hampered by lacking 
specific techniques to manipulate the rat stem cells which have been working very well in 
mice, rats were kicked out of the transgenic game for a long time. Zinc-Finger Nucleases 
(ZFN) technology to generate knock-in rats in which foreign genes have been inserted, or 
‘knocked-in’, into the rat genome in a precisely targeted manner (Geurts et al., 2009). This 
breakthrough achievement represents a major step forward in the creation of a transgenic 
animal, which may serve as more predictive models of human disease, especially in 
cardiovascular diseases. For example, first rat knockout in the renin-angiotensin system has 
demonstrated the efficacy of the ZFN technology for creating knockout rats for 
cardiovascular disease on any genetic background (Moreno et al., 2011). 
2.1.7 Computer-based simulation of ischemia and reperfusion model 
Experimental models, however, have their own set of limitations that hamper the 
comprehensive evaluation of heart functional mechanisms. At the end of the last century, 
some scientists pursued to develop a biochemically and biophysically detailed model that 
could provide a novel approach to studying myocardial ischaemia and reperfusion (Ch'en et 
al., 1998). Over the last decade, analysis of electrophysiological phenomena following 
coronary occlusion has been significantly augmented and advanced by the use of 
mathematical modeling and computer simulations, from the ionic channel to the whole 
organ. One of the major contributions of computational research in electrophysiology has 
been the ability of mathematical models to dissect various effects and to tease out important 
relations between electrophysiological parameters. This part has been well reviewed by 
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Conventional 12-lead electrocardiography (ECG) as well as analysis of serum markers still 
play a non-replaceable role clinically and even in the animal model research. In addition, a 
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et al., 2005; Mahnken et al., 2005), single photon emission computed tomography (SPECT), 
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and positron emission tomography (PET) have been devised to support diagnosis in the 
patients who show ambiguous symptoms and ECG findings. Major advantage of these latter 
methods is that infarct size can be non-invasively and repeatedly measured in vivo. Major 
limitation of the non-invasive imaging techniques in humans is the lack of quantification of 
the risk zone.  
In preclinical small animal models, the use of above mentioned novel non-invasive imaging 
techniques is also limited due to several technical problems (e.g. lack of area at risk 
determination, insufficient temporal and spatial resolution, irradiation, etc.) and their high 
cost. Therefore, direct post-sacrifice techniques such as e.g. the triphenyltetrazolium (TTC) 
staining as well as nitroblue tetrazolium (NBT) staining, is still the most widely used, low-
cost method to assess infarct size in animal models. 
2.2.1 Modified ECG and multiple-electrode mapping 
Identifying patients at risk of ST segment elevations (most frequently observed in heart 
attack) by use of body surface electrical measures is controversial. To probe the principal 
variations during myocardial ischemia, scientists have pursued to measure the 
electrophysiological changes of heart by modified ECG (s). In our lab, to circumvent some of 
these problems and to further our knowledge of the cardiovascular disorders we have 
undertook a series of investigations that consisted of designing novel modified ECG since 
1970s. Two different modified ECGs were successfully developed and characterized 
including: epicardial electrograms (Li, 1978; Liu et al., 2002) and body surface ECG (BS-
ECG) (Liu et al., 2007b). See the section “EECG and BS-ECG” below for the details. 
Other lab worldwide besides our lab should also be reviewed here as to design very 
sensitive, multiple-electrode mapping technology. Mimicking the body 12-lead ECG, 
scientists from University of Oxford recorded ventricular epicardial electrograms from 5 
anesthetized pigs with a 127-electrode sock and simultaneously investigated torso ECG 
using a specifically designed vest with 256 ECG electrodes. One of breakthroughs they have 
made in this study is that with chest reclosed, simultaneous arrays of epicardial 
electrograms and torso ECGs can be recorded during LAD occlusion and reperfusion (Nash 
et al., 2003).  
The earlier identification of coronary occlusion with ST-segment elevation, the better 
outcomes patients undergoing heart attack may have due to timing of revascularization. 
Using an implantable, high-fidelity, intracardiac electrogram monitoring system with long-
range telemetry in porcine subjected to acute coronary occlusion precipitated by stent 
thrombosis, researchers from Michigan State University real-timely detected acute ST-
segment elevation and analyzed its correlations with thrombotic coronary occlusion. High 
sensitivity and specificity (100% and 100%, respectively) in such a system make it possible to 
advance the time frame of reperfusion therapy and potentially prevent, rather than 
interrupt, acute myocardial infarction in patients with coronary artery disease (Fischell et 
al., 2006). 
In a porcine acute infarct and reperfusion model induced by balloon occlusion of the left 
anterior descending coronary artery for 45 minutes, endocardial electromechanical mapping 
(EMM) was performed to evaluat the extent of myocardial ischemia. Even though there was 
significant intersegmental threshold variability at baseline and after infarction, the 
electromechanical activity thresholds, for infarct detection, could be established. In this 
study, the capacity of separating myocardium with evolving necrosis from viable 
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myocardium was so promising that would result in potential clinical uses (Odenstedt et al., 
2003).  
2.2.2 Advanced imaging systems 
Conventional methods to quantify infarct size after myocardial infarction in mice are not 
ideal. Cardiologists therefore implemented a fast, high-resolution method to directly 
measure infarct size in vivo using three-dimensional (3D) late gadolinium enhancement 
MRI (3D-LGE). They had validated an improved 3D MRI method to noninvasively quantify 
infarct size in mice with unsurpassed spatial resolution and tissue contrast. This method is 
particularly suited to studies requiring early quantification of initial infarct size, for 
example, to measure damage before intervention with stem cells (Bohl et al., 2009). Another 
study group combined the small-animal PET and MRI data to acquire quantitative in vivo 
insights into cardiac pathophysiology, and sought to determine the feasibility of PET and 
MRI for the quantification of ischemic injury in the rat model. Successful integrating 
information from small-animal PET and clinical MRI instrumentation allows for the 
quantitative assessment of cardiac function and infarct size in the rat model. The MRI 
measurements of scar can be complemented by metabolic imaging, addressing the extent 
and severity of ischemic injury and providing endpoints for therapeutic interventions 
(Higuchi et al., 2007). 
2.2.3 Histological analysis of infarct size 
In preclinical studies, still the postmortem histological analysis is considered to be the gold 
standard for measuring infarct size. However, there are a number of disadvantages of this 
technique, making a reliable non-invasive alternative highly desirable. First, histological 
methods leave no residual tissue for further analysis. Second, visual interpretation and 
planimetry of heart sections may be subjective in cases with poor viable/non-viable contrast 
due to hemoglobin residues within the necrotic regions or with TTC-induced geometric 
distortion of the sample. Finally, animals must be euthanized to measure injury, meaning 
longitudinal studies require separate groups of animals for each time point (Bohl et al., 
2009). 
Conventional TTC staining allows the quantification of infarct size much sooner than 
standard histological techniques, and has been shown to be equally sensitive and specific. 
Therefore, the direct post-sacrifice techniques such as e.g. the TTC staining, is still the most 
widely used, low-cost and high throughput method to assess infarct size in animal models 
(Skrzypiec-Spring et al., 2007). 
2.2.4 Other novel methodologies 
Many new methods were employed in cardiovascular functional measurement after 
ischemia or infarction. By using a three-axis accelerometer, researchers developed a novel 
technique for continuous real-time assessment of myocardial ischaemia in 14 anaesthetized 
open-chest pigs. Two accelerometers sutured on the left ventricle (LV) surface in the 
perfusion areas of the left anterior descending (LAD) and circumflex (CX) arteries, 
measured acceleration in the longitudinal, circumferential, and radial directions, and the 
corresponding epicardial velocities were calculated. The accelerometer had the ability to 
distinguish ischaemia from interventions altering global myocardial function, by which the 
myocardial ischaemia can be monitored in a continuous real-time mode (Halvorsen et al., 
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and positron emission tomography (PET) have been devised to support diagnosis in the 
patients who show ambiguous symptoms and ECG findings. Major advantage of these latter 
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limitation of the non-invasive imaging techniques in humans is the lack of quantification of 
the risk zone.  
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determination, insufficient temporal and spatial resolution, irradiation, etc.) and their high 
cost. Therefore, direct post-sacrifice techniques such as e.g. the triphenyltetrazolium (TTC) 
staining as well as nitroblue tetrazolium (NBT) staining, is still the most widely used, low-
cost method to assess infarct size in animal models. 
2.2.1 Modified ECG and multiple-electrode mapping 
Identifying patients at risk of ST segment elevations (most frequently observed in heart 
attack) by use of body surface electrical measures is controversial. To probe the principal 
variations during myocardial ischemia, scientists have pursued to measure the 
electrophysiological changes of heart by modified ECG (s). In our lab, to circumvent some of 
these problems and to further our knowledge of the cardiovascular disorders we have 
undertook a series of investigations that consisted of designing novel modified ECG since 
1970s. Two different modified ECGs were successfully developed and characterized 
including: epicardial electrograms (Li, 1978; Liu et al., 2002) and body surface ECG (BS-
ECG) (Liu et al., 2007b). See the section “EECG and BS-ECG” below for the details. 
Other lab worldwide besides our lab should also be reviewed here as to design very 
sensitive, multiple-electrode mapping technology. Mimicking the body 12-lead ECG, 
scientists from University of Oxford recorded ventricular epicardial electrograms from 5 
anesthetized pigs with a 127-electrode sock and simultaneously investigated torso ECG 
using a specifically designed vest with 256 ECG electrodes. One of breakthroughs they have 
made in this study is that with chest reclosed, simultaneous arrays of epicardial 
electrograms and torso ECGs can be recorded during LAD occlusion and reperfusion (Nash 
et al., 2003).  
The earlier identification of coronary occlusion with ST-segment elevation, the better 
outcomes patients undergoing heart attack may have due to timing of revascularization. 
Using an implantable, high-fidelity, intracardiac electrogram monitoring system with long-
range telemetry in porcine subjected to acute coronary occlusion precipitated by stent 
thrombosis, researchers from Michigan State University real-timely detected acute ST-
segment elevation and analyzed its correlations with thrombotic coronary occlusion. High 
sensitivity and specificity (100% and 100%, respectively) in such a system make it possible to 
advance the time frame of reperfusion therapy and potentially prevent, rather than 
interrupt, acute myocardial infarction in patients with coronary artery disease (Fischell et 
al., 2006). 
In a porcine acute infarct and reperfusion model induced by balloon occlusion of the left 
anterior descending coronary artery for 45 minutes, endocardial electromechanical mapping 
(EMM) was performed to evaluat the extent of myocardial ischemia. Even though there was 
significant intersegmental threshold variability at baseline and after infarction, the 
electromechanical activity thresholds, for infarct detection, could be established. In this 
study, the capacity of separating myocardium with evolving necrosis from viable 
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myocardium was so promising that would result in potential clinical uses (Odenstedt et al., 
2003).  
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Conventional methods to quantify infarct size after myocardial infarction in mice are not 
ideal. Cardiologists therefore implemented a fast, high-resolution method to directly 
measure infarct size in vivo using three-dimensional (3D) late gadolinium enhancement 
MRI (3D-LGE). They had validated an improved 3D MRI method to noninvasively quantify 
infarct size in mice with unsurpassed spatial resolution and tissue contrast. This method is 
particularly suited to studies requiring early quantification of initial infarct size, for 
example, to measure damage before intervention with stem cells (Bohl et al., 2009). Another 
study group combined the small-animal PET and MRI data to acquire quantitative in vivo 
insights into cardiac pathophysiology, and sought to determine the feasibility of PET and 
MRI for the quantification of ischemic injury in the rat model. Successful integrating 
information from small-animal PET and clinical MRI instrumentation allows for the 
quantitative assessment of cardiac function and infarct size in the rat model. The MRI 
measurements of scar can be complemented by metabolic imaging, addressing the extent 
and severity of ischemic injury and providing endpoints for therapeutic interventions 
(Higuchi et al., 2007). 
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In preclinical studies, still the postmortem histological analysis is considered to be the gold 
standard for measuring infarct size. However, there are a number of disadvantages of this 
technique, making a reliable non-invasive alternative highly desirable. First, histological 
methods leave no residual tissue for further analysis. Second, visual interpretation and 
planimetry of heart sections may be subjective in cases with poor viable/non-viable contrast 
due to hemoglobin residues within the necrotic regions or with TTC-induced geometric 
distortion of the sample. Finally, animals must be euthanized to measure injury, meaning 
longitudinal studies require separate groups of animals for each time point (Bohl et al., 
2009). 
Conventional TTC staining allows the quantification of infarct size much sooner than 
standard histological techniques, and has been shown to be equally sensitive and specific. 
Therefore, the direct post-sacrifice techniques such as e.g. the TTC staining, is still the most 
widely used, low-cost and high throughput method to assess infarct size in animal models 
(Skrzypiec-Spring et al., 2007). 
2.2.4 Other novel methodologies 
Many new methods were employed in cardiovascular functional measurement after 
ischemia or infarction. By using a three-axis accelerometer, researchers developed a novel 
technique for continuous real-time assessment of myocardial ischaemia in 14 anaesthetized 
open-chest pigs. Two accelerometers sutured on the left ventricle (LV) surface in the 
perfusion areas of the left anterior descending (LAD) and circumflex (CX) arteries, 
measured acceleration in the longitudinal, circumferential, and radial directions, and the 
corresponding epicardial velocities were calculated. The accelerometer had the ability to 
distinguish ischaemia from interventions altering global myocardial function, by which the 
myocardial ischaemia can be monitored in a continuous real-time mode (Halvorsen et al., 
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2009). With the support of interventional techniques, intravascular ultrasound probe or 
intravascular Doppler velocimetry can be introduced into coronary artery and epicardial 
cross-sectional area and coronary flow velocity can be detected (Hutchison et al., 2005). 
Some study indicated that endocardial voltage amplitudes were closely related with 
sustaining myocardial ischemia or infarction. LV endocardial unipolar voltage (UpV) 
mapping was performed using the Biosense 3D navigation system 4 weeks after ameroid 
constrictor placement around the left circumflex coronary artery. Meanwhile, 
echocardiography was used to assess regional changes in myocardial wall thickening (MT) 
and fluorescent microspheres (4 x 10/injection) were used to quantify rest regional 
myocardial blood flow (MBF) in ischemic (left circumflex)  and remote non-ischemic (left 
anterior descending) regions (Fuchs and Kornowski, 2005).  
2.3 EECG and BS-ECG 
Once a new myocardial ischemic/infarction model was to be established, validating it 
should be placed on the first priority. Without any doubt, traditional electrocardiogram is 
of first choice. Since 1970 last century, we have made much effort in developing 
practically modified electrocardiograms. The first one is so-called 30-point epicardial 
electrocardiogram (EECG), which was introduced in exposed heart. The multi-point 
epicardial electrodes were sutured on the ventricular surface and physiological monitor 
was connected to record the electrocardiogram (EECG). (Fig. 3. ) ST segment elevated 
more than 2 mV was regarded as ischemic criterion to calculate the degree of myocardial 
ischemia (total mV of ST segment elevating, Σ-ST) and myocardial ischemic scope (total 
point number of ST segment elevating, N-ST) (Liu et al., 2007a; Liu et al., 2002; Yu et al., 
2007b). (Fig. 4. and 5.) 
 
 
Fig. 3. Schematic components of EECG mapping system (A) and representative EECG in 
swine (B). 
Body surface electrocardiogram (BS-ECG) is another well designed method, especially for 
closed chest and repeated measurement during a long period. The 30 point electrode was 
placed on the chest surface in the cardiac projective area and then connected to recorder 
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Fig. 4. The degree of myocardial ischemia (Σ-ST) determined by the epicardiogram 
mapping. We proposed that the percent of ischemic condition (before treatment) was 
100%,Σ-ST % was obtained by the comparison with ischmemic condition. DIL, diltiazem, a 
classical calcium channel blocker. Pre-Tre: pre-treatment, Post-Tre: post-treatment. *P<0.05, 




Fig. 5. The scope of myocardial ischemia (N-ST) determined by the epicardiogram mapping. 
We proposed that the percent of ischemic condition (before treatment) was 100%, N-ST % 
was obtained by the comparison with ischmemic condition. DIL, diltiazem, a classical 
calcium channel blocker.  Pre-Tre: pre-treatment, Post-Tre: post-treatment. *P<0.05, **P<0.01 
vs Control. 
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(Fig. 6.) (Liu et al., 2007b). Differently from EECG criteria due to relatively lower voltage on 
the skin, in BS-ECG, ST segment elevated to more than 0.8 mV was regarded as criterion to 
calculate the degree of myocardial ischemia (total mV of ST segment elevating, Σ-ST) and 
myocardial ischemic scope (total point number of ST segment elevating, N-ST). At the end 
of the protocol, the animals sacrificed and heart taken out. Under the coronary occlusion 
spot, the ventricle was transversely divided into 5 pieces of equal thickness. The pieces were 
then infiltrated with N-BT staining solution at 25 °C for 15 min. Both the ischemic area (N-
BT non-stained area, white to grey) and non-ischemic area (N-BT-stained area, dark brown) 
were determined by histological methods. 
 
 
Fig. 6. BS-ECG machine (A), myocardium slices (B) (dark brown: live muscle; white: dead 
muscle), and BS-ECG (C). 
3. Conclusion 
The last few decades have seen significant advancement in the therapy of ischemic heart 
diseases. This is a direct outcome of the increasing knowledge of the molecular mechanisms 
involved during an ischemic insult of the myocardium. Another important factor is the 
development of animal model study, both academically and practically. The miniature 
swine was now widely used as research subject because of its anatomic similarity in 
coronary circulation to human beings (Hughes et al., 2003). Chest-closed improvement has 
been one of breakthroughs since birth of interventional technology. The newly introduced 
intervention technique avoided thoracotomy and disturbance to the environment of thoracic 
cavity. Moreover, cardiovascular variations could be chronically, continually and 
systematically observed in these models. 
Despite tremendous advances in cardiovascular research and clinical therapy, ischemic 
heart disease remains the leading cause of serious morbidity and mortality in western 
society and is growing in developing countries. For researchers involving in basic science of 
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heart diseases, one of the primary impediments to successful drug R&D is the frequent 
failure of successfully translating positive results obtained in animal models to human 
disease. To a large degree, this discrepancy is secondary to the substantial biological 
differences between species. We hope the information contained in this chapter will be 
helpful for researchers to consider prospectively their research plan regarding with 
myocardial ischemia/infarction animal study, which will someday bridge the gap between 
disease and the key molecular processes involved. 
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1. Introduction 
In the life of a human being, the early neonatal period is the most prone to life-threatening 
events. After birth, following the transition from the intra- to the extra–uterine environment, 
babies experience dramatic hemodynamic changes. Once babies begin life in the extra-
uterine environment, they must regulate their own homeostasis in order to survive. Preterm, 
low birth weight, newborn are even more vulnerable and require the mechanical support for 
proper tissue oxygenation and nutrition in order to grow and survive in the extra-uterine 
environment. The adaptation to extra-uterine life is a slow and difficult process for these 
babies because of their prematurity.  
At this critical period, hypothermia, apnoea, respiratory distress, and cardiac instabilities 
such as bradycardia and hypotension are common features in these newborn babies (Bhatt 
et al., 2010; Di Fiore et al.,2001; Dransfield et al., 1983; Tirosh et al., 2010; Trevisanuto et al., 
2005; Upton, et al., 1992), and the resulting hypoxia may lead to brain damage and cardiac 
arrest if the medical support of a special incubator equipped with a ventilator and systemic 
monitoring is not provided a as a “primary life support system”. Therefore, the continuous 
monitoring of heartbeat, respiration, oxygen saturation, blood pressure and temperature has 
been integrated into the neonatal intensive care unit (NICU) as a mandatory tool to support 
the fragile clinical conditions of these infants. 
Monitoring data collected using non-invasive electrocardiograms have been used to 
understand the physiological regulatory system of these vulnerable infants. The 
measurement of heart rate variability has been widely examined using various analytic 
methods (Ardura et al., 1997; Baldzer et al., 1989; Katona et al.,1980; Patural et al., 2004; 
Yiallourou et al., 2010). Among them, circadian rhythms have been documented to be a 
prognostic marker of physiological stability and the maturation of the physiological 
regulatory system, which can be defined as the long-term regulatory system. The 
endogenous circadian rhythm is generated by the endogenous biological clock located in the 
anterior hypothalamic suprachiasmatic nuclei (Panda et al., 2002) and may be modulated by 
exogenous factors (Reppert & Weaver, 2002). It has been documented in the growing foetus 
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(Patrick et al., 1982) controlled by maternal circadian signal (Seron-Ferre M et al). In full-
term neonates, circadian rhythm are documented after birth, subsequently disappear and 
are not detectable within 3 or 4 weeks of postnatal age (Dimitriou et al., 1999; Mirmiran & 
Kok, 1991). However, in preterm neonates, the development of circadian rhythms is still 
controversial (Ardura et al., 1997; Begum et al, 2006; Bueno et al., 2001; Dimitriou et al., 1999; 
Korte et al., 2001; Mirmiran & Kok, 1991; Schimmel et al., 2002; Updike et al., 1985; Weinert 
et al., 1994) and the clinical relevance remains obscure. 
Heart rate variability (HRV), derived from fast Fourier transform analysis of the R to R 
interval (RR interval) using an electrocardiogram, is another popular method to assess the 
autonomic nervous system (ANS) (Akselrod et al., 1981; Danguole et al., 2001; Finley et al., 
1987; Kamen, 1996; Malik, 1996; Mazurak et al., 2010; Pontet et al., 2003; van Geijn et al., 
1980). Continuous changes in sympathetic and parasympathetic neural impulses in the ANS 
induce changes in heart rate and cause oscillations around the mean, which is the HRV 
(Malik, 1996). In a frequency-based analysis of HRV, the low frequency (LF) band (0.04-
0.15Hz) derived from the frequency domain analysis expresses the activity of both the 
sympathetic nervous system (SNS) and parasympathetic nervous system, and the high 
frequency (HF) band (0.15-0.5Hz) expresses the parasympathetic nervous system (PNS) 
activity of the ANS (Akselrod et al., 1981). The LF to HF ratio reflects the sympathovagal 
balances. Reports regarding the relevance of HRV to cardiac-health-related events that 
contribute to the ANS in the foetus, such as asphyxia (Bocking, 2003), foetal distress (Karin 
et al., 1993); in infants, such as respiratory distress, apnoea, sepsis, bradycardia (Bennet & 
Gunn, 2009; Frasch et al., 2009; Li et al., 2005; Logier et al., 2008 ; Sampson et al., 1980), and 
hypotension (Di Fiore et al., 2001; Dransfield et al., 1983; Fairchild & O’Shea, 2010; Frasch et 
al., 2009; Upton et al., 1992; Wennergren et al., 1986); and adults, such as stroke and 
myocardial events (Faber, 1996; Korpelainen et al., 1999; Sosnowski et al., 2002), are 
numerous and well-documented. In foetuses and preterm infants, the ANS is highly 
dependent on the SNS while the PNS is immature (Chatow et al., 1995), and the role of the 
PNS increases with the increase in gestational age (Van Leeuwen et al., 2003). Evidence of 
the effect of HRV on the adaptation of the ANS in preterm, low birth weight infants during 
the early neonatal period is not widely available, although it is known that an immature 
ANS is one of the factors contributing to the vulnerability of these infants.  
In this research review, developmental and adaptation changes will be described based on 
heart rate records from ECG monitors. This description will provide an important 
perspective on the developmental physiological homeostasis of preterm infants during the 
early neonatal period in the intensive care unit. 
2. Utilisation of the electrocardiogram - analytical methods of heart rate 
assessment 
2.1 Monitoring and data recording through NICU local area network (LAN) system 
All infants hospitalised in the NICU are monitored via electrocardiogram (ECG) for heart 
rate (HR) and respiration rate (RR), with a pulse oxymeter on the wrist or foot for pulse rate 
(PR) and oxygen saturation by pulse oxymetry (SpO2), and arterial blood pressure (ABP) 
using a catheter manometer system occasionally. In our study, the monitored physiological 
information is transformed to measurement variables using the Wave Achieving System 
(WAS) or Clinical Database Engine (CDE) (Philips Electronics Japan, Tokyo, Japan) through 
NICU LAN system (Fig. 1) (Begum et al., 2006). In this report, we will explain the circadian 
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rhythmicity of neonate as long-term regulatory system and HRV as short-term regulatory 
system of physiological homeostasis. 
 
 
Fig. 1. NICU LAN system for recording physiological parameters. 
2.2 Analysis of the heart rate circadian rhythm as a long-term regulatory system 
2.2.1 Data acquisition and trend removal  
For each patient, the heart rate was continuously recorded for 24 hours for the four postnatal 
periods (P): P1: 0-3, P2: 4-6, P3: 7-13, and P4: 14-21 postnatal days. Subjects with a 
continuous disruption in the data of more than 1 minute were excluded from the study. Any 
linear trend was removed using least square regression methods. 
 
 
Fig. 2. Determination of the dominant cycle using spectral analysis. A: Plot of original data 
for heart rate (HR). B: Periodogram intensities for HR. The largest peak of the periodogram 
was selected as the cycle component. C: The intensity of the cycle corresponding to the 
largest peak in the periodogram was reconstructed to fit the sinusoidal function. The bold 
red line is the detected cycle superimposed on the original data. 
 
Advances in Electrocardiograms – Clinical Applications 
 
194 
(Patrick et al., 1982) controlled by maternal circadian signal (Seron-Ferre M et al). In full-
term neonates, circadian rhythm are documented after birth, subsequently disappear and 
are not detectable within 3 or 4 weeks of postnatal age (Dimitriou et al., 1999; Mirmiran & 
Kok, 1991). However, in preterm neonates, the development of circadian rhythms is still 
controversial (Ardura et al., 1997; Begum et al, 2006; Bueno et al., 2001; Dimitriou et al., 1999; 
Korte et al., 2001; Mirmiran & Kok, 1991; Schimmel et al., 2002; Updike et al., 1985; Weinert 
et al., 1994) and the clinical relevance remains obscure. 
Heart rate variability (HRV), derived from fast Fourier transform analysis of the R to R 
interval (RR interval) using an electrocardiogram, is another popular method to assess the 
autonomic nervous system (ANS) (Akselrod et al., 1981; Danguole et al., 2001; Finley et al., 
1987; Kamen, 1996; Malik, 1996; Mazurak et al., 2010; Pontet et al., 2003; van Geijn et al., 
1980). Continuous changes in sympathetic and parasympathetic neural impulses in the ANS 
induce changes in heart rate and cause oscillations around the mean, which is the HRV 
(Malik, 1996). In a frequency-based analysis of HRV, the low frequency (LF) band (0.04-
0.15Hz) derived from the frequency domain analysis expresses the activity of both the 
sympathetic nervous system (SNS) and parasympathetic nervous system, and the high 
frequency (HF) band (0.15-0.5Hz) expresses the parasympathetic nervous system (PNS) 
activity of the ANS (Akselrod et al., 1981). The LF to HF ratio reflects the sympathovagal 
balances. Reports regarding the relevance of HRV to cardiac-health-related events that 
contribute to the ANS in the foetus, such as asphyxia (Bocking, 2003), foetal distress (Karin 
et al., 1993); in infants, such as respiratory distress, apnoea, sepsis, bradycardia (Bennet & 
Gunn, 2009; Frasch et al., 2009; Li et al., 2005; Logier et al., 2008 ; Sampson et al., 1980), and 
hypotension (Di Fiore et al., 2001; Dransfield et al., 1983; Fairchild & O’Shea, 2010; Frasch et 
al., 2009; Upton et al., 1992; Wennergren et al., 1986); and adults, such as stroke and 
myocardial events (Faber, 1996; Korpelainen et al., 1999; Sosnowski et al., 2002), are 
numerous and well-documented. In foetuses and preterm infants, the ANS is highly 
dependent on the SNS while the PNS is immature (Chatow et al., 1995), and the role of the 
PNS increases with the increase in gestational age (Van Leeuwen et al., 2003). Evidence of 
the effect of HRV on the adaptation of the ANS in preterm, low birth weight infants during 
the early neonatal period is not widely available, although it is known that an immature 
ANS is one of the factors contributing to the vulnerability of these infants.  
In this research review, developmental and adaptation changes will be described based on 
heart rate records from ECG monitors. This description will provide an important 
perspective on the developmental physiological homeostasis of preterm infants during the 
early neonatal period in the intensive care unit. 
2. Utilisation of the electrocardiogram - analytical methods of heart rate 
assessment 
2.1 Monitoring and data recording through NICU local area network (LAN) system 
All infants hospitalised in the NICU are monitored via electrocardiogram (ECG) for heart 
rate (HR) and respiration rate (RR), with a pulse oxymeter on the wrist or foot for pulse rate 
(PR) and oxygen saturation by pulse oxymetry (SpO2), and arterial blood pressure (ABP) 
using a catheter manometer system occasionally. In our study, the monitored physiological 
information is transformed to measurement variables using the Wave Achieving System 
(WAS) or Clinical Database Engine (CDE) (Philips Electronics Japan, Tokyo, Japan) through 
NICU LAN system (Fig. 1) (Begum et al., 2006). In this report, we will explain the circadian 
The Emergence and Development of 
Physiological Regulatory Systems of Newborn Infants in a Neonatal Intensive Care Unit 
 
195 
rhythmicity of neonate as long-term regulatory system and HRV as short-term regulatory 
system of physiological homeostasis. 
 
 
Fig. 1. NICU LAN system for recording physiological parameters. 
2.2 Analysis of the heart rate circadian rhythm as a long-term regulatory system 
2.2.1 Data acquisition and trend removal  
For each patient, the heart rate was continuously recorded for 24 hours for the four postnatal 
periods (P): P1: 0-3, P2: 4-6, P3: 7-13, and P4: 14-21 postnatal days. Subjects with a 
continuous disruption in the data of more than 1 minute were excluded from the study. Any 
linear trend was removed using least square regression methods. 
 
 
Fig. 2. Determination of the dominant cycle using spectral analysis. A: Plot of original data 
for heart rate (HR). B: Periodogram intensities for HR. The largest peak of the periodogram 
was selected as the cycle component. C: The intensity of the cycle corresponding to the 
largest peak in the periodogram was reconstructed to fit the sinusoidal function. The bold 
red line is the detected cycle superimposed on the original data. 
 
Advances in Electrocardiograms – Clinical Applications 
 
196 
2.2.2 Analysis of circadian rhythm  
Circadian rhythmicity can be analyzed using various methods such as chi square 
periodogram, cosinor analysis.In our study, the existence of rhythmicity was analysed using 
power spectral analysis (periodogram) with SPSS 11.5 software (SPSS Inc. Chicago, IL) 
(Warner, 1998). Briefly, 24-hour sessions in 10-second intervals were run and aggregated 
into 1-minute time blocks. A periodogram analysis was performed using a time series of 
1440 minutes. The Fisher test was used to assess the statistical significance of the cycle 
components (N = 1440, α = 0.05) (Russell, 1985). In our study, the cycle with the largest peak 
in the periodogram was considered to be the dominant cycle for each time series among the 
significant cycles. All dominant cycles were confirmed by Fourier analysis, further circadian 
cycles were confirmed by cosinor analysis with a significance of p < 0.05 by least squares 
analysis (Fig. 2) (Nelson, 1993). 
2.3 Analysis of heart rate variability (HRV) as a short - term regulatory system 
2.3.1 Data acquisition of RR interval and the detection of outliers  
To calculate R to R intervals in our study, for each patient, the heart rate wave was digitally 
transported to the CDE system, and the digital data for the heart rate was exported as a CSV 
file at a sampling rate of 500Hz. The RR interval was calculated by using MemCalc (GMS, Tokyo, 
Japan) which is statistical software specialised for entropy-based spectral analysis (Fig. 3).  
 
 
Fig. 3. Transformation of the RR interval from the waveform of a heart rate signal.  
The data set obtained for the RR interval was visually inspected to identify any abnormal R 
– waves or artefacts. The presence of outliers in the RR interval data set can adversely effect 
both the time and the frequency domain analyses of HRV. Data outside of three standard 
deviations from the mean of RR interval data set were assumed to be statistically irrelevant 
and were tagged as outliers unless they were part of a trend (Niles, 2003). The missing 
values were replaced by the mean of the total data set.  
2.3.2 Methods for HRV analysis - time domain analysis, frequency domain analysis 
and Poincare plot of the RR interval 
Heart rate variability can be analysed in two ways: time domain and frequency domain 
analyses (Akselrod et al., 1981; Malik, 1996). For a geometric representation of the RR 
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interval, the non-linear Poincare plot can be analysed (Brennan et al., 2002). In this study, we 
have used the Heart Rate Variability Software (Kubios HRV, version 2.0) to analyse the time 
domain and frequency domain analysis as well as Poincare plot also. 
2.3.2.1 Time domain analysis 
Time domain measurements can be easily described using the RR interval data. From the 
time domain analysis, the standard deviation of RR (SDRR), and the root mean square of 
successive differences (RMSSD) were calculated as follows: 





   
The root mean square of successive differences (RMSSD) 




( )N n nnN RR RR


   
2.3.2.2 Frequency domain analysis of the RR interval 
For the frequency domain analysis, a spectral analysis of the RR interval was performed 
using fast Fourier transformation (FFT). The frequency domain analysis is widely used and 
is well recognised for analysing HRV. The low frequency (LF: 0.04 - 0.15 Hz) band and the 
high frequency (HF: 0.15 - 0.50 Hz) band were calculated.  
2.3.2.3 Poincare plot of the RR interval 
Poincare plots were calculated for the geometric representations of the RR intervals. The 
non-linear Poincare plot presents a figure with each RR interval plotted against the previous 
RR interval (RRn+1, RRn) and provides a detail of beat-to-beat information for the total data 
set (Brennan et al., 2002).  
 
 
Fig. 4. An example Poincare plot: A standard Poincare plot of the R-R intervals of a healthy 
neonate born with 35 weeks of gestational age (GA). SD1 and SD2 represent the dispersion 
along the minor and major axes of the fitted eclipse. 
The SD1, the width of the Poincare plot (the dispersion of points perpendicular to the line of 
identity), expresses the level of short-term heart rate variability, and SD2, the length (the 
dispersion along the line of identity), expresses the level of long-term heart rate variability 
(Fig. 4) (Brennan et al., 2001). The equations for SD1 and SD2 are as follows: 
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Width of RRn vs. RR (n+1) distribution (SD1)2 1 22 SDSD  
Length of RRn vs. RR(n+1) distribution (SD2) 12 222SDSD SDSD   
3. Evidence of circadian rhythmicity during the early neonatal period with 
clinical relevance 
3.1 The development of a circadian rhythm in the neonatal period  
Infants admitted in the NICU are vulnerable because of their physiological instability, and 
hypothermia, apnoea, respiratory distress, bradycardia and hypotension are common 
features for them. Frequent medical examination and therapy are common for them. Within 
this fragile environment, how do they adapt a physiological homeostasis? In our study, we 
have observed the circadian rhythmicity of preterm and full-term infants at four postnatal 
periods to observe their adaptation and developmental processes. The circadian rhythms of 
the heart rate were analysed in 187 neonates. The median GA was 34 weeks (range: 23–42 
weeks). (Begum et al, 2006). 
By analysing the distribution of circadian rhythmicity (Fig. 5), circadian rhythms were 
observed to be dominant among preterm infants (40%, < 28 wks of GA) compared to full-
term infants, and a similar tendency was observed in other periods. These results partially 
support the previous studies (Dimitriou et al., 1999; Mirmiran & Kok, 1991).  
 
 
Fig. 5. The distribution of circadian cycles according to gestational age groups 
In examining the relationship between circadian rhythmicity and post-conceptional age 
(PCA), an analysis of the correlation coefficient was performed using the amplitudes of each 
period. The amplitudes of the heart rate circadian rhythms were positively correlated with 
PCA in all four periods (Fig. 6).  
The higher percentages for the existence of circadian rhythms in preterm infants compared 
to full-term infants suggest that the maternal influence on circadian rhythm may persist in 
preterm infants more strongly than in full-term infants during the neonatal period. 
However, the observed increase in circadian amplitude with PCA implies that the 
magnitude of circadian rhythmicity parallels the maturation of neonates.  
Further, we analysed the heart rate circadian rhythmicity of infants born with small weight 
for gestational age (SGA: birth weight and height bellow < -2SDs) during 0-2 postnatal days 
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and compared with infants born with average weight for gestational age (AGA: > -1.5 to < 
1.5SDs). In the cases for which significant circadian rhythms were observed, significant 
differences were not observed between SGA and AGA infants, however, the amplitudes of 
the heart rate circadian rhythms were significantly smaller in SGA infants compared to 









Fig. 7. The existence and amplitude of circadian rhythms in AGA and SGA neonates. A: 
Distribution of the infants with significant circadian rhythm and significant differences was 
not observed between AGA and SGA. B: Distribution of circadian amplitudes for AGA and 
SGA. The amplitudes were significantly smaller in SGA infants compared to AGA infants. * 
p <0.05, AGA vs. SGA 
A decreased amplitudes in the circadian rhythm of SGA infants as shown above, 
intrauterine growth retardation might have influences on the quality of circadian rhythm 
rather than its existence.  
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4. Evidence of HRV in the early neonatal period and the clinical relevance 
4.1 Experimental observation of alterations in HRV during the hourly neonatal period 
in extremely premature infants 
The ANS plays an important role in the control of the physiological regulation. However, an 
immature ANS has been reported in the preterm infants after birth which prolongs to the 
later life also (De Rogalski Landrot et al., 2007). In preterm infants, particularly in extremely 
premature infants, the early neonatal period is a life-threatening period when cardiac 
failure, shock, loss of variability is frequently occurs to them. Numerous studies on ANS 
have been reported the GA based information with longitudinal evidences (Chatow et al., 
1995; Longin et al., 2005, 2006) in preterm and full-term infants. However, the capacity and 
the recovery of ANS activity of extremely preterm infants immediate birth remain unclear. 
Thus, experimentally we observed the ANS activity of preterm infants born less than 28 
weeks of GA from 3 hours after birth to 7 days to understand the changes into the capacity 
and recovery of ANS. For a micro-observation, ANS activity was observed at 3-hours, 6-
hours, 12-hours, 24-hours, 72-hours and 7-days after birth using a dynamic analytic 
approach of HRV and observed the alterations in ANS through this critical period.  
For analysis of HRV, a 30-minutes ECG signal data set was recorded for the calculation of 
RR interval from 13 extremely premature infants during a rest time at 3-hours, 6-hours, 12-
hours, 24-hours, 72-hours, and 7-days after birth. From time domain analysis of HRV, mean 
RR, Mean HR, SDNN and RMSSD was calculated shown in Fig. 8. With the increase of time 
after birth, heart rates were decreased while RR intervals increased and this relation 
indicates the increase of the ability of the heart to function economically. Further, the 
increases in SDNN and RMSSD with the increase of the time after birth, might be indicated 
an increase in the amount of HRV. The increase in variability, which in turn indicates the 
significant interplay between SNS and PNS of the ANS.  
 
 
Fig. 8. Alterations in the parameters for the time domain analysis of the RR interval for HRV 
through the early neonatal period in extremely preterm infants (n=13). The RR interval was 
obtained for 30 minutes at each time point.  
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The power of LF region and HF region from the frequency domain analysis and SD1 and 
SD1 from Poincare plot analysis was calculated for each session. The power of both the LF 
and the HF was significantly lower at 3 hours or 6 hours after birth compared to the highest 
value at 7-days and the increase of LF and HF with the time after birth may indicate the 
maturation of the ANS. In the Poincare plot analysis, SD1 and SD2 also increased with the 
time after birth (Fig.9).  
 
 
Fig. 9. Alterations in the parameters from the frequency domain analyses and Poincare plot 
analysis of HRV through the early neonatal period (n=13, mean gestational age = 27weeks, 
mean birth body weight = 875g).  
The decreased HRV till 12 hours of birth may indicate the loss of variability immediate birth 
and transition of adaptation period for the short - term regulatory system and the increase of 
HRV from 24-hour to 7-days after birth might be indicated the increase in the ability of the 
adaptation capacity and as a sign of maturity.  
4.2 Experimental observation of pain response during the early neonatal period: 
Three case analyses for three different gestational ages 
The adverse consequences of pain response during the early neonatal period have been 
documented by numerous study (Grunau et al., 2006), and an emphasis has been placed on 
pain responses in the NICU (Brown, 2009; Johnston et al., 2010; Stevens et al., 2006, 2010). 
The most common pain event in NICU is blood procurement including heel lance and 
venepuncture (Carbajal et al., 2008). Changes in facial expression, sleep states, heart rate and 
SpO2 are used as indicator of pain response in term infants, not in preterm infants (Stevens 
et al., 1996). The measures calculated from HRV provide sensitive indices to investigate the 
response of stressful stimuli. These indices are very helpful to investigate the pain response 
in preterm infants (Lindh et al., 1999; Morison et al., 2001; Oberlander & Saul, 2002; Padhye 
et al., 2009). The intensity of pain response in infants has been thought to be related with 
ANS activity maturation (Grunau et al., 2006). We have experimentally observed three cases 
with different GA (26, 31, 35 weeks) to analyse the differences in the intensity of the 
response to the pain stimuli during blood sampling. A heel lance episode was divided into 5 
sessions as follows: A: 0-30-second (prior to needle puncture); B: 30-60 second (start of 
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1995; Longin et al., 2005, 2006) in preterm and full-term infants. However, the capacity and 
the recovery of ANS activity of extremely preterm infants immediate birth remain unclear. 
Thus, experimentally we observed the ANS activity of preterm infants born less than 28 
weeks of GA from 3 hours after birth to 7 days to understand the changes into the capacity 
and recovery of ANS. For a micro-observation, ANS activity was observed at 3-hours, 6-
hours, 12-hours, 24-hours, 72-hours and 7-days after birth using a dynamic analytic 
approach of HRV and observed the alterations in ANS through this critical period.  
For analysis of HRV, a 30-minutes ECG signal data set was recorded for the calculation of 
RR interval from 13 extremely premature infants during a rest time at 3-hours, 6-hours, 12-
hours, 24-hours, 72-hours, and 7-days after birth. From time domain analysis of HRV, mean 
RR, Mean HR, SDNN and RMSSD was calculated shown in Fig. 8. With the increase of time 
after birth, heart rates were decreased while RR intervals increased and this relation 
indicates the increase of the ability of the heart to function economically. Further, the 
increases in SDNN and RMSSD with the increase of the time after birth, might be indicated 
an increase in the amount of HRV. The increase in variability, which in turn indicates the 
significant interplay between SNS and PNS of the ANS.  
 
 
Fig. 8. Alterations in the parameters for the time domain analysis of the RR interval for HRV 
through the early neonatal period in extremely preterm infants (n=13). The RR interval was 
obtained for 30 minutes at each time point.  
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The power of LF region and HF region from the frequency domain analysis and SD1 and 
SD1 from Poincare plot analysis was calculated for each session. The power of both the LF 
and the HF was significantly lower at 3 hours or 6 hours after birth compared to the highest 
value at 7-days and the increase of LF and HF with the time after birth may indicate the 
maturation of the ANS. In the Poincare plot analysis, SD1 and SD2 also increased with the 
time after birth (Fig.9).  
 
 
Fig. 9. Alterations in the parameters from the frequency domain analyses and Poincare plot 
analysis of HRV through the early neonatal period (n=13, mean gestational age = 27weeks, 
mean birth body weight = 875g).  
The decreased HRV till 12 hours of birth may indicate the loss of variability immediate birth 
and transition of adaptation period for the short - term regulatory system and the increase of 
HRV from 24-hour to 7-days after birth might be indicated the increase in the ability of the 
adaptation capacity and as a sign of maturity.  
4.2 Experimental observation of pain response during the early neonatal period: 
Three case analyses for three different gestational ages 
The adverse consequences of pain response during the early neonatal period have been 
documented by numerous study (Grunau et al., 2006), and an emphasis has been placed on 
pain responses in the NICU (Brown, 2009; Johnston et al., 2010; Stevens et al., 2006, 2010). 
The most common pain event in NICU is blood procurement including heel lance and 
venepuncture (Carbajal et al., 2008). Changes in facial expression, sleep states, heart rate and 
SpO2 are used as indicator of pain response in term infants, not in preterm infants (Stevens 
et al., 1996). The measures calculated from HRV provide sensitive indices to investigate the 
response of stressful stimuli. These indices are very helpful to investigate the pain response 
in preterm infants (Lindh et al., 1999; Morison et al., 2001; Oberlander & Saul, 2002; Padhye 
et al., 2009). The intensity of pain response in infants has been thought to be related with 
ANS activity maturation (Grunau et al., 2006). We have experimentally observed three cases 
with different GA (26, 31, 35 weeks) to analyse the differences in the intensity of the 
response to the pain stimuli during blood sampling. A heel lance episode was divided into 5 
sessions as follows: A: 0-30-second (prior to needle puncture); B: 30-60 second (start of 
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needle puncture); C: 60-90 second (squeezing for blood collection); D: 90-120 second (30 
second after the end of blood collection); E: 120-150 second (after 60 second of blood 
collection). The RR interval data were analysed separately for each session.  
Frequency domain analyses and Poincare plot analyses were applied to interpret the 
intensity of the response to pain. The distribution of the Fourier plot and Poincare plot is 
shown in Fig 10 and Fig. 11. The total spectral power increased after the pain procedure in 
all cases; however, it was low in the case of a 26-week GA neonate. The spectral power of 
the LF quickly increased following the needle puncture and gradually decreased with the 
cessation of the procedure in a 35-week GA infant. In contrast, the power of the HF was 
delayed in a 31-week GA infant and was low in a 26-week GA infant (Fig10).  
 
 
Fig. 10. A Spectral plot on the intensity of pain response during blood sampling for three 
different GA during early neonatal period. A: 0-30-seconds (prior to needle puncture); B: 30-
60 second (start of needle puncture); C: 60-90 seconds (squeezing for blood sampling); D: 90-
120 seconds (30 seconds after the end of blood sampling); E: 120-150 second (after 60 
seconds of blood sampling).  
 
 
Fig. 11. Poincare plot analysis of the RR interval during blood sampling. A: 0-30 second 
(prior to needle puncture); B: 30-60 second (start of needle puncture); C: 60- 90 second 
(squeezing for blood sampling); D: 90-120 second (30 seconds after the end of blood 
sampling); E: 120-150 second (after 60 seconds of blood sampling).  
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By Poincare analysis of the RR interval, the response of the painful procedure was well 
recognized (Fig. 11). The Poincare plot was strongly shifted to the upper right quadrant in 
the 35-week GA infant, and the shift was small in the 31-week GA infant, while almost no 
shift was observed for the procedure in a 26-week GA infant.  
Based on these findings, we suggest that an increased physiological response to painful 
events is related to the maturity of the ANS, and late preterm infants may be affected more 
strongly than extremely premature infants by painful events. Because of the immaturity of 
the ANS in infants <26 weeks, the response to pain was comparatively lower than that of 
other infants. 
4.3 Kangaroo care for preterm infants as physiological relaxation 
Kangaroo care (KC) has been widely practiced for preterm and low birth weight (LBW) 
infants in the neonatal intensive care unit (NICU). KC is now practiced not only in 
developing countries, but also in developed countries as developmental care because 
improved outcome in mortality and morbidity have been reported in infants who undergo 
KC. There have been many studies performed to evaluate the psychological and 
physiological responses during KC in preterm infants. Although still there is some 
contradiction on the influences of KC in infants, positive influences also reported by many 
literature (Bauer et al., 1997; Fohe et al., 2000; Acolet et al., 1989; Cattaneo et al., 1998; 
Feldman & Eidelman, 2003; Messmer et al., 1997).  
In our study on the physiological responses during kangaroo care, significant differences 
was observed in the spectral power of heart rate within the different sessions (the %LF was 
significantly increased during KC, while %HF was decreased, without significant changes in 
the ratio of LF/HF, Fig. 12). Behavioural states were observed during kangaroo care using 
the Brazelton Neonatal Behaviour Assessment Scale (Brazelton, 1984). The percentage of 
infants with quiet sleep states remarkably increased during KC compared to those before 
KC. This percentage increased further at the end of KC and decreased again 30 minutes after 




Fig. 12. Changes in heart rate variability during KC. A: mean difference in heart rate; B: 
power spectral density of LF and HF; C: ratio of LF/HF. *P < 0.05 (Repeated measures 
ANOVA) 
 
Advances in Electrocardiograms – Clinical Applications 
 
202 
needle puncture); C: 60-90 second (squeezing for blood collection); D: 90-120 second (30 
second after the end of blood collection); E: 120-150 second (after 60 second of blood 
collection). The RR interval data were analysed separately for each session.  
Frequency domain analyses and Poincare plot analyses were applied to interpret the 
intensity of the response to pain. The distribution of the Fourier plot and Poincare plot is 
shown in Fig 10 and Fig. 11. The total spectral power increased after the pain procedure in 
all cases; however, it was low in the case of a 26-week GA neonate. The spectral power of 
the LF quickly increased following the needle puncture and gradually decreased with the 
cessation of the procedure in a 35-week GA infant. In contrast, the power of the HF was 
delayed in a 31-week GA infant and was low in a 26-week GA infant (Fig10).  
 
 
Fig. 10. A Spectral plot on the intensity of pain response during blood sampling for three 
different GA during early neonatal period. A: 0-30-seconds (prior to needle puncture); B: 30-
60 second (start of needle puncture); C: 60-90 seconds (squeezing for blood sampling); D: 90-
120 seconds (30 seconds after the end of blood sampling); E: 120-150 second (after 60 
seconds of blood sampling).  
 
 
Fig. 11. Poincare plot analysis of the RR interval during blood sampling. A: 0-30 second 
(prior to needle puncture); B: 30-60 second (start of needle puncture); C: 60- 90 second 
(squeezing for blood sampling); D: 90-120 second (30 seconds after the end of blood 
sampling); E: 120-150 second (after 60 seconds of blood sampling).  
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By Poincare analysis of the RR interval, the response of the painful procedure was well 
recognized (Fig. 11). The Poincare plot was strongly shifted to the upper right quadrant in 
the 35-week GA infant, and the shift was small in the 31-week GA infant, while almost no 
shift was observed for the procedure in a 26-week GA infant.  
Based on these findings, we suggest that an increased physiological response to painful 
events is related to the maturity of the ANS, and late preterm infants may be affected more 
strongly than extremely premature infants by painful events. Because of the immaturity of 
the ANS in infants <26 weeks, the response to pain was comparatively lower than that of 
other infants. 
4.3 Kangaroo care for preterm infants as physiological relaxation 
Kangaroo care (KC) has been widely practiced for preterm and low birth weight (LBW) 
infants in the neonatal intensive care unit (NICU). KC is now practiced not only in 
developing countries, but also in developed countries as developmental care because 
improved outcome in mortality and morbidity have been reported in infants who undergo 
KC. There have been many studies performed to evaluate the psychological and 
physiological responses during KC in preterm infants. Although still there is some 
contradiction on the influences of KC in infants, positive influences also reported by many 
literature (Bauer et al., 1997; Fohe et al., 2000; Acolet et al., 1989; Cattaneo et al., 1998; 
Feldman & Eidelman, 2003; Messmer et al., 1997).  
In our study on the physiological responses during kangaroo care, significant differences 
was observed in the spectral power of heart rate within the different sessions (the %LF was 
significantly increased during KC, while %HF was decreased, without significant changes in 
the ratio of LF/HF, Fig. 12). Behavioural states were observed during kangaroo care using 
the Brazelton Neonatal Behaviour Assessment Scale (Brazelton, 1984). The percentage of 
infants with quiet sleep states remarkably increased during KC compared to those before 
KC. This percentage increased further at the end of KC and decreased again 30 minutes after 




Fig. 12. Changes in heart rate variability during KC. A: mean difference in heart rate; B: 
power spectral density of LF and HF; C: ratio of LF/HF. *P < 0.05 (Repeated measures 
ANOVA) 
 





Fig. 13. Changes in the behavioural states of infants during KC. Five different behavioural 
states were observed: 1) Quiet sleep; 2) Active sleep; 3) Drowsiness; 4) Alert inactivity; and 
5) Active awake.  
As shown above, an increase in %LF during KC was observed without fluctuation of the 
LF/HF ratio, and infants tended to sleep deeply during KC. These findings suggest that 
parasympathetic nerve activity may be suppressed during KC and that decreased 
parasympathetic nerve activity may induce deep sleep. Improved outcome and health status 
with KC may be due to relaxation of vagal tone.  
5. Conclusion 
In this chapter, we explained the emergence and development of the ANS as physiological 
regulatory systems of new- born infants. Circadian rhythm, we defined it as long-term 
regulatory system, exist immidiate birth and persist through the neonatal period in preterm 
infants, while it does not persist after birth in full-term infants. On the contrary, the heart 
rate variability of extremely premature infants is suppressed on the day of birth and 
increases with time in the early neonatal period. The maternal influence on circadian 
rhythms may be important for extremely premature infants because the autonomic nervous 
system is not fully developed in these infants, as has been shown in the session on 
physiological response to pain. 
In infants with later gestational ages, however, the physiological response to pain is 
stronger. During hospitalisation, infants with later gestational ages may be more sensitive to 
stressful stimuli. Developmental support such as Kangaroo care may offer relief from the 
stressful stimuli of the NICU, and relaxation during their stay in the NICU may be an 
important aspect for improved outcomes and later health status.  
Finally, understanding the development of auto-regulation in newborn infants during the 
early neonatal period provides new information on the factors that influence the 
vulnerability of newborn infants in the NICU. Bedside monitoring of physiological 
hemodynamics and the implications of these monitored variables are key tools for 
neonatologists, not only for improving survival, but also for improving the quality of life for 
these vulnerable infants. 
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1. Introduction 
1.1 Sleep and sleep disorders 
Sleep, which is defined as a passive period in organic physiology until the mid-20th century, 
is accepted to be an indispensable period of life cycle with today’s technological advances. 
While wakefulness is associated with the active excitation of Central Nervous System (CNS), 
sleep has been recognized as a passive period by the elimination of excitation. However, 
recent studies have shown that sleep is independent of wakefulness, generated by a 
sequence of changes in CNS, and a combination of five periods with clear boundaries. Sleep 
is not the disruption of daily life for a period of time or a waste of time. It is an active period 
which is important to renew our mental and physical health everyday and is covering one–
third of our lives. Sleep activity is important for resting during the working period of basal 
metabolism of human body.  
The advances in technology enabling the measurement and quantification of brain activity 
make possible the micro and macro analysis of brain during both sleep and wakefulness 
states. With the studies investigating the CNS, it is observed the existence of some centrals 
causing the sleep by inhibiting the other regions of brain. As a result, sleep, which is an 
active and other state of consciousness, is a brain state of high coordination (Erdamar, 
2007). 
Since breathing is established autonomously during sleep, it is affected by many anatomical 
and physiological parameters. Depending on this situation, various sleep disorders occur. 
There are more than eighty known sleeping diseases. Most of them cause person’s health to 
deteriorate and a decrease in life quality. As a result of the research carried out for many 
years, a list of sleep disorders, which are generally occurring, can be seen as in Table 1. Sleep 
disorders can be examined in two classes, parasomnia and dissomnia.  
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1.2 Sleep respiration disorders 
A significant portion of the sleep disorders are the respiratory disorders during sleep. It is 
thought that sudden deaths during sleep, daytime sleepiness, fatigue and snoring at night are 
caused by respiratory disorders in sleep. Therefore, regular breathing during sleep has vital 
importance for human health (Aksahin, 2010). The most important one of the sleep breathing 
disorders is the sleep apnea. Identification and monitoring of apnea during sleep is of great 
importance. As a result, in order to help physicians during the process of diagnosis and 
treatment of apnea, there are many studies on the topics of the detection and quantitative 
characteristics of sleep apnea using analytical methods from sleep records in literature.  
The most important work on sleep in the field of engineering is the measurement and 
recording of physiological signals during sleep.  
The device used for measuring and recording physiological signals during sleep is called as 
polysomnograph and the signals retrieved from the device are called as polysomnography 
(PSG). By the use of PSG, it is possible to observe the physiological changes in humans 
during sleep.  
Various physiological signals of the patients are recorded simultaneously by the PSG device, 
which has an embedded multi-channel data acquisition system. The recording process made 
as analog recordings in the 90s has left its place to digital recorders after the development of 
digital systems. Thus, the prevention of errors caused by the hardware chaos of analog 
systems is provided (Erogul, 2008). By the use of these devices, Electroencephalogram 
(EEG), Electrocardiogram (ECG), Electromyogram (EMG), Electrooculogram (EOG), 
breathing, Pulseplethysmograph (PPG) and various desired or necessary signals of patients 
in sleep are recorded. In this way, the patients’ statuses are determined during the night 
sleep and their diagnosis and treatment outcomes can be delineated. The classification of 
sleep apnea is also realized by the investigation of these physiological signals obtained from 
the PSG device.  
The first time application of PSG by Gastaut in 1965 has increased the interest in research of 
breathing disorders in sleep. Sleep Apnea Syndrome defined as a separate disease by 
Guilleminault in 1973 is renamed as “Sleep Apnea-Hypopnea Syndrome” in 1988 by the 
identification of hypopneas with polysomnography (Erdamar, 2007). 
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In 1997, ASDA (American Sleep Disorder Association) has defined obstructive sleep apnea 
syndrome as “A syndrome characterized by recurrent obstructions in upper respiratory 
tract (URT) during sleep and seen often with a decrease in oxygen saturation”. The 
prevalence of the disease is 1-5%. Even generally knowing the risk factors during the 
beginning of this disease, which has no less than prevalence of Diabetes (Diabetes Mellitus) 
and Bronchial Asthma, the physiopathology of the obstructions are not totally explained. 
By a general evaluation, the stopping of breathing during sleep for at least 10 seconds is 
defined as ‘sleep apnea’. Due to stopping of breathing during sleep, sleep qualities of such 
patients are disturbed since they often wake up at night. Additionally, they become sleepy 
during most of the day and have promoted degrees of pulmonary artery pressure and 
arterial PCO2. Sleep apnea is mostly observed amongst premature infants, adult males and 
post-menopausal women (Firat, 2003).  
The frequency of occurrence of apneas is high in obese and snoring individuals with narrow 
URT. Apneas can be observed in the stages of sleep other than rapid eye movement (REM) 
and non-REM (NREM) stages. The apnea types occurring during sleep and respiratory 
parameters related to these types can be defined as follows. 
1.3 Sleep apnea and its types 
In literature, there are three types of sleep apnea. These are listed as central, obstructive and 
mixed apnea. Obstructive sleep apnea (OSA) has the highest prevalence. Together with the 
absence of respiratory effort in the lungs, the absence of air flow inside the mouth and nose 
is defined as central sleep apnea. Despite the respiratory effort, the lack of air flow in the 
nose and mouth is obstructive sleep apnea. The situation starting with central sleep apnea 
and continuing as obstructive sleep apnea is defined as mixed sleep apnea. Mixed apnea 
patients can be treated by the methods applied to the patients with obstructive sleep apnea. 
Obstructive sleep apnea is the most common sleep apnea syndrome (Aydin et al., 2005). 
Obstructive sleep apnea is the state of absence of oral and nasal air flow despite the 
respiratory effort. Although the diaphragm and intercostal muscle activity continued, 
exchange of air through the nose and mouth stands (Aydin et al., 2005). In this case, it Is 
thought to be an obstruction at the URT of patient. In order to prevent the blockage, an 
intense activity in the chest and abdomen is observed. 
Central sleep apnea (CSA) is the state in the absence of both respiratory effort and air flow 
together. Central apneas grow by the corruption of the central regulation of respiration. 
Mixed sleep apnea is the state starting with central sleep apnea and continuing the absence 
of oral and nasal air flow when the respiratory effort begins. How the respiratory effort after 
the central sleep apnea starts is still a unresolved research topic. In the new terminology, 
mixed apneas are discussed as obstructive apneas. 
1.4 Sleep respiratory parameters 
There are a few basic definitions of sleep respiratory parameters in literature. Hypopnea is 
the 50% reduction of air flow during sleep for at least 10 seconds, 3% decrease in blood 
oxygen saturation or the staging of arousal. Arousal is defined as sudden sleep state 
transition to lighter sleep stages or wakefulness. Arousal terminates the apnea or hypopnea. 
Apnea Index (AI) is defined as the number of apneas per hour during sleep Apnea+Hypopnea 
Index (AHI) is defined as the number of apneas and hypopneas per hour during sleep. It is 
also called as Respiratory Distress Index (RDI). Respiratory Arousal Index (RAI) is defined as the 
number of arousals per hour during sleep. Obstructive Sleep Apnea is the situation AHI>5 
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during sleep. Obstructive Sleep Apnea Syndrome is the clinical situation that AHI>5 and major 
symptoms (snoring, witnessed apnea, excessive daytime sleepiness or drowsiness) met 
together.  
Central Sleep Apnea Syndrome is the situation where more than 50% of detected apneas are 
central type. The physician examining the patients with sleep respiratory parameters 
suggest the diagnosis of sleep apnea syndrome. 
Therefore, the scoring process performed over the PSG data obtained after sleep recording 
operations is extremely critical, specialized work, time consuming and inferential process 
(Roche et al. 1999; Firat, 2003; Aydin et al., 2005).  
1.5 Previous studies for the detection and classification of sleep apnea  
In sleep analyzing studies, there are a lot of approaches which are about detection and 
classification of sleep apnea. In recent years, the popular studies contain automated 
detection and classification of sleep apnea. The newly developed techniques have given an 
increased speed to the classification and detection of sleep apnea. However, these new 
techniques are usually built over the detection over a data scored by a health authority. Few 
works have tried to construct an automated system which will detect or classify the 
measured data and score by itself. Most of the automated systems developed in this manner 
have used only one bio-signal to detect or classify the apnea. However, a fusion of features 
extracted from the multiple bio-signals (ECG and EEG synchronization) can be expected to 
give better success rates for the detection and classification.  
Another interesting issue for the previously studied works is the classifier selection. Most of 
the works are designed to work on neural networks. Thoroughly, sleep EEG series recorded 
from patients are classified by using Feed Forward Neural Network (FFNN). The NN 
architecture has several numbers of neurons and hidden layers. This method shows that the 
degree of central EEG synchronization during night sleep is closely related to CSA and OSA 
(Aksahin et al., 2010). However, neural networks are very unstable structures when the 
design constraints are not selected carefully. In contrasting, very few of the works use well-
known stable classifier such as support vector machines (SVM). Additionally, it is possible 
to use a feature selection scheme to observe the effects of the features to the success rates. 
Khandoker et al. (Khandoker, 2009a) proposed an SVM based algorithm to identify 
Obstructive Sleep Apnea Syndrome (OSAS) over 125 patients by using their 8-hour-long 
ECG recordings. They achieved high success rates to classify OSAS and non-OSAS patients. 
Their method covers determining the class of a patient. However, they do not mention 
where the apnea occurs. In the same year, Khandoker et al. (Khandoker, 2009b) tried to 
differentiate between OSAS and hypopnea patient in a similar methodology. Mendez et al. 
(Mendez, 2008) have developed an autoregressive model to screen sleep apnea from a single 
ECG lead. They used RR intervals and the area of QRS complex as their features for the 
analysis. According to Xu et al. (Xu, 2009), it is possible classify the sleep apnea by 
monitoring the variations on heart rate variability (HRV) signal. 
Another approach to detect the OSAS patient is to use EEG signal as a source to generate 
features from Liu et al. (Liu, 2008) have proposed a neural network based detection method 
for OSAS and narcolepsy patients. They used the energy of EEG signal, theta and beta wave 
activities as features to detect patients correctly.  
In literature, there are no previous works combining the detection and classification 
procedures. In this context, an automated system can be constructed to detect apnea regions 
and classify them as obstructive, central or mixed apnea as a new approach.  
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This shows it is a new area in biomedical engineering and it needs some good research to 
reveal the relationships between bio-signals and sleep apnea. In order to detect apnea, this 
chapter presents a methodology over ECG recordings, which contains time and frequency 
domain features. Moreover, EEG recordings are used to verify the detection of sleep apnea. 
The basic frequency domain features of ECG are very low frequency (VLF), low frequency 
(LF), high frequency (HF), the ratio of LF and HF (LF/HF) over HRV information. To obtain 
true HRV information, we will use Teager's energy operator to detect R-R durations. The 
Teager energy operator (Hamila et al., 1999) was first defined over real-valued signals and 
then defined for multidimensional continuous-domain signals and used for image 
demodulation. From the first appearance of the Teager energy operator, it has been used in 
several applications such as one dimensional (1-D) signal processing, image processing, and 
color image processing.  
There are previously very few works about Teager energy operator for detection of RR 
intervals. We will also use wavelet information to find the exact positions for P, Q-R-S and T 
complexes. In addition, TEO is used for other physiological signals (speech, EEG etc.). For 
EEG signals, short time period correlations and power spectral densities will reveal the 
apnea regions and help us to find the type of apnea. Power spectral densities are calculated 
by a few methods for example Pyulear, Welch, Burg (Stoica, 1997). These features will have 
valuable information for the classification of apnea types. In extent, the change in frequency 
features of HRV information will help us to detect the apnea regions. The consideration of 
this change can be determined by using statistical methods such as Annova-Mannova, and 
types of t-test (Gula et al., 2003). These analyze methods can be used over the considerable 
measurements. Their logical validation is determined by using the reliability consistency 
test which is a statistical analysis method and measures how much accurate is a 
measurement set. For example, if a scale can give the same result with the measurement 
process repeated n times and statistical reliability factor is close to the value α= 1, then we 
conclude that the measurements of the scale are reliable. The presence of the nonparametric 
variables in the physiological signals obtained from the patient shows the idea that the 
reliability test cannot be applied to these types of measurements. 
2. Sleep recording and scoring  
Sleep records began in the 1960s for the first time, took its final form with the addition of 
respiratory recordings and their final definition, which is still valid, is issued by Holland 
and his colleagues in 1974.  
Holland used the term polysomnography to indicate the simultaneous recording, analysis 
and interpretation of various physiological parameters during the sleep through the night. 
2.1 Polysomnograph and recording system 
Polysomnography is mainly investigating the structure and physiological changes of sleep 
during sleep. This investigation provides reviewing sleep structure, psychological, 
biological and pathological changes in sleep by relating them with the sleep stages. 
Furthermore, it enables to investigate the sleep changes in human physiology under the 
conditions of sleep itself. During these investigations, whether a physiological event can be 
addressed alone, or multiple event and their implications can be explicated (Aydn et al., 
2005).By examining data collected during sleep, the turn-up form, characteristics, the 
process and the response to the treatment of various diseases can be examined. In Fig. 1, 
output records for a sample polysomnogram are shown.  
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Fig. 1. Output records for a polysomnogram 
Simultaneous recording of the sleep parameters should be able to give sufficient information 
about both the sleep and breathing pattern in sleep. In order to do staging of sleep, at least 
2-channel EEG, EOG, chin EMG, oro-nasal air flow, arterial oxygen saturation, respiratory 
effort and ECG or pulse recordings must be done. In many cases, the anterior tibial EMG 
recording can be useful to detect periodic motion disorder.  
Polysomnogram is used, in general, for the investigation, diagnosis and following up the 
treatment of sleep related breathing disorders. 
2.2 Electrocardiogram (ECG) recordings 
The technology interpreting the changes in electrical potential during heart activity is called 
as electrocardiography and the recorded by the device are called as electrocardiogram 
(ECG). Fig. 2 shows a normal ECG recording.  
The duration of P wave and QRS complex is 0.1 seconds while the average wave amplitude 
(peak R) is around 1 mV. This peak value rarely rises up to 5 mV. These nominal values can 
change from one person to another by the patient’s heart and body size and body 
conductivity. 
2.3 Electroencephalography (EEG) recordings 
EEG is the system used to measure and record the electrical activity of the brain. The brain 
waves obtained from EEG system have delta, theta, alpha, and beta wave bands.  
Delta waves have 0.5-4 Hz frequency band with 20-400 μV amplitudes and are encountered 
in the situations of very low activity of brain, such as deep sleep and general anesthetic 
state.  
Theta waves have 4-8 Hz frequency band with 100-500 μV amplitudes and are encountered 
in the situations of low activity of brain, such as dreaming sleep and medium anesthetic 
state.  
Alpha waves have 8-13 Hz frequency band with 2-10 μV amplitudes and they are closest 
ones to the sinusoidal form between EEG waves. They are observed at awake individuals 
with closed eyes in a physically and mentally full resting condition.  
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Fig. 2. QRS complex of a ECG signal (Köhler et al., 2002) 
Beta waves are observed at the frequencies higher than 13 Hz and their amplitudes change 
in the range of 1-5 μV. They are observed at focused attention, mental working states, and 
rapid eye movement stages of sleep. These waves correspond to the level of the highest 
activity of the brain waves (Pehlivan, 2004). 
By using EEG signals, sleep stages during the sleep period can be distinguished. These 
stages are divided into 5 classes. In general, as the sleep gets deeper, a frequency decrease in 
EEG signals. In sleep, there are two change stages following each other periodically. These 
are REM (Rapid Eye Movement – Paradoxical Sleep) and NREM (Non-Rapid Eye 
Movement) stages. The period between eyes shut to sleep and full sleep stage is called as the 
latent period of diving into sleep. After latent period, the exchange periods start. 
NREM sleep is occasionally divided into 5 phases based on the electroencephalographic 
changes occurring during the course of sleep. Phase 0 is wakefulness stage, Phase 1 and 2 is 
the shallow sleep period, Phase 3 and 4 are the periods of deep sleep. It is possible to 
observe high amplitude low frequency waves and spindles in EEG. In this stage, there is no 
eye movements, muscle tones are decreased, pulse and respiratory are slowed. In Table 2, 
the phases of NREM sleep and their characteristics are given (Park, 2000). 
REM sleep is the dream stage of sleep or the dreams seen in this stage can be remembered in 
wakefulness state. This stage is interspersed between the other phases of the sleep. It is 
connected with a large number of different features.  
 
NREM Sleep Phases Characteristics 
Phase 0 (Wakefulness) The stage before diving into sleep. 
Phase I The state one individual who is diving into sleep has faced. If 
the individual is forced to wake up in this phase of sleep, he 
will say he was usually awake even he was not aware of the 
events around him. 
Phase II In this phase of sleep, consciousness is in a state that he will be 
aware of he was in sleep when he was forced to wake up. EEG 
patterns can be seen. K- complex and sleep spindles are 
expected to be seen.  
Phase III and IV Low frequency deep sleep. 
Table 2. NREM Sleep Phases and their characteristics. 
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in the situations of very low activity of brain, such as deep sleep and general anesthetic 
state.  
Theta waves have 4-8 Hz frequency band with 100-500 μV amplitudes and are encountered 
in the situations of low activity of brain, such as dreaming sleep and medium anesthetic 
state.  
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ones to the sinusoidal form between EEG waves. They are observed at awake individuals 
with closed eyes in a physically and mentally full resting condition.  
Automated Detection and Classification of  




Fig. 2. QRS complex of a ECG signal (Köhler et al., 2002) 
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NREM Sleep Phases Characteristics 
Phase 0 (Wakefulness) The stage before diving into sleep. 
Phase I The state one individual who is diving into sleep has faced. If 
the individual is forced to wake up in this phase of sleep, he 
will say he was usually awake even he was not aware of the 
events around him. 
Phase II In this phase of sleep, consciousness is in a state that he will be 
aware of he was in sleep when he was forced to wake up. EEG 
patterns can be seen. K- complex and sleep spindles are 
expected to be seen.  
Phase III and IV Low frequency deep sleep. 
Table 2. NREM Sleep Phases and their characteristics. 
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2.4 Other physiological measurement parameters 
EMG (Electromyography) is the method of observing and recording of skeletal electrical 
activity. EMG signals contain very high frequency components ranging between 10 and 5000 
Hz. EOG is the method of observing and recording of eye movements resulting from 
electrical activity of muscles. 
Thermistor is the sensor detecting the air flow from the nose. With the help of thermistor, it is 
determined whether there is an obstruction at the upper respiratory tract or not. 
Microphone records the sound from the mouth. With the help of microphone, the recorded 
sounds of snoring can be examined. 
Thoracic respiratory signal, which is obtained from the expansion and narrowing of the chest, 
is recorded by wounding a special type of tape around the chest. The breathing can be 
examined through the recorded signal. 
SpO2 is the signal showing the blood oxygen saturation. With the signal recorded through 
PPG device, amount of change of oxygen in the blood after breathing is analyzed. 
3. The sleep apnea features based on electrocardiogram (ECG) and 
electroencephalogram (EEG) biosignals 
Sleep apnea detection approach over ECG and EEG physiological signals taken from 
polysomnograph recently appears to be a popular study. The methods apart from the classical 
methods followed by the physician to detect sleep apnea is based on the examination of 
features correlated with the sleep apnea from ECG and EEG signals to construct an automatic 
decision support mechanism. 
3.1 Sleep apnea features based on electrocardiogram biosignals 
Heart rate variability (HRV) information takes the first place amongst the researchers 
conducted on ECG physiological signals. Heart rate variability is related to the nature and 
the presence of sleep apnea. While many commercial medical equipments measure the 
automatically, they cannot bring a fully automated approach on detection and diagnosis of 
disorders such as sleep apnea.  
Heart rate variability includes many features in both time and frequency domains and needs 
different methods in calculation of these features. ECG raw data, which is analyzed 
statistically in both time and frequency domains, is separated as short term and long term 
by the length of data (Camm et al., 1996). 
3.1.1 Calculation of heart rate variability 
In order to perform the calculation of heart rate variability from the ECG signal, first of all, 
R-wave detection needs to be done as much as possible. There are many approaches in 
detection of R-wave in the literature. Some of these methods are summarized in Table 3. 
For example, there are methods based on wavelet transform and digital filtering for R-wave 
detection. In order to remove noise from ECG signal, it is passed through a wavelet 
transform block and QRS complex is emphasized in contrast to P and T waves by the 
moving average based low pass filter given in Eq. 1. In Eq. 1, y1 is the output signal, x[n] is 
the input signal and M is regarded as the length of the filter. Later, the processed ECG 
signal, which is passed through a nonlinear amplifier, is applied to an adaptive thresholding 
block (Chen et al., 2006). 
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Teager Energy Operator (TEO) 
Wavelet Transform  
Support Vector Machines 
Pan- Tompkins Algorithm  
Filtering in Frequency Domain 
Zero Crossing Rate 
Table 3. R-wave Detection Methods 
From Table 3, it can be said that the most commonly used method is the Teager energy 
operator based on derivative operation. Teager energy operator is a very convenient method 
for studying over a single component in both continuous and discrete domains. It carries a 
lot of attributes together and is derived from the signal energy. In continuous domain, 
Teager energy operator is defined as: 






Teager energy operator is applied off-line over the signal on the basis of discrete time 
domain. Sampled at a particular frequency, ECG signal is applied to the discrete version of 
the Teager energy operator given below: 
Ψ[x(n)] = x�(n) − x(n + 1)x(n − 1) (3)
Teager energy operator covering the three samples of the signal side by side, shows a very 
local feature of the signal (Kaiser, 1993). In Fig. 3, an exemplary sequence of the ECG signal 
and the corresponding output of the Teager energy operator is given.  
Before applying the Teager energy operator, ECG signal must be freed from noise. These 
noises are usually seen as baseline drift and motion artifact. In both time and frequency 
domains, there are algorithms used to eliminate these types of noises. For example, if there 
is a low frequency noise on ECG signal, a "moving average filter" in time domain 
(Rangayyan, 2002) or high-pass filters in frequency domain are applied. 
After the TEO algorithm is applied to ECG signal, a threshold value comparison should be 
made to determine the R-wave peak points. 60% of the maximum value of the output signal 
from TEO block can be chosen as the threshold value. If the output of TEO exceeds the 
threshold at time t0 and no greater value in the next 0.25 seconds is observed, t0 is marked 
as R-wave peak point (Erdamar, 2007). TEO output of a sample ECG signal and detected R 
wave peaks after the threshold comparison is shown in Fig. 4.  
Heart rate variability is defined as the time differences between the two consecutive R-wave 
peak points and are expressed in units of milliseconds or seconds. Heart rate variability data 
given in Fig. 5 is examined in both time and frequency domains. In case of missing R wave 
or finding extra R waves, we can observe upside or downside peaks on the HRV data. In 
order to eliminate this situation, an adaptive thresholding algorithm must be applied to 
detect R-wave peak points.  
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Fig. 5. Heart rate variability obtained from ECG signal  
HRV parameter can be used to obtain the time and frequency domain features given in 
Table 4. Time domain features are calculated over 24 hours (long term) recordings and 
frequency domain features are calculated over 2-5 minutes (short term) recordings (Camm 
et al., 1996; Roche et al., 2002). The difficulty of the long term analysis is the impossibility of 
finding 24 hours noiseless raw data. 
 
Time Domain Features 
SDNN Standard deviation of all normal RR intervals long term 
SDANN Standard deviation of the mean of all consecutive 5 
minute segments of normal RR intervals  
long term  
SDNN index Mean of the standard deviation of consecutive 5 minute 
segments 
long term 
r-MSSD Root mean square of successive differences between 
adjacent normal RR intervals  
long term 
NN50 count Number of pairs of adjacent NN intervals differing by 
more than 50 ms in the entire recording. Three variants 
are possible counting all such NN intervals pairs or only 
pairs in which the first or the second interval is longer. 
long term 
pNN50 NN50 count divided by the total number of all NN 
intervals. 
long term 
Frequency Domain Features 
VLF Very low frequency   0.015- 0.04 Hz short term 
LF Low frequency     0.04-0.15 Hz short term 
HF High frequency     0.15- 0.4 Hz short term 
LF/HF  Short term 
Table 4. Time and Frequency Domain Features of HRV 
While the time domain analyses are calculated through HRV itself, the frequency domain 
analyses are calculated through the power spectral density of HRV. In order to do a frequency 
domain analysis, HRV must be freed from its DC component and resampled at 2 Hz.  
In most studies, it is observed that the power spectral densities obtained from the signals 
containing the sleep apnea syndrome have more intense low frequency (LF) components 
than that of the normal signals. After the treatment of sleep apnea it is usually seen that low 
frequency density has decreased and converged to the nominal values of normal individuals 
(Roche et al., 1999). 
Table 5 exhibits the time and frequency domain feature values of a normal individual 
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data gathered from different patient groups and different polysomnography devices. The 
reasons for these differences are the resolution of the device and patients having different 
characteristics of physiological parameters affecting AHI values. We suggest creating 
simultaneously a control group of healthy subjects as a reference in HRV analysis procedures.  
 
 
Fig. 6. Power Spectral Density of HRV 
Choosing the created control group as a reference and analyzing the other patient groups 
will be useful to obtain statistically significant results.  
Statistical methods, such as Anova-Manova, student's t test, multi variable regression and 
correlation, are used for scientific analysis of the features obtained from the spectral analysis 
of HRV. For instance, ANOVA test can be applied to show the statistical difference between 
groups of patients with sleep apnea. Within the scope of this test, it is clarified as a result 
that two groups are different when P<0.05 between the groups is achieved (Gula et al., 
2001).  
 
Variables Units Normal Values (mean ± SD) 
Time Domain Analysis of 24 h 
SDNN ms 141±39 
SDANN ms 127±35 
RMSSD ms 27±12 
Spectral analysis of stationary supine 5-min recording 
Total power ms2 3466±1018 
LF ms2 1170±416 
HF ms2 975±203 
LF/HF ratio nu  
Table 5. Normal values of HRV features 
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Another statistical methods based parameter is Form Factor. This parameter is a statistical 
value depending on the exchange of activity amongst one-second-long signals (Hjorth, 1973; 
Rangayyan, 2002).  
In form factor calculation, ��� (activity-variance) and ��� (variability) are used. In Eq. 4, the 
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3.2 The features based on electroencephalogram biosignals 
EEG signals are another physiological signal type used in the detection and classification of 
sleep apnea. Due to the morphological properties separating from the ECG signals, they are 
applied to different analyses. Since sleep apnea is a ten second long event, they can usually 
be detected by an examination of epochs before and after sleep apnea. If the analyses cover 
20-30 seconds part, they contain macro structure. The processes such as spindle scaling, 
slow wave activities, and arousal detection are included in macro structure analysis 
(Malinowska et al., 2006). 
In Fig. 7, a regular part of the respiratory system and the corresponding sub-band 
representation of the EEG signal in that epoch are shown. The horizontal axis represents the 
time and the vertical axis represents amplitude. In occurrence of sleep apnea, changes 
observed at the corresponding sub-band range. 
 
 
Fig. 7. a) Thermistor signal b) EEG sub-bands 
In Fig. 8, respiratory signal with apnea and the corresponding sub-bands of EEG signal are 
shown. In this representation, change in the sub-bands of the EEG section corresponding to 
the respiratory signal with apnea is observed. The existence and amount of this change can 
be proved by calculating power spectral density. The analyses are made over 10 second 
portions within the scope of micro structure (Erdamar, 2007).  
Some approaches are based on the EEG arousal detection of micro-structures. This is 
because the EEG signal of a patient diagnosed with OSA contains arousal structures during  
Delta Theta Alpha Beta 1 Beta 2 
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Fig. 8. a) Thermistor signal b) EEG sub-bands 
sleep apnea. In detection of arousal structures, data from EEG, pressure and temperature of 
thermistor, chin-EMG, and tibialis EMG are used. 
In order to detect the status that arousal response is longer than 3 seconds, the PSG data is 
examined in 1.28-second segments with a 0.4 Hz frequency resolution. Chin-EMG and 
tibialis EMG records are important for the detection of pathological events. Since arousal 
events inside the EEG signal generates rapid changes in all frequency components, direct 
analysis methods give no results (Sugi, 2008).  
In addition, the important alterations are observed on previous divisions of sleep apneas. In 
sleep apnea events, the most significant alternations are observed in alpha and beta waves. 
These alterations cannot be realized in whole EEG spectrum because of their sizes. 
Therefore, EEG signals can be analyzed by using short time fouirer transform of narrow 
windows (Erdamar, 2007). 
4. Results  
The R detection algorithm based on TEO and adaptive thresholding (Fig.3 and Fig 4.) was 
applied over 600 epochs (200 epochs normal patients, 200 epochs OSA, 200 epochs CSA). 
The LF/HF rates calculated from HRV of these patients are shown in Table 6. 
 




0.73 0.49 0.3 0.81 0.3 0.73 0.671 0.7 0.21 0.89 0.58 
Normal 
Patient 2 
0.4 0.64 1.126 0.45 0.66 0.82 0.9 0.86 0.23 1.52 0.76 
OSA 1 0.87 0.97 1.45 1.15 1.46 1.28 1.42 1.81 1.03 2.6 1.4 
OSA 2 1.1 3.4 1.1 5.3 1.58 3.5 1.1 1.87 5 2.5 2.7 
CSA 1 2.03 5.21 0.520 1.21 0.59 0.74 2.149 0.35 0.71 2.747 1.63 
CSA 2 3.09 1.13 0.73 1.06 1.62 1.15 3.12 0.49 1.22 1.33 1.5 
Table 6. LF/HF rates of three different patients 
In Table 6, it is shown that the LF/HF rates of OSA and CSA are higher than normal 
patients’ values. This difference is visible on Table 6 but, we need to do a statistical test to 
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prove the difference. In this context, the statistical data of the LF / HF rates obtained from 
600 epochs (300 minutes) ECG recordings is gathered in Table 7. 
 
  Number of Epoch  
Normal OSA 200 - 200 P=0.000 (<0.05)*  
Normal CSA 200 - 200 P=0.004 (<0.05)* 
OSA CSA 200 - 200 P=0.001 (<0.05)*  
*Statistically significant 
Table 7. Independent samples T-test between the patients groups 
In independent samples T-test, P value less than 0.05 means that analyzed two groups are 
statistically different from each other. The results show that OSA, CSA and normal 
diagnosed patients can be separated by a statistical analysis on change of LF / HF rates of 
each other. 
In order to observe the ability to separate between the epochs with and without apnea, 
paired sampled t-test analysis method is used. In Table 8, it is shown that 10 epochs with 
apnea and 10 epochs without apnea of an OSA patient are statistically different from each 
other (P = 0.006 <0.05). 
This statistical result scientifically indicates that the parts with apnea have different 
morphological features than the ones without apnea even for the same patient's 24 hours 
(long term) ECG recordings. 
 











95% Confidence Interval 
of the Difference 
  Lower Upper 
Pair 




3.89091 3.74696 1.12975 1.37367 6.40815 3.444 10 .006 
Table 8. Paired Samples Test Outputs 
On the other hand, form factor (FF) calculation can be shown as a different approach for the 
detection of sleep apnea and different approach from literature. FF calculations made for a 
segment from 160 msec before to 240 msec after of each detected R-wave of the ECG signal 
can be thought as a determining factor for predicting the sleep apnea. In experimental 
works, a threshold FF value was determined in ECG recordings to identify apnea. In this 
context, apnea is appeared for 4 and upper FF values in ECG recordings. Fig. 9 corresponds 
to the FF series of an ECG recording with apnea.  
In Fig. 10, the thermistor signal with 256 Hz sampling frequency of non-apnea patient and 
corresponding FF values calculated on ECG signal are given. When a number of FF values 
obtained from apnea and non-apnea patient recordings with equal length are examined, a 
decrease in heart rate in case of apnea is found.  
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In Table 6, it is shown that the LF/HF rates of OSA and CSA are higher than normal 
patients’ values. This difference is visible on Table 6 but, we need to do a statistical test to 
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prove the difference. In this context, the statistical data of the LF / HF rates obtained from 
600 epochs (300 minutes) ECG recordings is gathered in Table 7. 
 
  Number of Epoch  
Normal OSA 200 - 200 P=0.000 (<0.05)*  
Normal CSA 200 - 200 P=0.004 (<0.05)* 
OSA CSA 200 - 200 P=0.001 (<0.05)*  
*Statistically significant 
Table 7. Independent samples T-test between the patients groups 
In independent samples T-test, P value less than 0.05 means that analyzed two groups are 
statistically different from each other. The results show that OSA, CSA and normal 
diagnosed patients can be separated by a statistical analysis on change of LF / HF rates of 
each other. 
In order to observe the ability to separate between the epochs with and without apnea, 
paired sampled t-test analysis method is used. In Table 8, it is shown that 10 epochs with 
apnea and 10 epochs without apnea of an OSA patient are statistically different from each 
other (P = 0.006 <0.05). 
This statistical result scientifically indicates that the parts with apnea have different 
morphological features than the ones without apnea even for the same patient's 24 hours 
(long term) ECG recordings. 
 











95% Confidence Interval 
of the Difference 
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Pair 




3.89091 3.74696 1.12975 1.37367 6.40815 3.444 10 .006 
Table 8. Paired Samples Test Outputs 
On the other hand, form factor (FF) calculation can be shown as a different approach for the 
detection of sleep apnea and different approach from literature. FF calculations made for a 
segment from 160 msec before to 240 msec after of each detected R-wave of the ECG signal 
can be thought as a determining factor for predicting the sleep apnea. In experimental 
works, a threshold FF value was determined in ECG recordings to identify apnea. In this 
context, apnea is appeared for 4 and upper FF values in ECG recordings. Fig. 9 corresponds 
to the FF series of an ECG recording with apnea.  
In Fig. 10, the thermistor signal with 256 Hz sampling frequency of non-apnea patient and 
corresponding FF values calculated on ECG signal are given. When a number of FF values 
obtained from apnea and non-apnea patient recordings with equal length are examined, a 
decrease in heart rate in case of apnea is found.  
 














Fig. 10. Thermistor signal without apnea and corresponding FF values 
In the ECG signal without apnea, more R-waves is found and as a result of that phenomena, 
it is understood that power spectral density of HRV has shifted to HF area. Thus, FF values 
are closely related to apnea events over ECG recordings.  
5. Conclusion  
Due to the fact that human physiology do not continuously respond in the same way to the 
same stimulus, both automated and adaptive analysis procedures over biosignals are 
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limited. Thus, the sections, that have negative effect on variance and cause the algorithm to 
work inaccurately, are removed from the ECG signal and then the HRV analysis is done. 
When an automated system is requested, a general algorithm that can remove these 
corrupted fields from the ECG signal can be written at most. For this purpose, it is possible 
to find approaches in both time and frequency domains.  
In detection and classification of sleep apneas, usage of support vector machines (SVM) 
instead of neural network based algorithms may be a better and more original approach. 
SVM, similar to neural networks, uses a part of the data for training purposes and the rest of 
data to testing purposes. On contrary, by its structure, it can present a more determined 
working strategy in contrast to neural networks. 
It is possible to obtain a very good HRV curve with the help of an algorithm that does not 
miss R-peaks as much as possible. In order to investigate the frequency domain attributes of 
HRV, the frequency characteristics are obtained from the HRV after the fast fourier 
transform (FFT) of it calculated. Thus, the features obtained from healthy patients and 
patients with sleep apnea can be easily differentiated. 
With a quite smooth algorithm, the obtained HRV curves from the healthy patients fluctuate 
around a constant value in the amplitude range. In the fourier domain, we get the results in 
discrete time series.  
For the detection of QRS complex, finding many adaptive approaches are possible. From the 
output of Teager energy operator, 60% of the average of the magnitudes of previous 
detected consecutive n (<6) R-peaks can be used as the threshold value for the detection of 
current R-peak. Thus, it will be possible to detect signal with slowly changing magnitude 
threshold value will be adaptive to catch the magnitudes correctly. However, the signal loss 
due to the misplacement of electrodes on the surface of body cannot be recovered with this 
adaptive structure. Actually, there is possibly no way to get the signal from nothing. 
Another approach in design of an automated system can be a template matching algorithm. 
The basic requirement for this algorithm is the selection of a good clean QRS complex. There 
are numerous methods to decide a clean signal. If the cross correlation between the signal 
and the selected QRS complex, we get normalized outputs peaking at the R-peaks. In order 
to improve the results, this operation can be applied before the TEO operator and adaptive 
thresholding. This approach will give a more precise and an automated result. This 
operation is done by the normalized cross-correlation formulation given as: 
Normalized	Cross Correlation Function = ∑ (temp� − temp�������) ∗ (ecg� − ecg����)
������
�∑ (temp� − temp�������)� ∗ ∑ (ecg� − ecg����)�������������
 (6)
temp= chosen template QRS complex 
ecgi = windowing of raw ECG (size of temp) 
ecg=raw data 
The critical point of this methodology is that the correct choice of the QRS template should 
be done automatically. Selections can lead to incorrect outputs with a wrong template, and 
this may lead other analyses converge to an erroneous point. 
During a decrease in the respiratory frequency, physiological systems of human body also 
reduce heart rhythm in order to provide homeostasis. In this way, oxygenated blood to spill 
all the biological system is more efficient.  
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limited. Thus, the sections, that have negative effect on variance and cause the algorithm to 
work inaccurately, are removed from the ECG signal and then the HRV analysis is done. 
When an automated system is requested, a general algorithm that can remove these 
corrupted fields from the ECG signal can be written at most. For this purpose, it is possible 
to find approaches in both time and frequency domains.  
In detection and classification of sleep apneas, usage of support vector machines (SVM) 
instead of neural network based algorithms may be a better and more original approach. 
SVM, similar to neural networks, uses a part of the data for training purposes and the rest of 
data to testing purposes. On contrary, by its structure, it can present a more determined 
working strategy in contrast to neural networks. 
It is possible to obtain a very good HRV curve with the help of an algorithm that does not 
miss R-peaks as much as possible. In order to investigate the frequency domain attributes of 
HRV, the frequency characteristics are obtained from the HRV after the fast fourier 
transform (FFT) of it calculated. Thus, the features obtained from healthy patients and 
patients with sleep apnea can be easily differentiated. 
With a quite smooth algorithm, the obtained HRV curves from the healthy patients fluctuate 
around a constant value in the amplitude range. In the fourier domain, we get the results in 
discrete time series.  
For the detection of QRS complex, finding many adaptive approaches are possible. From the 
output of Teager energy operator, 60% of the average of the magnitudes of previous 
detected consecutive n (<6) R-peaks can be used as the threshold value for the detection of 
current R-peak. Thus, it will be possible to detect signal with slowly changing magnitude 
threshold value will be adaptive to catch the magnitudes correctly. However, the signal loss 
due to the misplacement of electrodes on the surface of body cannot be recovered with this 
adaptive structure. Actually, there is possibly no way to get the signal from nothing. 
Another approach in design of an automated system can be a template matching algorithm. 
The basic requirement for this algorithm is the selection of a good clean QRS complex. There 
are numerous methods to decide a clean signal. If the cross correlation between the signal 
and the selected QRS complex, we get normalized outputs peaking at the R-peaks. In order 
to improve the results, this operation can be applied before the TEO operator and adaptive 
thresholding. This approach will give a more precise and an automated result. This 
operation is done by the normalized cross-correlation formulation given as: 
Normalized	Cross Correlation Function = ∑ (temp� − temp�������) ∗ (ecg� − ecg����)
������
�∑ (temp� − temp�������)� ∗ ∑ (ecg� − ecg����)�������������
 (6)
temp= chosen template QRS complex 
ecgi = windowing of raw ECG (size of temp) 
ecg=raw data 
The critical point of this methodology is that the correct choice of the QRS template should 
be done automatically. Selections can lead to incorrect outputs with a wrong template, and 
this may lead other analyses converge to an erroneous point. 
During a decrease in the respiratory frequency, physiological systems of human body also 
reduce heart rhythm in order to provide homeostasis. In this way, oxygenated blood to spill 
all the biological system is more efficient.  
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A slowdown in heart rhythm causes observing the HRV power spectral density to shift to 
VLF-LF region. In the normal case, an opposite loop is provided, and the HRV power 
spectrum density increases towards HF band. 
Within the scope of sleep apnea detection processes, it is needed to use statistical analysis 
softwares to make sense in the scientific manner from the results. For example, for two 
different groups of independent samples, it is possible to prove that they different from each 
other in statistical sense by t-test. 
Pulse Transit Time (PTT), which will constitute the basis of the study, is thought to be a very 
strong microstructure for the detection of sleep apnea and obtained from ECG, EEG and 
PPG signals. PTT analyses can rarely be seen in the literature (Smith et al. 1999). PTT is the 
duration of arterial pulse pressure occurring during the instance of pumping of blood from 
aortic leaflet to peripherals (limbs). PTT can be detected by reference to R-peaks on ECG 
signals. 
After the ventricle depolarization corresponding to a R-peaking, PTT can be taken as the 
time of transmission of blood pressure to the fingers. For this purpose, the PPG signal from 
the oxygen plethysmograph probe is needed. The PPG located inside the PSG system with 
the name PLETH provides this data. By looking at the average duration of PTT, we can 
make a correlation analysis on respiratory effort. As a result of this analysis, the features to 
detect sleep apnea can be obtained (Pitson et al., 1995). 
The experimental studies show that HRV power spectral densities in patients with OSA and 
CSA shift towards the low frequency (VLF-LF) band while a dense nature in high frequency 
(HF) band is observed for normal patients. In this extent, the statistical analyses before and 
after uvulopalatofarengoplasti (UPPP) surgical operation, one of the methods used in 
treatment of sleep apnea, can be a good approach to measure the performance of the 
surgical operation. Another study conducted by our group is the evaluation of statistical 
analysis methods on the preoperative and postoperative sleep time and frequency domain 
parameters. 
It is thought that a prediction to sleep apnea and an implementation of indirect diagnosis 
system to help the physician are possible by investigating the cases called microstructures, 
which are impossible to see on ECG signals and EEG sub-bands, in the 1-2 epochs before 
and after the parts that contain sleep apnea in the EEG and ECG signals. This approach can 
provide more specific and original results.  
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softwares to make sense in the scientific manner from the results. For example, for two 
different groups of independent samples, it is possible to prove that they different from each 
other in statistical sense by t-test. 
Pulse Transit Time (PTT), which will constitute the basis of the study, is thought to be a very 
strong microstructure for the detection of sleep apnea and obtained from ECG, EEG and 
PPG signals. PTT analyses can rarely be seen in the literature (Smith et al. 1999). PTT is the 
duration of arterial pulse pressure occurring during the instance of pumping of blood from 
aortic leaflet to peripherals (limbs). PTT can be detected by reference to R-peaks on ECG 
signals. 
After the ventricle depolarization corresponding to a R-peaking, PTT can be taken as the 
time of transmission of blood pressure to the fingers. For this purpose, the PPG signal from 
the oxygen plethysmograph probe is needed. The PPG located inside the PSG system with 
the name PLETH provides this data. By looking at the average duration of PTT, we can 
make a correlation analysis on respiratory effort. As a result of this analysis, the features to 
detect sleep apnea can be obtained (Pitson et al., 1995). 
The experimental studies show that HRV power spectral densities in patients with OSA and 
CSA shift towards the low frequency (VLF-LF) band while a dense nature in high frequency 
(HF) band is observed for normal patients. In this extent, the statistical analyses before and 
after uvulopalatofarengoplasti (UPPP) surgical operation, one of the methods used in 
treatment of sleep apnea, can be a good approach to measure the performance of the 
surgical operation. Another study conducted by our group is the evaluation of statistical 
analysis methods on the preoperative and postoperative sleep time and frequency domain 
parameters. 
It is thought that a prediction to sleep apnea and an implementation of indirect diagnosis 
system to help the physician are possible by investigating the cases called microstructures, 
which are impossible to see on ECG signals and EEG sub-bands, in the 1-2 epochs before 
and after the parts that contain sleep apnea in the EEG and ECG signals. This approach can 
provide more specific and original results.  
6. References 
Aksahin, M.F. (2010). Classification of Sleep Apnea Types, Baskent University PhD Thesis, 
Ankara, Turkey 
Aydin, H.; Ozgen, F.; Yetkin, S. & Sütcügil, L. (2005). Sleep and Respiratory Disorders in Sleep, 
GATA Printing House, Ankara, Turkey  
Camm, A. J.; Malik, M.; Bigger, J. T.; Breithardt, G.; Cerutti, S.; Cohen, R. J.; Coumel, P.; 
Fallen, E. L.; Kennedy, H. L.; Kleiger, R. E.; Lombardi, F.; Malliani, A.; Moss, A. J.; 
Rottman, J. N.; Schmidt, G.; Schwartz, P. J. & Singer, D. H. (1996). Heart rate 
variability-Standards of measurement, physiological interpretation, and clinical use, 
European Heart Journal, Vol. 17, No.3, (March 1996), pp.354-381 
Chen, S-W.; Chen H-C. & Chen H-C. (2005). A real time QRS detection method based on 
moving- averaging incorporating with wavelet denosing, Elsevier Computer Methods 
Automated Detection and Classification of  
Sleep Apnea Types Using Electrocardiogram (ECG) and Electroencephalogram (EEG) Features 
 
229 
and Programs in Biomedicine, Vol. 82, No. 3, (November 2005), pp.187-195, ISSN 
0169-2607 
Erdamar, A. (2007). A model development for prediction of sleep apnea and stimulation of 
genoglossus muscle, Hacettepe University PhD Thesis, Ankara, Turkey 
Erogul, O. (2008). Engineering Approaches in Sleep Studies, Proceedings of 9th Sleep Medicine 
Congress, Aydin, Turkey, 2008 
Firat, H. (2003). Sleep apnea syndrome diagnosis (definition, physiopathology, clinic, 
diagnosis methods, scores), Turkish Thoracic Society Second Winter School, (January 
2003), Lecture Notes 
Gula,L.J.; Krahn, A.D.; Skanes, A.; Kathleen, A. F.; George, C.; Yee, R. and Klein G.J. (2003). 
Heart rate variability in obstructive sleep apnea: a prospective study and frequency 
domain analysis, A.N.E, Vol. 8, No. 2, (april 2003), pp. 144-149, ISSN 1542-474X  
Hamila, R.; Astola, J.; Alaya Cheikh, F.; Gabbouj, M.; & Renfors, M. (1999). Teager energy 
and the ambiguity function, IEEE Transactions on Signal Processing, Vol. 47, No. 1, 
(January 1999), pp. 260-262, ISSN 1053–587X. 
Hjorth, B. (1973). Physical significance of time domain descriptors in EEG analysis, 
Electroencephalography and Clinical Neurophysiology, Vol. 34, No. 3, (March 1973), pp. 
321-325, ISSN 0013-4694 
Kaiser, J. F., (1993). Some useful properties of teager's energy operators, acoustics, speech and 
signal processing, ICASSP-93, IEEE International Conference, Vol.3, Issue April 1993, 
pp.149-152, ISSN 1520-6149 
Khandoker, A. H.; Palaniswami, M.; & Karmakar, C. K. (2009a), Automated scoring of 
obstructive sleep apnea and hypopnea events using short-term electrocardiogram 
recordings, IEEE Transactions On Information Technology In Biomedicine, Vol. 13, No. 
6, ( November 2009), pp. 1057-1067, ISSN 1089-7771. 
Khandoker, A. H.; Gubbi, J.; & Palaniswami, M. (2009b), Support vector machines for 
automated recognition of obstructive sleep apnea syndrome from ECG recordings, 
IEEE Transactions On Information Technology In Biomedicine, Vol. 13, No. 1, (January 
2009), pp. 37-48, ISSN 1089-7771. 
Köhler, B-U.; Henning, C. & Orglmeister, R. (2002). The Principles of Software QRS 
Detection-Reviewing and Comparing Algorithms for Detecting this Important ECG 
Waveform, IEEE Engineering In Medicine And Biology, Vol. 21, No. 1, (January 
2002), pp.42-57, ISSN 0739-5175 
Liu, D.; Pang, Z.; Lloyd, S. R. (2008). Neural Network Method for Detection of Obstructive 
Sleep Apnea and Narcolepsy Based on Pupil Size and EEG, IEEE Transactions on 
Neural Networks, Vol. 19, No. 2, (February 2008), pp. 308-318, ISSN 1045-9227. 
Malinowska, U.; Durka, P-J.; Blinowska K-J.; Szelenberger W. & Wakarow A. (2006). Micro 
and Macrostructure of Sleep EEG, IEEE Engineering Medicine and Biology Magazine, 
Vol. 25, No. 4, August 2006, pp. 26-31, ISSN 0739-5175 
Mendez, M. O.; Bianchi, A. M.; Matteucci, M.; Cerutti, S.; & Penzel, T. (2008) Sleep Apnea 
Screening by Autoregressive Models From a Single ECG Lead, IEEE Trans. on 
Biomed. Eng., Vol. 56, No. 12, ISSN 0018-9294. 
Park, H. (2000). Automated Sleep Stage Analysis Using Hybrid Rule-Based and Case-Based 
Reasoning, Interdisciplinary Program of Medical and Biological Engineering Major 
Seoul National University PhD Thesis, Seoul, Korea 
Pehlivan, F. (2004). Biophysics, Hacettepe Tas Printing, ISBN 975-7731-45-5 
 
Advances in Electrocardiograms – Clinical Applications 
 
230 
Pitson, D.J., Sandell, A., Hout, R.V., Stradling, J.R., 1995. Use of Pulse Transit Time as a 
Measure of Inspiratory Effort in Patients with Obstructive Sleep Apnoea, European 
Respiratory Journal, Vol.8, No.10, (October 1995), pp.1669-1674. 
Rangayyan, R. M. (2002). Biomedical Signal Analysis: A Case-Study Approach, IEEE Press, ISBN 
0-471-20811-6, USA  
Roche, F.; Gaspoz, J-M.; Fortune, I.; Minini, P.; Pichot, V.; Duverney, D.; Costes, F.; Lacour J-
R. & Barthelemy, J-C. (1999). Screening of Obstructive Sleep Apnea Syndrome by 
Heart Rate Variability Analysis, Journal of the American Heart Assocation-
Circulation,Vol. 100, (June 1999), pp.1411-1415, 1524-4539 
Roche F.; Duverney D.; Gortune-Court I.; Pichot V.; Costes F.; Lacour J-R.; Antonladis A.; 
Gaspoz J-M. & Barthelemy J-C. (2002). Cardiac Interbeat Interval Increment for the 
Identication of Obstructive Sleep Apnea, Journal of Pacing and Clinical 
Electrophysilogy, Vol. 25, No.8, (August 2002), pp.1192-1199, 10504-0418 
Smith, P.R.; Argod, J.; Pepin, J.L. & Levy, P.A. (1999). Pulse Transit Time: An Appraisal of 
Potential Cliniccal Applications, Journal of Throax, Vol.54, No.5, (May 1999), pp.452 
– 457,  
Stoica, P. & Moses , R.L. (1997), Introduction to spectral analysis, Prentice Hall, ISBN: 0-13-
258419-0, New Jersey, U.S. 
Sugi, T.; Kawana, F. & Nakamura M. (2009). Automatic EEG Arousals Detection for 
Obstructive Sleep Apnea Syndrome, Biomedical Signal Processing and Control, Vol. 4, 
No. 4, (October 2009), pp. 329-337 
Xu, W., & Liu, X. (2009), Sleep Apnea Assessment by ECG Pattern, 2nd International Congress 
on Image and Signal Processing, 2009. CISP '09, ISBN: 978-1-4244-4129-7, Tianjin, 
China, October 2009. 
13 
Low Heart Rate Variability in 
Healthy Young Adult Males 
Richard M. Millis, Stanley P. Carlyle, Mark D. Hatcher and Vernon Bond 
Department of Physiology & Biophysics, College of Medicine, 
Howard University, Washington, DC, 
USA 
1. Introduction 
The autonomic nervous system coordinates a person’s responsiveness to physiological and 
environmental stressors. Attenuated respiratory sinus arrhythmia (RSA) with small 
standard deviation of the normal-normal electrocardiogram RR intervals (SDNN) is found 
in subjects with low heart rate variability (HRV) by time domain analysis (Montano et al., 
2009). Low HRV is also characterized by sympathovagal balance shifted toward sympathetic 
predominance observed as an increase in the low frequency/high frequency ratio by 
frequency domain (fast Fourier transform) spectral analysis (Montano et al., 2009). However, 
inter- and intra-individual spectral changes are highly variable (Taverner et al., 1996) and 
the physiological significance is not always clear. Paced breathing at 0.2 Hz normally shifts 
sympathovagal balance toward greater vagal and less sympathetic activity (Driscoll and 
Dicicco, 2000) because of increased tidal volume and/or minute ventilation (Pinna et al., 
2006). Sympathovagal imbalance related to low HRV is a risk factor for hypertension and 
various other cardiovascular and non-cardiovascular diseases (Kuch et al., 2001; Montano et 
al., 2009). Epidemiological studies estimate that the prevalence of hypertension ranges from 
8% in an urban adolescent population (Rabinowitz et al., 1993) to 43% in black physicians 
twenty-two years after medical school (Gillum, 1999). However, no studies have determined 
the incidence and behavioral significance of sympathovagal imbalance in healthy young 
adult African-Americans. Abnormal autonomic responsiveness to environmental stressors is 
thought to be an important factor in the evolution of essential hypertension (Fauvel et al., 
1996; Mezzacappa et al., 2001; Lucini et al., 2002a; 2002b) and African-American males are a 
subpopulation at high risk for such hypertension (Gillum, 1979; Kaplan, 1994; Gillum, 1999). 
The present study was, therefore, designed to determine whether sympathovagal imbalance 
related to low HRV occurs in a population of healthy young adult African-American males 
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students was included in the study. Criteria for inclusion in the study were: non-smoking 
status, absence of alcohol abuse (less than two standard alcohol drinks a day), absence of 
use of medication that could interfere with autonomic modulation, resting systolic/diastolic 
blood pressure <140/90 mm Hg and body mass index less than 28 kg m-1. 
2.1.1 Paced breathing 
After entering the laboratory subjects were instrumented and instructed as to the 
experimental procedures. Subjects breathed normally while seated and at rest and 5 min of 
this resting data was recorded. Following the normal breathing protocol subjects were 
instructed to perform 5 min of paced breathing in such a manner that each respiratory cycle 
was 5 s in duration or 12 breaths per min (0.2 Hz). The subject observed a visual tracking 
image on a computer monitor for periodic durations of inspirations and expirations. Each 
subject practiced paced breathing for a period of 1 min and was then instructed to perform 
the paced respiration for 5 min during which time the electrocardiogram signal was 
recorded using a Biopac MP100 data acquisition system (Biopac Systems, Santa Barbara, 
CA).  The electrocardiogram electrodes were placed on the subject’s chest in a standard 
three-lead position with recordings obtained from lead II.  
2.1.2 Group assignment 
Two groups of subjects were a priori classified as either “broadband” or “narrowband”.  
The criterion for the “narrowband” group was that the maximum SDNN value, a time-
domain marker of vagal modulation, was more than one standard deviation below the mean 
SDNN for the study population during the 5 min trial of paced breathing. The “broadband” 
group, thereby, consisted of the subjects exhibiting SDNN one standard deviation less than 
that of the mean SDNN of the study population. Figure 1 shows cardiotachogram tracings of 
representative broadband and narrowband subjects. 
2.1.3 Heart rate variability analyses 
Heart rate was measured in beats · min-1 and vagal modulation of HRV in the time domain 
was measured as the standard deviation of all normal-to-normal standard 
electrocardiogram inter-beat intervals (SDNN). Time domain HRV, measured as standard 
deviation of the RR intervals, was expressed in ms and was computed using data acquisition 
and analysis software specifically designed to measure HRV in the time and frequency 
domain (Nevrokard, Version 6.3.1, Ljubljana, Slovenia). All time domain HRV data were 
reported herein as mean SDNN ± standard error. Fast Fourier transform analysis of the 
electrocardiogram RR intervals was used to spectrally decompose HRV in the frequency 
domain. For the frequency domain analysis, vagal modulation was represented by the area 
under the high-frequency power spectrum (HF: 0.14-0.4 Hz) expressed as the power in ms2. 
We also included the LF/HF ratio of heart rate variability as a measure of sympathetic 
modulation according to the Task Force of the European Society of Cardiology and the 
North American Society of Pacing and Electrophysiology (1996).  However, this concept has 
received great criticism (Eckberg, 1999). All time and frequency domain analyses were 
carried out in accordance with the guidelines put forth by the Task Force of the European 
Society of Cardiology and the North American Society of Pacing and Electrophysiology 
(1996).  
 







Fig. 1. Electrocardiogram RR intervals for broadband and narrowband subjects. 
Representative cardiotachogram tracings showing electrocardiogram RR intervals (ms) on 
the ordinate and time (s) on the abscissa for a representative subject exhibiting 
characteristics for assignment to the broadband group (Top Panel) and to the narrowband 
group (Bottom Panel). 
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2.1.4 Aerobic capacity (VO2peak) 
The functional work capacity measure of VO2peak was performed during a graded exercise 
treadmill test using the Bruce protocol with stage 1 beginning at an incline of 10% at a speed 
of 1.7 mph for 3 min. After stage 1, the treadmill incline was increased by 2% and the speed 
by 0.8 mph every 3 min until voluntary fatigue. Respiratory measures of ventilation and gas 
fractions of oxygen and carbon dioxide were performed using a Physio-Dyne Max I 
metabolic system (Physio-Dyne Inc., Quogue, NY). VO2peak was defined as the VO2 value 
achieved during the last min of the graded treadmill exercise test. Before the graded exercise 
test of VO2peak, the metabolic system was calibrated with known gas concentrations of 
oxygen and carbon dioxide. The participants performed the VO2peak test during the first 
laboratory visit at the beginning of the study. 
2.1.5 Paced and uncontrolled spontaneous breathing conditions 
The subjects were trained to breathe at 0.2 Hz by following an analog signal generated by a 
computer for timing the inspiratory and expiratory phases of respiration. Measurements of 
heart rate variability made during paced and uncontrolled spontaneous breathing were 
performed while sitting in a chair. 
2.1.6 Mental and nociceptive stress conditions 
Mental stress was produced by Stroop word-color conflict testing and physical stress by 
cold pressor testing using single foot immersion in an ice bath. 
2.2 Statistical analysis 
The significance of differences in SDNN, the absolute HF power, the LF/HF power was 
determined by comparing the paced breathing control to the spontaneous breathing 
condition using Student’s t-test for paired samples. Linear regression analysis was used to 
verify the correlation between SDNN and HF power. The significance of intergroup 
(“broadband” vs. “narrowband”) differences was determined using Student’s t-test for 
independent samples. Probability for all analyses was set at P<0.05. Significance of 
differences in SDNN across testing conditions was evaluated by analysis of variance 
(ANOVA), with significance at P<0.05. 
3. Results 
Table 1 presents the physiological characteristics of the study population showing that it 
consisted of a healthy group of 18-26 year-old healthy male African-American university 
students measured during the paced breathing control condition.  
 
Age (years) 20.92 ± 2.48 
Weight (kg) 76.03 ± 10.89 
Height (cm) 179.44 ± 7.06 
Resting Systolic Blood Pressure (mm Hg) 130.08 ± 8.64 
Resting Diastolic Blood Pressure (mm Hg) 76.36 ± 9.33 
Resting Heart Rate (beats· min-1) 75.48 ± 9.65 
Peak Oxygen Consumption (mL· kg-1· min-1) 35.30 ± 7.28 
* Mean ± standard deviation 
Table 1. Physiological characteristics of the study population* 
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The heart rates of the study population measured during the normal spontaneous breathing 
condition were found to be lower than those measured during the paced breathing control 
condition (67.9 ± 1.8 vs. 70.1 ± 1.7, P=0.01); this difference was extremely small (3%) and, 
therefore, not of physiological significance. On the other hand, the heart rates measured 
during the Stroop word color conflict and cold pressor testing were 16% higher (81.3 ± 2.3 
and 81.3 ± 2.3 vs. 70.1 ± 1.7, P<0.01, respectively) and the heart rates during exercise at 30%-
50% of peak oxygen consumption were 34%-77% higher (94.5 ± 2.1 and 124.6 ± 3.5 vs. 70.1 ± 
1.7, P<0.01, respectively) than those measured during the paced breathing control condition; 
these differences were considered to be physiologically significant. 
The study group of 52 subjects was characterized by a maximum SDNN of 249.70 ms, a 
minimum SDNN of 39.15 ms and a mean ± standard deviation of 108.40 ± 40.95 ms during 
the paced breathing control condition. A subgroup of subjects met the criterion for low HRV 
(6/52, 12%) and, by experimental design, exhibited a very small SDNN, more than one 
standard deviation below the mean of the study population, during paced breathing at a 
fixed frequency (0.2 Hz). This subgroup was differentiated from the larger study group by a 
minimum SDNN of 39.15 ms, a maximum of 64.55 and a mean ± standard deviation of 49.40 
± 7.15 ms (P<0.0001).  
Figure 1 demonstrates the range of SDNN values measured in this study and shows a 
significantly greater SDNN of the study population for the paced breathing control 
condition than for the two conditions of exercise at 30% and 50% of peak oxygen 
consumption (P<0.0001).  SDNN measured during the periods of normal spontaneous 
breathing, at 0.18-0.48 Hz while at rest sitting in a chair and on a cycle ergometer, and 
Stroop word color conflict testing (mental stress) were smaller than the SDNN measured 
during the paced breathing control period and intermediate between the largest SDNN 
during paced breathing and the smallest SDNN measured measured during aerobic exercise 
(P<0.001). The SDNN measured during cold pressor testing (cold stress) was not 
significantly different that that during the paced breathing control (P>0.1).  
Figure 2 shows that the SDNN of the study group during the control paced breathing was 
significantly greater than that during the uncontrolled spontaneous breathing, both 
measured while sitting in a chair (P<0.05). Figure 3 demonstrates that the group of 6 subjects 
(“narrowband” group) found to have significantly smaller SDNN of the remaining group of 
46 subjects (“broadband” group) during normal spontaneous breathing (0.18-0.4 Hz), both 
measured at rest while sitting in a chair (P<0.05). Figure 4 shows that, between the normal 
spontaneous breathing and paced breathing conditions, the SDNN of this “low HRV, 
narrow heart rate bandwidth” or “narrowband” group of 6 subjects increased by 1.58 ± 
13.59%; whereas, that of the remaining group of 46 “normal HRV, broad heart rate 
bandwidth” subjects (“broadband” group) increased by 30.41 ± 2.29% (P=0.0006) during 
paced breathing at 0.2 Hz.  
Figure 5 presents a comparison of the SDNN of the broad and narrow heart rate bandwidth 
groups across all of the physiological states studied. By experimental design, the SDNN 
measured during the paced breathing control condition differentiated between the narrow 
and broad heart rate bandwidth groups which were also found to be differentiated by the 
SDNN measured during the normal spontaneous breathing state. These groups were not 
differentiated by the SDNN measured during the experimental conditions of Stroop word 
color conflict testing (mental stress), cold pressor testing (cold stress) and exercise at 30% 
and 50% of peak oxygen consumption. 
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Fig. 2. Heart rate variability across various testing conditions. Bars represent heart rate 
variability (HRV, ms) expressed as time domain measure of mean standard deviation of 
normal-normal electrocardiogram RR intervals (SDNN) during paced breathing at 0.2 Hz 
(pace), normal uncontrolled spontaneous breathing at rest sitting in a chair (rest), Stroop 
word-color conflict testing of mental stress (mental), cold pressor testing of nociceptive 
stress (cold), normal uncontrolled spontaneous breathing at rest sitting on a cycle ergometer 
(rest cycle) and aerobic exercise stress at 30% and 50% of peak oxygen consumption (30% 
VO2peak, 50% VO2peak). Subjects are 52 healthy young adult African-American males. Data in 
mean ± standard error. ♦ SDNN different from paced breathing control (pace) at P<0.05.  
The “broadband” group’s total spectral power was significantly greater than the 
“narrowband” group’s total HRV spectral power for paced but not for spontaneous 
breathing (16,600 ± 1,842 vs. 2,858 ± 176 ms2, P=0.01 and 7,807 ± 1,224 vs. 2,106 ± 424 ms2, 
P=0.1, respectively). The “broadband” versus “narrowband” intergroup difference in 
absolute LF power was not significant for spontaneous breathing. The “broadband” group’s 
absolute LF power was significantly higher than the “narrowband” group’s absolute LF 
power (12,830 ± 1,461 vs. 1,981 ± 296 ms2, P=0.01) for paced breathing. The “broadband” 
group’s absolute HF power was not significantly different than the “narrowband” group’s 
absolute HF power for both paced and spontaneous breathing (P=0.12). The “broadband” 
versus “narrowband” intergroup difference in the percentages of total LF and HF power 
was also not significant. 
 





Fig. 3. Heart rate variability for paced and uncontrolled breathing conditions. Bars 
represent heart rate variability (HRV, ms) expressed as time domain measure of mean 
standard deviation of normal-normal electrocardiogram RR intervals (SDNN) during paced 
breathing at 0.2 Hz (pace) and normal uncontrolled spontaneous breathing at rest sitting in a 
chair (rest). Subjects are 52 healthy young adult African-American males. Data in mean ± 
standard error. The rest condition is different from paced breathing control (pace) at P<0.05. 
Figure 6 shows that the LF/HF ratio of HRV spectral power, a measure of cardiac 
sympathovagal balance, was significantly higher during paced breathing at 0.2 Hz than 
during uncontrolled spontaneous breathing for the study group of 52 subjects (P<0.01) and, 
during paced breathing at 0.2 Hz, was significantly higher for the narrowband band group 
of 6 subjects than for the broadband group of 46 subjects (P<0.05). 
4. Discussion 
Humans vary in their responsiveness to environmental stressors and HRV measurements 
may serve as physiological markers for such variation (DeBecker et al., 1998). HRV in the 
time domain, measured as standard deviation or standard error, estimates the range of 
differences in the time intervals between heartbeats (Lucini et al., 2002c). HRV has been 
used as a measure of autonomic balance that emanates from endogenous sympathetic and 
parasympathetic rhythms which are partly modulated by respiratory sinus arrhythmia 
(Hayano et al., 1990; Hrushesky, 1991). Fast Fourier transform (FFT) analysis of HRV 
differentiates the frequency components of the heart’s inter-beat intervals and yields more 
detailed information about autonomic tone than time domain analysis (Petretta et al., 1995). 
Such analysis makes it possible to differentiate conditions with physiological features in 
common. For example, common autonomic contributions to HRV have been evaluated by 
examining specific FFT frequency bands. This frequency domain analysis is useful under 
diverse physiological states such as dynamic exercise (Pichon et al., 2004), hypertension 
associated with sleep apnea (Vanninen et al., 1996; Narkiewicz et al., 1998; Salo et al., 2000) 
and optic neuropathy (Gutierrez et al., 2002). In this study, we found that healthy young 
adult African-Americans exhibit greater SDNN, a time domain measure of HRV, during 
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absolute HF power for both paced and spontaneous breathing (P=0.12). The “broadband” 
versus “narrowband” intergroup difference in the percentages of total LF and HF power 
was also not significant. 
 





Fig. 3. Heart rate variability for paced and uncontrolled breathing conditions. Bars 
represent heart rate variability (HRV, ms) expressed as time domain measure of mean 
standard deviation of normal-normal electrocardiogram RR intervals (SDNN) during paced 
breathing at 0.2 Hz (pace) and normal uncontrolled spontaneous breathing at rest sitting in a 
chair (rest). Subjects are 52 healthy young adult African-American males. Data in mean ± 
standard error. The rest condition is different from paced breathing control (pace) at P<0.05. 
Figure 6 shows that the LF/HF ratio of HRV spectral power, a measure of cardiac 
sympathovagal balance, was significantly higher during paced breathing at 0.2 Hz than 
during uncontrolled spontaneous breathing for the study group of 52 subjects (P<0.01) and, 
during paced breathing at 0.2 Hz, was significantly higher for the narrowband band group 
of 6 subjects than for the broadband group of 46 subjects (P<0.05). 
4. Discussion 
Humans vary in their responsiveness to environmental stressors and HRV measurements 
may serve as physiological markers for such variation (DeBecker et al., 1998). HRV in the 
time domain, measured as standard deviation or standard error, estimates the range of 
differences in the time intervals between heartbeats (Lucini et al., 2002c). HRV has been 
used as a measure of autonomic balance that emanates from endogenous sympathetic and 
parasympathetic rhythms which are partly modulated by respiratory sinus arrhythmia 
(Hayano et al., 1990; Hrushesky, 1991). Fast Fourier transform (FFT) analysis of HRV 
differentiates the frequency components of the heart’s inter-beat intervals and yields more 
detailed information about autonomic tone than time domain analysis (Petretta et al., 1995). 
Such analysis makes it possible to differentiate conditions with physiological features in 
common. For example, common autonomic contributions to HRV have been evaluated by 
examining specific FFT frequency bands. This frequency domain analysis is useful under 
diverse physiological states such as dynamic exercise (Pichon et al., 2004), hypertension 
associated with sleep apnea (Vanninen et al., 1996; Narkiewicz et al., 1998; Salo et al., 2000) 
and optic neuropathy (Gutierrez et al., 2002). In this study, we found that healthy young 
adult African-Americans exhibit greater SDNN, a time domain measure of HRV, during 















































Fig. 4. Heart rate variability for broadband and narrowband groups.  Bars represent heart 
rate variability (HRV, ms) expressed as time domain measure of mean standard deviation of 
normal-normal electrocardiogram RR intervals (SDNN) during paced breathing at 0.2 Hz 
(Bottom Panel) and normal uncontrolled spontaneous breathing at rest sitting in a chair 
(Top Panel). Subjects are 46 broadband (BB) healthy young adult African-American males 
with normal HRV compared to a similar group of 6 narrowband (NB) subjects with low 
HRV defined as exhibiting SDNN during paced breathing more than one standard deviation 
from the mean SDNN of the study group of 52 subjects. Data in mean ± standard error. The 
rest condition is different from paced breathing control (pace) at P<0.05. 
and mental stress. We also identified a small subpopulation (12%) of subjects exhibiting 
SDNN more than one SD below the mean SDNN of the larger study population of 52 males 
during the paced breathing condition. It was beyond the scope of this part of the study to 
measure HRV spectral power. Because of the high variability of frequency domain 
measurements during short time intervals (Taverner et al., 1996), we limited a part of this 















































Fig. 5. Percent change in heart rate variability for broadband and narrowband groups.  Bars 
represent percent increase in heart rate variability expressed as time domain measure of mean 
standard deviation of normal-normal electrocardiogram RR intervals (SDNN) during paced 
breathing at 0.2 Hz.  Subjects are 46 broadband (BB) healthy young adult African-American 
males with normal HRV compared to a similar group of 6 narrowband (NB) subjects with low 
HRV defined as exhibiting SDNN during paced breathing less than one standard deviation 
from the mean SDNN of the study group of 52 subjects. Data in mean ± standard error. The 
percent increase in SDNN of the BB group is different from that of the NB group at P<0.05. 
Respiratory sinus arrhythmia is thought to be the main source of HRV. However, there may 
be other non-autonomic contributions to respiratory sinus arrhythmia and to the high 
frequency (HF) components of HRV which may distort the signal-to-noise ratio and 
estimates of capacity for vagal modulation of heart rate (Pichon et al., 2004).  HF HRV may 
mostly reflect noise if breathing shifts a substantial amount of HRV power to the low 
frequency (LF) range. The low time domain HRV occurring in subjects with apnea 
syndromes (Vanninen et al., 1996; Narkiewicz et al., 1998; Salo et al., 2000) could also be an 
effect of respiratory rate and/or tidal volume (Pinna et al., 2006). Low time domain HRV has 
been found in subjects exhibiting pre-hypertensive (Lucini et al., 2002a) and obesity (Salo et 
al., 2000) risk factors. Acetylcholine, when released from the vagus nerve, appears to act 
synergistically with vasoactive intestinal peptide to increase respiratory sinus arrhythmia 
(Markos and Snow, 2001). Higher HRV spectral frequencies and greater inter-beat intervals 
have been associated with a high capacity for vagal modulation of heart rate which occurs in 
normotensive healthy adults breathing at rest (Gutierrez et al., 2002). The peak HRV spectral 
frequency occurs in the range of HF in normotensive healthy adults breathing at rest and 
shifts to the range of LF during periods of exercise and stress, as well as, during disease 
states such as hypertension (Murakami et al., 1996) 
Because of the respiration-related variability of electrocardiogram inter-beat (RR) intervals, 
the necessity of controlling respiratory frequency during measurements of HRV has been 
demonstrated (De Meersman et al., 1995). We used the frequency of 0.2 Hz during the paced 
breathing trial because this frequency produced the most reproducible conditions across 
subjects. As expected, the time domain HRV during paced breathing was significantly 
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rest condition is different from paced breathing control (pace) at P<0.05. 
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Fig. 5. Percent change in heart rate variability for broadband and narrowband groups.  Bars 
represent percent increase in heart rate variability expressed as time domain measure of mean 
standard deviation of normal-normal electrocardiogram RR intervals (SDNN) during paced 
breathing at 0.2 Hz.  Subjects are 46 broadband (BB) healthy young adult African-American 
males with normal HRV compared to a similar group of 6 narrowband (NB) subjects with low 
HRV defined as exhibiting SDNN during paced breathing less than one standard deviation 
from the mean SDNN of the study group of 52 subjects. Data in mean ± standard error. The 
percent increase in SDNN of the BB group is different from that of the NB group at P<0.05. 
Respiratory sinus arrhythmia is thought to be the main source of HRV. However, there may 
be other non-autonomic contributions to respiratory sinus arrhythmia and to the high 
frequency (HF) components of HRV which may distort the signal-to-noise ratio and 
estimates of capacity for vagal modulation of heart rate (Pichon et al., 2004).  HF HRV may 
mostly reflect noise if breathing shifts a substantial amount of HRV power to the low 
frequency (LF) range. The low time domain HRV occurring in subjects with apnea 
syndromes (Vanninen et al., 1996; Narkiewicz et al., 1998; Salo et al., 2000) could also be an 
effect of respiratory rate and/or tidal volume (Pinna et al., 2006). Low time domain HRV has 
been found in subjects exhibiting pre-hypertensive (Lucini et al., 2002a) and obesity (Salo et 
al., 2000) risk factors. Acetylcholine, when released from the vagus nerve, appears to act 
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breathing trial because this frequency produced the most reproducible conditions across 
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Fig. 6. Heart rate variability across various testing conditions for broadband and 
narrowband subjects. Bars represent heart rate variability (HRV, ms) expressed as time 
domain measure of mean standard deviation of normal-normal electrocardiogram RR 
intervals (SDNN) during paced breathing at 0.2 Hz (pace), normal uncontrolled 
spontaneous breathing at rest sitting in a chair (rest), Stroop word-color conflict testing of 
mental stress (mental), cold pressor testing of nociceptive stress (cold), normal uncontrolled 
spontaneous breathing at rest sitting on a cycle ergometer (rest cycle) and aerobic exercise 
stress at 30% and 50% of peak oxygen consumption (30% VO2peak, 50% VO2peak). Subjects are 
46 broadband (BB) healthy young adult African-American males with normal HRV 
compared to a similar group of 6 narrowband (NB) subjects with low HRV defined as 
exhibiting SDNN during paced breathing more than one standard deviation from the mean 
SDNN of the study group of 52 subjects. Data in mean ± standard error. ♦ NB different from 
BB at P<0.05.  
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under technical supervision and in the low range of normal respiratory rate. Breathing in 
the range of 3-9 breaths per minute (0.05-0.15 Hz) may produce higher amplitude 
respiratory sinus arrhythmia because of more complete acetylcholine metabolism during 
exhalation (Song and Lehrer, 2003). Respiratory sinus arrhythmia might also be maximized 
if subjects breathe at frequencies controlled by other physiological processes. For example, 
when breathing between 4-7 breaths per minute (0.07-0.12 Hz), the baroreceptor reflex 
might be stimulated; thereby, causing a resonance effect and an increase in HRV (Vaschillo 
et al., 2002). In the present study, paced breathing was associated with significantly lower 
SDNN (0.2 Hz) than the spontaneous breathing trials (0.18-0.48 Hz) and we did not measure 
tidal volume which has been shown to positively modulate the high frequency (vagal) 
component of HRV spectral power (Pinna et al., 2006). At a high respiratory frequency 
paced breathing has been shown to produce predominance of the HF power of HRV in 
normal healthy adult subjects during meditation (Cysarz and Bussing,  2005). HRV studied 
during paced breathing in subgroups of pre-hypertensive and hypertensive middle-aged 
men and women has been shown to produce greater HF power in the pre-hypertensive than 
in the hypertensive subgroups (Prakash et al., 2005). 
HRV in a subgroup of healthy normotensive middle-aged persons whose natural 
spontaneous respiratory frequency ranged 9-27 breaths per minute (0.15-0.45 Hz) with 
predominance of the HF power of HRV was compared to another subgroup whose natural 
respiratory frequency was less than 9 breaths per min (0.15 Hz) (Pinna et al., 2006). In that 
study, paced breathing at 15 breaths per min (0.25 Hz) failed to alter either the time domain 
or the frequency domain HRV parameters. In a study population of healthy adults, data sets 
matching respiratory frequencies at rest with those during dynamic exercise demonstrated 
that the LF and HF powers of HRV were not changed by controlled breathing in the absence 
of dynamic exercise but were significantly decreased at the same respiratory frequencies 
during exercise (Bartels et al., 2004). Because of the expected transients and uncertainties 
about the role of respiration and significance of changes in frequency domain HRV, we 
limited this part of the study to use of a time domain measure of HRV that, based on the 
current knowledge, would be more easily interpreted. 
5. Conclusions 
This study has demonstrated a wide range of SDNN measurements performed under 
various experimental conditions from the largest SDNN measured during paced breathing 
at 0.2 Hz to the smallest during exercise at 30%-50% of peak oxygen consumption in a group 
of 52 healthy young adult African-American males. The SDNN measured during short 
periods of normal spontaneous breathing at 0.18-0.48 Hz while at rest sitting both in a chair 
and on a cycle ergometer, cold stress and mental stress were intermediate, between those of 
paced breathing and aerobic exercise. SDNN was used to differentiate a “narrowband” 
subgroup (6/52 subjects, 12%) on the basis of a much smaller observed difference in SDNN 
between paced and normal spontaneous breathing and, despite an increase in the heart rate, 
the absence of a decrement in SDNN during a state of mental stress. These findings suggest 
that mental stress, elicited by Stroop word conflict testing, seems to have a differentiating 
effect on SDNN, an easily performed and interpreted time domain measure of heart rate 
variability. In the frequency domain, higher LF/HF heart rate variability spectral power, a 
reliable measure of sympathetic modulation of the heart rate, differentiated the paced from 
the uncontrolled spontaneous breathing condition and the same “narrowband” subgroup, 
as demonstrated in figures 7 and 8.  
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Fig. 7. Heart rate variability spectral power measure of sympathovagal balance for paced 
and uncontrolled breathing conditions. Bars represent low frequency/high frequency ratio 
(LF/HF) of heart rate variability spectral power measured by fast Fourier transform analysis 
of electrocardiogram RR intervals during paced breathing at 0.2 Hz (pace) and normal 
uncontrolled spontaneous breathing at rest sitting in a chair (rest). Subjects are 52 healthy 
young adult African-American males. Data in mean ± standard error. The rest condition is 















Fig. 8. Heart rate variability spectral power measure of sympathovagal balance for 
broadband and narrowband groups. Bars represent low frequency/high frequency ratio 
(LF/HF) of heart rate variability spectral power measured by fast Fourier transform analysis 
of electrocardiogram RR intervals during paced breathing at 0.2 Hz. Subjects are 46 
broadband (BB) healthy young adult African-American males with normal HRV compared 
to a similar group of 6 narrowband (NB) subjects with low HRV defined as exhibiting 
SDNN during paced breathing more than one standard deviation from the mean SDNN of 
the study group of 52 subjects. Data in mean ± standard error. LF/HF of the BB group is 
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Fig. 7. Heart rate variability spectral power measure of sympathovagal balance for paced 
and uncontrolled breathing conditions. Bars represent low frequency/high frequency ratio 
(LF/HF) of heart rate variability spectral power measured by fast Fourier transform analysis 
of electrocardiogram RR intervals during paced breathing at 0.2 Hz (pace) and normal 
uncontrolled spontaneous breathing at rest sitting in a chair (rest). Subjects are 52 healthy 
young adult African-American males. Data in mean ± standard error. The rest condition is 















Fig. 8. Heart rate variability spectral power measure of sympathovagal balance for 
broadband and narrowband groups. Bars represent low frequency/high frequency ratio 
(LF/HF) of heart rate variability spectral power measured by fast Fourier transform analysis 
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than 64 years. The loss of productive years of life has negative influence neither to private, 
nor public economical sector. 
The common electrocardiographic finding on exercise stress test, which can be evident for 
CAD, is recurrent, load-induced ST-segment depression. It points to myocardial ischemia in 
patient with significantly narrowed coronary arteries in status of progressive oxygen 
demand, while at rest blood flow is not limited. The sensitivity of the stress test increases 
along with severity of disease. It is possible correctly to identify the patients with proximal 
several arteries disease or left main artery stenosis performing a standard exercise stress test, 
nevertheless it gives unsufficient prognostic information in patient with less severe 
obstructive disease. 
Progression of coronary artery restenosis after percutaneous coronary intervention (PCI) is a 
clinical “final” result, which reflects complex pathophysiological process, including different 
combinations of residual coronary stenosis and neointimal proliferation. Unfortunately, the 
set of clinical symptoms is uncertain criteria for detection of coronary artery restenosis, 
patient’s complaints could be similar to non-coronary pain post revascularization (‘false-
positive’ symptoms), at the same time – “silent” ischemia may be present in many patients 
(‘pseudo-negative’ symptoms). Restenosis is observed in 25% of cases (data of balloon 
angioplasty) in asymptomatic patients with documented ischemic changes on exercise test 
(Bengston et al., 1990). 
Discussions are still extended, whether early performed strategy of exercise test is with 
prognostic value for clinical events in patients after PCI. There are no conclusive results 
about association of complaints’ limited exercise tests and long-term prognosis early after 
PCI. 
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CAD patients with left main coronary artery (LM) stenosis is another one group of interest, 
and there is stable introduced invasive PCI treatment and stent implantation for this 
patients’ group. It is important to evaluate the efficacy of new treatment, outcomes and 
following risk of cardiovascular events. Patients after LM PCI are at higher risk of 
thrombosis and restenosis, angiographic follow-up of these patients is expensive enough, 
with additional radiation dose and contrast amount for patients. Thus, high attention is 
focused on non-invasive investigation methods in patients with CAD. 
The results of recent studies should be taken into account, that the higher risk of 
cardiovascular events is observed in patients with unstable atheromatous plaque, even in 
case if stenosis of coronary artery is not significant (in segment of this plaque location). 
Exercise test in this situation should be evaluated more precisely and seriously in order to 
improve the prognostic value of the method. The question is – whether exercise test (with 
electrocardiogramm (ECG)) can be used in evaluation of prognostic criteria for patient along 
with possibility to detect obstructive lesion of coronary arteries with a goal to decrease 
effectively the risk of sudden death and serious coronary events? 
2. Objective of the study  
The aim of the study was to evaluate effectiveness of medical and invasive treatment in 
patients with CAD after PCI by performing physical test and proving test prognostic value 
of cardiovascular events - clinical (myocardial infarction, recurrent hospitalization, cardiac 
death) and angiographic (restenosis and/or new stenosis of coronary arteries) events. 
The main goals were defined: 
1. to define specific criteria of exercise stress test for possible restenosis diagnostics; 
2. to develop the algorhythm for the patients’ functional status evaluation after PCI, as 
well as for evaluation the possibility of coronary artery stenosis correction 
(intervention); 
3. to create the prognostic model, which can help to evaluate and reveal the patients with 
unfavorable long-term outcomes or unsatisfactory treatment results timely; 
4. to integrate targeted follow-up patients’ programme.  
3. Materials and methods 
The follow-up programme was developed in 1990 in the Latvian Centre of Cardiology and 
surveyed patients with CAD which underwent PCI treatment method. 
The programme has been proceeded since the first patient was treated with the method of 
coronary angioplasty in Latvia. 
The study was implemented from January, 2004 till January, 2009. The patients with 
established CAD (based on coronary angiography data) were included in the study. The 
patients underwent invasive treatment – PCI in the Latvian Centre of Cardiology. The 
number of performed PCIs during mentioned period of time – 16 109. All patients were 
informed about possibility to be included in the follow-up programme. 
The data of 7 300 patients with CAD and complete 24-months follow-up after PCI were 
included in the study. 
The patients were observed in defined follow-up periods of time after PCI by performing 
exercise stress test (veloergometry – bicycle ergometer exercise test): 
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 1-3 months after invasive treatment – immediate risk evaluation and correction of 
medical treatment; 
 3-6 months after PCI – distant period – determination of possibility of restenosis and 
correction of medical treatment; 
 12-24 months after PCI – late period – determination of possibility of restenosis and 
correction of medical treatment. 
Control coronary angiography was performed based on indications, which included 
following patients groups: 
 patients with new-onset angina proved by ischemic changes on ECG during exercise 
stress test; 
 patients without typical coronary complaints, but with registered ischemic changes on 
exercise test ECG; 
 patients with non-sufficient information on exercise test in order to evaluate indications 
for coronary angiography, therefore exercise test with additional visualization method 
was performed – myocardial perfusion scintigraphy. 
 Patients without indications for control coronary angiography underwent the correction 
of medical treatment (if it was needed) and were included in the next scheduled 
exercise test control. 
Large patients group was revealed during the follow-up process – patients without typical 
coronary chest pain but with registered ischemic changes on ECG during exercise test. These 
patients were defined like „silent” ischemia patients group which has the higher risk of 
cardiovascular events and worse prognosis. 
All the patients of this group underwent control coronary angiography and were divided 
into different groups according to angiographic finding: 
 patients with restenosis of coronary artery (in previously repaired segment); 
 patients with new stenosis of coronary artery; 
 patients without restenosis or new stenosis on angiographic finding.  
Patients with restenosis or new stenosis underwent PCI and were included in consequent 
follow-up plan and medical treatment correction. Patients without restenosis or new 
stenosis continued previously defined follow-up plan. 
The analysis of used medications groups was performed because of medical treatment 
correction during follow-up process. It was dependent on obtained data during exercise test 
(e.g., arterial blood pressure and/or heart rate, compliance of these parameters changes to 
physical load, etc.). Medications after performed PCI (recommended on discharge) and in 
one year follow-up period were compared. 
Very high risk patients were included into the separate group analysis (400 patients) with 
LM stenotic lesion. All patients were informed about possibility to be included in the 24 
months follow-up plan. 133 patients have accomplished complete follow-up programme (1, 
3, 6, 12 and 24 months after PCI). In order to define precise indications for control coronary 
angiography, myocardial perfusion scintigraphy with physical or pharmacological test was 
performed in this patients group (94 examinations). This examination was performed in 12-
24 months period after PCI in patients without indications for control angiography. 
Phone follow-up survey was also performed in this patients group in order to clarify 
possible coronary events – hospitalization, myocardial infarction or death. Patients groups 
with and without performed follow-up programme were compared. 
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SPSS 12.0.1. version was used for statistical analyses. Baseline characteristics were 
summarized as frequencies and percentages for categorical variables and as means and SDs 
for continuous variables. Analyses were performed using χ2/Fisher exact test for categorical 
variables and Student t test/ ANOVA method for continuous variables. The correction with 
Tukey test was performed in post hoc analysis for multiple comparisons correction. 
Differences were considered statistically significant at p<0.05. 
3.1 Exercise test – veloergometry  
Exercise stress test – veloergometry was performed in sitting or reclining position in patients 
of the study, depending on used bicycle ergometer (in sitting position – veloergometer 
„Ergometrs 900” and since April, 2008 – veloergometer „e-bike” for test performing in 
reclining position). Modified Bruce protocol was used during exercise test – standardized 
load grading programme according to the protocol accepted by Latvian Cardiology Society:     
 first degree – three minutes with 50 Watt (W) load; 
 second degree – three minutes with 100 W load; 
 third degree – three minutes with 150 W load; 
 fourth degree – three minutes with 200 W load; 
 fifth degree – three minutes with 250 W load. 
Maximal allowed load was defined as 250 W. In specific cases (if it was necessary) or 
according to patient condition (patients with chronic heart failure) the protocol was 
accommodated individually – the load was increased for 25 W every three minutes with the 
beginning of second degree of the test protocol.  
ECG was monitored continuously during the test time, increasing the load till the goal heart 
rate was achieved – 85 % of maximal heart rate according (appropriate) to concrete age or 
the load was limited by symptoms of ischemia.  
Following indications were defined for the test discontinuation: 
a. typical increasing chest pain and/or ST-segment changes on ECG (ST-segment 
depression > 2 mm – as a relative indication for the test interruption, ST-segment 
depression > 3 mm – as a absolute indication for the test interruption); 
b. ST-segment elevation > 1 mm (if pathologic Q-wave is not present on ECG at rest); 
c. arrhythmias (supraventricular tachycardia, multiple politope and pair premature beats 
(extrasystoles)); 
d. systolic blood pressure decrease (> 10 mmHg compared with onset blood pressure 
level), despite of the load increase; 
e. hypertension (> 250 mmHg systolic and > 115 mmHg diastolic blood pressure); 
f. central nervous system symptoms (ataxy, weakness, syncope); 
g. signs of decreased perfusion (cyanosis); 
h. fatigue, dyspnoe, leg cramps, claudication; 
i. complete left His bundle branch block; 
j. achieved submaximal heart rate; 
k. patient’s request to terminate the test; 
l. technical problems. 
Exercise test was defined as positive, if there were registered changes on ECG associated 
with myocardial ischemia: 
 horizontal or downslopping ST-segment depression or elevation, greater than or equal 
with 1 mm 60 msec after QRS complex; 
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 especially, if these changes were associated with chest pain, appeared at lower load (< 
75 W) and lasting for more than 3 minutes after load was finished. 
Following parameters were analized:   
a. Electrocardiographic parameters: 
- maximal ST-segment depression; 
- maximal ST-segment elevation; 
- configuration (shape) of ST-segment depression (horizontal, downslopping, 
upslopping); 
- the number of leads ST-segment changes registered in; 
- duration of ST-segment changes at the test phase of rest (after load discontinued); 
- ST/pulse index; 
- ventricular arrhythmias induced by exercise; 
- the time to ST-segment changes appeared at. 
b. Hemodynamic parameters: 
- maximal heart rate; 
- maximal systolic blood pressure; 
- maximal double rate-pressure product (Robinson index) (maximal heart rate 
multiply by maximal systolic arterial pressure, divided by 100) 
- total exercise (load) time; 
- hypotension (arterial pressure decrease under the blood pressure level before load 
was started); 
- chronotropic incompetence. 
c. Symptomatic parameters: 
- angina provoked by load; 
- load-limiting symptoms; 
- time to the onset of angina.  
Following information was included in the protocol of veloergometry (accordingly the 
methodological guidelines): 
 maximal load; 
 total time of the load; 
 heart rate at the beginning; 
 initial systolic and diastolic blood pressure; 
 maximal heart rate; 
 maximal systolic and diastolic blood pressure; 
 double rate-pressure product; 
 the intensity and quantity of ECG changes; 
 recovering period after load; 
 patient’s complaints; 
 test termination reasons; 
 tolerance of the exercise (load) (high, satisfactory, lowered, low); 
 load-limiting factors. 
The data mentioned above (collected from veloergometry test protocols) were included into 
the total database of the study. 
There were no any complications registered during exercise test perfoming – myocardial 
infarction, life-threating arrhythmias or death. 
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Myocardial perfusion scintigraphy was perfomed in patients at the case of embarrassing 
interpretation of ECG, and in order to evaluate the indications for control coronary 
angiography. 
Myocardial perfusion scintigraphy was also performed in patients after LM PCI. 
3.2 Coronary angiography and PCI 
The information about atherosclerotic lesions degree of coronary arteries was collected and 
included into the total database of the study (based on coronary angiography finding). 
Follow-up period results were included – data of coronary angiography finding (restenosis 
and/or new stenosis of coronary artery(-ies)), acute coronary events (recurrent 
hospitalization, myocardial infarction, coronary artery bypass grafting, recurrent coronary 
angiography and/ or PCI). 
The result of revascularization was defined, basing on the data of coronary angiography 
finding: 
- successful PCI defined as a dilatation of coronary artery stenosis with complete 
revascularization, if residual stenosis of coronary artery(-ies) does not exceed 50 % 
(Wenaweser et al., 2008); 
- incomplete revascularization defined as a residual stenosis (narrowing of the lumen of 
artery after performed PCI) greater than or equal with 50 % in any coronary artery 
(Chalela et al., 2006). 
Restenosis of coronary artery at the follow-up period was defined as a narrowing of 
coronary artery(-ies) lumen greater than or equal with 50 % and progression of coronary 
artery disease, if new stenosis of coronary artery was diagnosed (Chalela et al., 2006). 
4. Results 
4.1 Data registry of the patients with coronary artery disease treated with PCI 
In total 7300 patients with established CAD and performed treatment with PCI, with 
complete follow-up programme – 1, 3, 6 and 12 months follow-up visits, were included into 
the study. The patients underwent physical stress test, correction of used medications plan 
and doses of drugs, if it was necessary, and the control of risk factors. Control coronary 
angiography was performed in 2583 patients accordingly the indications.  
Indications for performance of control coronary angiography were determined basing on 
exercise test (13% of cases), restenosis on angiography was detected in 6.4% of the total 
patients’ group. 
In the patients’ group with left main artery stenosis (LM group) 400 patients were observed, 
133 of them worked out complete follow-up program and underwent control coronary 
angiography. Myocardial perfusion scintigraphy was performed in 98 LM-patients in order 
to evaluate more precisely the indications for coronary angiography. 
In total patients’ group 1226 patients (17%) showed coronary complaints, and ST-segment 
changes on ECG, which could be associated with myocardial ischemia, were observed in 975 
patients (13% of total number of patients). According to the indications these patients 
underwent coronary angiography. In general, angiographically confirmed coronary artery 
restenosis was diagnosed in 470 patients (6.4%) of all controlled patients’ group (7300) 
(Figure 1.). 
 




Fig. 1. Results of the follow-up programme (the total number of the patients – 7300). 
Exercise test is useful in detection of patients with „silent” ischemia (22%), which have 
the indications for control angiography; restenosis is found in 9% of this patients group. 
 
 
Fig. 2. Patients with „silent” ischemia. 
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It was observed during patients follow-up, that a separate group of the patients is forming, 
which is characterized by no complaints of chest pain, but significant ST-segment changes 
on exercise test ECG (so-called, silent ischemia, poor prognostic factor). These are 22% of the 
patients (1608 patients), all of them underwent coronary angiography. Restenosis of 
coronary artery was detected in 656 patients (9% of the total number of patients) and new 
hemodinamically significant stenosis in coronary artery (> 50% of artery lumen) – in 146 
patients (2%) of this patients group (Figure 2.). 
4.2 New specific criteria in restenosis diagnostics 
Several new specific criteria were found in restenosis diagnostics field additionally to ST-
segment ischemic changes on ECG during exercise stress test – reduced load tolerance, 
decreased maximal heart rate and maximal systolic blood pressure, maximal rate-pressure 
product (double product) – Robinson index, also increased ST/pulse index (ST/p index). 
Differences in parameters derived from exercise tests in patients with restenosis, new 
stenosis and in patients without restenosis/new stenosis on coronary angiography are 
shown in Figure 3.   
 
 
Fig. 3. Results of exercise test in „silent” ischemia patients’ group.  
Patients with restenosis on coronary angiography (first group) showed definitely ischemic 
changes on exercise ECG at lower physical load 121.4±33.2 W compared with those patients’ 
group with neither restenosis, nor new stenosis on coronary angiography (third group) – 
160.0±25.8 W (p<0.05). Achieved maximal heart rate and systolic blood pressure during 
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physical load also showed lower parameters in the first group, which is characterized by 
double rate-pressure product compared in both groups – 212.8±42.9 and 252.62±36.9, 
accordingly, in the first and third patients’ group (p<0.05)  (Figure 4.). 
 
 
Fig. 4. Analysis of average parameters of veloergometry data (maximal heart rate, maximal 


























121.4±33.2 118.8±14.6  181.5±28.3 212.8±42.9 1.3±0.5 
2. New stenosis
(n=146) 





160.0±25.8 135.0±40.1  189.2±23.3 252.62±36.9 0.9±0.2 
Table 1. Analysis of average parameters of veloergometry data (achieved physical load, 
maximal heart rate, maximal systolic blood pressure, Robinson index, ST/pulse index). 
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Parameters of neither maximal heart rate, nor maximal systolic arterial blood pressure, and 
so Robinson index, accordingly, are significantly lower in patients’ group witht coronary 
artery restenosis. The most important parameter, which can reflect patient’s risk of 
restenosis more precisely is ST/pulse index. In restenosis group this parameter is the 
highest one (1.3±0.5) (Table 1. and 2.). 
 













First and second 
group 
< 0.05 < 0.05 0.012 < 0.05 < 0.05 
Second and third 
group 
0.396 0.118 0.48 < 0.05 0.004 
First and third 
group 
< 0.05 < 0.05 < 0.05 < 0.05 < 0.05 
Table 2. Statistical analysis in comparison of different patients’ groups. 
4.3 Patients with left main coronary artery (LM) stenosis  
The database of the patients with LM stenosis was created. 
The group of the patients (n=400) with LM stenosis and performed PCI with drug-eluting 
stents (DES) was analyzed. In a period of years 2005-2010, 133 patients accomplished 
complete follow-up programme. Veloergometry was regularly performed in 3, 6, 12 and 24 
months after PCI, also control coronarography was performed in 6-12 months after PCI. 
Clinical characteristics of the patients:  
LM patients group – 80% of the patients are males, with mean age 61.3 ± 9.8 years. The most 
part of the patients is characterized with most important risk factors of coronary artery 
disease: in 96% of cases – dyslipidemia, in 77% of cases – arterial hypertension, smoking 
habits – active smokers (18%) or ex-smokers (30.8%). Previous myocardial infarction – in 
45.1% of patients, positive family history (first-line relatives at young age with CAD) in 
36.1% of cases (Table 3.). 
All the patients underwent LM PCI: 47 patients (38%) underwent solely LM PCI and 86 
patients (65%) – also PCI additionally in other artery (Table 4.). 
The changes of the parameters registered on exercise test (maximal heart rate, maximal 
systolic blood pressure and Robinson index) in every follow-up period (independently of 
the follow-up data on coronary angiography) are showed in Table 5. 
4.3.1 Association of veloergometry results with clinical events 
Recurrent hospitalization was ascertained for 14 patients (8.3%) in analysis of clinical events 
in follow-up period. The reasons for recurrent admission to the hospital: in two cases – 
myocardial infarction, in four cases – chest pain (angina) (three of these patients underwent 
recurrent coronary angiography), in two cases – next step PCI, in two cases – heart rhythm 
disorders (in one case – implantation of permanent pacemaker), in one case – stroke, in one 
case – elevated arterial blood pressure, in two cases – non-coronary reasons for 
hospitalization.  
 




Gender (males), n (%) 107 (80.5) 
Age, mea(±SD) 61.3 (± 9.8) 
Dyslipidemia, n (%) 96 (72.2) 
Arterial hypertension, n (%) 77 (57.9) 
Diabete mellitus, n (%) 11 (8.3) 
Smoking status: 
     Active smoker, n (%) 
     Ex-smoker, n (%) 





Positive family history, n (%) 48 (36.1) 
Prior myocardial infarction, n (%) 60 (45.1) 
Prior PCI, n (%) 26 (19.5) 
Prior coronary artery bypass grafting, n (%) 7 (5.3) 
Table 3. Clinical characteristics of the patients (demographic parameters and risk factors of 
coronary artery disease) (n=133). 
 
Characteristics Prevalence 
Coronary artery disease: 
        One-vessel disease, n (%) 
        Two- vessel disease, n (%) 






Complete/incomplete revascularization, % 40/27 
PCI LM only, n (%) 
PCI LM and other artery: 
       PCI LAD, n (%) 
47 (38.0) 
47 (35.3) 
       PCI LCx, n (%) 26 (19.5) 
       PCI RCA, n (%) 14 (10.5) 
       PCI RIM, n (%) 4 (3.0) 
       PCI D1, n (%) 3 (2.3) 
       PCI M1, RPL, RPD, n (%) 1 (0.8) 
LM–left main coronary artery; LAD–left anterior descending artery; LCx–left circumflex artery; RCA–
right coronary artery; RIM–ramus intermedius; D1–first diagonal branch; M1–first marginal branch; 
RPL–right posterolateral branch; RPD-right posterodiaphragmal branch. 
Table 4. Caracteristics of angiographic and PCI data of the patients (n=133). 
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Data of exercise test/ 
follow-up period 
1-3 months 3-6 months 6-12 months 12-24 months >24 months 
Maximal heart rate 
(bpm ± SD) 118 ± 16 122 ± 17 121 ± 16 119 ± 15 119 ± 15 
Maximal systolic blood 
pressure (mmHg ± SD) 180 ± 31 181 ± 29 182 ± 29 183 ± 31 184 ± 32 
Robinson index(max heart 
rate x max systolic blood 
pressure/100) ± SD  
213.27±51.02 220.93±52.55 221.55±45.9 217.84±47.68 219.32±48.46 
Table 5. Mean values of parameters analyzed on exercise test follow-up (maximal heart rate, 
maximal systolic blood pressure, Robinson index).  
Indications for control angiography were defined according to ST-segment ischemic changes 
on ECG and/or typical patients’ complaints during exercise test. 
Control angiography in follow-up period was performed in 33.8% of cases – 3-6 months 
after PCI, in 36.8% and in 10.5% of cases – 6-12 months and 12-24 months after PCI, 
respectively.   
4.3.2 Analysis of the results of control exercise tests (1-3 and 3-6 months after PCI) 
and coronary angiography 
There was no significant difference between patients group with LM restenosis and/or 
other coronary artery restenosis  on control coronary angiography and patients group 
without diagnosed restenosis, analyzing maximal achieved physical load in early follow-up 
period (control exercise test performed 1-3 and 3-6 months after PCI).  
Statistically significant difference (in maximal achieved physical load analysis) was 
observed comparing with the patients group with new coronary artery stenosis on control 
coronary angiography: these patients achieved lower maximal load on 1-3 months control 
exercise test – 90 ± 17 W vs. 129 ± 26 W, accordingly (p=0.027).   
There was no significant difference observed between patients with and without LM 
restenosis (or other artery restenosis) in analysis of achieved maximal heart rate during 
exercise test 1-3 and 3-6 months after PCI, also between patients groups with and without 
diagnosed new artery stenosis on coronary angiography (Table 6.). 
 
Maximal heart rate 
(mean ± SD) 
Exercise test control 














1-3 months 114.70 ± 8.87 10 118.49 ± 19.96 49 0.49 
3-6 months 120.93 ± 17.43 15 122.07 ± 16.92 58 0.82 
6-12 months 119.06 ± 14.63 16 120.69 ± 15.39 55 0.71 
12-24 months 112.79 ± 10.03 14 120.58 ± 15.71 38 0.09 
> 24 months 112.4 6± 13.48 13 120.74 ± 15.90 38 0.10 
Table 6. Maximal heart rate analysis in different exercise test control periods. 
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In maximal systolic blood pressure analysis, almost statistically significant difference was 
observed (trend) between ‘restenosis’ group and ‘non-restenosis’ patients group on exercise 
test 1-3 months and 3-6 months follow-ups (Table 7.). 
 
Maximal systolic blood pressure 
(mean ± SD) 
Exercise test control














1-3 months 161.70 ± 23.64 10 182.27 ± 32.32 49 0.06 
3-6 months 170.33 ± 27.55 15 185.00 ± 28.91 58 0.08 
6-12 months 176.44 ± 37.51 16 182.67 ± 26.22 54 0.45 
12-24 months 177.14 ± 30.76 14 184.16 ± 30.60 38 0.47 
> 24 months 186.92 ± 32.27 13 183.39 ± 32.90 38 0.74 
Table 7. Maximal systolic  blood pressure in different exercise test control periods. 
The difference in analysis of double product (maximal rate-pressure product) or Robinson 
index was expected, on basis of previously obtained results. The following trend was 
observed – patients with coronary artery restenosis at control coronary angiography 1-3 
months after performed PCI showed lower parameters of Robinson index. In turn, 
independently of stenosis location – LM or other coronary artery, or patients with new 
detected coronary artery stenosis – statistically significant difference and association with 
Robinson index changes between patients groups was not ascertained. 
Variability of Robinson index changes on exercise test could become possible additional 
parameter to ST-segment changes in restenosis diagnostics (Table 8., Figure 5.). 
 
Robinson index 
(mean ± SD) 
Exercise test control 
(months after PCI) 




1-3 months 185.70 ± 32.96 217.51 ± 54.09 0.08 
3-6 months 208.12 ± 56.00 226.73 ± 53.81 0.24 
6-12 months 210.41 ± 51.57 223.22 ± 45.16 0.34 
12-24 months 197.89 ± 27.17 223.41 ± 50.73 0.08 
> 24 months 210.23 ± 46.75 221.48 ± 50.63 0.49 
Table 8. Robinson index analysis in different exercise test control periods. 
Patients with angiographically detected coronary artery stenosis have achieved lower 
physical load (in Watts), not achieving submaximal pulse, because of termination the 
veloergometry, if ischemic changes or typical chest pain is appearing. This explains the 
curve difference of Robinson index in patients with and without coronary artery restenosis, 
also, statistically significant difference between mentioned groups is not present in analysis 
of maximal achieved heart rate and maximal systolic blood pressure. However, oscillations 
of Robinson index parameters are obviously seen in patiens of ‘restenosis’ group in relative 
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1 – without restenosis on control coronary angiography 
2 – with restenosis on control coronary angiography   
Fig. 5. Analysis of different exercise test parameters (Robinson index, maximal heart rate 
and maximal systolic blood pressure) during follow-ups in patients with and without 
coronary artery restsenosis (on control angiography).  
risk period – 6-12 months follow-up. These curves repeatedly are establishing the role of 
targeted follow-up programme after performed PCI for more precise evaluation of risk of 
restenosis, taking into account not only patient’s complaints and ischemic changes on ECG, 
but also the changes of Robinson index parameters in dynamics. 
It is supposed, that the number of analyzed patients was not sufficient for statistical 
significance between groups in ST/p index analysis, in order to definitely conclude the role 
of this parameter in restenosis diagnostics (Table 9.) 
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In LM patients’ group analysis – 50% of cases of coronary artery restenosis are detected in 
early period (3-6 months after PCI), left 43% and 7% – 6-12 and 12-24 months after PCI, 
respectively. Angiographic results in early coronary angiography follow-up period (3-6 
months after performed PCI) correlate with ECG changes on 1-3 months control of physical 
test: there is statistically significant difference between patients groups – ST-segment 
depression on exercise ECG is obvious in all patients with restenosis established at control 
coronary angiography (Table 10.). 
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Table 10. Restenosis and ST-segment changes on exercise ECG prior the control coronary 
angiography. 
The sensitivity of veloergometry test in 1-3 months – 29%, specificity – 100 %. Lower 
parameters of Robinson index also were registered in this patients’ group.  
Correlation of ST-segment changes with restenosis development is obvious also in later 
control of veloergometry (3-6 months after PCI). The sensitivity of veloergometry test – 50%, 
specificity – 86 %. All the patients with diagnosed new coronary artery stenosis (in other 
coronary artery) at control coronary angiography (3-6 months after PCI) showed ST-
segment depression on exercise ECG in early stress test control (1-3 months), but in patients 
group without restenosis ECG without any dynamical changes is observed in 92.9% of cases. 
The sensitivity of the test – 33%, specificity – 93 %. 
4.4 Algorithms 
Basing on the previously obtained data and on the significance of exercise test in patients’ 
follow-up after performed PCI, several algorithms were developed for evaluation of 
patients’ functional status after PCI, also for evaluation of possible treatment strategy of 
coronary artery stenosis. 
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Fig. 6. Exercise test algorithm in patients after PCI (complete revascularization). 
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 Exercise test should be performed in 1-3 months after PCI in patients with complete 
revscularization (performed with PCI method); 
 Patients should continue medical treatment and exercise test control every 6 months, if 
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 Patients should undergo myocardial perfusion scintigraphy investigation or stress 
echocardiography in case of no angina, but with presentation of ischemic changes on 
exercise ECG. If ischemic changes are not present on additional examination tests, 
medical treatment shoul be continued and control of exercise test every 6 months; 
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Fig. 7. Exercise test algorithm in patients after PCI (incomplete revascularization). 
 In case of angina and ischemic changes on exercise ECG patients should undergo 
control coronary angiography. 
Patients with incomplete revascularization ( Figure 7.): 
 Exercise test should be performed in 1-3 months after PCI in patients with incomplete 
revascularization (and hemodinamically sigfnificant stenosis, left on angiography); 
 Myocardial perfusion scintigraphy investigation or stress echocardiography should be 
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changes are present (in additional investigations), next step PCI should be performed. If 
ischemic changes are not present, patients should continue medical treatment and 
perform exercise test every 6 months; 
 In case of ischemic changes on exercise ECG, independently of patient’s complaints, 
next step PCI should be performed. 
 
 
Fig. 8. Exercise test algorithm in patients after LM PCI. 
Patients after left main coronary artery (LM) revascularization (Figure 8.): 
 Exercise test should be performed in 1-3 months after LM PCI. Myocardial perfusion 
scintigraphy could be performed in 4-6 months in case of inconclusive ECG; 
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 Patients should continue medical treatment and should perform exercise test every 6 
months in case of no hemodinamically significant stenosis on coronary angiography; 
 Myocardial perfusion scintigraphy investigation or stress echocardiography should be 
performed in case of ischemic changes on exercise ECG. If If ischemic changes are 
present (in additional investigations), coronary angiography should be performed. If 
ischemic changes are not present, patients should continue medical treatment and 
perform exercise test every 6 months; 
 Patients with incomplete revascularization and angiographycally with hemodynamically 
significant stenosis are left, exercise test should be performed in 1-3 months after PCI. If 
ischemic changes are not present, patients continue medical treatment and perform 
exercise test every 6 months. In case of ischemic changes on exercise test, patient should 
visit invasive cardiologist in order to make decision of next step PCI. 
5. Discussion 
In this study we raised the question whether physical exercise test alone beside accurate 
diagnosis of obstructive lesions provides an opportunity to prognose cardiovascular risk. 
We claim that this is possible, which is demonstrated in our study by a significant number 
of patients with silent ischemia. The potential gain from reducing the risk of reverse cardiac 
events is actually greatest in those with silent ischemia at the time of follow-up presentation, 
because those patients are at especially high risk (Pepine and Deedwania, 1994). Nowadays 
it is clear that chest pain in history does not correlate tightly with ischemic ST-segment 
deviation following physical loading and with haemodynamically significant stenosis on 
angiography either.  
Published data as well as national and international guidelines state that physical exercise 
test following PCI is a useful method in diagnosis of restenosis in high risk or symptomatic 
patients and should be conducted six months after intervention (Gibbons et al., 2002). Our 
results showed that the exercise test should be done not later than three to six months after 
intervention. The highest rate of restenosis was observed in patients after interventional 
treatment of LM disease in 1-3 months after procedure. The importance of the physical test 
does not decrease later; more than third part of all documented restenosis was registered at 
six months after intervention (including the patients with newly diagnosed stenosis on 
coronary angiography). One year after PCI the specific weight of restenosis was 16.7% of all 
diagnosed restenosis. 
The clinical value of exercise electrocardiograms following interventional therapy in the 
early period is high in evaluation of early post-interventional results (Roffi et al., 2003). This 
is supported with our results, which demonstrated high specificity of exercise test 
performed in the first six months after PCI. Exercise electrocardiograms 1–3 months after 
PCI did not show a shift of the ST-segment for all patients without restenosis. However, 
angiography depression of the ST-segment was registered on exercise electrocardiogram 
only for patients with restenosis. This demonstrates a clear correlation between ST-segment 
depression and restenosis.   
Adequate implementation of drug therapies depending on patient clinical and functional 
status allow to reach goals set by national and international guidelines. Based on 
epidemiological studies, even small decreases in low density lipoprotein cholesterol and 
blood pressure levels translate into significant reductions in cardiovascular morbidity and 
mortality (LaRosa et al., 2005). Moreover, especially important is the patient compliance, 
which can be achieved through frequently scheduled visits. 
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changes are present (in additional investigations), next step PCI should be performed. If 
ischemic changes are not present, patients should continue medical treatment and 
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 Patients should continue medical treatment and should perform exercise test every 6 
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The clinical course and prognosis of patients with coronary artery disease can be modified 
favourably by successful translation of recommendations for secondary coronary prevention 
into effective clinical care. Crucial to the outcome of any preventive strategy is patient 
attitude to lifestyle modification and compliance with drug therapies over the long term. We 
tend to claim that an aggressive follow-up programme could help us to reach the goals in 
secondary prevention of coronary artery disease set by European Societies and Latvian 
Society of Cardiology. 
The physical exercise test is a safe method with high specificity, but is limited by poor test 
sensitivity for the evaluation of efficacy of interventional and medical treatment for patients 
with coronary artery disease. A focussed exercise test performed on a regular basis 
indirectly influences clinical results and prognosis. Timely set diagnosis of restenosis 
provides necessary treatment measures, therefore, alienating adverse cardiac events such as 
unstable angina and myocardial infarction. Moreover, an exercise test performed on a 
regular basis provides essential corrections in drug therapy. After comparison of drug 
therapies recommended three months and one year after PCI, we can conclude that regular 
follow-ups provide the opportunity to sustain acceptable patient compliance and use of 
medications even twelve months after an intervention. 
A focussed follow-up programme with an exercise test allows to evaluate clinical status of 
patients as well as to determine timely possible risk of restenosis, to adapt medication doses, 
to reduce risk factors and to influence positively patient compliance. The exercise test provides 
accurate estimation of possible restenosis in patients with complete revascularization. In 
patients with incomplete revascularization the exercise test specificity is reduced. Taking 
into account the results of the current study, we are sure, that focussed physical exercise test 
should be advised for all patients after interventional treatment. It is of high importance to 
achieve submaximal heart rate during the exercise test. In all cases when this is not possible 
for any reason, myocardial perfusion scintigraphy is indicated.  
Advantages of the study (benefits) 
The results of this study can be used with a goal to determine possible risk of restenosis in a 
time, to prescribe medications according to patient’s functional status, to correct possible 
risk factors, which can have negative influence on development of disease. 
Regular patients’ follow-ups increase the compliance of the patients and ‘participation’ in 
treatment process, thus increasing accuracy of data and foundation of the results. 
Possible disadvantages (limits) of the study 
Irregular patients’ follow-ups, thus exclusion from statistycal analysis. 
Insufficient information about patient recurrent hospitalization at district hospital. Also the 
variability in medical treatment (general practitioner like „middle stage” between patient 
and cardiologist). 
The lack of patients compliance in medication use, the lack of motivation in modification of 
their possible risk factors. 
Low availability of myocardial perfusion scintigraphy, thus, not possibility to perform 
necessary investigation in position of diagnosis making and more detailed evaluation of 
clinical situation. 
6. Conclusions 
1. Exercise test (veloergometry) is established as a safe method with high specificity, but 
lower sensitivity in evaluation of invasive and medical treatment efficiacy in patients 
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with CAD, evolving different invasive treatment methods (with drug-eluting stents, 
balloon angioplasty, etc.) 
2. The database of the patients with left main coronary artery stenosis was analyzed, 
evaluating the efficacy of invasive treatment of left main stenosis, analyzing possible 
progression of restenosis and evaluating following treatment steps. 
3. New specific criteria were extracted for risk evaluation and detection with exercise 
stress test. 
4. Algorithms were developed for CAD patients’ clinical status evaluation after 
percutaneous coronary intervention. 
5. Follow-up programme with targeted exercise test allows to personalize exact treatment 
strategy and risk factor correction for each patient individually.   
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1. Introduction  
There are numerous toxins and drugs that can cause, in overdose, electrocardiogram (ECG) 
changes, even in patients without history of cardiac pathology. The diagnosis and 
management of patients with an abnormal ECG encountered in a specific toxicity can 
challenge experienced physicians. One must have serious knowledge of basic cardiac 
physiology, in order to understand the ECG changes associated with various drugs and 
toxins.  
The main mechanisms involved include membrane – depressant action (sodium channel 
blockers, slow calcium channel blockers, outward potassium (K+) channel blockers, and 
sodium-potassium adenosine-triphosphatase blockers), and action on autonomic nervous 
system and its sites of cardiovascular action (beta-adrenergic blockers and other 
sympathetic-inhibitors, sympathomimetic, anticholinergic and cholinomimetic substances). 
Many toxins and medications have actions that involve more than one of these mechanisms, 
including hypoxia, electrolyte and metabolic imbalances, and thus may result in a 
combination of electrocardiographic changes. 
In resting state, the myocardial cell membrane is impermeable to positively charged sodium 
ions (Na+). The Na+/K+ ATPase maintains a negative electric potential of approximately 90 
mV in the myocyte. The rapid opening of Na+ channels and massive Na+ influx (phase 0 of 
action potential) explains depolarization of the cardiac cell membrane (fig.1), causing the 
rapid upstroke of the cardiac action potential, which is conducted through the ventricles and 
is expressed as the QRS complex of the ECG. The closure of Na+ channels and the transient 
opening of Ito K+ efflux channels (phase 1) mark the peak of the action potential. Then, phase 
2 of the action potential occurs when the opening of slow calcium (Ca2+) channels produces 
an influx of positive ions with a steady maintenance of the membrane potential and 
myocardial contraction continues. The end of the cardiac cycle is marked by the closure of 
the Ca2+ channels and the activation of the K+ efflux channels, which allow the action 
potential to return to its resting potential of – 90 mV (phase 3). This K+ efflux from the 
myocardial cell is directly responsible for the QT interval on the ECG (Holstege et al., 2006). 
During phase 4 of the cardiac cell action potential, some cardiac fibers allow sodium ions to 
enter the cell, increasing the resting membrane potential, known as spontaneous diastolic 
depolarization. When the threshold in membrane potential is reached, the Na+ channels 
open and another action potential is generated.  
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including hypoxia, electrolyte and metabolic imbalances, and thus may result in a 
combination of electrocardiographic changes. 
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ions (Na+). The Na+/K+ ATPase maintains a negative electric potential of approximately 90 
mV in the myocyte. The rapid opening of Na+ channels and massive Na+ influx (phase 0 of 
action potential) explains depolarization of the cardiac cell membrane (fig.1), causing the 
rapid upstroke of the cardiac action potential, which is conducted through the ventricles and 
is expressed as the QRS complex of the ECG. The closure of Na+ channels and the transient 
opening of Ito K+ efflux channels (phase 1) mark the peak of the action potential. Then, phase 
2 of the action potential occurs when the opening of slow calcium (Ca2+) channels produces 
an influx of positive ions with a steady maintenance of the membrane potential and 
myocardial contraction continues. The end of the cardiac cycle is marked by the closure of 
the Ca2+ channels and the activation of the K+ efflux channels, which allow the action 
potential to return to its resting potential of – 90 mV (phase 3). This K+ efflux from the 
myocardial cell is directly responsible for the QT interval on the ECG (Holstege et al., 2006). 
During phase 4 of the cardiac cell action potential, some cardiac fibers allow sodium ions to 
enter the cell, increasing the resting membrane potential, known as spontaneous diastolic 
depolarization. When the threshold in membrane potential is reached, the Na+ channels 
open and another action potential is generated.  
 




Fig. 1. Cardiac cycle action potential with corresponding ion changes across the membrane 
and electrocardiographic tracing. Dotted line indicates the changes associated with Na+ 
channel blocker toxicity. Dashed line indicates the changes associated with K+ efflux blocker 
toxicity. Ito= transient outward K+ current; ICa= L-type Ca2+ current; INa= late sodium channel 
current; IKr= rapidly activating delayed-rectifier K+ current; IKs= slowly activating delayed 
rectifier K+ current; IK1= inward rectifier K+ current (adapted from Holstege et al., 2005). 
The atrial and ventricular myocardium contraction, and the conduction in the His-Purkinje 
system depend on sodium entry via the fast sodium channels in phase 0 of the action 
potential, while the conduction in sinoatrial node and atrioventricular (AV) node depend on 
Ca2+ entry during phase 0 via the slow Ca2+ channels (Patel & Benowitz, 2005).  
Cardiac activity is controlled, among other mechanisms, by the autonomic nervous system. 
Sympathetic fibers increase the heart rate, the rate of AV nodal conduction and the 
contracility of the myocardium. The norepinephrine released by postganglionic fibers leads 
to an interaction with beta 1-adrenergic cardiac receptors, and increasing cells’ permeability 
to Na+ and Ca2+, with an increase of contractility, excitability, and conduction. The 
parasympathetic postganglionic fibers innervate the sinus node and AV node. Stimulation 
of muscarinic receptors via releasing of acetylcholine decreases atrial excitability and slows 
the conduction of impulses to the ventricles (Patel & Benowitz, 2005).  
In the setting of drug overdose or of a toxic exposure, ECG abnormalities, especially 
arrhythmias, are produced by direct or indirect sympathomimetic effects, anticholinergic 
effects, the effects of altered central nervous system (CNS) regulation of peripheral 
autonomic system, and myocardial membrane depression. Genesis of arrhythmias in the 
poisoned patient is based on the same three mechanisms as in an ischemic patient: abnormal 
impulse formation, abnormal impulse conduction, and triggered activity. Contributing 
factors to ECG changes are hypotension, hypoxia, acid-base and electrolyte imbalances. 
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2. Membrane – depressant drugs and toxins 
Cardiotoxins are responsible of ECG changes through a combination of membrane 
depressant effects, autonomic disturbances and metabolic changes. The severity of a toxic-
induced conduction block varies depending on the toxin involved and its site of action. 
2.1 Sodium channel blockers 
Inhibition of the fast Na+ channels, in the phase 0 of the action potential (AP), decreases the 
rate of rise and amplitude of the AP in Purkinje fibers, and in atrial and ventricular 
myocardial cells.  As a result, the upslope of depolarization is slowed and the QRS complex 
becomes wide. In a toxicological situation, QRS complex widening likely results directly 
from Na+ channel blockage or indirectly from toxin-induced hyperkalemia (Holstege et al., 
 
Inhibitors of fast Na+ 
channels 
1. Cardiovascular drugs: 
- Type Ia antiarrhythmics (Quinidine, Disopyramide, 
Procainamide) 
- Type Ic antiarrhythmics (Flecainide, Encainide, Propafenone, 
Moricizine) 
- Propranolol and other membrane depressant beta-blockers* 
- Verapamil, Diltiazem 
2. Psychiatric drugs: 
- Carbamazepine 
- Cyclic antidepressants (Amitriptyline, Amoxapine, 
Desipramine, Doxepin, Imipramine, Nortriptyline, 
Maprotiline) 
- Neuroleptics (Thioridazine, Mesoridazine) 
-  Other antidepressants (Citalopram) 
- Antipsychotics (Loxapine) 
3. Other drugs: 
- Amantadine  
- Antihistamines (Diphenhydramine) 
- Chloroquine, Hydroxychloroquine 
- Orphenadrine  
- Narcotic pain relievers (Propoxyphene) 
4. Illicit drugs: Cocaine 
5. Toxins: Quinine, Saxitoxin, Tetrodotoxin 
ECG changes QRS widening 
Right bundle branch pattern 
R wave elevation in aVR lead  
Rightward deviation of QRS axis 
Ventricular tachycardia (VT) and ventricular fibrillation (VF) 
Bradycardia with wide QRS complex  
Asystole  
ST/T changes consistent with ischemia (cocaine toxicity) 
*mechanism not  involving the beta-receptor. 
Table 1. Na+ channel blockers and the resulting ECG changes.  
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2005). Direct toxin-induced blockade of cardiac Na+ channels will cause QRS complex 
widening, and it has been described as a membrane stabilizing effect, a local anesthetic 
effect, or a quinidine-like effect. Some drugs in this category (Table 1) may also affect other 
myocardial ion transfers, such as the Ca2+ influx and K+ efflux (Holstege et al., 2006). Other 
abnormal QRS complex configurations are also possible. In the most severe cases, the QRS 
complex widening becomes so profound that the ultimate origin of the rhythm disturbance 
is impossible (fig. 2). 
 
 
Fig. 2. Na+ channel blocker toxicity (patient with acute Propafenone overdose). Note the 
wide QRS complex, at a rate of 134/min, which suggests, at a first view, monomorphic VT.  
R wave elevation in aVR ≥ 3 mm (fig.3) is the only ECG variable that significantly indicates 
the risk of seizures and arrhythmias in acute tricyclic antidepressant poisoning (Liebelt et 
al., 1995). In addition, QT interval prolongation can occur with tricyclic antidepressant 
poisoning, as well as rightward axis deviation of the terminal 40 msec of the frontal plane 
QRS axis, which is unknown in other Na+ channel blocking agents (Wolfe et al. 1989; 
Berkovitch et al, 1995). Continued prolongation of the QRS complex may result in a sine 
wave pattern and eventual asystole.  
 
 
Fig. 3. Acute poisoning with Amitriptyline. ECG reveals sinus tachycardia 148/min, RBBB 
pattern, QRS complex ≥ 120 ms, as well as R wave elevation in aVR ≥ 3 mm. 
Na+ channel blockers may determine slowed intraventricular conduction, unidirectional 
block, the development of a reentrant circuit, and a resulting VT as well as VF. Because 
many of the Na+ channel blocking agents have also anticholinergic or sympathomimetic 
effects, bradydisrrhythmias are rare. In Na+ channel blocker poisoning by anticholinergic 
and sympathomimetic drugs, the combination of a wide QRS complex and bradycardia is a 
 
Toxic and Drug-Induced Changes of the Electrocardiogram 
 
275 
sign of severe poisoning, indicating that the Na+ channel blockade is so profound that 
tachycardia does not occur, despite the clinical muscarinic antagonism or adrenergic 
agonism (Holstege et al., 2006). Nevertheless, bradycardia may occur because of slowed 
depolarization of pacemaker cells that depend on entry of Na+ ions. 
2.2 Slow Calcium Channel Blockers (CCB)  
All CCBs (Table 2) inhibit the voltage sensitive L-type Ca2+ channel within the cell 
membrane. In the pacemaker cells of the sinoatrial node and AV node, the primary ion 
channel, which controls depolarization, is the slow Ca2+ channel. When inhibited, there is a 
slowing or an inhibition of the specialized tissue to conduct a cardiac impulse (Patel & 
Benowitz, 2005).  
 
Inhibitors of slow 
Ca2+ channels 
1. Dihydropyridines: 
- 1st generation: Nicardipine, Nifedipine 
- 2nd generation: Felodipine, Isradipine, Nimodipine 
- 3rd generation: Amlodipine, Nitrendipine  
- 4th generation: Lercanidipine, Lacidipine  
2. Phenylalkylamine: 
- Verapamil 
- Gallopamil  
3. Benzothiazepine: 





ECG changes Sinus bradycardia 
Reflex tachycardia (ex. Nifedipine) 
Varying degrees of AV block 
Sinus arrest with AV junctional rhythm 
Asystole  
Wide QRS complex 
ST/T changes  
Table 2. Calcium channel blockers and the resulting ECG changes. 
In CCB toxicity initially occurs a sinus bradycardia, followed by various degrees of AV 
block (fig.4), and junctional and ventricular bradydysrhythmias on ECG. Depending on the 
agent involved, other dysrhythmias may be seen (Gordon, 2006): sinus tachycardia 
(specifically Nifedipine), atrial arrhythmias, and junctional rhythms (fig. 5, 6,7). A wide QRS 
complex may appear, caused by ventricular escape rhythms or by CCB-induced Na+ 
channel blockade which delays of phase 0 of depolarization. Sudden shifts from 
bradydysrhythmias to cardiac arrest have been reported.  
In addition, ECG changes associated with cardiac ischemia (fig.8) may occur as a result of 
the hypotension and changes in the cardiovascular status, especially in patients with pre-
existing cardiac disease (Patel & Benowitz, 2005; Holstege et al., 2006). 
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sign of severe poisoning, indicating that the Na+ channel blockade is so profound that 
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All CCBs (Table 2) inhibit the voltage sensitive L-type Ca2+ channel within the cell 
membrane. In the pacemaker cells of the sinoatrial node and AV node, the primary ion 
channel, which controls depolarization, is the slow Ca2+ channel. When inhibited, there is a 
slowing or an inhibition of the specialized tissue to conduct a cardiac impulse (Patel & 
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agent involved, other dysrhythmias may be seen (Gordon, 2006): sinus tachycardia 
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complex may appear, caused by ventricular escape rhythms or by CCB-induced Na+ 
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In addition, ECG changes associated with cardiac ischemia (fig.8) may occur as a result of 
the hypotension and changes in the cardiovascular status, especially in patients with pre-
existing cardiac disease (Patel & Benowitz, 2005; Holstege et al., 2006). 
 





Fig. 4. Acute poisoning with Verapamil in a 61-years old female. ECG reveals sinus 
bradycardia 41/min, minor right bundle ranch block (RBBB), first-degree AV block (PR 0.32 
sec) and long QT interval (0.64 sec). 
 
 
Fig. 5. Acute poisoning with Norvasc 300 mg in a 31-years old female. ECG reveals sinus 
tachycardia 114/min, signs of ischemia in infero-lateral leads, 14 hours after ingestion 
(systolic blood pressure 70 mmHg). 
 
 
Fig. 6. Same patient, two days after ingestion. ECG reveals accelerated junctional rhythm 
(sinus coronary rhythm, or Zahn rhythm) 114/min, with negative P waves in leads DII, DIII, 
aVF, and disappearance of ischemic changes present at admission. 
 
 
Fig. 7. Acute Diltiazem poisoning at admission. ECG reveals accelerated junctional rhythm 
75/min, retrograde atrial conduction (negative P waves after QRS), and atrial premature beats. 
 




Fig. 8. Same patient (Diltiazem poisoning), second day of evolution. ECG reveals atrio-
ventricular dissociation, with escape junctional rhythm and some ventricular captures, and 
signs of ischemia (in inferior and lateral leads). 
2.3 Outward potassium channel blockers 
Medications in the K+ efflux blocker category block the outward flow of K+ from 
intracellular to extracellular spaces. Blockade of the outward K+ currents may prolong the 
cardiac cycle action potential (Fig. 1). The primary electrocardiographic manifestation is QT 
interval prolongation (QTc interval greater than 0.45 seconds in men and 0.47 seconds in 
women). Delay of repolarization causes the myocardial cell to have less charge difference 
across its membrane, and result in the activation of the inward depolarization current (early 
after-depolarization), which is seen on ECG as prominent U waves (Murphy et al., 2007). 
This may promote triggered activity, which potentially can progress to re-entry and 
subsequent polymorphic VT. Toxin-induced blockade of K+ efflux channels during phase 3 
of the action potential corresponding with repolarization and QT interval prolongation may 
place the patient at risk for polymorphic VT or torsades de pointes (Holstege et al., 2005; 
Holstege et al., 2006). The drugs and toxins reported to have this effect are listed in table 3. 
Risk factors for torsades de pointes (TdP) among patients treated with medications that 
prolong QT interval include, among others, female gender, hypokalemia, hypomagnesemia, 
bradycardia, overdose, drug interactions (fig.9), digitalis therapy, and background of the 
patient (preexisting cardiac disease, long QT interval or family history of long QT). (Murphy 
et al., 2007; Roden, 2004) 
 
 
Fig. 9. Drug-induced long QT interval, following interaction between Bisoprolol and 
Amiodarone.  ECG shows long QT interval (0.80 sec), couples of PVB with R/T 
phenomenon preceding a short episode of polymorphic VT. 
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- Class IA antidysrhythmics**(Disopyramide, Quinidine, Procainamide) 
- Class IC antidysrhythmics (Encainide, Flecainide, Moricizine, 
Propafenone) 
- Class III antidysrhythmics** (e.g. Amiodarone, Dronedarone, Dofetilide, 
Ibutilide, Sotalol, Vernakalant) 
- Anti-anginal/vasodilators*,** (Bepridil, Prenylamine, Terodiline) 
- Antihypertensives (Ketanserin*) 
2. Psychiatric drugs: 
- Antipsychotics (Chlorpromazine, Droperidol, Haloperidol, Mesoridazine, 
Pimozide, Quetiapine, Risperidone, Thioridazine, Ziprasidone) 
- Cyclic antidepressants (Amitriptyline, Amoxapine, Desipramine, 
Doxepin, Imipramine, Nortriptyline, Maprotiline) 
- Other antidepressants (Citalopram, Venlafaxine) 
- Phenothiazines 
3. Other drugs: 
- Antihistamines (Astemizole, Diphenhydramine, Loratidine, 
Terfenadine*, Hydroxyzine) 
- Serotonin 5-HT4 receptor agonist (Cisaprid*,**) 
- Antimicrobials and antimalarics (Ciprofloxacin, Gatifloxacin, 
Levofloxacin, Moxifloxacin, Sparfloxacin, Clarithromycin**, 
Erythromycin**, Pentamidine**, Chloroquine**, Halofantrine, 
Hydroxychloroquine, etc.) 
- Arsenic trioxide 
- Probucol* 
4. Synthetic opioids: Levomethadyl 
5. Opium alkaloids: Papaverine** 
6. Toxins: Quinine, Organophosphates (fig.10) 
ECG changes QT interval prolongation
T- or U-wave abnormalities 
Premature ventricular beats (PVB) followed by TdP 
Sinus tachycardia 
*removed from the market; ** TdP reported. 
Table 3. K+ efflux channel blockers, and the resulting ECG changes. 
 
 
Fig. 10. Acute organophosphate poisoning, five days after ingestion. ECG shows long QT 
interval (0.60 sec), PVB with R/T phenomenon (arrows) preceding a short episode of TdP 
(TORS). 
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Many of these drugs have other effects that can result in significant electrocardiographic 
changes, such as antipsychotics, that can cause muscarinic acetylcholine receptor and alpha-
adrenergic receptor blockade and cardiac cell K+, Na+, and Ca2+ channel blockade (Holstege 
et al., 2006). These effects lead to sinus tachycardia (secondary to anticholinergic effect) or 
reflex tachycardia (secondary to alpha-adrenergic blockade). 
2.4 Sodium–potassium ATPase blockers 
Cardiac glycosides (table 4) inhibit the Na+/K+ adenosine triphosphatase (Na+/K+ATPase) 
pump. As a result, there is an inhibition of the active transport of Na+ and K+ across cell 
membrane, intracellular Na+ increases and the Na+/Ca2+exchanger is secondary activated. 
The intracellular Ca2+ level increases, and augments myofibril activity in cardiac myocytes, 
which results in a positive inotropic effect, and increased automaticity. The cardiac 
glycosides also increase vagal tone that may lead to a direct atrioventricular (AV) nodal 
depression (Holstege et al., 2006). Digitalis derivatives in therapeutic doses are used to 
increase myocardial contractility or slow AV conduction. They modify ECG, changes known 
as ‘‘digitalis effect’’, expressed by abnormal inverted or flattened T waves coupled with ST 
segment depression (most pronounced in leads with tall R waves), QT interval shortening 
(as a result of decreased ventricular repolarization time), PR interval lengthening (increased 
vagal activity), and prominent U-waves. Sagging ST segments, inverted T waves, and 
normal or shortened QT intervals are sometimes identified by their similar appearance to 
“Salvador Dali’s mustache” (Clancy, 2007). These ECG changes are seen with therapeutic 





- Digoxin (Lanoxin) 
- Digitoxin 
2. Plants producing cardiac glycosides: 
- Cardenolide type: Strophanthus – ouabain g/k/e-strophanthin, 
Digitalis lanata and Digitalis purpurea (foxglove) – digoxin, digitoxin, 
Nerium oleander (oleander) – oleandrin, Convallaria majalis (Lily of 
the valley), Apocynum cannabinum (Dogbane), Asclepias species. 
- Bufadienolide type: Urginea maritima (Red squill) 
3. Animals producing cardiac glycosides: 
- Bufadienolide type: Bufo marinus toads 
ECG changes - Excitant activity: atrial and junctional premature beats, atrial 
tachycardia, atrial flutter (rare), AF (rare), accelerated junctional 
rhythms, PVB, bigeminy and multifocal, VT, bi-directional VT, VF. 
- Suppressant activity: sinus bradycardia, sinoatrial block, type I 
second degree AV block (Wenckebach), bundle branch blocks, 
complete AV block, type II second degree AV block (rare). 
- Combination of these: atrial tachycardia with AV block, sinus 
bradycardia with junctional tachycardia, Wenckebach with 
junctional premature beats, regularization of ventricular rhythm 
with AF. 
Table 4. Na+/K+ ATPase blocking agents and ECG changes in intoxication (adapted from 
Gordon, 2006; Lapostolle & Borron, 2007). 
 







- Class IA antidysrhythmics**(Disopyramide, Quinidine, Procainamide) 
- Class IC antidysrhythmics (Encainide, Flecainide, Moricizine, 
Propafenone) 
- Class III antidysrhythmics** (e.g. Amiodarone, Dronedarone, Dofetilide, 
Ibutilide, Sotalol, Vernakalant) 
- Anti-anginal/vasodilators*,** (Bepridil, Prenylamine, Terodiline) 
- Antihypertensives (Ketanserin*) 
2. Psychiatric drugs: 
- Antipsychotics (Chlorpromazine, Droperidol, Haloperidol, Mesoridazine, 
Pimozide, Quetiapine, Risperidone, Thioridazine, Ziprasidone) 
- Cyclic antidepressants (Amitriptyline, Amoxapine, Desipramine, 
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- Other antidepressants (Citalopram, Venlafaxine) 
- Phenothiazines 
3. Other drugs: 
- Antihistamines (Astemizole, Diphenhydramine, Loratidine, 
Terfenadine*, Hydroxyzine) 
- Serotonin 5-HT4 receptor agonist (Cisaprid*,**) 
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Levofloxacin, Moxifloxacin, Sparfloxacin, Clarithromycin**, 
Erythromycin**, Pentamidine**, Chloroquine**, Halofantrine, 
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4. Synthetic opioids: Levomethadyl 
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*removed from the market; ** TdP reported. 
Table 3. K+ efflux channel blockers, and the resulting ECG changes. 
 
 
Fig. 10. Acute organophosphate poisoning, five days after ingestion. ECG shows long QT 
interval (0.60 sec), PVB with R/T phenomenon (arrows) preceding a short episode of TdP 
(TORS). 
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Many of these drugs have other effects that can result in significant electrocardiographic 
changes, such as antipsychotics, that can cause muscarinic acetylcholine receptor and alpha-
adrenergic receptor blockade and cardiac cell K+, Na+, and Ca2+ channel blockade (Holstege 
et al., 2006). These effects lead to sinus tachycardia (secondary to anticholinergic effect) or 
reflex tachycardia (secondary to alpha-adrenergic blockade). 
2.4 Sodium–potassium ATPase blockers 
Cardiac glycosides (table 4) inhibit the Na+/K+ adenosine triphosphatase (Na+/K+ATPase) 
pump. As a result, there is an inhibition of the active transport of Na+ and K+ across cell 
membrane, intracellular Na+ increases and the Na+/Ca2+exchanger is secondary activated. 
The intracellular Ca2+ level increases, and augments myofibril activity in cardiac myocytes, 
which results in a positive inotropic effect, and increased automaticity. The cardiac 
glycosides also increase vagal tone that may lead to a direct atrioventricular (AV) nodal 
depression (Holstege et al., 2006). Digitalis derivatives in therapeutic doses are used to 
increase myocardial contractility or slow AV conduction. They modify ECG, changes known 
as ‘‘digitalis effect’’, expressed by abnormal inverted or flattened T waves coupled with ST 
segment depression (most pronounced in leads with tall R waves), QT interval shortening 
(as a result of decreased ventricular repolarization time), PR interval lengthening (increased 
vagal activity), and prominent U-waves. Sagging ST segments, inverted T waves, and 
normal or shortened QT intervals are sometimes identified by their similar appearance to 
“Salvador Dali’s mustache” (Clancy, 2007). These ECG changes are seen with therapeutic 





- Digoxin (Lanoxin) 
- Digitoxin 
2. Plants producing cardiac glycosides: 
- Cardenolide type: Strophanthus – ouabain g/k/e-strophanthin, 
Digitalis lanata and Digitalis purpurea (foxglove) – digoxin, digitoxin, 
Nerium oleander (oleander) – oleandrin, Convallaria majalis (Lily of 
the valley), Apocynum cannabinum (Dogbane), Asclepias species. 
- Bufadienolide type: Urginea maritima (Red squill) 
3. Animals producing cardiac glycosides: 
- Bufadienolide type: Bufo marinus toads 
ECG changes - Excitant activity: atrial and junctional premature beats, atrial 
tachycardia, atrial flutter (rare), AF (rare), accelerated junctional 
rhythms, PVB, bigeminy and multifocal, VT, bi-directional VT, VF. 
- Suppressant activity: sinus bradycardia, sinoatrial block, type I 
second degree AV block (Wenckebach), bundle branch blocks, 
complete AV block, type II second degree AV block (rare). 
- Combination of these: atrial tachycardia with AV block, sinus 
bradycardia with junctional tachycardia, Wenckebach with 
junctional premature beats, regularization of ventricular rhythm 
with AF. 
Table 4. Na+/K+ ATPase blocking agents and ECG changes in intoxication (adapted from 
Gordon, 2006; Lapostolle & Borron, 2007). 
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Electrocardiographic abnormalities with cardiac glycoside toxicity are the result of increased 
automaticity (from increased intracellular Ca2+) accompanied by slowed conduction through 
the AV node. In 10% to 15% of cases, ectopic rhythms will be the first sign of intoxication. AV 
block or an increase in ventricular automaticity are the most common manifestations of 
Digoxin toxicity and have been shown to occur in 30%to 40%of verified cases of toxicity. The 
nonspecific dysrhythmias consist of premature ventricular contractions (especially bigeminal 
and multiform), first-, second-, and third degree AV block, sinus bradycardia (fig.11), sinus 
tachycardia, sino-atrial block or arrest, atrial fibrillation (AF) with slow ventricular response 
(fig.12), atrial tachycardia, junctional escape rhythm, AV dissociation, ventricular bigeminy 
and trigeminy, VT (fig.13), TdP, and VF. The more specific dysrhythmias are AF with slow, 
regular ventricular rate (AV dissociation), nonparoxysmal junctional tachycardia (rate 70-130), 
atrial tachycardia with block (atrial rate is usually 150-200), and bi-directional VT. Bi-
directional VT is particularly characteristic of severe toxicity and is the result of alterations of 
intraventricular conduction, junctional tachycardia with aberrant intraventricular conduction, 
or, on rare occasions, alternating ventricular pacemakers. Typically, in the young, slow 
rhythms and conduction defects predominate over ventricular ectopy, which is more 
prominent in older Digoxin-toxic patients. (Litonjua et al., 2005) 
 
 
Fig. 11. Sinus bradicardia 47/min, with ST/T changes, 20 hours after attempted suicide with 
10 mg Digoxin, in an 18 years old man.  
 
 
Fig. 12. AF 56/min, with a pause of 2.96 sec, 15 hours after attempted suicide with Digoxin, 
in a 68 years old woman.  
 
 
Fig. 13. PVB and a short episode of non-sustained VT 135/min, in a 56 years old male with 
Digoxin overdose in attempted suicide.  
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3. Drugs and toxins acting on autonomic nervous system 
In an acute poisoning, ECG changes, especially arrhythmias, can be explained by direct or 
indirect sympathomimetic effects, anticholinergic effects, and the effects of altered central 
nervous system (CNS) regulation of peripheral autonomic activity. Sympathetic fibers 
innervate most parts of the heart. Postganglionic fibers release norepinephrine, which 
interacts with the beta 1- adrenergic cardiac receptors, to increase permeability to Na+ and 
Ca2+, thus leading to increased excitability, conduction and contractility. The vagal 
postganglionic parasympathetic fibers locally release acetylcholine. Vagal stimulation of the 
muscarinic receptors primarily decreases excitability of the atria, and slows the conduction 
of impulse into the ventricles, to a complete blockade of transmission in the AV node, with 





- Oxprenolol (membrane stabilizing effect, intrinsic 
sympathomimetic activity) 
- Propranolol (membrane stabilizing effect) 
- Alprenolol, Nadolol  
- Pindolol (intrinsic sympathomimetic activity) 
- Sotalol (K+ channel blockade) 
- Timolol  
2nd generation 
- Acebutolol (membrane stabilizing effect, intrinsic sympathomimetic 
activity) 
- Practolol, Atenolol, Metoprolol  
- Betaxolol (membrane stabilizing effect, vasodilation secondary to 
calcium channel blocking properties) 
- Bisoprolol  
- Esmolol  
3rd generation 
- Labetalol (vasodilation, alpha-adrenergic antagonist activity) 
- Carvedilol (vasodilation, alpha-adrenergic antagonist activity) 
- Nebivolol (vasodilation by release of nitric oxide) 
- Carteolol (vasodilation by release of nitric oxide) 
- Celiprolol (vasodilation, alpha 2-adrenergic antagonism activity) 
ECG changes Sinus or nodal bradycardia  
AV blocks (first-degree AV block is common) 
Prolonged PR, and QTc intervals 
Prolonged QRS complex (membrane stabilizing agents) 
Ventricular tachydysrhythmias  (membrane stabilizing agents) - fig.14 
Multifocal ventricular extrasystoles, VT, VF (Sotalol) 
Asystole (in severe poisoning) 
Mild tachycardia (Pindolol overdose) 
Table 5. Beta-blockers and ECG changes in intoxication (adapted from Gordon, 2006; 
Holstege et al., 2006; Brubacher, 2007) 
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calcium channel blocking properties) 
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ECG changes Sinus or nodal bradycardia  
AV blocks (first-degree AV block is common) 
Prolonged PR, and QTc intervals 
Prolonged QRS complex (membrane stabilizing agents) 
Ventricular tachydysrhythmias  (membrane stabilizing agents) - fig.14 
Multifocal ventricular extrasystoles, VT, VF (Sotalol) 
Asystole (in severe poisoning) 
Mild tachycardia (Pindolol overdose) 
Table 5. Beta-blockers and ECG changes in intoxication (adapted from Gordon, 2006; 
Holstege et al., 2006; Brubacher, 2007) 
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3.1 Beta-adrenergic blockers (BB) 
BBs competitively inhibit various β-adrenergic receptors, and are listed in table 5.   
They cause in most cases sinus bradycardia. Serious arrhythmias result from purely 
anticholinergic compound poisoning, especially in patients with underlying ischemic heart 
disease (e.g. atrial tachycardia and PVB). In acute BB overdose, the most pronounced effects 
are bradycardia (from decreased sinoatrial node function), varying degrees of AV block, and 
hypotension. Beta-adrenergic antagonists competitively antagonize the effects of 
catecholamines at the beta-adrenergic receptor and blunt the chronotropic and inotropic 
response to catecholamines (Bird, 2007). 
Inhibition of the conducting system most commonly causes first-degree AV block, but 
higher levels of toxicity can promote second- and third-degree AV block (fig.15), junctional 
rhythms, and intraventricular conduction delays (Anderson, 2008). 
Three beta-blockers are known to prolong QTc intervals: Sotalol (fig.16), Propranolol, and 
Acebutolol. Sotalol blocks K+ channels, thereby prolonging the action potential and the 
repolarization duration. The prolongation of the QTc interval predisposes the patient to 
ventricular tachyarrhythmias and TdP, which have been described after both Sotalol 
overdose and therapeutic administration. Propranolol overdose has caused QTc 
prolongation and torsades on rare occasion (Delk et al., 2006). 
 
 
Fig. 14. Acute poisoning 3 hours after ingestion of 2 grams of Propranolol, presenting with 
accelerated idioventricular rhythm 115/min, in a young female. Note the absence of P 
waves, wide QRS complex (0.12 msec). 
 
 
Fig. 15. Acute Metoprolol poisoning presenting with third degree AV block, with narrow 
QRS complex at a rate of 35/min. Atrial activity is represented by P waves, 80/min.  
Beta-adrenergic antagonists also cause myocardial depression, at least in part, by an action 
independent of either catecholamine antagonism or membrane-depressant activity 
(Brubacher, 2007). 
 




Fig. 16. Acute Sotalol poisoning presenting with bradyarrhythmias, with severe QT 
prolongation, and monomorphic PVB, R/T phenomenon, and a couple of polymorphic PVB 
(leads V1-V3).   
3.2 Other sympathetic – inhibitors (other than BB) 
Cardiac disturbances caused by sympathetic-inhibiting drugs are listed in table 6.  
 
Sympathetic-inhibiting agents Methyldopa 
Clonidine and other imidazoline derivatives 
Reserpine, Guanethidine 
Prazosin and other alpha-blockers 
ECG changes Sinus, atrial, junctional and ventricular 
bradyarrhythmias 
First degree AV block 
Ventricular tachyarrhythmias 
Table 6. Sympathetic-inhibitors and the resulting ECG changes. 
These drugs are used for their antihypertensive action, explained by central and peripheral 
alpha 2-adrenergic agonist effects. In acute overdose they cause ECG changes, along with 
hypotension, and cardiac failure. Cardiac arrests have been described in adults with 
Clonidine poisoning. Over-the-counter topical decongestants commonly contain 
imidazoline derivatives (naphzoline, tetrahydrozoline, oxymetazoline, and xylometazoline), 
and can cause systemic toxicity after topical exposure, or ingestion, with sympatholytic 
effects, such as bradyarrhythmias and hypotension, related to central alpha 2-adrenergic 
and imidazoline receptor stimulation (Murphy et al., 2007; Wiley II, 2007). 
3.3 Sympathomimetic toxicity 
Sympathetic overactivity can be caused by a number of drugs and toxins (table 7), such as 
illicit drugs, and hydrocarbon solvents, but also by sedative drug withdrawal syndromes. 
The typical ECG changes are sinus and atrial tachycardia, and occasionally ventricular 
dysrrhythmias (in massive exposures). Sinus tachycardia may be the first manifestation of 
exposure to a sympathomimetic. 
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3.3 Sympathomimetic toxicity 
Sympathetic overactivity can be caused by a number of drugs and toxins (table 7), such as 
illicit drugs, and hydrocarbon solvents, but also by sedative drug withdrawal syndromes. 
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dysrrhythmias (in massive exposures). Sinus tachycardia may be the first manifestation of 
exposure to a sympathomimetic. 
 




drugs and toxins 
1. Drugs: 
- Monoamine oxidase inhibitors 
- Phenylpropanolamine and other over-the-counter 
sympathomimetics (decongestants containing phenylephrine, 
pseudoephedrine, ephedrine) 
- Theophylline 
- Ergot alkaloids 
- Beta-adrenoreceptor agonists (Albuterol, Dobutamine, 
Epinephrine, Isoproterenol, Norepinephrine, Ritodrine, 
Terbutaline) 
- Caffeine 
- Chloral hydrate (sedative and hypnotic drug)    




- Delta-tetrahydrocannabinol (cannabis) – fig.17 
- Lysergic acid diethylamide 
- Psilocybin and other hallucinogens 
3. Toxins: 
- Ethanol 
- Hydrocarbon solvents (e.g. toluene, benzene, chloroform, etc.) 
- Freon (and other fluorocarbon aerosols) 
ECG abnormalities Sinus tachycardia  
Sinoatrial slowing with escape junctional or ventricular rhythms 
(solvent inhalation) 
Atrial tachycardia – fig. 18 
Ventricular premature beats 
VT, VF 
Myocardial ischemia or infarction (cocaine, amphetamines, or 
hydrocarbons ingestion) 
Table 7. Sympathomimetic drugs and toxins and the resulting ECG changes. 
 
 
Fig. 17. Paroxysmal supraventricular tachycardia 169/min, in a young female with acute 
cannabis and ethanol poisoning. 
However, other supraventricular or ventricular dysrhythmias may develop if an abnormal 
rhythm is generated in another part of the heart. 
 




Fig. 18. Atrial tachycardia 150/min, with variable AV block, in a female with a chronic 
respiratory disease and Theophylline overdosage. 
Either as a result of excessive circulating catecholamines observed with cocaine and 
sympathomimetics, or myocardial sensitization secondary to halogenated hydrocarbons or 
thyroid hormone, or increased second-messenger activity secondary to theophylline, the 
extreme inotropic and chronotropic effects cause dysrhythmias. Altered repolarization, 
increased intracellular Ca2+ concentrations, or myocardial ischemia may cause the 
dysrhythmia. Additionally, cocaine that produce focal myocardial ischemia, can lead to 
malignant ventricular dysrhythmias (Clancy, 2007). In high dose, along with its potent 
sympathomimetic action, cocaine blocks fast Na+ channels in the myocardium, with a 
depression of depolarization, and slowing of conduction velocity, manifested on ECG with 
prolonged PR, QRS, and QT intervals (Murphy et al., 2007). 
3.4 Anticholinergic toxicity 
There are numerous and various anticholinergic drugs and toxins that may be ingested 
(table 8) and produce ECG abnormalities. 
 
Anticholinergic 
drugs and toxins 
1. Drugs: 
- Antihistamines  
- Atropine, scopolamine 
- Tricyclic antidepressants 
- Antipsychotics (e.g. Phenothiazines, Clozapine, Olanzapine) 
2. Toxins: 
- Toxic plants from Solanaceae family containing belladonna 
alkaloids: Belladonna (Atropa belladonna), Henbane 
(Hyoscyamus niger), Jimson Weed (Datura stramonium), 
Mandrake (Mandragora officinarum) 
- Toxic mushrooms: Amanita muscaria 
ECG changes Sinus and atrial tachycardia 
Premature ventricular beats 
Table 8. Drugs and toxins with anticholinergic effect, with induced ECG abnormalities. 
They cause in most cases sinus tachycardia. Serious arrhythmias result from purely 
anticholinergic compound poisoning, especially in patients with underlying ischemic heart 
disease (e.g. atrial tachycardia and ventricular premature beats). Atropine, for example, 
increases myocardial oxygen demand secondary to tachycardia, and can lead to VT and 
fibrillation in patients after myocardial infarction. Patients presenting with anticholinergic 
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Table 8. Drugs and toxins with anticholinergic effect, with induced ECG abnormalities. 
They cause in most cases sinus tachycardia. Serious arrhythmias result from purely 
anticholinergic compound poisoning, especially in patients with underlying ischemic heart 
disease (e.g. atrial tachycardia and ventricular premature beats). Atropine, for example, 
increases myocardial oxygen demand secondary to tachycardia, and can lead to VT and 
fibrillation in patients after myocardial infarction. Patients presenting with anticholinergic 
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toxidrome (mydriasis, diminished bowel sounds, urinary retention, dry mouth, flushed 
skin, tachycardia, and agitation) may have ingested antihistamine-sympathomimetic 
combinations, or tricyclic antidepressants and neuroleptics, having both anticholinergic and 
membrane-depressant effects, which can explain the presence of serious cardiovascular 
disturbances (such as widening of the QRS complex, and a rightward deflection of the 
terminal 40 msec of the QRS complex, with prolongation of the QTc, which creates a 
substrate for the development of TdP). (Murphy et al., 2007; Juurlink, 2007)   
3.5 Cholinomimetic toxicity 
Poisoning by cholinomimetic drugs and toxins (table 9) lead to different ECG aspects. The 
most common type of cholinomimetic toxicity is poisoning with organophosphate and 
carbamate pesticides, resulting in the excessive inhibition of the cholinesterase. The ECG 





- Causing acetylcholine release (Alpha 2-adrenergic antagonists, 
Aminopyridines, Carbachol, Guanidine) 
- Direct muscarinic agonists (Pilocarpine, Bethanechol, Methacholine) 
- Direct nicotinic agonists (Carbachol, Succinylcholine) 
- Indirect neuronal nicotinic agonists (Chlorpromazine, local and 
volatile anesthetics, Ketamine) 
- Anticholinesterases (Pyridostigmine, Neostigmine, Physostigmine) 
- Central cholinesterase inhibitors (Rivastigmine, Galantamine, 
Donepezil) 
2. Toxins: 
- Organophosphate and carbamate pesticides 
- Nicotine 
- Muscarine 
- Black widow spider venom 





Atrial, junctional, or ventricular bradycardia 
AV block 
Sinus tachycardia (seen in early stages of cholinesterase inhibition and 
nicotine poisoning due to ganglionic stimulation) 
VT associated with QT interval prolongation 
Asystole  
Table 9. Cholinomimetic drugs and toxins, and ECG changes induced in acute exposure. 
Early in the course, tachycardia is present, due to acetylcholine stimulation of nicotinic 
receptors, followed by bradycardia, secondary to muscarinic receptor stimulation. In severe 
poisonings, advanced AV block, bradydysrhythmias and asystole may occur (Murphy et al., 
2007). Up to 5 days after exposure, QTc interval prolongation is followed by ventricular 
tachyarrhythmias (fig.19), including TdP (fig.10), due to persistent imbalance between 
sympathetic and parasympathetic influences on the heart, as well as dyselectrolytemias. A 
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rare feature is acute myocardial infarction (fig.20), with a complex mechanism (fig.21) 
explaining its presence (coronary spasm induced by parasympathetic hyperactivity, direct 
toxic effect of pesticide on myocardium). 
 
 
Fig. 19. Acute organophosphate poisoning, five days after exposure. ECG shows QT interval 
prolongation (0.60 sec), short episode of ventricular flutter (FLV), a couple of PVB, and one 
PVB with R on T phenomenon (R/T). 
Patients with clinical signs of cholinesterase inhibition and abnormal ECG (including long 
QT interval) should be monitored continuously, because of the risk of developing 
ventricular arrhythmias (Lionte et al., 2007). Reversible acetylcholinesterase inhibitors, such 
as Donepezil, have a high selectivity for neuronal acetylcholinesterase, and in accidental 




Fig. 20. Acute organophosphate poisoning, four days after exposure, serum cholinesterase 
normalized with antidote. ECG shows acute ST segment elevation anterior myocardial 
infarction (with increased cardiac enzymes), sinus tachycardia 106/min, QT interval 0.32 
sec.  
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Fig. 21. Cardiac manifestations of organophosphate poisoning and mechanisms involved. 
4. Other substances inducing ECG changes 
4.1 Chemical asphyxiants  
Chemical asphyxiants act in one of two ways. Some prevent the uptake of oxygen in the 
blood. Carbon monoxide interferes with the transport of oxygen to the tissues by strongly 
binding with hemoglobin to form carboxyhemoglobin, which leaves inadequate hemoglobin 
available for oxygen transport. Hydrogen cyanide does not permit the normal oxygen 
transfer either from the blood to the tissues or within the cell itself, resulting in tissue 
hypoxia. Acute exposure to these agents leads to coma and metabolic acidosis, the last 
explaining in part ECG abnormalities (table 10) recorded in such poisoning.   
 
Chemical asphyxiants ECG changes 
Carbon monoxide (CO) T wave flattening or inversion 
ST segment depression or elevation 
Conduction disturbance 
Myocardial infarction (fig.22, 23, 24) 
Arrhythmias occasionally (PVB, atrial fibrillation) 
Hydrogen cyanide  Tachycardia (early) 
Bradicardia, heart block (late) 
Shortening of the ST segment with eventual fusion of the T wave 
into the QRS complex. 
Erratic supraventricular and vntricular arrhythmias 
Ischemic changes 
Asystole  
Zinc phosphide Atrial extrasystoles 
Ventricular arrhythmias 
ST/T changes (fig.25) 
Table 10. Major chemical asphyxiants and their effect on ECG in acute poisoning (adapted 
from Hall, 2007; Murphy et al., 2007; Schraga et al., 2008) 
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Myocardial injury from CO poisoning results from tissue hypoxia, and as damage at the 
cellular level. The affinity of hemoglobin for CO is 200 to 250 times greater than its affinity 
for oxygen. This results in competitive inhibition of oxygen release due to a shift in the 
oxygen-hemoglobin dissociation curve, reduced oxygen delivery, and subsequent tissue 
hypoxia. In CO poisoning, magnitude of ST/T changes doesn’t correlate with the severity of 
the myocardial impairment, other tests, such as echocardiography, being necessary. All 
cardiovascular changes are more prominent in patients with underlying cardiac pathology 
(Murphy et al., 2007; Satran et al., 2005). 
 
 
Fig. 22. ECG in acute CO poisoning, 24 hours after exposure (flattened T wave in DI, 
negative T wave in aVL, ST segment elevation and T wave changes in V1-V3).  
 
 
Fig. 23. ECG in acute CO poisoning, same patient, 52 hours after exposure. Note the 
evolution of ST/T changes in precordial leads. 
 
 
Fig. 24. Same patient, 4 days after exposure. Note the evolution of ST/T changes in 
precordial and lateral leads. 
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In humans, cyanide produces histotoxic hypoxia by combining with the ferric ion in 
mitochondrial cytochrome oxidase, preventing electron transport in the cytochrome system 
and bringing oxidative phosphorylation and ATP production to a halt. The inhibition of 
oxidative metabolism puts increased demands on anaerobic glycolysis, which results in 
lactic acid production and may produce severe acid-base imbalance. Myocardial depression 
with decreased cardiac output produces stagnation hypoxia. Abnormal heartbeat can occur 
in cases of severe poisoning. Bradycardia, intractable low blood pressure, and death may 
result (Hall, 2007). 
 
 
Fig. 25. Attempted suicide with zinc phosphide ingestion in a 19 years old female, 
presenting circulatory collapse and dyspnea. ECG (leads aVR, aVL, aVF, V1-V3) reveals 
tachycardia 160 /min with wide QRS complex, multiple PVC (trigeminy), some with R/T 
phenomenon, and ST/T changes. 
Zinc phosphide is a highly effective insecticide and rodenticide. It is mediated by 
phosphine, which inhibits cytochrome C oxidase. It has been shown recently in nematodes 
that phosphine rapidly perturbs mitochondrial morphology, inhibits oxidative respiration 
by 70%, and causes a severe drop in mitochondrial membrane potential. This failure of 
cellular respiration is likely to be due to a mechanism other than inhibition of cytochrome C 
oxidase. In addition, phosphine and hydrogen peroxide can interact to form the highly 
reactive hydroxyl radical and phosphine also inhibits catalase and peroxidase; both 
mechanisms result in hydroxyl radical associated damage such as lipid peroxidation. The 
major lethal consequence of zinc phosphide ingestion, profound circulatory collapse, is 
secondary to factors including direct effects on cardiac myocytes, fluid loss, and adrenal 
gland damage. There is usually only a short interval between ingestion and the appearance 
of systemic toxicity. Phosphine-induced impairment of myocardial contractility and fluid 
loss leads to circulatory failure, and pulmonary edema. Metabolic acidosis, or mixed 
metabolic acidosis and respiratory alkalosis, are frequent, and contribute to ECG changes 
(Lionte et al., 2004; Proudfoot, 2009).  
4.2 Natural products  
Many natural products and toxins have cardiovascular effects, leading to ECG changes 
(table 11). The clinical and myocardial histological manifestations of scorpion sting resemble 
those of catecholamine infusion. Myocardial infarction has been documented in scorpion 
envenomation with a pathophysiological mechanism involving transient myocardial 
“stunning” (Thomas et al., 2007). 
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Poisonous animals and plants  ECG abnormalities 
Poisonous scorpion stings (venom) Sinus tachycardia, conduction abnormalities, ST/T 
changes with peaked T waves, QT prolongation, atrial 
and ventricular arrhythmias, myocardial infarction 
Black widow spider bites (venom) Tachycardia  
Atrial arrhythmias 
Hymenoptera (bees and wasps) 
stings (venom) 
Tachycardia, dysrhythmias, myocardial infarction 
Ciguatera fish (ciguatoxin) Bradycardia, arrhythmias  
Puffer fish (tetrodotoxin) Bradycardia, arrhythmias 
Scombroid fish (scombrotoxin) Bradycardia, sinus tachycardia, ventricular 
arrhythmias, acute myocardial infarction (fig.26) 
Aconite poisoning (Chinese herbs 
or teas that contain Aconitum 
carmichaelii or A. kusnezoffii) 
Bradycardia 
VT (monomorphic or polymorphic) 
VF 
Table 11. ECG changes induced by natural products poisoning (adapted from Hahn, 2007; 
Lionte, 2010; Murphy et al., 2007; Wandersee, 2006). 
In the pathogenesis of clinical syndrome produced by black widow spider bites was 
suggested to be also involved an excess of catecholamines, while in patients affected by 
Hymenoptera stings, histamine plays a role in pathogenesis.  
Fish-borne poisoning has multiple pathogenic mechanisms, depending on the toxin 
involved. Some of these toxins are heat stable, therefore unaffected by cooking, and gastric 
acid, while others produce the poisoning because of improper fish handling.   
 
 
Fig. 26. Scombroid fish poisoning, 1 hour after ingestion, in a young female, presenting chest 
pain and hypotension (BP 70/45 mmHg). ECG reveals signs of subendocardial myocardial 
infarction (sustained by enzymatic evidence), and sinus tachycardia 139/min.  
Aconite poisoning results from alkaloids contained in teas and herbs, which are not boiled 
enough before ingestion, such as aconitine and mesaconitine (Murphy et al., 2007). 
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Aconitine has Na+ channel-binding properties (maintaining them in an open position), 
which explain, in part, its neurological and cardiovascular toxicity (cardiodepressant 
effects). Vagal stimulation is also involved in pathogenesis of aconitine poisoning. Aconitine 
has a propensity to cause early and delayed after-depolarizations in ventricular myocytes 
that may be due to increased intracellular Ca2+ and Na+. This explains the presence of 
biventricular tachycardia and TdP on ECG (Smolinske et al., 2007).   
4.3 Drugs of abuse 
Some of the most commonly abused drugs are alcohol, nicotine, marijuana, amphetamines, 
cocaine, opium alkaloids and synthetic opioids, gamma-hydroxybutyrate, 3,4-
methylenedioxymethamphetamine (MDMA, ecstasy), and phencyclidine. Drug abuse may 
lead to organ damage, addiction, and disturbed patterns of behavior. Some illicit drugs, 
such as heroin, lysergic acid diethylamide, and phencyclidine hydrochloride, have no 
recognized therapeutic effect in humans. Cardiovascular toxicity of illicit drugs relies on 
multiple pathophysiological mechanisms. Table 12 presents major categories of drugs, and 
the ECG abnormalities reported in acute setting. 
 




Sinus tachycardia and supraventricular tachyarrhythmias 
Myocardial ischemia, and infarction 
PVB and ventricular tachydysrhythmias 
Cannabis (marijuana)  Tachycardia (fig. 17) 
Non-specific ST/T changes 
PVC (occasional) and AF 
Cocaine  Sinus bradycardia, complete heart block, bundle branch 
block 
Prolonged QTc, and QRS 
Supraventricular tachyarrhythmias 





Transient P wave inversion in DII, right bundle branch 
block, ST-segment elevation (pediatric) 
U waves (in adults) 
First degree AV block, transient AF (rare) 
Hallucinogens  Tachycardia  
Opiates and opioids Bradycardia (opioids) 
Cardiac conduction abnormalities and dysrhythmias 
(heroin) 
Prolonged QT interval and TdP (methadone) 
QRS prolongation, dysrhythmias (Propoxyphene) 
Tachycardia (Tramadol) 
Table 12. Drugs of abuse and consequent ECG changes in acute poisoning (adapted from 
Albertson, 2004; Albertson et al., 2007, a; Delgado, 2007; Quang, 2007; Traub, 2007; Yip et al., 
2007). 
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Amphetamine and related drugs activate the sympathetic nervous system via central 
nervous system stimulation, peripheral release of catecholamines, inhibition of neuronal 
reuptake of catecholamines, and inhibition of monoamine oxidase. Fenfluramine and 
dexfenfluramine cause serotonin release and block neuronal serotonin uptake. 
Methamphetamine (crank, speed), 3,4-methylenedioxymethamphetamine (MDMA, ecstasy), 
and several other amphetamine derivatives (Lysergic Acid Diethylamide), as well as a 
number of prescription drugs, are used orally and intravenously as illicit stimulants. “Ice” is 
a smokable form of methamphetamine (Albertson, 2004). Direct catecholamine effects, and 
ischemic effects, after coronary vasospasm explain arrhythmias, in amphetamine use. The 
last is involved in the pathogenesis of myocardial infarction after amphetamine use, 
together with direct cardiac toxicity (myocarditis), and thrombus formation (Albertson et al., 
2007, b).  
Most of the hallucinogens are indoleamine or phenylethylamine derivatives, structurally 
similar to the neurotransmitter serotonin. Commonly used hallucinogens include lysergic 
acid diethylamide (LSD), mescaline, 5-methoxy-N,N-diisopropyltriptamine, and psilocybin 
(“magic mushrooms”). They produce a variety of autonomic effects, both parasympathetic 
and sympathetic (Traub, 2007).  
Cocaine is one of the most popular drugs of abuse. Rapidly after smoking or intravenous 
injection (mediated by sympathetic overactivity) appear cardiovascular signs of toxicity. 
Coronary artery spasm and/or thrombosis may result in myocardial infarction, even in 
patients with no coronary disease. Chest pain with electrocardiographic evidence of 
ischemia or infarction in a young, otherwise healthy person suggests cocaine use (Benowitz, 
2004). At low doses, occur sinus bradycardia and ectopic rhythms, based on cocaine’s local 
anesthetic properties and its effects on catecholamines. At high doses, cocaine produces 
direct Na+ and K+ channel blockade (see section 3.3). Enhanced sympathetic stimulation will 
increase intracellular Ca2+ within myocardial cells, and will enhance automaticity, leading to 
afterdepolarizations, and ectopic rhythms (Albertson et al., 2007, a). 
The cannabinoid delta 9-tetrahidrocannabinol (THC) is the principal psychoactive 
constituent of Cannabis sativa (marijuana consists of the leaves and flowering parts of the 
plant). Cardiovascular toxicity is dose-related, and is explained by stimulation of the 
autonomic nervous system, involving both parasympathetic and sympathetic pathways. The 
effects tend to be more serious in patients with preexisting cardiovascular pathology (for 
example, an increased risk of myocardial infarction was reported in the hour following 
marijuana use), but in young, healthy patients, these effects have no serious consequences 
(Delgado, 2007). 
Opiates are a group of naturally occurring compounds derived from the juice of the poppy 
Papaver somniferum. The term opioid refers to these and other derivatives of naturally 
occurring opium (e.g., morphine, heroin, codeine, and hydrocodone) as well as new, totally 
synthetic opiate analogs (e.g., fentanyl, butorphanol, meperidine, methadone, and 
propoxyphene). In general, opioids share the ability to stimulate a number of specific opiate 
receptors in the CNS. With mild or moderate overdose, pulse rate is decreased. 
Cardiotoxicity similar to that seen with tricyclic antidepressants and quinidine can occur in 
patients with severe propoxyphene intoxication. Heroin and propoxyphene toxicity is 
associated with ECG changes, such as non-specific ST/T wave abnormalities, first-degree 
AV block, AF, prolonged QTc intervals, and ventricular dysrhythmias. In the pathogenesis 
of these cardiovascular findings contribute electrolyte, and metabolic derangements, 
hypoxia, or adulterants (e.g. quinine) found in street drugs (Yip et al., 2007). 
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of these cardiovascular findings contribute electrolyte, and metabolic derangements, 
hypoxia, or adulterants (e.g. quinine) found in street drugs (Yip et al., 2007). 
 




ECG is a valuable source of information in poisoned patients and has the potential to 
enhance and direct their care. Although it seems obvious that an ECG is required following 
exposure to a drug used for cardiovascular indications, many drugs with no overt 
cardiovascular effects from therapeutic dosing become cardiotoxic in overdose. An ECG 
should be examined extremely early in the initial evaluation of most poisoned patients. 
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1. Introduction 
Natural occurrence of arsenic in groundwater is found in the Americas, European, Western 
Africa, and Asia including Taiwan, Japan, southern Thailand and China where in some 
areas, drinking water supplies are primarily based on groundwater resources 2. For general 
population in southwestern coast Taiwan, the major arsenic exposure resource is the 
ingestion of arsenic contaminated groundwater. The residents have used high-arsenic 
contaminated well water for drinking and cooking for many decades since early 1910s. The 
tap water supply system was implemented in the early 1960s, however artesian well water 
has not been used for drinking or cooking until mid-1970s 3. 
Because arsenic toxicity operates in a highly nonlinear manner and different levels of exposure 
measurements applied result in large discrepancy across studies and made it difficult to come 
up a reliable dose-response relationship for arsenic hazard. There is a long-standing 
observation of individual variability in susceptibility to arsenic toxicity 4 and this variation 
may be partly due to differences in age and sex distribution across areas, and also individual 
arsenic metabolism capabilities 5,6. Inter-individual differences in the speciation and amounts 
of arsenic metabolites have been reported among subjects chronically exposed to arsenic 7 and 
significant genetic determinants of arsenic metabolism was supported by epidemiological 
study 8. Toenail and hair arsenic has been reported to provided an integrated measure of 
internal arsenic exposure 9. However epidemiologic studies showed that external 
contamination lead to overestimation of internal dose and urinary arsenic concentration seems 
to be a better marker than concentrations in drinking water10. Growing epidemiological 
evidence also suggests that some factors such as age, sex and genetic susceptibility are related 
to its metabolism and can be important predictors for arsenic-related health hazard 11,12. 
1.1 Nature history of cardiovascular disease (CVD) 
Heart disease or cardiovascular disease is defined as the class of disease that involved the 
cardiac or blood vessels including arteries and veins. Although the term technically refers to 
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Heart disease or cardiovascular disease is defined as the class of disease that involved the 
cardiac or blood vessels including arteries and veins. Although the term technically refers to 
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any disease that affects the cardiovascular system, it is usually to refer to those related to 
atherosclerosis and arterial disease since they shared similar conditions of causes, 
mechanisms and treatments13. The primary underlying disease process that leads to 
atherosclerosis is the deposition of lipid on the arterial surface progress to form plaques that 
reduced blood flow and induced blood clots that blocked flow entirely 14. 
Most countries face high and increasing rates of cardiovascular disease. In United States, 
mortality from heart and hypertensive diseases was greater than mortality from neoplasm. 
In recent years, cardiovascular risk in women has been increasing and has killed more 
women than breast cancer 15. The estimated age-adjusted mortalities of cardiovascular 
disease in US is 152.1 per 100,000 in year 2002 and is 48.3 in Taiwan 2005 16. By the time that 
heart problems are detected, the underlying causes, atherosclerosis, is usually quite 
advanced, have progressed for decades 17. Therefore increased emphasis on preventing 
atherosclerosis by modifying risk factors is remained important. 
1.2 Arsenic-related CVD 
Chronic arsenic exposure can lead to hyperkeratosis and loss of skin pigmentation as well as 
cancers of the skin, bladder, and lung. The international Agency for Research on Cancer 18 and 
the U.S. EPA 19 have classified arsenic as a group 1 and group A carcinogen based on human 
evidence. However, the mechanism of action for iAs-induced carcinogenicity is not known 20. 
Cardiovascular death is the major cause of mortality worldwide, and a small increased risk 
may imply a large quantity of excess mortality 21. Arsenic has also been shown to be a major 
risk factor of an unique form of peripheral vascular disease, Blackfoot disease (BFD) 22,23, 
especially in southwest Taiwan. Although the etiology of BFD development is still unclear, the 
dose-response relationships between arsenic and the prevalence of cardiovascular diseases 
have been documented including atherosclerosis, peripheral vascular disease (PVD), ischemic 
heart disease (IHD), hypertension, and cerebrovascular disease 21. IHD is a disease 
characterized by reduced blood supply to heart muscle, usually due to atherosclerosis of the 
coronary arteries. Its risk increases with age, smoking, hypercholesterolemia, diabetes, 
hypertension, and is more common in men and those who have close relatives with ischemic 
heart disease. Standard diagnosis of IHD including electrocardiogram, blood tests with cardiac 
enzymes, history and physical examinations. 
Although both population-based and occupational studies had shown that long-term 
exposure to inorganic arsenic has significant toxic effects on the cardiovascular system and 
the maximum arsenic contamination level in drinking water has been lowered from 0.05 to 
0.01 ppm by US Environmental Protection Agency in 2006. The allowable limit for arsenic in 
drinking water is 0.025 for Canada 24 and 0.05 ppm for Bengal, India, and Bangladesh 25. , 
the long-term association with chronic exposure to arsenic remains unclear and there is still 
epidemiological evidence needed for developing regulatory guidelines 26,27. 
1.3 Genetic factors associated with arsenic metabolism and CVD 
Although the mechanism of action for iAs-induced CVD hazards is not known 20. Proposed 
mechanisms include arsenic metabolism, pathogenesis of atherosclerosis and oxidative 
stress 28-30. More than one of these mechanisms may occur, and some may work together.  
1.4 Arsenic metabolism genes 
In general, the distribution of arsenic in human urine is 10-30% iAs, 10-20% MMA(V), and 
60-70% DMA(V) 6. However, some populations showed significant variation of arsenic 
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methylation levels in urine 31 which suggests that there are genetic factors in the regulation 
of the enzymes that metabolize arsenic, which may lead to difference in toxicity related to 
arsenic exposure. Not until recently have genes encoding enzymes that are responsible for 
arsenic metabolism been cloned and characterized. These genes include AS3MT and GSTO. 
The AS3MT gene directly encodes a cytosolic enzyme, arsenic methyltransferase, which 
catalyzes the multi-step process to convert inorganic arsenic to monomethyl arsenical 
(MMA) and dimethyl arsenical (DMA) 32. Glutathione S-transferases (GSTs) are Phase II 
detoxification enzymes that catalyze the conjugation of reduced glutathione (GSH) to a wide 
variety of endogenous and exogenous electrophilic compounds 33. A subfamily of GSTs, 
GST omega class,was shown to be identical with human monomethylarsonic acid (MMAV) 
reductase that is the rate-limiting enzyme for biotransformation of inorganic arsenic. 
Polymorphisms of GSTO genes were shown associated with the intracellular thiol status 
and arsenic biotransformation efficiency of the cell 34.  
1.5 Atherosclerosis- and CVD-related genes 
High-density lipoprotein (HDL) is postulated to prevent the development of atherosclerosis 
by inhibiting the oxidation of low-density lipoprotein (LDL). Human paraoxonase (PON1) is 
a serum esterase/lactonase transported on HDL particles which is considered the major 
determinant of the antioxidant action of HDL 35. Both in vitro studies and animal studies 
using PON1-knockout mice have shown that PON1 can prevent both HDL and LDL 
oxidation and therefore a protective enzyme against the development of atherosclerosis 36-38. 
Our previous data also showed significant synergistic effects of genetic variations in the 
PON gene cluster and chronic arsenic exposure on electrocardiogram abnormality 39. 
1.6 Other genes may linked to arsenic-related CVD 
A recent review article also pointed out that some other genes that associated with arsenic 
toxicity and altered gene expression in humans including genes involved in stress response, 
DNA damage response and apoptosis related genes, cell cycle regulatory genes and cell 
signaling and altered growth factor 40. Evidence from experimental studies had also 
suggested that arsenic increases the production of reactive oxygen species (ROS) 41-43. The 
induction of oxidative stress by arsenic may influence gene expression, inflammatory 
responses, and endothelial nitric oxide homeostasis 44, which play an important role in 
maintaining vascular tone. Genes involved in endogenous defenses against ROS thus may 
modify arsenic’s effect. Genetic material is constantly being subjected to insult from a wide 
range of DNA damage agents and this damage is controlled by the action of DNA repair 
enzymes.  
1.7 Arsenic-related early effect-biomarkers for CVD 
Preclinical or subclinical disease was defined as the pathological changes in the heart and 
arteries that develop early in the course of cardiovascular disease before symptoms or 
morbid events occur. They were developed before the evaluation of any of the risk factors or 
the determination of the subsequent incidence and mortality and thus are unbiased. Persons 
with subclinical disease, regardless of whether other risk factors are present, are at greater 
risk of future cardiovascular events than are those without subclinical disease 45. Although 
standard methods of cardiac risk assessment from the physical examination, laboratory 
tests, and treadmill exercise testing are often used clinically in cardiovascular disease 
stratification 46, evaluation of subclinical disease often not taken into account.  
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any disease that affects the cardiovascular system, it is usually to refer to those related to 
atherosclerosis and arterial disease since they shared similar conditions of causes, 
mechanisms and treatments13. The primary underlying disease process that leads to 
atherosclerosis is the deposition of lipid on the arterial surface progress to form plaques that 
reduced blood flow and induced blood clots that blocked flow entirely 14. 
Most countries face high and increasing rates of cardiovascular disease. In United States, 
mortality from heart and hypertensive diseases was greater than mortality from neoplasm. 
In recent years, cardiovascular risk in women has been increasing and has killed more 
women than breast cancer 15. The estimated age-adjusted mortalities of cardiovascular 
disease in US is 152.1 per 100,000 in year 2002 and is 48.3 in Taiwan 2005 16. By the time that 
heart problems are detected, the underlying causes, atherosclerosis, is usually quite 
advanced, have progressed for decades 17. Therefore increased emphasis on preventing 
atherosclerosis by modifying risk factors is remained important. 
1.2 Arsenic-related CVD 
Chronic arsenic exposure can lead to hyperkeratosis and loss of skin pigmentation as well as 
cancers of the skin, bladder, and lung. The international Agency for Research on Cancer 18 and 
the U.S. EPA 19 have classified arsenic as a group 1 and group A carcinogen based on human 
evidence. However, the mechanism of action for iAs-induced carcinogenicity is not known 20. 
Cardiovascular death is the major cause of mortality worldwide, and a small increased risk 
may imply a large quantity of excess mortality 21. Arsenic has also been shown to be a major 
risk factor of an unique form of peripheral vascular disease, Blackfoot disease (BFD) 22,23, 
especially in southwest Taiwan. Although the etiology of BFD development is still unclear, the 
dose-response relationships between arsenic and the prevalence of cardiovascular diseases 
have been documented including atherosclerosis, peripheral vascular disease (PVD), ischemic 
heart disease (IHD), hypertension, and cerebrovascular disease 21. IHD is a disease 
characterized by reduced blood supply to heart muscle, usually due to atherosclerosis of the 
coronary arteries. Its risk increases with age, smoking, hypercholesterolemia, diabetes, 
hypertension, and is more common in men and those who have close relatives with ischemic 
heart disease. Standard diagnosis of IHD including electrocardiogram, blood tests with cardiac 
enzymes, history and physical examinations. 
Although both population-based and occupational studies had shown that long-term 
exposure to inorganic arsenic has significant toxic effects on the cardiovascular system and 
the maximum arsenic contamination level in drinking water has been lowered from 0.05 to 
0.01 ppm by US Environmental Protection Agency in 2006. The allowable limit for arsenic in 
drinking water is 0.025 for Canada 24 and 0.05 ppm for Bengal, India, and Bangladesh 25. , 
the long-term association with chronic exposure to arsenic remains unclear and there is still 
epidemiological evidence needed for developing regulatory guidelines 26,27. 
1.3 Genetic factors associated with arsenic metabolism and CVD 
Although the mechanism of action for iAs-induced CVD hazards is not known 20. Proposed 
mechanisms include arsenic metabolism, pathogenesis of atherosclerosis and oxidative 
stress 28-30. More than one of these mechanisms may occur, and some may work together.  
1.4 Arsenic metabolism genes 
In general, the distribution of arsenic in human urine is 10-30% iAs, 10-20% MMA(V), and 
60-70% DMA(V) 6. However, some populations showed significant variation of arsenic 
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methylation levels in urine 31 which suggests that there are genetic factors in the regulation 
of the enzymes that metabolize arsenic, which may lead to difference in toxicity related to 
arsenic exposure. Not until recently have genes encoding enzymes that are responsible for 
arsenic metabolism been cloned and characterized. These genes include AS3MT and GSTO. 
The AS3MT gene directly encodes a cytosolic enzyme, arsenic methyltransferase, which 
catalyzes the multi-step process to convert inorganic arsenic to monomethyl arsenical 
(MMA) and dimethyl arsenical (DMA) 32. Glutathione S-transferases (GSTs) are Phase II 
detoxification enzymes that catalyze the conjugation of reduced glutathione (GSH) to a wide 
variety of endogenous and exogenous electrophilic compounds 33. A subfamily of GSTs, 
GST omega class,was shown to be identical with human monomethylarsonic acid (MMAV) 
reductase that is the rate-limiting enzyme for biotransformation of inorganic arsenic. 
Polymorphisms of GSTO genes were shown associated with the intracellular thiol status 
and arsenic biotransformation efficiency of the cell 34.  
1.5 Atherosclerosis- and CVD-related genes 
High-density lipoprotein (HDL) is postulated to prevent the development of atherosclerosis 
by inhibiting the oxidation of low-density lipoprotein (LDL). Human paraoxonase (PON1) is 
a serum esterase/lactonase transported on HDL particles which is considered the major 
determinant of the antioxidant action of HDL 35. Both in vitro studies and animal studies 
using PON1-knockout mice have shown that PON1 can prevent both HDL and LDL 
oxidation and therefore a protective enzyme against the development of atherosclerosis 36-38. 
Our previous data also showed significant synergistic effects of genetic variations in the 
PON gene cluster and chronic arsenic exposure on electrocardiogram abnormality 39. 
1.6 Other genes may linked to arsenic-related CVD 
A recent review article also pointed out that some other genes that associated with arsenic 
toxicity and altered gene expression in humans including genes involved in stress response, 
DNA damage response and apoptosis related genes, cell cycle regulatory genes and cell 
signaling and altered growth factor 40. Evidence from experimental studies had also 
suggested that arsenic increases the production of reactive oxygen species (ROS) 41-43. The 
induction of oxidative stress by arsenic may influence gene expression, inflammatory 
responses, and endothelial nitric oxide homeostasis 44, which play an important role in 
maintaining vascular tone. Genes involved in endogenous defenses against ROS thus may 
modify arsenic’s effect. Genetic material is constantly being subjected to insult from a wide 
range of DNA damage agents and this damage is controlled by the action of DNA repair 
enzymes.  
1.7 Arsenic-related early effect-biomarkers for CVD 
Preclinical or subclinical disease was defined as the pathological changes in the heart and 
arteries that develop early in the course of cardiovascular disease before symptoms or 
morbid events occur. They were developed before the evaluation of any of the risk factors or 
the determination of the subsequent incidence and mortality and thus are unbiased. Persons 
with subclinical disease, regardless of whether other risk factors are present, are at greater 
risk of future cardiovascular events than are those without subclinical disease 45. Although 
standard methods of cardiac risk assessment from the physical examination, laboratory 
tests, and treadmill exercise testing are often used clinically in cardiovascular disease 
stratification 46, evaluation of subclinical disease often not taken into account.  
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Epidemiology studies have showed that the population attributable fractions to CHD of 
subclinical disease was 36.8% and 42.5% for men and women respectively, which is much 
higher than for most of the known risk factors or combination of risk factors and further 
documents the importance of subclinical disease as a contributor to subsequent incident 
clinical disease 45. Among coronary artery disease (CAD) patients, the preoperative 
electrocardiogram (ECG) is shown to be predictive of long-term outcome independent of 
clinical findings and perioperative ischemia 47. Moreover, unrecognized silent myocardial 
infarction as diagnosed by electrographic changes is a major risk factor for subsequent 
myocardial infarction and coronary disease deaths 48, and it is also a useful additional tool 
for differentiating the x-lined form of hereditary cardiac myopathies 49. Subclinical disease 
and clinical disease shared similar risk factors and thus aggressive interventions to prevent 
clinical disease should be oriented to individuals with subclinical disease 50. 
Various ECG abnormalities have been observed among cases of acute arsenic poisoning and 
in acute promyelocytic leukemia patients treated with arsenic trioxide. Individuals exposed 
to excess arsenic through drinking water showed some of the ECG abnormalities 51. QT 
prolongation and dispersion have been implicated in the genesis of ventricular arrhythmia 
and directly predictors of cardiovascular and all-cause mortality 52,53. The gradient 
relationship of chronic arsenic poisoning and prolonged QT interval and increased QT 
dispersion has been reported recently 54,55 and arsenic-induced QT dispersion was 
associated with atherosclerosis disease and predicted cardiovascular mortality. However, 
evidence was based on risk assessment on subjects with previous exposure to high arsenic 
level and biomarkers for methylation metabolism were not considered. Besides, the 
accuracy and reproducibility of ECG reading including QT dispersion measurement have 
been restricted by difficulties with reliable determination of T-waves offset. Further study 
with a standardize measurement of ECG reading is warranted for a reliable assessment of 
ECG abnormality. 
Although an association between chronic arsenic exposure and CVD has been found in 
many studies, nearly all of these studies were limited by use of cross-sectional data, and 
longitudinal evidence by follow-up study was still limited. Besides, majority of previous 
studies were focus on the clinical arsenic-related cardiovascular disease, instead of the 
manifest of preclinical or subclinical detections. Morbidity and mortality from peripheral 
vascular disease, ischemic heart disease, and cerebral infarction are relative late clinical 
manifestations of chronic arsenic damage. These health effects may be the consequence of 
the interactions between predisposing and precipitating factors for cardiovascular diseases. 
The risk assessment based on these late cardiovascular events may be underestimated due 
to competing causes of death and the correctness in the diagnosis of the sudden death from 
cardiovascular diseases. Studies based on subclinical finding including ECG abnormality are 
needed to detect the early sign of chronic poisoning. 
Furthermore, the variation in distribution of arsenic in human urine across areas 31 
suggested that there are genetic factors in the regulation of the enzymes that metabolize 
arsenic, which may lead to difference in toxicity related to arsenic exposure. Association 
studies based on genetic polymorphisms have not provided consensus data that could 
generate a viable hypothesis on the molecular mechanism that determines the genetic basis 
of arsenic toxicity. The major objective of this study is to investigate the joint contribution of 
genetic factors including PON1, AS3MT, and GSTO gene families and the long-term arsenic 
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impacts on cardiovascular disease through measuring ECG abnormality as subclinical 
phenotypes and to evaluate whether the arsenic methylation patterns modifies the 
association between cumulative arsenic exposure and the risk of CVD.  
2. Materials and methods 
2.1 Study area and population  
The study included a community-based cohort from previous arseniasis-endemic area in 
southwestern Taiwan and a non-exposed population recruited from documented non-
endemic area in the same county with similar age, gender contribution and ecological status 
in 2002. The arseniasis-endemic area included Homei, Fusin and Hsinming villages in Putai 
Township on the southwestern coast of Taiwan which had been described previously 56-58. 
In short, residents in the study area consumed high-arsenic contaminated well water for 
decades since the 1910s because of the high salinity in shallow village wells 23. The arsenic 
concentration of artesian well water measured in the early 1960s was from 0.035 to 1.14 
ppm, with a median of 0.78 ppm 59,60. An estimated total daily amount of arsenic ingested by 
local residents was as high as 1 mg, mainly from drinking water 61. A tap water supply 
system was implemented in the area in the early 1960s and the entire arseniasis-endemic 
area has been supplied with municipal water since the early 1970s. The arsenic 
concentration of tap water supplied in the study area was less than 0.01 ppm 62. The original 
cohort established in 1989 including 1571 residents and 1081 subjects provided informed 
consents and enrolled in the study cohort. In 1993, 732 residents from the villages had a 12-
lead baseline Electrocardiogram (ECG) recorded. In 2002, after an average follow up period 
of eight years, 216 out of 380 subjects recruited provided a second ECG recording; 141 of 
them provided blood and urine specimens without an ECG recording; 229 were dead and 
their mortality determined through linkage with the national database; and the remaining 
146 were lost to follow-up. Among the 121 residents with normal baseline ECGs, 42 
developed an ECG abnormality at follow up. The non-exposed area was Chiali Township 
where the arsenic concentration of well water was very low according to the results of 
surveys conducted in 1960s and 1970s60,63. Climate, ethnic background (Han Chinese), 
urbanization degree and socioeconomic status were similar between Putai and Chiali. 
Frequency matching by age strata and gender were conducted for recruitment of resident 
and a total of 303 subjects were recruited.  
2.2 Measurement of arsenic exposure 
Arsenic level of well water for this study area was measured by the National Taiwan 
University group60. The water-contained arsenic recovery efficiencies were 95 percent or 
greater and were obtained using a PerkinElmer UV-VIS Spectrophotometer incorporating 
with Klett-Summerson Colorimeter. Detail validations of the water arsenic levels have been 
presented previously57,64. For villages which used more than one artesian well as a source of 
potable water, the medial levels of water arsenic contamination across those wells were 
assigned. The arsenic levels in artesian well water in this study area have been reported to 
be stable65. An index of cumulative arsenic exposure (micrograms per liter-years) were 
defined as the summation of products derived by multiplying the arsenic concentration (in 
micrograms per liter) in well water by duration of water consumption (in years) during 
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Epidemiology studies have showed that the population attributable fractions to CHD of 
subclinical disease was 36.8% and 42.5% for men and women respectively, which is much 
higher than for most of the known risk factors or combination of risk factors and further 
documents the importance of subclinical disease as a contributor to subsequent incident 
clinical disease 45. Among coronary artery disease (CAD) patients, the preoperative 
electrocardiogram (ECG) is shown to be predictive of long-term outcome independent of 
clinical findings and perioperative ischemia 47. Moreover, unrecognized silent myocardial 
infarction as diagnosed by electrographic changes is a major risk factor for subsequent 
myocardial infarction and coronary disease deaths 48, and it is also a useful additional tool 
for differentiating the x-lined form of hereditary cardiac myopathies 49. Subclinical disease 
and clinical disease shared similar risk factors and thus aggressive interventions to prevent 
clinical disease should be oriented to individuals with subclinical disease 50. 
Various ECG abnormalities have been observed among cases of acute arsenic poisoning and 
in acute promyelocytic leukemia patients treated with arsenic trioxide. Individuals exposed 
to excess arsenic through drinking water showed some of the ECG abnormalities 51. QT 
prolongation and dispersion have been implicated in the genesis of ventricular arrhythmia 
and directly predictors of cardiovascular and all-cause mortality 52,53. The gradient 
relationship of chronic arsenic poisoning and prolonged QT interval and increased QT 
dispersion has been reported recently 54,55 and arsenic-induced QT dispersion was 
associated with atherosclerosis disease and predicted cardiovascular mortality. However, 
evidence was based on risk assessment on subjects with previous exposure to high arsenic 
level and biomarkers for methylation metabolism were not considered. Besides, the 
accuracy and reproducibility of ECG reading including QT dispersion measurement have 
been restricted by difficulties with reliable determination of T-waves offset. Further study 
with a standardize measurement of ECG reading is warranted for a reliable assessment of 
ECG abnormality. 
Although an association between chronic arsenic exposure and CVD has been found in 
many studies, nearly all of these studies were limited by use of cross-sectional data, and 
longitudinal evidence by follow-up study was still limited. Besides, majority of previous 
studies were focus on the clinical arsenic-related cardiovascular disease, instead of the 
manifest of preclinical or subclinical detections. Morbidity and mortality from peripheral 
vascular disease, ischemic heart disease, and cerebral infarction are relative late clinical 
manifestations of chronic arsenic damage. These health effects may be the consequence of 
the interactions between predisposing and precipitating factors for cardiovascular diseases. 
The risk assessment based on these late cardiovascular events may be underestimated due 
to competing causes of death and the correctness in the diagnosis of the sudden death from 
cardiovascular diseases. Studies based on subclinical finding including ECG abnormality are 
needed to detect the early sign of chronic poisoning. 
Furthermore, the variation in distribution of arsenic in human urine across areas 31 
suggested that there are genetic factors in the regulation of the enzymes that metabolize 
arsenic, which may lead to difference in toxicity related to arsenic exposure. Association 
studies based on genetic polymorphisms have not provided consensus data that could 
generate a viable hypothesis on the molecular mechanism that determines the genetic basis 
of arsenic toxicity. The major objective of this study is to investigate the joint contribution of 
genetic factors including PON1, AS3MT, and GSTO gene families and the long-term arsenic 
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impacts on cardiovascular disease through measuring ECG abnormality as subclinical 
phenotypes and to evaluate whether the arsenic methylation patterns modifies the 
association between cumulative arsenic exposure and the risk of CVD.  
2. Materials and methods 
2.1 Study area and population  
The study included a community-based cohort from previous arseniasis-endemic area in 
southwestern Taiwan and a non-exposed population recruited from documented non-
endemic area in the same county with similar age, gender contribution and ecological status 
in 2002. The arseniasis-endemic area included Homei, Fusin and Hsinming villages in Putai 
Township on the southwestern coast of Taiwan which had been described previously 56-58. 
In short, residents in the study area consumed high-arsenic contaminated well water for 
decades since the 1910s because of the high salinity in shallow village wells 23. The arsenic 
concentration of artesian well water measured in the early 1960s was from 0.035 to 1.14 
ppm, with a median of 0.78 ppm 59,60. An estimated total daily amount of arsenic ingested by 
local residents was as high as 1 mg, mainly from drinking water 61. A tap water supply 
system was implemented in the area in the early 1960s and the entire arseniasis-endemic 
area has been supplied with municipal water since the early 1970s. The arsenic 
concentration of tap water supplied in the study area was less than 0.01 ppm 62. The original 
cohort established in 1989 including 1571 residents and 1081 subjects provided informed 
consents and enrolled in the study cohort. In 1993, 732 residents from the villages had a 12-
lead baseline Electrocardiogram (ECG) recorded. In 2002, after an average follow up period 
of eight years, 216 out of 380 subjects recruited provided a second ECG recording; 141 of 
them provided blood and urine specimens without an ECG recording; 229 were dead and 
their mortality determined through linkage with the national database; and the remaining 
146 were lost to follow-up. Among the 121 residents with normal baseline ECGs, 42 
developed an ECG abnormality at follow up. The non-exposed area was Chiali Township 
where the arsenic concentration of well water was very low according to the results of 
surveys conducted in 1960s and 1970s60,63. Climate, ethnic background (Han Chinese), 
urbanization degree and socioeconomic status were similar between Putai and Chiali. 
Frequency matching by age strata and gender were conducted for recruitment of resident 
and a total of 303 subjects were recruited.  
2.2 Measurement of arsenic exposure 
Arsenic level of well water for this study area was measured by the National Taiwan 
University group60. The water-contained arsenic recovery efficiencies were 95 percent or 
greater and were obtained using a PerkinElmer UV-VIS Spectrophotometer incorporating 
with Klett-Summerson Colorimeter. Detail validations of the water arsenic levels have been 
presented previously57,64. For villages which used more than one artesian well as a source of 
potable water, the medial levels of water arsenic contamination across those wells were 
assigned. The arsenic levels in artesian well water in this study area have been reported to 
be stable65. An index of cumulative arsenic exposure (micrograms per liter-years) were 
defined as the summation of products derived by multiplying the arsenic concentration (in 
micrograms per liter) in well water by duration of water consumption (in years) during 
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consecutive periods of living in the defacement villages. Both cumulative arsenic exposure 
and average arsenic concentrations in drinking water were calculated only for subjects who 
had complete information on arsenic exposure from drinking water throughout his or her 
lifetime. 
2.3 Questionnaire interview 
At both baseline and follow-up, well trained public health nurses carried out the 
standardized personal interview based on a structured questionnaire to acquire information 
regarding demographic and socioeconomic characteristics, artesian well water usage, 
residential history, lifestyle variables, personal and family disease history of hypertension, 
diabetes, and cardiovascular diseases. Cumulative arsenic exposure (in ppm-years) was 
derived from the median arsenic concentration in artesian well water (ppm) in the village 
where the subject lived and the duration of consuming the artesian well water (years)while 
residing in the village. The human Ethical Committee of the National Health Research 
Institutes in Taiwan approved the study protocol which based on the ethical standards 
formulated from the Helsinki Declarations of 1964 and revised in 2000 66. Informed consent 
was provided to each subject before participation. 
2.4 Biochemical measurements 
Fasting plasma was used for quantitative determination of blood glucose, cholesterol, 
triglycerides, high- and low-density lipoproteins, and urine acid were analyzed using the 
same instrument.  
Urinary samples were collected from each subject for arsenic species analyses. Subjects were 
asked not to consume seafood three days before urine collection. Arsenic species in urine 
including arsenite (AsIII), arsenate (AsV), monomethyl arsenical (MMA) and dimethyl 
arsenical (DMA) were quantified using high-performance liquid chromatography (HPLC) 
coupled with flow injection atomic absorption spectrometry. The HPLC system consisted of 
a solvent delivery pump (PU-1580, Jasco, Tokyo, Japan) and a silica-based anion-exchange 
column (Nucleosil 10 SB, 250 mm×4.6 mm; Phenomenex, CA, USA) with a guard column 
packed with the same material. A flow injection analysis system (FIAS-400, PerkinElmer, 
CT, USA) was designed as the on-line interface to the continuous hydride generation system 
(Analyst 100, PerkinElmer, CT, USA) used in this study. With this method, the within-say 
and between-day precision (coefficient of variance, CV%) for AsIII, AsV, MMA, and DMA 
determinations ranged from 1.0 to 3.7% were observed. Furthermore, the recoveries for 
AsIII, AsV, MMA, and DMA were 99.0, 98.9, 99.0, and 99.0% while the detection limits were 
0.75, 1.47, 1.19, and 0.76 μg/L, respectively. The primary methylation index (PMI) was 
defined as the ratio between MMA and iAs levels, and the secondary methylation index 
(SMI) was defined as the ratio between DMA and MMA.  
2.5 Genotyping 
Eight functional polymorphisms: C-108T (promoter), L55M (exon 3) and Q192R (exon 6) of 
PON1, A148G (exon 5) and C311S (exon 9) of PON2, M287T (exon 9) of AS3MT, A140D (exon 
4) of GSTO1, and N142D (exon 5) of GSTO2. SNPs were selected from NCBI’s SNP database 
based on prior implication in disease and minor allele frequency. Genomic DNA was extracted 
from whole blood using standard techniques. The AS3MT M287T polymorphism was 
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determined using a commercially designed TaqMan SNP Genotyping Assay (Applied 
Biosystems, USA). All other genotypes will be conducted by PCR amplification followed by 
polymorphism-specific restriction enzyme digestion and gel analysis. 
2.6 Physical examination 
Resting twelve-lead conventional ECG recording was performed at the Beimen Branch, 
Shinyin Hospital. Minnesota standardized code classification 1 was evaluated for both baseline 
and follow-up ECG readings at Epidemiological Cardiology Research Center (EPICARE), 
Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-
Salem, North Carolina, USA (blinded to all other study data). ECG readings were classified 
into normal and abnormal (including minor and major abnormality) according to the 
definition of cardiac function by myocardial infarction or ischemia (Q wave and STT change) 
(MC_1, MC_4, MC_5, MC_92), conduction defect (MC_7), arrhythmias (MC_6, 
MC_81~MC_88), atrial enlargement or ventricular hypertrophy (LVH_MC3/LVH_CV), and 
prolonged ventricular repolarization. Fasting plasma was analyzed for blood glucose, 
cholesterol, triglycerides, high- and low-density lipoproteins, and urine acid by Beckmen 
SYNCHRON LX20 System (Beckman Coulter, Fullerton, CA). 
2.7 Statistical analysis  
Differences in demographic characteristics and cardiovascular risk factors between ECG 
normal and abnormal subjects were assessed. Continuous variables were expressed as mean  
standard deviation (SD) and evaluated by student’s t or Wilcoxon rank-sum test. Categorical 
variables were expressed as proportions and compared using chi-square test or Fisher’s exact 
test. Allele frequencies, genotype frequencies, and Hardy-Weinberg equilibrium were assessed 
separately in ECG abnormal and normal groups using SAS-genetics package. Relative 
distribution of polymorphisms in the ECG abnormal and ECG normal groups was assessed by 
chi-square analyses. Linkage disequilibrium (LD) as measured by D’ was assessed using 
Haploview 4.0 (http://www.broad.mit.edu/mpg/haploview/). Haplotypes and tag SNPs 
were inferred using SAS. Logistic regression analysis was used to assess the effect of 
cardiovascular risk factors and genetic polymorphisms in relation to ECG abnormality. 
Arsenic exposure and ECG abnormality in between study subjects in Putai and Chiali areas 
were also compared. Arsenic exposure in Putai area were stratified into two categories by 
median levels and subjects in Chiali area were used as reference group, and a trend test was 
conducted to evaluate the dose-relationship. ANOVA was conducted to evaluate urinary 
arsenic species between subjects with normal and abnormal ECG reading. A p value <0.05 was 
considered statistically significant. Permutation test, a significance test used to obtain the 
unknown reference distribution by calculating all possible values of the test statistic under 
random rearrangements of the disease status on the observed study subjects , was used to 
control for type 1 error for multiple testing due to the limited sample size, and the empirical p-
values were reported 67. Statistical analyses were conducted using SAS version 9.1 (SAS, Inc., 
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consecutive periods of living in the defacement villages. Both cumulative arsenic exposure 
and average arsenic concentrations in drinking water were calculated only for subjects who 
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column (Nucleosil 10 SB, 250 mm×4.6 mm; Phenomenex, CA, USA) with a guard column 
packed with the same material. A flow injection analysis system (FIAS-400, PerkinElmer, 
CT, USA) was designed as the on-line interface to the continuous hydride generation system 
(Analyst 100, PerkinElmer, CT, USA) used in this study. With this method, the within-say 
and between-day precision (coefficient of variance, CV%) for AsIII, AsV, MMA, and DMA 
determinations ranged from 1.0 to 3.7% were observed. Furthermore, the recoveries for 
AsIII, AsV, MMA, and DMA were 99.0, 98.9, 99.0, and 99.0% while the detection limits were 
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determined using a commercially designed TaqMan SNP Genotyping Assay (Applied 
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unknown reference distribution by calculating all possible values of the test statistic under 
random rearrangements of the disease status on the observed study subjects , was used to 
control for type 1 error for multiple testing due to the limited sample size, and the empirical p-
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normal study subjects showed ECG deterioration at follow-up. Compared to ECG normal 
subjects, those with an ECG abnormality had significantly higher arsenic exposure as shown 
by both years of drinking artesian water and cumulative arsenic exposure index. Age and 
proportion of cigarette smoking in the ECG abnormal group tended to be higher but did not 
reach statistical significance. No differences were observed in other cardiovascular risk 
factors including gender, alcohol consumption, BMI, serum lipids, blood pressure, and 
plasma glucose. 
 
Variable ECG normal (n=79) 
ECG abnormal 
(n=42) 
Age (years) 62.0 ± 7.3 64.9 ± 8.7 
Male (% ) 29 (36.7) 18 (42.9) 
Cigarette Smoking (%) 14 (17.7) 13 (31.0) 
Alcohol consumption (%) 10 (12.7) 6 (14.3) 
Residency (years) 41.5 ± 12.4 43.3 ± 14.3 
Drinking Artesian Water (years) 19.2 ± 9.3 25.1 ± 9.7 
Cumulative As exposure (ppm-years) 13.6 ± 8.4 18.0 ± 8.4 
BMI (kg/m^2) 24.9 ± 3.13 24.5 ± 3.4 
Triglycerides (mg/dl) 113.1 ± 64.7 132.3 ± 106.9 
Total Cholesterol (mg/dl) 220.2 ± 45.0 211.7 ± 42.5 
HDL (mg/dl) 60.3 ± 18.1 59.2 ± 14.3 
LDL (mg/dl) 121.9 ± 48.1 124.6 ± 76.3 
Cholesterol /HDL ratio 4.0 ± 1.6 3.8 ± 1.2 
Uric acid (mg/dl) 6.1 ± 1.9 5.7 ± 1.8 
SBP (mmHg) 124.8 ± 19.3 128.2 ± 17.3 
DBP (mmHg) 82.2 ± 11.1 84.2 ± 8.6 
AC glucose (mg/dl) 98.6 ± 23.1 104.4 ± 37.3 
PC glucose (mg/dl) 127.3 ± 52.2 129.1 ± 78.1 
Data are reported as mean ± SD or counts (%) 
HDL: high density lipoprotein; LDL: low density lipoprotein; CHOL: total cholesterol levels; SBP: 
systolic blood pressure; DBP: diastolic blood pressure, AC: ante cibum, PC: post cibum 
Table 1. Baseline characteristics of arsenic and CVD risk factors among baseline-normal 
study participants classified by ECG status at follow-up 
3.1 Univariate SNPs association analysis 
Eight functional polymorphisms: C-108T, L55M and Q192R of PON1, A148G and C311S of 
PON2, M287T of AS3MT, A140D of GSTO1, and N142D of GSTO2 were screened for 
association with ECG abnormality and Hardy-Weinberg equilibrium (HWE). None reached 
statistical significance, suggesting no univariate SNP association in the analysis. Genotypic 
frequencies of M287T showed a significant departure from HWE but because of the limited 
number of participants carrying the T alleles in this study population, they were excluded 
from subsequent analysis.  
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ECG status  
Normal Abnormal OR (95% CI) 
PON1 Q192R    
 RR 18 14 1.00 (reference) 
 QR 27 9 0.43 (0.15-1.20) 
 QQ 11 3 0.35 (0.08-1.50) 
 L55M    
 LL 48 21 1.00 (reference) 
 LM 14 4 0.65 (0.19-2.22) 
 MM 0 0 - 
 C-108T    
 CC 17 7 1.00 (reference) 
 CT 30 15 1.21 (0.41-3.56) 
 TT 15 6 0.97 (0.27-3.54) 
PON2 C311S    
 SS 31 18 1.00 (reference) 
 CS 24 7 0.50 (0.18-1.40) 
 CC 2 2 1.72 (0.22-13.30) 
 A148G    
 AA 30 15 1.00 (reference) 
 AG 28 10 0.71 (0.28-1.85) 
 GG 3 2 1.33 (0.20-8.86) 
AS3MT M287T    
 MM 67 30 1.00 (reference) 
 MT 2 1 1.12 (0.10-12.80) 
 TT 0 0 - 
GSTO1 A140D    
 AA 41 21 1.00 (reference) 
 AD 22 9 0.80 (0.31-2.04) 
 DD 5 2 0.78 (0.14-4.37) 
GSTO2 N142D    
 NN 35 16 1.00 (reference) 
 ND 30 14 1.02 (0.43-2.43) 
 DD 4 2 1.09 (0.18-6.60) 
Hardy-Weinberg Equilibrium (HWE) test was conducted among all study subjects 
Table 2. Association of SNPs and Hardy-Weinberg equilibrium test 
Figure 1 shows the related position and linkage disequilibrium (LD) between SNPs in the 
PON and GSTO gene clusters. Two SNPs within PON2 (C311S and A148G) and GSTO1-
A140D and GSTO2-N142 were in high LD but SNPs within PON1 or adjacent SNPs 
between PON1 and PON2 (C-108T and C311s) had low LD measurements, implying they 
were not in the same LD block. Q192R, C-108T, C311S and A140D were identified as tag-
SNPs. 
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Fig. 1. Linkage disequilibrium (LD) plot of PON1 and GSTO gene clusters in 121 study 
subjects. The measure of LD (D’) among all possible pairs of SNPs is shown graphically. 
Dark red represents high D’ while white represents low D’ 
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3.2 Haplotype analysis and association with ECG abnormality 
Haplotypes of PON1, PON2, GSTO1, GSTO2 and tag-SNPs of the PON gene cluster were 
constructed, and those whose frequencies were <5% were excluded from association 
analysis (Table 3). Overall, the effects of these haplotypes on ECG abnormality were not 
statistically significant after 10,000 permutations; however, the haplotype R-C-S constructed 
by Q192R, C-108T and C311S had the highest odds, 1.92 (95% CI: 0.76-4.85) times increased 
risk toward ECG abnormality. 
 
Haplotypes ECG normal ECG abnormal OR 
Q192R L55M C-108T    
R L T 46 (37.1%) 24 (42.9%) 1.00 (reference) 
Q L C 38 (30.7%) 10 (17.9%) 0.50 (0.22-1.18) 
R L C 18 (14.5%) 15 (26.8%) 1.60 (0.69-372) 
Q M C 8 (6.5%) 4 (7.1%) 0.96 (0.26-3.51) 
Q L T 8 (6.5%) 3 (5.4%) 0.72 (0.17-2.96) 
      
Q192R C-108T     
R T  52 (41.9%) 24 (42.9%) 1.00 (reference) 
Q C  46 (37.1%) 14 (25.0%) 0.66 (0.31-1.42) 
R C  18 (14.5%) 15 (26.8%) 1.81 (0.78-4.18) 
Q T  8 (6.5%) 3 (5.4%) 0.81 (0.20-3.33) 
      
C311S A148G     
S A  89 (71.8%) 40 (70.4%) 1.00 (reference) 
C G  32 (25.8%) 10 (17.9%) 0.70 (0.31-1.56) 
      
A140D N142D     
A N  96 (69.5%) 43 (67.2%) 1.00 (reference) 
D D  28 (20.3%) 10 (15.6%) 0.80 (0.36-1.77) 
A D  10 (7.3%) 8 (12.5%) 1.79 (0.66-4.84) 
      
Q192R C-108T C311S    
R T S 47 (37.9%) 21 (37.5%) 1.00 (reference) 
Q C S 27 (21.7%) 9 (16.1%) 0.75 (0.30-1.86) 
R C S 14 (11.3%) 12 (21.4) 1.92 (0.76-4.85) 
Q C C 19 (15.3%) 5 (8.9%) 0.59 (0.19-1.79) 
Q T S 8 (6.5%) 3 (5.4%) 0.84 (0.20-3.48) 
Haplotypes with a frequency less than 5% were removed. 
Empirical P-value: a Haplotype-specific test, b Haplotype-global test 
Table 3. Estimated haplotype frequencies and haplotypes association analysis with ECG 
abnormality 
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The relative odds of lipid profiles for PON-haplotype R-C-S carrier compared with non-
carriers are shown in Figure 2. The R-C-S haplotype was positively correlated with higher 
serum HDL-cholesterol, LDL-cholesterol, and triglyceride levels without statistical 
significance, but was significantly associated with increased total cholesterol levels 





Fig. 2. Odds ratios of lipid profiles for Q192R, C-108T and C311S R-C-S haplotype carrier 
among study subjects (N=121) 
3.3 Synergistic association of PON haplotype and arsenic on ECG abnormality 
The synergistic associations between PON haplotype and arsenic exposure are summarized 
in Table 4. The PON R-C-S haplotype carrier with higher cumulative arsenic exposure 
(greater than the median value of 14.7 ppm-years) showed a >14.66 (95% CI: 1.83-117.64) 
increased risk for ECG abnormality compared to non-RCS haplotype carriers with low 
cumulative arsenic exposure (<14.7 ppm-years) (Table 4a). The PON R-C-S haplotype carrier 
with more years of drinking artesian water (greater than the median of 21 years) had a 
10.83-fold (95% CI: 1.83-64.03) increased risk (Table 4b). These associations were even 
stronger after adjusting for age, gender, and cigarette smoking, when the odds increased to 
19.19 (95% CI: 1.86-197.76) and 21.09 (95% CI: 2.77-160.35) for cumulative exposure index 
and drinking years, respectively. 
Table 5 showed the correlation between cumulative arsenic exposure and urinary arsenic 
species from arsenic endemic and non-endemic areas in southwestern Taiwan. Subjects 
with higher cumulative arsenic exposure had significantly higher levels of As (III), iAs, 
MMA, Summation of iAs and MMA. However, DMA levels and SMI were significantly 
lower among subjects with high arsenic exposure. Similar pattern was observed when 
urinary arsenic was analyzed in percentage. Subjects with higher cumulative arsenic 
exposure had higher percentages of As(III), iAs and MMA in urinary and lower DMA 
percentage.  
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R-C-S CAE ECG Normal
ECG 
Abnormal OR (95% CI) OR (95% CI)
a Empirical 
P-value a 
- - 22 3 1.00 (reference) 1.00 (reference) - 
+ - 8 2 1.83 (0.26-13.06) 1.57 (0.19-13.00) 0.319 
- + 17 11 4.74 (1.14-19.72) 4.27 (0.83-22.08) 0.632 
+ + 2 4 14.66 (1.83-117.64) 19.19 (1.86-197.76) 0.014 
a Permutation analysis adjusted by age, gender and cigarette smoking 
CAE: Cumulative arsenic exposure (ppm-years) 
R-C-S: Q192R, C-108T and C311S R-C-S haplotype 
Table 4a. Synergistic effects of Q192R, C-108T, and C311S R-C-S haplotypes carrier and high 
cumulative arsenic exposure (CAE) (> median of 14.7 ppm-years) on ECG abnormality 
 
R-C-S DAW ECG Normal
ECG 
Abnormal OR (95% CI) OR (95% CI)
a Empirical 
P-value a 
- - 26 3 1.00 (reference) 1.00 (reference) - 
+ - 8 2 2.17 (0.31-15.33) 1.90 (0.24-14.94) 0.190 
- + 19 15 6.84 (1.73-27.02) 10.66 (2.12-53.55) 0.055 
+ + 4 5 10.83 (1.83-64.03) 21.09 (2.77-160.35) 0.010 
a Permutation analysis adjusted by age, gender and cigarette smoking 
DAW: Drinking artesian water (years) 
RCS: Q192R, C-108T & C311S R-C-S haplotype 
Table 4b. Synergistic effects of Q192R, C-108T, and C311S R-C-S haplotypes carrier and 
more years of drinking artesian water (DAW) (> mean of 21 years) on ECG abnormality 
 
Variable  Non-exposed 
(Chiali) (N=302) 
≤ 14.7 (Putai) 
(N=191) 
> 14.7 (Putai) 
(N=103) 
Urinary arsenic level    
As (III) (μg/g creatinine)** 2.07 (2.98) 4.61 (9.46) 4.73 (6.24) 
As (V) (μg/g creatinine) 2.78 (3.16) 3.13 (3.66) 2.21 (1.92) 
iAs (μg/g creatinine)** 4.85 (4.66) 7.73 (11.54) 6.95 (6.74) 
MMA (μg/g creatinine)** 3.13 (3.79) 4.48 (6.30) 4.21 (3.25) 
Σ(iAs +MMA) (μg/g creatinine)** 7.98 (6.84) 12.21 (14.66) 11.15 (7.84) 
DMA (μg/g creatinine)* 42.87 (34.48) 33.64 (27.34) 37.37 (24.32) 
Σ(iAs + MMA + DMA) 
(μg/g creatinine) 50.85 (37.86) 45.87 (33.60) 48.58 (28.53) 
PMI (MMA/iAs) 0.87 (1.02) 0.84 (0.75) 0.85 (0.60) 
SMI (DMA/MMA)** 23.68 (22.80) 15.44 (28.38) 15.94 (20.86) 
Urinary arsenic percentage     
As (III) %** 4.59 (5.18) 10.08 (13.22) 9.18 (9.08) 
As (V) %** 6.23 (5.62) 8.27 (7.76) 5.81 (7.58) 
iAs %** 10.82 (8.37) 18.35 (16.50) 14.99 (10.73) 
MMA %** 7.45 (8.59) 10.90 (9.05) 10.12 (7.57) 
DMA %** 81.73 (13.84) 70.75 (20.23) 74.89 (13.99) 
a P-value for ANOVA 
*P-value < 0.05, ** P-value < 0.01 
Table 5. Correlation of cumulative arsenic exposure and urinary metabolism capacity 
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The relative odds of lipid profiles for PON-haplotype R-C-S carrier compared with non-
carriers are shown in Figure 2. The R-C-S haplotype was positively correlated with higher 
serum HDL-cholesterol, LDL-cholesterol, and triglyceride levels without statistical 
significance, but was significantly associated with increased total cholesterol levels 





Fig. 2. Odds ratios of lipid profiles for Q192R, C-108T and C311S R-C-S haplotype carrier 
among study subjects (N=121) 
3.3 Synergistic association of PON haplotype and arsenic on ECG abnormality 
The synergistic associations between PON haplotype and arsenic exposure are summarized 
in Table 4. The PON R-C-S haplotype carrier with higher cumulative arsenic exposure 
(greater than the median value of 14.7 ppm-years) showed a >14.66 (95% CI: 1.83-117.64) 
increased risk for ECG abnormality compared to non-RCS haplotype carriers with low 
cumulative arsenic exposure (<14.7 ppm-years) (Table 4a). The PON R-C-S haplotype carrier 
with more years of drinking artesian water (greater than the median of 21 years) had a 
10.83-fold (95% CI: 1.83-64.03) increased risk (Table 4b). These associations were even 
stronger after adjusting for age, gender, and cigarette smoking, when the odds increased to 
19.19 (95% CI: 1.86-197.76) and 21.09 (95% CI: 2.77-160.35) for cumulative exposure index 
and drinking years, respectively. 
Table 5 showed the correlation between cumulative arsenic exposure and urinary arsenic 
species from arsenic endemic and non-endemic areas in southwestern Taiwan. Subjects 
with higher cumulative arsenic exposure had significantly higher levels of As (III), iAs, 
MMA, Summation of iAs and MMA. However, DMA levels and SMI were significantly 
lower among subjects with high arsenic exposure. Similar pattern was observed when 
urinary arsenic was analyzed in percentage. Subjects with higher cumulative arsenic 
exposure had higher percentages of As(III), iAs and MMA in urinary and lower DMA 
percentage.  
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R-C-S CAE ECG Normal
ECG 
Abnormal OR (95% CI) OR (95% CI)
a Empirical 
P-value a 
- - 22 3 1.00 (reference) 1.00 (reference) - 
+ - 8 2 1.83 (0.26-13.06) 1.57 (0.19-13.00) 0.319 
- + 17 11 4.74 (1.14-19.72) 4.27 (0.83-22.08) 0.632 
+ + 2 4 14.66 (1.83-117.64) 19.19 (1.86-197.76) 0.014 
a Permutation analysis adjusted by age, gender and cigarette smoking 
CAE: Cumulative arsenic exposure (ppm-years) 
R-C-S: Q192R, C-108T and C311S R-C-S haplotype 
Table 4a. Synergistic effects of Q192R, C-108T, and C311S R-C-S haplotypes carrier and high 
cumulative arsenic exposure (CAE) (> median of 14.7 ppm-years) on ECG abnormality 
 
R-C-S DAW ECG Normal
ECG 
Abnormal OR (95% CI) OR (95% CI)
a Empirical 
P-value a 
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Table 4b. Synergistic effects of Q192R, C-108T, and C311S R-C-S haplotypes carrier and 
more years of drinking artesian water (DAW) (> mean of 21 years) on ECG abnormality 
 
Variable  Non-exposed 
(Chiali) (N=302) 
≤ 14.7 (Putai) 
(N=191) 
> 14.7 (Putai) 
(N=103) 
Urinary arsenic level    
As (III) (μg/g creatinine)** 2.07 (2.98) 4.61 (9.46) 4.73 (6.24) 
As (V) (μg/g creatinine) 2.78 (3.16) 3.13 (3.66) 2.21 (1.92) 
iAs (μg/g creatinine)** 4.85 (4.66) 7.73 (11.54) 6.95 (6.74) 
MMA (μg/g creatinine)** 3.13 (3.79) 4.48 (6.30) 4.21 (3.25) 
Σ(iAs +MMA) (μg/g creatinine)** 7.98 (6.84) 12.21 (14.66) 11.15 (7.84) 
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(μg/g creatinine) 50.85 (37.86) 45.87 (33.60) 48.58 (28.53) 
PMI (MMA/iAs) 0.87 (1.02) 0.84 (0.75) 0.85 (0.60) 
SMI (DMA/MMA)** 23.68 (22.80) 15.44 (28.38) 15.94 (20.86) 
Urinary arsenic percentage     
As (III) %** 4.59 (5.18) 10.08 (13.22) 9.18 (9.08) 
As (V) %** 6.23 (5.62) 8.27 (7.76) 5.81 (7.58) 
iAs %** 10.82 (8.37) 18.35 (16.50) 14.99 (10.73) 
MMA %** 7.45 (8.59) 10.90 (9.05) 10.12 (7.57) 
DMA %** 81.73 (13.84) 70.75 (20.23) 74.89 (13.99) 
a P-value for ANOVA 
*P-value < 0.05, ** P-value < 0.01 
Table 5. Correlation of cumulative arsenic exposure and urinary metabolism capacity 
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Distribution between levels of cumulative arsenic exposure and ECG abnormality was 
summarized in Table 6. Significant dose-response relationships were observed between 
higher levels of cumulative arsenic exposure and ECG reading regarding abnormalities, 
myocardial infarction or ischemia disease, and also atrial enlargement and ventricular 
hypertrophy. Increased cumulative arsenic exposure was also correlated with a higher 
proportion of abnormality in prolonged ventricular repolarization however not reach 
statistical significance. 
 
Variable  Non-exposed 
(Chiali) (N=302)
≤ 14.7 (Putai) 
(N=191) 
> 14.7 (Putai) 
(N=103) 
ECG reading (ECG group)**    
  0: Normal 155 (51.3) 96 (50.3) 40 (38.8) 
  1: Minor abnormal 122 (40.3) 70 (36.7) 40 (38.8) 
  2: Major abnormal 25 (8.3) 25 (13.0) 23 (22.4) 
Myocardial Infarction or Ischemia (MC_MI)*    
  0: Normal 216 (71.5) 136 (71.2) 68 (66.0) 
  1: Minor abnormal 72 (23.8) 37 (19.4) 20 (19.4) 
  2: Major abnormal 14 (4.6) 18 (9.4) 15 (14.6) 
Conduction defect (BBB; Bundle Branch Block)   
  0: Normal 261 (86.4) 174 (91.1) 86 (83.5) 
  1: Abnormal 41 (13.6) 17 (8.9) 17 (16.5) 
Arrhythmia (Arrhythmia)    
  0: Normal 265 (87.8) 170 (89.0) 97 (94.2) 
  1: Abnormal 37 (12.3) 21 (11.0) 6 (5.8) 
Atrial enlargement/Ventricular hypertrophy (Hypertrophy)** 
  0: Normal 286 (94.7) 167 (87.4) 85 (82.5) 
  1: Abnormal 16 (5.3) 24 (12.6) 18 (17.5) 
Prolonged ventricular repolarization (Long_QT)   
  0: Normal 299 (99.0) 187 (98.0) 99 (96.1) 
  1: Abnormal 3 (1.0) 4 (2.0) 4 (3.9) 
a P-value for trend test 
*P-value < 0.05, ** P-value < 0.01 
Table 6. Distribution of ECG reading by cumulative arsenic exposure 
4. Discussion 
Various ECG abnormalities have been observed among cases of acute arsenic poisoning and 
in acute promyelocytic leukemia patients treated with arsenic trioxide. Individuals exposed 
to excess arsenic through drinking water showed some of the ECG abnormalities51. Several 
epidemiologic studies showed that QT prolongation and increased CVD mortality among 
high levels of arsenic-exposed subjects. However, the results might not be applicable in 
subjects with low to moderate arsenic. Our data replicated this association in an arseniasis-
endemic area and a well-matched control area which no previous history of water 
contamination. We highlighted the correlation between previous chronic arsenic exposure 
and ECG abnormalities after cessation of arsenic-contaminated water consumption for 
decades.  
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The major strength of this study was to apply a standardized Minnesota coding 
classification of ECG reading that ensures good quality assurance and control. Furthermore, 
detailed parameters regarding ECG abnormalities allowed us to evaluate the minor changes 
due to arsenic toxicity. In current analyses, higher duration of arsenic water consumption 
was associated with ECG abnormality, myocardial infarction or ischemia, atrial enlargement 
or ventricular hypertrophy in a dose-response relationship. Besides, it was also positively 
correlated to arrhythmia and prolonged ventricular repolarization without reached the 
statistical significance. Moreover, higher levels of cumulative arsenic exposure were also 
associated with ECG parameters including higher PR duration, QRS duration and QRS axis 
and smaller JT duration, JT index and RaVL (data not shown).  
There were still some limitations for this study. First, results from this study were based on 
a population with history of arsenic exposure. Insignificant association between urinary 
methylation capabilities might due to attrition of high-level arsenic exposed subjects, 
competing risks for CVD mortality was not considered in current analysis. Another 
limitation of the present study was that the measurement of urinary metabolism species and 
physical evaluation were conducted at a cross-sectional design. The causal-relationship 
between urinary species of arsenic and ECG abnormality could not be inferred given current 
evidence. However, the previous exposure status was significantly correlated with current 
urinary arsenic species implied it was more efficient among subjects after cessation of long-
term exposure to high levels of arsenic. These results may have implications for arsenic 
mediation strategies in areas currently exposed to potentially harmful levels of arsenic in 
drinking water. Furthermore, CVD usually took years for disease development. Correlation 
may be biased due to unmeasured factors during a relative short follow-up period. Longer 
duration of follow-up with serial changes for ECG abnormality would help better 
understand the underlying mechanism regarding arsenic-induced hazards. 
The major significance by this study was the assessment of arsenic risk from subjects 
without exposure of inorganic arsenic to moderate and relatively high levels of cumulative 
arsenic exposure. Causal inference can be strengthened by the dose-response relationship by 
the stronger effect in a susceptible subgroup of the population. Besides, this study 
demonstrated significant gene-gene and gene-environment interactions by showing PON1 
gene cluster including polymorphisms of PON1: Q192R, PON1: C-108T, and PON2: C311S 
and latent effect of arsenic exposure on incidence of ECG abnormality. Besides, PON2: 
C311S was independently associated with LDH elevation and further predicted future CVD 
mortality independent to other conventional risk factors including age, gender, cigarette 
smoking, hypertension and diabetes mellitus. After cessation of arsenic-contaminated water 
consumption for decades, biomarkers for CVD mortality and morbidity was still associated 
with reduced risks for arsenic and attributable to underlying genetic predisposition. Such 
data may also help risk assessment in the population and provide knowledge about the 
underlying mechanisms. 
HDL has been shown to prevent atherogenesis in vivo and in vitro through anti-oxidative 
and anti-inflammatory activities35. The major part of anti-atherogenic properties associated 
with HDL is explained by the activity of Paraoxonase 168. Both PON1 and PON2 belong to 
the protein family of Paraoxonase 1 that includes PON3 which has been suggested that 
involved in CVD69. PON1 directly form part of HDL particles whereas PON2 found in 
endothelial cells, smooth muscle cells and macrophages that possesses antioxidant 
properties similar to PON1 by delays cellular oxidative stress and prevents apoptosis in 
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Distribution between levels of cumulative arsenic exposure and ECG abnormality was 
summarized in Table 6. Significant dose-response relationships were observed between 
higher levels of cumulative arsenic exposure and ECG reading regarding abnormalities, 
myocardial infarction or ischemia disease, and also atrial enlargement and ventricular 
hypertrophy. Increased cumulative arsenic exposure was also correlated with a higher 
proportion of abnormality in prolonged ventricular repolarization however not reach 
statistical significance. 
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(Chiali) (N=302)
≤ 14.7 (Putai) 
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> 14.7 (Putai) 
(N=103) 
ECG reading (ECG group)**    
  0: Normal 155 (51.3) 96 (50.3) 40 (38.8) 
  1: Minor abnormal 122 (40.3) 70 (36.7) 40 (38.8) 
  2: Major abnormal 25 (8.3) 25 (13.0) 23 (22.4) 
Myocardial Infarction or Ischemia (MC_MI)*    
  0: Normal 216 (71.5) 136 (71.2) 68 (66.0) 
  1: Minor abnormal 72 (23.8) 37 (19.4) 20 (19.4) 
  2: Major abnormal 14 (4.6) 18 (9.4) 15 (14.6) 
Conduction defect (BBB; Bundle Branch Block)   
  0: Normal 261 (86.4) 174 (91.1) 86 (83.5) 
  1: Abnormal 41 (13.6) 17 (8.9) 17 (16.5) 
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  0: Normal 265 (87.8) 170 (89.0) 97 (94.2) 
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Prolonged ventricular repolarization (Long_QT)   
  0: Normal 299 (99.0) 187 (98.0) 99 (96.1) 
  1: Abnormal 3 (1.0) 4 (2.0) 4 (3.9) 
a P-value for trend test 
*P-value < 0.05, ** P-value < 0.01 
Table 6. Distribution of ECG reading by cumulative arsenic exposure 
4. Discussion 
Various ECG abnormalities have been observed among cases of acute arsenic poisoning and 
in acute promyelocytic leukemia patients treated with arsenic trioxide. Individuals exposed 
to excess arsenic through drinking water showed some of the ECG abnormalities51. Several 
epidemiologic studies showed that QT prolongation and increased CVD mortality among 
high levels of arsenic-exposed subjects. However, the results might not be applicable in 
subjects with low to moderate arsenic. Our data replicated this association in an arseniasis-
endemic area and a well-matched control area which no previous history of water 
contamination. We highlighted the correlation between previous chronic arsenic exposure 
and ECG abnormalities after cessation of arsenic-contaminated water consumption for 
decades.  
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The major strength of this study was to apply a standardized Minnesota coding 
classification of ECG reading that ensures good quality assurance and control. Furthermore, 
detailed parameters regarding ECG abnormalities allowed us to evaluate the minor changes 
due to arsenic toxicity. In current analyses, higher duration of arsenic water consumption 
was associated with ECG abnormality, myocardial infarction or ischemia, atrial enlargement 
or ventricular hypertrophy in a dose-response relationship. Besides, it was also positively 
correlated to arrhythmia and prolonged ventricular repolarization without reached the 
statistical significance. Moreover, higher levels of cumulative arsenic exposure were also 
associated with ECG parameters including higher PR duration, QRS duration and QRS axis 
and smaller JT duration, JT index and RaVL (data not shown).  
There were still some limitations for this study. First, results from this study were based on 
a population with history of arsenic exposure. Insignificant association between urinary 
methylation capabilities might due to attrition of high-level arsenic exposed subjects, 
competing risks for CVD mortality was not considered in current analysis. Another 
limitation of the present study was that the measurement of urinary metabolism species and 
physical evaluation were conducted at a cross-sectional design. The causal-relationship 
between urinary species of arsenic and ECG abnormality could not be inferred given current 
evidence. However, the previous exposure status was significantly correlated with current 
urinary arsenic species implied it was more efficient among subjects after cessation of long-
term exposure to high levels of arsenic. These results may have implications for arsenic 
mediation strategies in areas currently exposed to potentially harmful levels of arsenic in 
drinking water. Furthermore, CVD usually took years for disease development. Correlation 
may be biased due to unmeasured factors during a relative short follow-up period. Longer 
duration of follow-up with serial changes for ECG abnormality would help better 
understand the underlying mechanism regarding arsenic-induced hazards. 
The major significance by this study was the assessment of arsenic risk from subjects 
without exposure of inorganic arsenic to moderate and relatively high levels of cumulative 
arsenic exposure. Causal inference can be strengthened by the dose-response relationship by 
the stronger effect in a susceptible subgroup of the population. Besides, this study 
demonstrated significant gene-gene and gene-environment interactions by showing PON1 
gene cluster including polymorphisms of PON1: Q192R, PON1: C-108T, and PON2: C311S 
and latent effect of arsenic exposure on incidence of ECG abnormality. Besides, PON2: 
C311S was independently associated with LDH elevation and further predicted future CVD 
mortality independent to other conventional risk factors including age, gender, cigarette 
smoking, hypertension and diabetes mellitus. After cessation of arsenic-contaminated water 
consumption for decades, biomarkers for CVD mortality and morbidity was still associated 
with reduced risks for arsenic and attributable to underlying genetic predisposition. Such 
data may also help risk assessment in the population and provide knowledge about the 
underlying mechanisms. 
HDL has been shown to prevent atherogenesis in vivo and in vitro through anti-oxidative 
and anti-inflammatory activities35. The major part of anti-atherogenic properties associated 
with HDL is explained by the activity of Paraoxonase 168. Both PON1 and PON2 belong to 
the protein family of Paraoxonase 1 that includes PON3 which has been suggested that 
involved in CVD69. PON1 directly form part of HDL particles whereas PON2 found in 
endothelial cells, smooth muscle cells and macrophages that possesses antioxidant 
properties similar to PON1 by delays cellular oxidative stress and prevents apoptosis in 
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vascular endothelial cells70,71. Regarding three common polymorphisms in coding region of 
the human PON1 gene, the frequencies of Q192R, L55M, and C-108T for Taiwanese 
population were similar to those reported in the literature for the Chinese population 72,73. 
Besides, we confirmed that paraoxonase, diazoxonase and arylesterase activities were 
directly influenced by the Q192R and C-108T polymorphisms. Previous studies had also 
shown that 311 C allele in PON2 was associated with increased risks of coronary artery 
disease, MI and also diabetic nephropathy74-76. Our data confirmed the significance of 
PON2: C311S polymorphism during pathogenesis of CVD among chronic arsenic exposed 
subject. This finding could help to identify subjects at higher risk of cardiovascular damage 
for arsenic toxicity. 
However, some other factors that might have influenced the arsenic methylation profiles 
were not considered. Nutritional status and dietary intake may also be uncontrollable 
factors. Besides, we could not obtain the accurate data on allele distribution three 
polymorphisms: PON1: C-108T, GSTO1:A140D, and AS3MT: L55M in our samples. We still 
could not rule out the intra- and inter-individual variability to arsenic methylation and also 
their impacts on pathogenesis of CVD morbidity and mortality. Besides, the arsenic levels in 
rice growing in the arsenic contaminated area or inorganic arsenic from fish intake may be 
elevated. This might potentially increase arsenic exposure in the endemic area77-80. Future 
study of exposure assessment is needed. In addition, arsenic exposure has also been shown 
to alter the methylation level of both global DNA and certain genes in studies that analyzed 
a limited number of epigenetic endpoints81. Therefore, it is necessary to enlarge sample size 
for the evaluation of genetic association and ECG abnormality and other confounders that 
may be directly related to arsenic risks. 
Genome-wide association studies (GWAS) have been applied in the search for suscepitibility 
genes to coronary artery disease, myocardial infarction and heart failure82-84. However, none 
of the candidate regions and genes showed a powerful association with CVD at genome-
wide significance and the molecular and biological mechanisms remains unclear. 
Atherosclerosis is a multifactorial disease that may lead to myocardial infarction or heart 
failure. A conservative estimate would be that at least 100 genes have the potential to affect 
the modifying factors including atherosclerosis, myocardial infarction and congestive heart 
failure with each having a genetic contribution of as much as 2% to the phenotype84. Since 
CVD usually took years to develop, correlation may be biased due to unmeasured factors 
during a relative short follow-up period or relatively underestimated by competing risk. 
Our studies with longer duration of follow-up with serial changes for ECG abnormality did 
help better understand the underlying mechanism and duration regarding arsenic-induced 
hazards. These findings emphasize the importance of long term arsenic effect, along with 
the necessity of intensive follow-up for preclinical or subclinical phenotypes such as ECG 
abnormality for preventing excessive CVD mortality. 
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1. Introduction 
Aluminum phosphide (AlP) is used throughout the world as pesticides to protect stored 
grains from rodents and other pests (Cienki, 2001).  The chemical is usually formulated in 
pellets, granules or as a dust. Upon contact with moisture in the environment, AlP 
undergoes a chemical reaction yielding phosphine gas (PH3), which is the active pesticidal 
component and a very toxic system poison, makes acute AlP poisoning (AAlPP) extremely 
dangerous (Sasser et al., 1998). 
AAlPP has been reported in literature since 1985. The majority of cases of AlP poisoning 
involving intentional suicide acts. It is a major health problem with a high mortality rate 
especially in developing countries where AlP is low cost and easily accessible (Mehpour et 
al., 2008; Louriz et al., 2009). Patients who intend to commit suicide take tablets. Once mixed 
with hydrochloric acid in the stomach, PH3 is immediately released and absorbed rapidly 
via the lungs causing systemic poisoning (Proudfoot, 2009). However, accidental exposure 
to AlP is a relatively common cause of poisoning from agriculture chemical exposure in 
many countries. The manufacture and application of AlP fumigants pose risks of inhalation 
exposure to PH3 (Sudakin, 2005).  
During the past 35 years, high mortality rates have been reported following significant 
exposures to aluminum phosphide. This mortality rates vary from 40% to 80% (Chugh et al., 
1991).  
2. Toxicology of phosphine gas 
The toxicity of AlP is attributed to the liberation of PH3 gas which is cytotoxic and causes 
free radical mediated injury (Sudakin, 2005). 
PH3 a nucleophile, acts as a strong reducing agent capable of inhibiting cellular enzymes 
involved in several metabolic processes. Early studies on PH3 demonstrated specific 
inhibitory effects on mitochondrial cytochrome c oxidase. Experimental and observational 
studies have subsequently demonstrated that the inhibition of cytochrome c oxidase and 
other enzymes leads to the generation superoxide radicals and cellular peroxides. Cellular 
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Fig. 1. Aluminum phosphide and liberation of phosphine gas. Al≡P : aluminum phosphide ; 
PH3 :  phosphine gas 
injury subsequently occurs through lipid peroxidation and other oxidant mechanisms 
(Chugh et al., 1996). Indeed, significant decreases in glutathione concentrations were shown 
in different tissues during AlP  poisoning (Hsu et al., 2002). Glutathione is known to be an 
important factor protecting against oxidation by catalyzing the reduction of the oxygen 
peroxide in O2 and H2O. 
Mutagenic effects resulting from oxidative damage to DNA have been reported in vitro. A 
cytogenetic study of phosphide fumigant applicators reported a significantly higher 
incidence of chromatid gaps and deletions in comparison to controls (Hsu et al., 1998).  
Very little information is available relating to the toxicokinetics of PH3 in humans. In an 
investigation of a series of patients with acute AlP poisoning , indicators of oxidative stress 
(malonydialdehyde levels, superoxide dismutase and catalase activity) appeared to peak 
within 48 hours of exposure, with normalization of most indicators occurring by day 5 
(Chugh et al., 1996a). Chugh et al. reported that, serum PH3 levels correlate positively with 
the severity of poisoning and levels equal to or less than 1.067 ± 0.16 mg % appear to be the 
limit of PH3 toxicity (Chugh et al., 1996b).  
A bedside test has been described for the diagnosis of AlP ingestion, using gastric aspirates 
and paper strips impregnated with silver nitrate. The test was found to be positive in 100% 
of cases of AlP ingestion (Chugh et al., 1994). The same test was also investigated to detect 
PH3 gas in the exhaled air of patients with intoxication with AlP ingestion, and the results 
were positive in 50 % of cases. 
3. Acute aluminum phosphide poisoning  
3.1 Clinical features of AAlPP 
AAlPP results in the rapid onset of gastrointestinal signs and symptoms, including 
epigastric pain and recurrent, profuse vomiting. Characteristic garlic smell of PH3 in the 
patient’s expired breath. Cardiovascular manifestations include hypotention and profound 
circulatory collapse.  Neurological manifestations following acute poisoning include 
headache, anxiety and dizziness, frequently accompanied by a normal mental state 
(National Institute of occupational Safety and Health  [NIOSH], 2003). Pulmonary injury 
and oedema have been described. Acute renal and liver injury can also develop. The 
prognosis from suicidal ingestion of AlP is poor.  
The major lethal consequence of AAlPP, myocardial  suppression with profound circulatory 
collapse, is reportedly secondary to toxins generated, which lead to direct effects on cardiac 
myocytes, fluid loss induced by several episodes of vomiting and adrenal gland damage.  
The AAlPP is involving young patients without history of cardiac diseases. However, 
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clinical, biological, electrical and histological observations suggest that myocardial 
involvement is responsible for the acute circulatory insufficiency (Lall et al., 1997). 
3.2 Biological abnormalities in AAlPP 
Increased CK with raised cardiac marker CK-MB fraction has been previously reported 
point to severe myocardial damage (Nakakita et al., 2009).  Controversies exist about the 
magnesium level and prognosis of AAlPP. Some studies seem to suggest that there is 
hypomagnesaemia associated with AAlPP and that there is a direct relationship between 
abnormal electrocardiographic findings and low magnesium levels. They report reduced 
mortality rates with magnesium therapy in these patients (Chugh et al., 1991).  However 
other studies have shown no such benefits and some have even demonstrated 
hypermagnesaemia in patients with AAlPP (Singh et al., 1991). The pathogenesis of 
magnesium level abnormalities was not clear. 
3.3 Histological injury in AAlPP 
PH3 also has corrosive effects on tissues. Louriz et al investigated microscopic changes in vital 
organs of the body, liver, heart and kidneys (Louriz et al., 2009). These changes were found to 
be suggestive of cellular hypoxia. Other recent studies with more patients were performed and 
showed congestion, edema and leukocytie or leukocyte infiltration in the liver, kidneys, heart, 
stomach, lungs, brain and adrenals (Arora et al., 1995; Sinha et al., 2005).  
Nakakita studied the histology of the heart. Histopathological finding of myocyte 
vacuolation and myocytolysis and degeneration are both suggestive of myocardial injury. 
The areas of increased waviness of myocardial fibers indicate an episode of myocardial 
infarction (Nakakita et al., 2009). 
3.4 Cardiotoxicity of AlP 
The toxicity of AlP is systemic and can affect all organs, but particularly cardiac and 
vascular tissues.  Myocardial injury following AlP poisoning has been documented on 
electrocardiograms in several studies. AlP induced cardiotoxicity was responsible for a high 
level of mortality. Cardiac toxicity due to AlP and PH3 exposure is represented by a 
depression in myocardial cellular metabolism, as well as myocardial necrosis due to the 
release of reactive oxygen intermediates.  
Several studies noted electric abnormalities in 38% to 91% of cases (Chugh et al., 1991; Karla 
et al., 1991). There are conduction disorders such as right and left  bundle branch block 
(25%), atrioventricular block (8%) and rarely, sinoatrial block (Karla et al., 1991). On the 
other hand, cardiac dysrhythmias were described as atrial fibrillation (4% to 61%), junctional 
rhythm (4% to 100%), ventricular and atrial extrasyxtoles (18%) and ventricular fibrillation 
(2%) (Gupta et al., 1995; Louriz et al, 2009). Finally, re-polarization disorders were also 
reported, such as ST segment depression (12% to 65%), ST segment elevation (4% to 65%) 
and T wave inversion (36%) induced by AAlPP (Lall et al., 1997).  
Indeed, in Shadnia’s study, 39 patients admitted to the ICU with AAlPP were studied. 
Average time elapsed between poisoning  and admission at the hospital was 3.4 ± 3.5 hours. 
Average ingested amount was 1.4 ± 0.9 tablets. ECG abnormalities were found in 17 (43.6%) 
cases at the time of admission with ST-T changes in 8 cases. Ischemic change in 3 cases and 
dysrhythmias in 6 cases. The nature of these dysrhythmias was not described. The mortality 
rate was high, about 67%. In this study, ECG abnormalities were a prognostic factor 
(Shadnia et al., 2010).  
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Fig. 2. Electrocardiographic changes following aluminium phosphide poisoning. 12-leads 
surface ECG recorded on admission showing: (A) Sinusal bradycardia (B) Ventricular 
extrasystoles (C) Sinusal tachycardia with ST segment depression in the leads D1, aVL, V5 
and V6 (D1, D2 &D3) Sinusal tachycardia with ST-T changes.  
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In Louriz’s study, 49 patients were enrolled. The ingested dose was 1.2 ± 0.7 grams. The time 
between ingestion and admission to the medical ICU was 9.1 ± 10.7 hours. The ECG was 
abnormal in 28 cases (58.7%) at the time of admission with myocardial ischemia in 21 cases, 
atrial fibrillation in 6 cases, ventricular extrasystoles in 9 cases and ventricular fibrillation in 
one case.  The mortality rate was 49%. In this study, ECG abnormalities were also a 
prognostic factor (Louriz et al., 2009).  
In Mathai’s study, 27 patients with AAlPP were admitted into the ICU. One and half grams 
of poison was consumed. There was a mean delay of 2.1 ± 1.55 hours before presenting to 
the hospital. Thirteen (48.1%) patients had dysrhythmia at admission of which the majority 
(69%) of supraventricular origin. Ventricular arythmias was found in 4 cases. The mortality 
rate was 59.3%.  In this study, the presence of ECG abnormalities did not predict mortality 
(Mathai et al., 2010).  
In these 3 studies cited above, there wasn’t any association between the dose of poison 
consumed or the time delay in presentation to the hospital with the mortality. All the ECG 
abnormalities found in these studies were recorded at the admission to the hospital. 
However, other ECG changes could be found during the hospitalization.  
Indeed, Bogle et al described a case of a lethal AAlPP caused by deliberate ingestion of AlP. 
ECG showed a sinus tachycardia 2 hours after ingestion of a 10 g sachet of pesticide with 
56% of AlP. ECG recorded 12 hours after ingestion showed extreme widening of the QRS 
complexe despite amiodarone therapy.  The rate of ECG abnormalities resulting of AAlPP 
might be under estimated (Bogle et al., 2006).  
Some electrical abnormalities noted in our practice are reported in Figure 2. 
In several studies, echocardiography showed a global hypokinesis of the left ventrivule 






A)                                                                   B) 
Fig. 3. Echocardiographically parasternal long axis depicted improvement of ventricle 
function following aluminum phosphide poisoning . A) Echocardiogram obtained on the 
second day after admission depicts global hypokinesis with LVEF of 30% and dilatation of 
LV. B) Echocardiogram taken eight days after admission showed improvement of ventricle 
function.  
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Indeed, Bahsin et al showed a generalized hypokinesis of left ventricle wall and 
interventricular septum in 80% of their cases. This study revealed akinesis and pericarditis in 
3% and 35% of the cases, respectively (Bhasin et al., 1991). Thus, Bajaj et al showed a global 
hypokinesis of the left ventricle in the three patients that underwent serial ventriculography 
(Bajaj et al., 1988). However, other authors have described a focal myocardial necrosis 
(Singh et al., 1991; Wilson et al., 1980). At a patient hospitalized in our intensive care unit, 
we observed an unusual and important dilation of right cardiac cavities explained partially 
by hypokinesia of the left ventricle but probably also by the direct toxicity of the AlP on the 
right ventricle (Figure 4). 
 
 
Fig. 4. Echocardiography parasternal long axis depicted improvement of ventricule function. 
Echocardiogram obtained at admission depicts global hypokinesis with left ventricle 
ejection fraction (LVEF) of 40% and important dilation of right ventricle and auricle.  
4. Conclusion  
The severity of the poisoning is judged by the cardiac failure and the unavailability of an 
antidote. Myocardial injury following AAlPP is responsible for significant mortality. Despite 
all intensive medical care efforts in supportive therapy, the prognosis of AAlPP is poor. 
Therefore the use and availability of the pesticide aluminium phosphide should be 
restricted as much as possible. 
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(Bajaj et al., 1988). However, other authors have described a focal myocardial necrosis 
(Singh et al., 1991; Wilson et al., 1980). At a patient hospitalized in our intensive care unit, 
we observed an unusual and important dilation of right cardiac cavities explained partially 
by hypokinesia of the left ventricle but probably also by the direct toxicity of the AlP on the 
right ventricle (Figure 4). 
 
 
Fig. 4. Echocardiography parasternal long axis depicted improvement of ventricule function. 
Echocardiogram obtained at admission depicts global hypokinesis with left ventricle 
ejection fraction (LVEF) of 40% and important dilation of right ventricle and auricle.  
4. Conclusion  
The severity of the poisoning is judged by the cardiac failure and the unavailability of an 
antidote. Myocardial injury following AAlPP is responsible for significant mortality. Despite 
all intensive medical care efforts in supportive therapy, the prognosis of AAlPP is poor. 
Therefore the use and availability of the pesticide aluminium phosphide should be 
restricted as much as possible. 
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